ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
hsa04010,MAPK signaling pathway,17/50,295/7852,1.2037365059096474e-12,1.9380157745145322e-10,1.1277110423785119e-10,17,kg,NAC,2353/3164/3725/3479/80310/4616/4804/1647/55970/3554/2318/1844/1969/51776/3303/781/3082,FOS/NR4A1/JUN/IGF1/PDGFD/GADD45B/NGFR/GADD45A/GNG12/IL1R1/FLNC/DUSP2/EPHA2/MAP3K20/HSPA1A/CACNA2D1/HGF
GO:0071559,response to transforming growth factor beta,12/53,249/18493,4.458035709878614e-12,5.300604459045673e-9,3.0713519706479513e-9,12,bp,NAC,2353/3725/80310/4088/3303/4093/1277/7472/7474/1278/8516/1281,FOS/JUN/PDGFD/SMAD3/HSPA1A/SMAD9/COL1A1/WNT2/WNT5A/COL1A2/ITGA8/COL3A1
GO:0071560,cellular response to transforming growth factor beta stimulus,12/53,242/18493,3.18702273905948e-12,5.300604459045673e-9,3.0713519706479513e-9,12,bp,NAC,2353/3725/80310/4088/3303/4093/1277/7472/7474/1278/8516/1281,FOS/JUN/PDGFD/SMAD3/HSPA1A/SMAD9/COL1A1/WNT2/WNT5A/COL1A2/ITGA8/COL3A1
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,12/53,340/18493,1.6683082668842459e-10,1.1424497710967049e-7,6.619745696806635e-8,12,bp,NAC,2353/3725/6424/4088/3303/353500/4093/7474/1278/8516/1281/3280,FOS/JUN/SFRP4/SMAD3/HSPA1A/BMP8A/SMAD9/WNT5A/COL1A2/ITGA8/COL3A1/HES1
GO:0048146,positive regulation of fibroblast proliferation,7/53,55/18493,1.9216985216092596e-10,1.1424497710967049e-7,6.619745696806635e-8,7,bp,NAC,3725/3479/80310/7472/7474/3981/1026,JUN/IGF1/PDGFD/WNT2/WNT5A/LIG4/CDKN1A
GO:0001704,formation of primary germ layer,8/53,118/18493,1.5077583124884146e-9,5.975748778495749e-7,3.462553738679535e-7,8,bp,NAC,9314/3679/4088/1969/2114/64321/7474/8516,KLF4/ITGA7/SMAD3/EPHA2/ETS2/SOX17/WNT5A/ITGA8
GO:0001933,negative regulation of protein phosphorylation,12/53,408/18493,1.3348561774663326e-9,5.975748778495749e-7,3.462553738679535e-7,12,bp,NAC,9314/3725/10252/4616/1647/9021/1844/3082/2810/3486/1026/324,KLF4/JUN/SPRY1/GADD45B/GADD45A/SOCS3/DUSP2/HGF/SFN/IGFBP3/CDKN1A/APC
GO:0050673,epithelial cell proliferation,12/53,420/18493,1.8522695324127357e-9,6.292424211539265e-7,3.6460463427492805e-7,12,bp,NAC,3164/3725/3479/6772/4804/4088/1969/2810/7472/7474/3486/3280,NR4A1/JUN/IGF1/STAT1/NGFR/SMAD3/EPHA2/SFN/WNT2/WNT5A/IGFBP3/HES1
hsa05202,Transcriptional misregulation in cancer,11/50,186/7852,1.638507334769337e-8,1.1306732426337892e-6,6.579268950271805e-7,11,kg,NAC,3479/7102/4616/4804/1647/7704/51513/862/3486/1026/8842,IGF1/TSPAN7/GADD45B/NGFR/GADD45A/ZBTB16/ETV7/RUNX1T1/IGFBP3/CDKN1A/PROM1
hsa05224,Breast cancer,10/50,147/7852,2.1068445514915326e-8,1.1306732426337892e-6,6.579268950271805e-7,10,kg,NAC,2353/3725/3479/4616/1647/7472/7474/1026/324/3280,FOS/JUN/IGF1/GADD45B/GADD45A/WNT2/WNT5A/CDKN1A/APC/HES1
GO:0042326,negative regulation of phosphorylation,12/53,448/18493,3.8288432363923805e-9,1.1381236520176352e-6,6.594678679523194e-7,12,bp,NAC,9314/3725/10252/4616/1647/9021/1844/3082/2810/3486/1026/324,KLF4/JUN/SPRY1/GADD45B/GADD45A/SOCS3/DUSP2/HGF/SFN/IGFBP3/CDKN1A/APC
GO:0048144,fibroblast proliferation,7/53,91/18493,7.085966926926511e-9,1.568547475347511e-6,9.088701895577408e-7,7,bp,NAC,3725/3479/80310/7472/7474/3981/1026,JUN/IGF1/PDGFD/WNT2/WNT5A/LIG4/CDKN1A
GO:0048145,regulation of fibroblast proliferation,7/53,90/18493,6.555180355808399e-9,1.568547475347511e-6,9.088701895577408e-7,7,bp,NAC,3725/3479/80310/7472/7474/3981/1026,JUN/IGF1/PDGFD/WNT2/WNT5A/LIG4/CDKN1A
GO:0072001,renal system development,10/53,286/18493,7.25568638722566e-9,1.568547475347511e-6,9.088701895577408e-7,10,bp,NAC,10252/80310/6772/7704/4088/64321/7474/8516/8842/3280,SPRY1/PDGFD/STAT1/ZBTB16/SMAD3/SOX17/WNT5A/ITGA8/PROM1/HES1
GO:0071900,regulation of protein serine/threonine kinase activity,12/53,496/18493,1.1921577158792977e-8,2.362459206967475e-6,1.368889868496492e-6,12,bp,NAC,3479/10252/80310/4616/1647/1844/51776/3082/2810/7474/1026/324,IGF1/SPRY1/PDGFD/GADD45B/GADD45A/DUSP2/MAP3K20/HGF/SFN/WNT5A/CDKN1A/APC
GO:0001655,urogenital system development,10/53,322/18493,2.2385974471559707e-8,3.8024176638120704e-6,2.2032511716745607e-6,10,bp,NAC,10252/80310/6772/7704/4088/64321/7474/8516/8842/3280,SPRY1/PDGFD/STAT1/ZBTB16/SMAD3/SOX17/WNT5A/ITGA8/PROM1/HES1
GO:0060759,regulation of response to cytokine stimulus,8/53,165/18493,2.134394225303078e-8,3.8024176638120704e-6,2.2032511716745607e-6,8,bp,NAC,9314/3977/6772/9021/3554/7097/3303/7474,KLF4/LIFR/STAT1/SOCS3/IL1R1/TLR2/HSPA1A/WNT5A
GO:0007369,gastrulation,8/53,181/18493,4.389729901707329e-8,6.959185137506686e-6,4.032390485147295e-6,8,bp,NAC,9314/3679/4088/1969/2114/64321/7474/8516,KLF4/ITGA7/SMAD3/EPHA2/ETS2/SOX17/WNT5A/ITGA8
hsa04151,PI3K-Akt signaling pathway,13/50,354/7852,1.989042594417851e-7,8.00589644253185e-6,4.658547129031283e-6,13,kg,NAC,3164/3479/80310/4804/55970/3679/7097/1969/3082/1277/1278/8516/1026,NR4A1/IGF1/PDGFD/NGFR/GNG12/ITGA7/TLR2/EPHA2/HGF/COL1A1/COL1A2/ITGA8/CDKN1A
GO:0001707,mesoderm formation,6/53,72/18493,5.595278118014776e-8,8.31598210289946e-6,4.818565168737726e-6,6,bp,NAC,9314/4088/1969/64321/7474/8516,KLF4/SMAD3/EPHA2/SOX17/WNT5A/ITGA8
GO:0048332,mesoderm morphogenesis,6/53,74/18493,6.605376541185497e-8,9.239756126434772e-6,5.353831512329299e-6,6,bp,NAC,9314/4088/1969/64321/7474/8516,KLF4/SMAD3/EPHA2/SOX17/WNT5A/ITGA8
GO:0007179,transforming growth factor beta receptor signaling pathway,8/53,193/18493,7.218206727666686e-8,9.536053110217433e-6,5.525516144161224e-6,8,bp,NAC,2353/3725/4088/3303/4093/1278/8516/1281,FOS/JUN/SMAD3/HSPA1A/SMAD9/COL1A2/ITGA8/COL3A1
GO:0050678,regulation of epithelial cell proliferation,10/53,368/18493,7.850362451043924e-8,9.825348372938133e-6,5.6931437387349025e-6,10,bp,NAC,3164/3725/3479/6772/4804/4088/2810/7472/7474/3280,NR4A1/JUN/IGF1/STAT1/NGFR/SMAD3/SFN/WNT2/WNT5A/HES1
GO:0002009,morphogenesis of an epithelium,11/53,479/18493,8.963466183286926e-8,1.0105090734259982e-5,5.855236054688291e-6,11,bp,NAC,9314/10252/6772/9021/4088/1969/3082/64321/7472/7474/3280,KLF4/SPRY1/STAT1/SOCS3/SMAD3/EPHA2/HGF/SOX17/WNT2/WNT5A/HES1
GO:0007498,mesoderm development,7/53,131/18493,8.953445528916957e-8,1.0105090734259982e-5,5.855236054688291e-6,7,bp,NAC,9314/4088/1969/2114/64321/7474/8516,KLF4/SMAD3/EPHA2/ETS2/SOX17/WNT5A/ITGA8
GO:1901652,response to peptide,11/53,481/18493,9.348696221771219e-8,1.0105090734259982e-5,5.855236054688291e-6,11,bp,NAC,9314/3164/3479/6772/4804/9021/7097/8835/781/1277/324,KLF4/NR4A1/IGF1/STAT1/NGFR/SOCS3/TLR2/SOCS2/CACNA2D1/COL1A1/APC
GO:0048762,mesenchymal cell differentiation,8/53,210/18493,1.383246744105254e-7,1.4301568510792583e-5,8.286819167202644e-6,8,bp,NAC,10252/6772/4088/3082/1277/7472/7474/3280,SPRY1/STAT1/SMAD3/HGF/COL1A1/WNT2/WNT5A/HES1
GO:0061614,pri-miRNA transcription by RNA polymerase II,5/53,44/18493,1.5899104636341134e-7,1.575336284384134e-5,9.12803858288182e-6,5,bp,NAC,2353/9314/3725/4804/4088,FOS/KLF4/JUN/NGFR/SMAD3
GO:0006469,negative regulation of protein kinase activity,8/53,222/18493,2.1175636546509847e-7,2.014226548304017e-5,1.1671119258686904e-5,8,bp,NAC,10252/4616/1647/9021/1844/2810/1026/324,SPRY1/GADD45B/GADD45A/SOCS3/DUSP2/SFN/CDKN1A/APC
GO:0019838,growth factor binding,7/52,137/17632,1.4649440347767403e-7,3.0617330326833874e-5,2.0046602581155398e-5,7,mf,NAC,3977/4804/3554/1277/1278/3486/1281,LIFR/NGFR/IL1R1/COL1A1/COL1A2/IGFBP3/COL3A1
GO:0033002,muscle cell proliferation,8/53,236/18493,3.3759892460339336e-7,3.087731702718729e-5,1.789137620671425e-5,8,bp,NAC,9314/3725/3479/80310/6772/7472/3486/1026,KLF4/JUN/IGF1/PDGFD/STAT1/WNT2/IGFBP3/CDKN1A
hsa05210,Colorectal cancer,7/50,86/7852,1.0076129653451776e-6,3.244513748411472e-5,1.8879485034888593e-5,7,kg,NAC,2353/3725/4616/1647/4088/1026/324,FOS/JUN/GADD45B/GADD45A/SMAD3/CDKN1A/APC
GO:0001101,response to acid chemical,9/53,332/18493,3.8454269065410673e-7,3.386824142131355e-5,1.9624420353459096e-5,9,bp,NAC,9314/80310/7097/4255/1277/7472/7474/1278/1281,KLF4/PDGFD/TLR2/MGMT/COL1A1/WNT2/WNT5A/COL1A2/COL3A1
GO:0043405,regulation of MAP kinase activity,9/53,335/18493,4.1468294191314634e-7,3.5218429852480786e-5,2.0406765825725884e-5,9,bp,NAC,3479/10252/80310/4616/1647/1844/51776/3082/7474,IGF1/SPRY1/PDGFD/GADD45B/GADD45A/DUSP2/MAP3K20/HGF/WNT5A
GO:0033673,negative regulation of kinase activity,8/53,244/18493,4.3489820168646017e-7,3.5661652538289736e-5,2.0663584247098965e-5,8,bp,NAC,10252/4616/1647/9021/1844/2810/1026/324,SPRY1/GADD45B/GADD45A/SOCS3/DUSP2/SFN/CDKN1A/APC
GO:0048660,regulation of smooth muscle cell proliferation,7/53,168/18493,4.886185318621755e-7,3.873116229227511e-5,2.2442163445880273e-5,7,bp,NAC,9314/3725/3479/80310/6772/3486/1026,KLF4/JUN/IGF1/PDGFD/STAT1/IGFBP3/CDKN1A
GO:0048659,smooth muscle cell proliferation,7/53,170/18493,5.293050158811473e-7,4.06028170246893e-5,2.3526664373121287e-5,7,bp,NAC,9314/3725/3479/80310/6772/3486/1026,KLF4/JUN/IGF1/PDGFD/STAT1/IGFBP3/CDKN1A
GO:1901653,cellular response to peptide,9/53,356/18493,6.893356417124654e-7,5.1226254874757584e-5,2.9682248519790045e-5,9,bp,NAC,9314/3164/3479/6772/4804/9021/8835/781/324,KLF4/NR4A1/IGF1/STAT1/NGFR/SOCS3/SOCS2/CACNA2D1/APC
hsa04550,Signaling pathways regulating pluripotency of stem cells,8/50,139/7852,2.2607353076830292e-6,5.807714560841195e-5,3.3794481589726474e-5,8,kg,NAC,9314/3479/3977/4088/4093/7472/7474/324,KLF4/IGF1/LIFR/SMAD3/SMAD9/WNT2/WNT5A/APC
hsa05217,Basal cell carcinoma,6/50,63/7852,2.525093287322259e-6,5.807714560841195e-5,3.3794481589726474e-5,6,kg,NAC,4616/1647/7472/7474/1026/324,GADD45B/GADD45A/WNT2/WNT5A/CDKN1A/APC
GO:0048645,animal organ formation,5/53,62/18493,9.111563267815887e-7,6.372734544372405e-5,3.6925809032727547e-5,5,bp,NAC,10252/64321/7472/7474/3280,SPRY1/SOX17/WNT2/WNT5A/HES1
GO:0060485,mesenchyme development,8/53,269/18493,9.086041317186522e-7,6.372734544372405e-5,3.6925809032727547e-5,8,bp,NAC,10252/6772/4088/3082/1277/7472/7474/3280,SPRY1/STAT1/SMAD3/HGF/COL1A1/WNT2/WNT5A/HES1
GO:0001822,kidney development,8/53,271/18493,9.60637014567917e-7,6.526842344692875e-5,3.781876246825274e-5,8,bp,NAC,10252/80310/6772/7704/4088/8516/8842/3280,SPRY1/PDGFD/STAT1/ZBTB16/SMAD3/ITGA8/PROM1/HES1
GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,4/53,27/18493,1.0046567772383437e-6,6.636316156313281e-5,3.8453091269151815e-5,4,bp,NAC,2353/3725/4804/4088,FOS/JUN/NGFR/SMAD3
GO:0051348,negative regulation of transferase activity,8/53,274/18493,1.043452672679874e-6,6.706298528737137e-5,3.885859313052505e-5,8,bp,NAC,10252/4616/1647/9021/1844/2810/1026/324,SPRY1/GADD45B/GADD45A/SOCS3/DUSP2/SFN/CDKN1A/APC
hsa04510,Focal adhesion,9/50,199/7852,3.668294750764813e-6,6.814378261456235e-5,3.965215202808794e-5,9,kg,NAC,3725/3479/80310/2318/3679/3082/1277/1278/8516,JUN/IGF1/PDGFD/FLNC/ITGA7/HGF/COL1A1/COL1A2/ITGA8
hsa05226,Gastric cancer,8/50,149/7852,3.809279773484852e-6,6.814378261456235e-5,3.965215202808794e-5,8,kg,NAC,4616/1647/4088/3082/7472/7474/1026/324,GADD45B/GADD45A/SMAD3/HGF/WNT2/WNT5A/CDKN1A/APC
GO:0001935,endothelial cell proliferation,7/53,190/18493,1.1185480116987464e-6,6.999755715314788e-5,4.0558984690129064e-5,7,bp,NAC,3164/3725/6772/4804/1969/7472/7474,NR4A1/JUN/STAT1/NGFR/EPHA2/WNT2/WNT5A
GO:0001503,ossification,9/53,380/18493,1.184917593597805e-6,7.224959070706615e-5,4.186389014897509e-5,9,bp,NAC,3479/7704/4088/1969/3082/353500/1277/7474/3486,IGF1/ZBTB16/SMAD3/EPHA2/HGF/BMP8A/COL1A1/WNT5A/IGFBP3
GO:0060070,canonical Wnt signaling pathway,8/53,284/18493,1.36504727150678e-6,8.115206029107808e-5,4.702228627374672e-5,8,bp,NAC,9314/6424/4088/64321/1277/7472/7474/324,KLF4/SFRP4/SMAD3/SOX17/COL1A1/WNT2/WNT5A/APC
hsa04115,p53 signaling pathway,6/50,72/7852,5.5598659000302665e-6,8.137621908226118e-5,4.735196795241089e-5,6,kg,NAC,3479/4616/1647/2810/3486/1026,IGF1/GADD45B/GADD45A/SFN/IGFBP3/CDKN1A
hsa05218,Melanoma,6/50,72/7852,5.5598659000302665e-6,8.137621908226118e-5,4.735196795241089e-5,6,kg,NAC,3479/80310/4616/1647/3082/1026,IGF1/PDGFD/GADD45B/GADD45A/HGF/CDKN1A
GO:0060395,SMAD protein signal transduction,5/53,69/18493,1.5586633799837176e-6,9.040247603905562e-5,5.238229433629491e-5,5,bp,NAC,2353/3725/4088/353500/4093,FOS/JUN/SMAD3/BMP8A/SMAD9
GO:0045995,regulation of embryonic development,6/53,130/18493,1.8818022710309519e-6,1.0612689064908693e-4,6.149355931993042e-5,6,bp,NAC,9314/3479/64321/7472/7474/3280,KLF4/IGF1/SOX17/WNT2/WNT5A/HES1
GO:0071229,cellular response to acid chemical,7/53,206/18493,1.9190312438649025e-6,1.0612689064908693e-4,6.149355931993042e-5,7,bp,NAC,9314/80310/1277/7472/7474/1278/1281,KLF4/PDGFD/COL1A1/WNT2/WNT5A/COL1A2/COL3A1
GO:0048565,digestive tract development,6/53,131/18493,1.9678311261865633e-6,1.0635232768344654e-4,6.162418526742134e-5,6,bp,NAC,4088/64321/7474/1281/1026/3280,SMAD3/SOX17/WNT5A/COL3A1/CDKN1A/HES1
GO:2000027,regulation of animal organ morphogenesis,7/53,208/18493,2.046407000337134e-6,1.0814124104003787e-4,6.266074300447506e-5,7,bp,NAC,10252/6772/3082/64321/7472/7474/3280,SPRY1/STAT1/HGF/SOX17/WNT2/WNT5A/HES1
GO:0001837,epithelial to mesenchymal transition,6/53,135/18493,2.3447052292059904e-6,1.1616060489691343e-4,6.730743739102285e-5,6,bp,NAC,10252/4088/3082/1277/7472/7474,SPRY1/SMAD3/HGF/COL1A1/WNT2/WNT5A
GO:0009952,anterior/posterior pattern specification,7/53,211/18493,2.2506912105842867e-6,1.1616060489691343e-4,6.730743739102285e-5,7,bp,NAC,7704/4088/2114/64321/7472/7474/3280,ZBTB16/SMAD3/ETS2/SOX17/WNT2/WNT5A/HES1
GO:0051090,regulation of DNA-binding transcription factor activity,9/53,412/18493,2.305949925935111e-6,1.1616060489691343e-4,6.730743739102285e-5,9,bp,NAC,2353/9314/3725/6424/4088/7097/3303/7472/7474,FOS/KLF4/JUN/SFRP4/SMAD3/TLR2/HSPA1A/WNT2/WNT5A
GO:0001558,regulation of cell growth,9/53,416/18493,2.4958609375916705e-6,1.2112565937944883e-4,7.018436019994624e-5,9,bp,NAC,3479/4088/8835/3303/64321/2810/7474/3486/1026,IGF1/SMAD3/SOCS2/HSPA1A/SOX17/SFN/WNT5A/IGFBP3/CDKN1A
hsa05225,Hepatocellular carcinoma,8/50,168/7852,9.283147482119017e-6,1.245488953850968e-4,7.247369525513971e-5,8,kg,NAC,4616/1647/4088/3082/7472/7474/1026/324,GADD45B/GADD45A/SMAD3/HGF/WNT2/WNT5A/CDKN1A/APC
GO:0045444,fat cell differentiation,7/53,217/18493,2.7107120725859286e-6,1.2892146617218676e-4,7.470151795821012e-5,7,bp,NAC,9314/3164/7704/4088/862/7474/3280,KLF4/NR4A1/ZBTB16/SMAD3/RUNX1T1/WNT5A/HES1
GO:0042542,response to hydrogen peroxide,6/53,141/18493,3.018737645516971e-6,1.40756041589007e-4,8.15588767385287e-5,6,bp,NAC,9314/3725/80310/6772/3082/1277,KLF4/JUN/PDGFD/STAT1/HGF/COL1A1
GO:0055123,digestive system development,6/53,143/18493,3.2756343875097994e-6,1.4979728025958276e-4,8.679768043016859e-5,6,bp,NAC,4088/64321/7474/1281/1026/3280,SMAD3/SOX17/WNT5A/COL3A1/CDKN1A/HES1
GO:0000302,response to reactive oxygen species,7/53,224/18493,3.344248192497754e-6,1.500494755048992e-4,8.69438110025732e-5,7,bp,NAC,2353/9314/3725/80310/6772/3082/1277,FOS/KLF4/JUN/PDGFD/STAT1/HGF/COL1A1
GO:0007389,pattern specification process,9/53,434/18493,3.5271450885147874e-6,1.5250092764523934e-4,8.83642664280547e-5,9,bp,NAC,10252/7704/4088/2114/64321/7472/7474/324/3280,SPRY1/ZBTB16/SMAD3/ETS2/SOX17/WNT2/WNT5A/APC/HES1
GO:0048732,gland development,9/53,434/18493,3.5271450885147874e-6,1.5250092764523934e-4,8.83642664280547e-5,9,bp,NAC,3725/4088/1969/8835/3082/4255/7472/7474/3280,JUN/SMAD3/EPHA2/SOCS2/HGF/MGMT/WNT2/WNT5A/HES1
GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,4/53,37/18493,3.701469459604158e-6,1.5718025669533373e-4,9.107563012447074e-5,4,bp,NAC,2353/3725/4804/4088,FOS/JUN/NGFR/SMAD3
GO:0003156,regulation of animal organ formation,4/53,38/18493,4.128178255061738e-6,1.670612263136046e-4,9.680100271989218e-5,4,bp,NAC,10252/7472/7474/3280,SPRY1/WNT2/WNT5A/HES1
GO:0006979,response to oxidative stress,9/53,441/18493,4.017454328799237e-6,1.670612263136046e-4,9.680100271989218e-5,9,bp,NAC,2353/9314/3725/80310/6772/3303/3082/4255/1277,FOS/KLF4/JUN/PDGFD/STAT1/HSPA1A/HGF/MGMT/COL1A1
GO:0045778,positive regulation of ossification,5/53,84/18493,4.1449168849885075e-6,1.670612263136046e-4,9.680100271989218e-5,5,bp,NAC,3479/7704/4088/3082/7474,IGF1/ZBTB16/SMAD3/HGF/WNT5A
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,7/53,235/18493,4.587125754244744e-6,1.818030840599e-4,1.0534294056677843e-4,7,bp,NAC,6424/4088/3303/353500/7474/8516/3280,SFRP4/SMAD3/HSPA1A/BMP8A/WNT5A/ITGA8/HES1
hsa04926,Relaxin signaling pathway,7/50,130/7852,1.602185523772022e-5,1.9842451486715043e-4,1.1546114300867204e-4,7,kg,NAC,2353/3725/55970/4088/1277/1278/1281,FOS/JUN/GNG12/SMAD3/COL1A1/COL1A2/COL3A1
GO:0001959,regulation of cytokine-mediated signaling pathway,6/53,155/18493,5.218151300334545e-6,2.0313525329344428e-4,1.1770353085791627e-4,6,bp,NAC,3977/6772/9021/3554/3303/7474,LIFR/STAT1/SOCS3/IL1R1/HSPA1A/WNT5A
GO:0003002,regionalization,8/53,341/18493,5.296209295287446e-6,2.0313525329344428e-4,1.1770353085791627e-4,8,bp,NAC,10252/7704/4088/2114/64321/7472/7474/3280,SPRY1/ZBTB16/SMAD3/ETS2/SOX17/WNT2/WNT5A/HES1
GO:0016055,Wnt signaling pathway,9/53,463/18493,5.959579938055294e-6,2.2495049353484902e-4,1.303440290545427e-4,9,bp,NAC,9314/6424/4088/7097/64321/1277/7472/7474/324,KLF4/SFRP4/SMAD3/TLR2/SOX17/COL1A1/WNT2/WNT5A/APC
GO:0198738,cell-cell signaling by wnt,9/53,465/18493,6.170579079414177e-6,2.2927557891948302e-4,1.328501318248875e-4,9,bp,NAC,9314/6424/4088/7097/64321/1277/7472/7474/324,KLF4/SFRP4/SMAD3/TLR2/SOX17/COL1A1/WNT2/WNT5A/APC
GO:0005583,fibrillar collagen trimer,3/53,11/19659,3.0066481308539465e-6,2.4955179486087757e-4,1.9622335169783652e-4,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0098643,banded collagen fibril,3/53,11/19659,3.0066481308539465e-6,2.4955179486087757e-4,1.9622335169783652e-4,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0003007,heart morphogenesis,7/53,253/18493,7.4410744718665e-6,2.7222884760151595e-4,1.5773872848053847e-4,7,bp,NAC,3725/10252/4088/64321/7472/7474/3280,JUN/SPRY1/SMAD3/SOX17/WNT2/WNT5A/HES1
GO:0046332,SMAD binding,5/52,80/17632,3.7259948243519065e-6,2.735103325433579e-4,1.7908004649023682e-4,5,mf,NAC,2353/3725/4088/1278/1281,FOS/JUN/SMAD3/COL1A2/COL3A1
GO:0048407,platelet-derived growth factor binding,3/52,11/17632,3.925985634593654e-6,2.735103325433579e-4,1.7908004649023682e-4,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0045165,cell fate commitment,7/53,257/18493,8.243234295134962e-6,2.970062296034991e-4,1.7209559317913343e-4,7,bp,NAC,9314/2114/64321/7472/7474/324/3280,KLF4/ETS2/SOX17/WNT2/WNT5A/APC/HES1
GO:0043406,positive regulation of MAP kinase activity,7/53,258/18493,8.454625143757934e-6,3.0007609838591593e-4,1.738743804112983e-4,7,bp,NAC,3479/80310/4616/1647/51776/3082/7474,IGF1/PDGFD/GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0016049,cell growth,9/53,485/18493,8.659231187762329e-6,3.028184083014532e-4,1.7546336880465774e-4,9,bp,NAC,3479/4088/8835/3303/64321/2810/7474/3486/1026,IGF1/SMAD3/SOCS2/HSPA1A/SOX17/SFN/WNT5A/IGFBP3/CDKN1A
GO:0001936,regulation of endothelial cell proliferation,6/53,175/18493,1.0464543048566544e-5,3.6064758506509047e-4,2.089715766677896e-4,6,bp,NAC,3164/3725/6772/4804/7472/7474,NR4A1/JUN/STAT1/NGFR/WNT2/WNT5A
hsa05165,Human papillomavirus infection,10/50,330/7852,3.435675071710348e-5,3.9510263324669004e-4,2.2990607622723383e-4,10,kg,NAC,6772/3679/1277/7472/7474/1278/8516/1026/324/3280,STAT1/ITGA7/COL1A1/WNT2/WNT5A/COL1A2/ITGA8/CDKN1A/APC/HES1
hsa04933,AGE-RAGE signaling pathway in diabetic complications,6/50,100/7852,3.706389303222181e-5,3.978191185458474e-4,2.314867705170345e-4,6,kg,NAC,3725/6772/4088/1277/1278/1281,JUN/STAT1/SMAD3/COL1A1/COL1A2/COL3A1
GO:0061138,morphogenesis of a branching epithelium,6/53,182/18493,1.3084306737879742e-5,4.444925917525432e-4,2.575542484193171e-4,6,bp,NAC,10252/9021/1969/3082/7472/7474,SPRY1/SOCS3/EPHA2/HGF/WNT2/WNT5A
GO:0035259,glucocorticoid receptor binding,3/52,14/17632,8.606956065154037e-6,4.4971345440429845e-4,2.9444849696579604e-4,3,mf,NAC,3164/4088/2114,NR4A1/SMAD3/ETS2
GO:0045930,negative regulation of mitotic cell cycle,7/53,281/18493,1.4716550341557166e-5,4.8605495433642974e-4,2.816369063903265e-4,7,bp,NAC,9314/1647/4088/51776/2810/1026/324,KLF4/GADD45A/SMAD3/MAP3K20/SFN/CDKN1A/APC
GO:0060760,positive regulation of response to cytokine stimulus,4/53,52/18493,1.4698089454732346e-5,4.8605495433642974e-4,2.816369063903265e-4,4,bp,NAC,3554/7097/3303/7474,IL1R1/TLR2/HSPA1A/WNT5A
GO:0090287,regulation of cellular response to growth factor stimulus,7/53,282/18493,1.505819688021888e-5,4.905259202898698e-4,2.8422753736418913e-4,7,bp,NAC,10252/6424/4088/3303/7474/8516/3280,SPRY1/SFRP4/SMAD3/HSPA1A/WNT5A/ITGA8/HES1
GO:0060537,muscle tissue development,8/53,395/18493,1.5434580840194544e-5,4.959923410538193e-4,2.873949689874063e-4,8,bp,NAC,2353/3479/4088/64321/7472/7474/8516/1281,FOS/IGF1/SMAD3/SOX17/WNT2/WNT5A/ITGA8/COL3A1
GO:0007517,muscle organ development,8/53,403/18493,1.7831792203800155e-5,5.579473929031154e-4,3.232938503431358e-4,8,bp,NAC,2353/3479/3679/4088/64321/7472/7474/1281,FOS/IGF1/ITGA7/SMAD3/SOX17/WNT2/WNT5A/COL3A1
GO:0034599,cellular response to oxidative stress,7/53,289/18493,1.76385586820837e-5,5.579473929031154e-4,3.232938503431358e-4,7,bp,NAC,2353/9314/3725/80310/3303/3082/4255,FOS/KLF4/JUN/PDGFD/HSPA1A/HGF/MGMT
hsa04310,Wnt signaling pathway,7/50,158/7852,5.647115555938143e-5,5.682410028162757e-4,3.306534766305887e-4,7,kg,NAC,3725/6424/4088/64321/7472/7474/324,JUN/SFRP4/SMAD3/SOX17/WNT2/WNT5A/APC
GO:0001763,morphogenesis of a branching structure,6/53,196/18493,1.9916077062568322e-5,6.150705357764606e-4,3.5639295796174896e-4,6,bp,NAC,10252/9021/1969/3082/7472/7474,SPRY1/SOCS3/EPHA2/HGF/WNT2/WNT5A
GO:0035014,phosphatidylinositol 3-kinase regulator activity,3/52,17/17632,1.5978695843318887e-5,6.679094862507294e-4,4.373116757118854e-4,3,mf,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0001836,release of cytochrome c from mitochondria,4/53,58/18493,2.274347601677684e-5,6.933844354858375e-4,4.017707166796341e-4,4,bp,NAC,3725/3479/3082/2810,JUN/IGF1/HGF/SFN
GO:0043010,camera-type eye development,7/53,302/18493,2.3402437137622697e-5,7.044429811805921e-4,4.081784172304879e-4,7,bp,NAC,9314/3725/4088/1969/7472/7474/8842,KLF4/JUN/SMAD3/EPHA2/WNT2/WNT5A/PROM1
GO:0008637,apoptotic mitochondrial changes,5/53,121/18493,2.46380483497312e-5,7.237622034475593e-4,4.193726370292839e-4,5,bp,NAC,3725/3479/3303/3082/2810,JUN/IGF1/HSPA1A/HGF/SFN
GO:0009612,response to mechanical stimulus,6/53,204/18493,2.495731736026067e-5,7.237622034475593e-4,4.193726370292839e-4,6,bp,NAC,2353/3725/6772/1647/1277/1281,FOS/JUN/STAT1/GADD45A/COL1A1/COL3A1
GO:0048568,embryonic organ development,8/53,422/18493,2.4809473368185096e-5,7.237622034475593e-4,4.193726370292839e-4,8,bp,NAC,9021/4088/1969/64321/7472/7474/8516/3280,SOCS3/SMAD3/EPHA2/SOX17/WNT2/WNT5A/ITGA8/HES1
GO:0050727,regulation of inflammatory response,8/53,425/18493,2.60970086951333e-5,7.476950202051445e-4,4.3324013166682934e-4,8,bp,NAC,9314/5320/9021/3554/4088/7097/3082/7474,KLF4/PLA2G2A/SOCS3/IL1R1/SMAD3/TLR2/HGF/WNT5A
GO:0001701,in utero embryonic development,7/53,311/18493,2.8240659527480058e-5,7.900739806629127e-4,4.5779595444546623e-4,7,bp,NAC,3479/9021/4088/64321/7472/3981/3280,IGF1/SOCS3/SMAD3/SOX17/WNT2/LIG4/HES1
GO:0030111,regulation of Wnt signaling pathway,7/53,311/18493,2.8240659527480058e-5,7.900739806629127e-4,4.5779595444546623e-4,7,bp,NAC,6424/4088/7097/64321/1277/7474/324,SFRP4/SMAD3/TLR2/SOX17/COL1A1/WNT5A/APC
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,6/53,209/18493,2.859802843462868e-5,7.907687397389187e-4,4.58198521675997e-4,6,bp,NAC,9314/4804/4088/3082/4255/2810,KLF4/NGFR/SMAD3/HGF/MGMT/SFN
GO:0060562,epithelial tube morphogenesis,7/53,313/18493,2.9420707853829333e-5,8.04166014671335e-4,4.6596136213747857e-4,7,bp,NAC,10252/4088/1969/64321/7472/7474/3280,SPRY1/SMAD3/EPHA2/SOX17/WNT2/WNT5A/HES1
R-HSA-449147,Signaling by Interleukins,11/45,462/10554,2.6400688875490597e-6,8.552146310255672e-4,6.853992856305383e-4,11,re,NAC,2353/3725/3977/6772/9021/3554/4088/8835/3082/1278/1026,FOS/JUN/LIFR/STAT1/SOCS3/IL1R1/SMAD3/SOCS2/HGF/COL1A2/CDKN1A
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,6/45,108/10554,5.881191648298688e-6,8.552146310255672e-4,6.853992856305383e-4,6,re,NAC,2353/6772/9021/3082/1278/1026,FOS/STAT1/SOCS3/HGF/COL1A2/CDKN1A
R-HSA-8874081,MET activates PTK2 signaling,4/45,30/10554,7.288761059876993e-6,8.552146310255672e-4,6.853992856305383e-4,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
GO:0001649,osteoblast differentiation,6/53,214/18493,3.265471668859256e-5,8.628101809497012e-4,4.999418028697973e-4,6,bp,NAC,3479/4088/1969/3082/1277/3486,IGF1/SMAD3/EPHA2/HGF/COL1A1/IGFBP3
GO:0030177,positive regulation of Wnt signaling pathway,5/53,128/18493,3.229760486200428e-5,8.628101809497012e-4,4.999418028697973e-4,5,bp,NAC,6424/4088/7097/1277/7474,SFRP4/SMAD3/TLR2/COL1A1/WNT5A
GO:0045598,regulation of fat cell differentiation,5/53,128/18493,3.229760486200428e-5,8.628101809497012e-4,4.999418028697973e-4,5,bp,NAC,7704/4088/862/7474/3280,ZBTB16/SMAD3/RUNX1T1/WNT5A/HES1
GO:0003143,embryonic heart tube morphogenesis,4/53,64/18493,3.363015446804554e-5,8.788187618133219e-4,5.092177235242524e-4,4,bp,NAC,4088/64321/7474/3280,SMAD3/SOX17/WNT5A/HES1
hsa04014,Ras signaling pathway,8/50,232/7852,9.457438454039743e-5,8.956750535884698e-4,5.211839148046671e-4,8,kg,NAC,5320/3479/80310/4804/55970/1969/2114/3082,PLA2G2A/IGF1/PDGFD/NGFR/GNG12/EPHA2/ETS2/HGF
GO:0009314,response to radiation,8/53,443/18493,3.5060292439200913e-5,9.062323415263019e-4,5.251020915665217e-4,8,bp,NAC,2353/3725/1647/51776/4255/1281/3981/1026,FOS/JUN/GADD45A/MAP3K20/MGMT/COL3A1/LIG4/CDKN1A
GO:0046677,response to antibiotic,7/53,323/18493,3.59482423486012e-5,9.09414045797592e-4,5.269456801155541e-4,7,bp,NAC,9314/3725/80310/6772/3082/4255/1277,KLF4/JUN/PDGFD/STAT1/HGF/MGMT/COL1A1
GO:0071902,positive regulation of protein serine/threonine kinase activity,7/53,323/18493,3.59482423486012e-5,9.09414045797592e-4,5.269456801155541e-4,7,bp,NAC,3479/80310/4616/1647/51776/3082/7474,IGF1/PDGFD/GADD45B/GADD45A/MAP3K20/HGF/WNT5A
hsa05212,Pancreatic cancer,5/50,75/7852,1.0531097794174885e-4,9.41948191590087e-4,5.481097682348332e-4,5,kg,NAC,6772/4616/1647/4088/1026,STAT1/GADD45B/GADD45A/SMAD3/CDKN1A
GO:0032677,regulation of interleukin-8 production,4/53,66/18493,3.798622661472834e-5,9.508552304191998e-4,5.509581234202704e-4,4,bp,NAC,9314/7097/3303/7474,KLF4/TLR2/HSPA1A/WNT5A
GO:0044389,ubiquitin-like protein ligase binding,7/52,301/17632,2.7298921496167758e-5,9.509124321165103e-4,6.226069814915453e-4,7,mf,NAC,3725/6772/4804/4088/3303/1026/324,JUN/STAT1/NGFR/SMAD3/HSPA1A/CDKN1A/APC
GO:0098644,complex of collagen trimers,3/53,19/19659,1.7389790056889487e-5,9.622350498145517e-4,7.566084094927355e-4,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0019207,kinase regulator activity,6/52,208/17632,3.247908711532067e-5,9.697327438717172e-4,6.34929522555141e-4,6,mf,NAC,9314/9021/8835/2810/1026/324,KLF4/SOCS3/SOCS2/SFN/CDKN1A/APC
GO:0071230,cellular response to amino acid stimulus,4/53,67/18493,4.031263956658202e-5,9.882830607147635e-4,5.726450916186206e-4,4,bp,NAC,80310/1277/1278/1281,PDGFD/COL1A1/COL1A2/COL3A1
GO:0071901,negative regulation of protein serine/threonine kinase activity,5/53,134/18493,4.023169358367382e-5,9.882830607147635e-4,5.726450916186206e-4,5,bp,NAC,10252/1844/2810/1026/324,SPRY1/DUSP2/SFN/CDKN1A/APC
GO:0070412,R-SMAD binding,3/52,23/17632,4.109809958967451e-5,0.0010736878517802466,7.029938087707482e-4,3,mf,NAC,2353/3725/4088,FOS/JUN/SMAD3
GO:0002088,lens development in camera-type eye,4/53,69/18493,4.5275962725880044e-5,0.0010766623936214275,6.238551074544946e-4,4,bp,NAC,4088/1969/7472/7474,SMAD3/EPHA2/WNT2/WNT5A
GO:0071300,cellular response to retinoic acid,4/53,69/18493,4.5275962725880044e-5,0.0010766623936214275,6.238551074544946e-4,4,bp,NAC,9314/1277/7472/7474,KLF4/COL1A1/WNT2/WNT5A
GO:0071479,cellular response to ionizing radiation,4/53,69/18493,4.5275962725880044e-5,0.0010766623936214275,6.238551074544946e-4,4,bp,NAC,1647/51776/4255/1026,GADD45A/MAP3K20/MGMT/CDKN1A
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,3/52,24/17632,4.687152862377394e-5,0.001088461053596528,7.126665170866213e-4,3,mf,NAC,2353/6772/1647,FOS/STAT1/GADD45A
GO:0030879,mammary gland development,5/53,141/18493,5.1311673750883376e-5,0.0011511241526377422,6.670008037726549e-4,5,bp,NAC,1969/8835/4255/7472/7474,EPHA2/SOCS2/MGMT/WNT2/WNT5A
GO:0061008,hepaticobiliary system development,5/53,140/18493,4.959915828615411e-5,0.0011511241526377422,6.670008037726549e-4,5,bp,NAC,3725/4088/3082/64321/3280,JUN/SMAD3/HGF/SOX17/HES1
GO:0061180,mammary gland epithelium development,4/53,71/18493,5.067191337912685e-5,0.0011511241526377422,6.670008037726549e-4,4,bp,NAC,1969/4255/7472/7474,EPHA2/MGMT/WNT2/WNT5A
GO:0070371,ERK1 and ERK2 cascade,7/53,341/18493,5.069369221721942e-5,0.0011511241526377422,6.670008037726549e-4,7,bp,NAC,9314/5320/3725/3479/10252/80310/1969,KLF4/PLA2G2A/JUN/IGF1/SPRY1/PDGFD/EPHA2
GO:0072073,kidney epithelium development,5/53,140/18493,4.959915828615411e-5,0.0011511241526377422,6.670008037726549e-4,5,bp,NAC,10252/6772/4088/8842/3280,SPRY1/STAT1/SMAD3/PROM1/HES1
GO:2000116,regulation of cysteine-type endopeptidase activity,6/53,232/18493,5.125579496315295e-5,0.0011511241526377422,6.670008037726549e-4,6,bp,NAC,9314/4804/4088/3082/4255/2810,KLF4/NGFR/SMAD3/HGF/MGMT/SFN
GO:0002053,positive regulation of mesenchymal cell proliferation,3/53,26/18493,5.515854259280553e-5,0.0012219289543665337,7.080275336487065e-4,3,bp,NAC,6772/7472/7474,STAT1/WNT2/WNT5A
GO:0032637,interleukin-8 production,4/53,73/18493,5.652320646775387e-5,0.0012219289543665337,7.080275336487065e-4,4,bp,NAC,9314/7097/3303/7474,KLF4/TLR2/HSPA1A/WNT5A
GO:0035050,embryonic heart tube development,4/53,73/18493,5.652320646775387e-5,0.0012219289543665337,7.080275336487065e-4,4,bp,NAC,4088/64321/7474/3280,SMAD3/SOX17/WNT5A/HES1
GO:0060828,regulation of canonical Wnt signaling pathway,6/53,236/18493,5.636142400124895e-5,0.0012219289543665337,7.080275336487065e-4,6,bp,NAC,6424/4088/64321/1277/7474/324,SFRP4/SMAD3/SOX17/COL1A1/WNT5A/APC
GO:0001654,eye development,7/53,351/18493,6.0826876272861384e-5,0.0012914849265791462,7.48330648883229e-4,7,bp,NAC,9314/3725/4088/1969/7472/7474/8842,KLF4/JUN/SMAD3/EPHA2/WNT2/WNT5A/PROM1
GO:0010212,response to ionizing radiation,5/53,146/18493,6.057186696190167e-5,0.0012914849265791462,7.48330648883229e-4,5,bp,NAC,1647/51776/4255/3981/1026,GADD45A/MAP3K20/MGMT/LIG4/CDKN1A
GO:0007050,cell cycle arrest,6/53,241/18493,6.330793366993306e-5,0.0012978126402336276,7.51997143139223e-4,6,bp,NAC,1647/4088/51776/2810/1026/324,GADD45A/SMAD3/MAP3K20/SFN/CDKN1A/APC
GO:0007259,JAK-STAT cascade,5/53,147/18493,6.256936383627108e-5,0.0012978126402336276,7.51997143139223e-4,5,bp,NAC,3479/6772/9021/8835/3280,IGF1/STAT1/SOCS3/SOCS2/HES1
GO:0032642,regulation of chemokine production,4/53,75/18493,6.285295403524746e-5,0.0012978126402336276,7.51997143139223e-4,4,bp,NAC,9314/7097/1969/7474,KLF4/TLR2/EPHA2/WNT5A
GO:0150063,visual system development,7/53,352/18493,6.192544329982307e-5,0.0012978126402336276,7.51997143139223e-4,7,bp,NAC,9314/3725/4088/1969/7472/7474/8842,KLF4/JUN/SMAD3/EPHA2/WNT2/WNT5A/PROM1
GO:0048880,sensory system development,7/53,357/18493,6.766521777186777e-5,0.0013752810928333466,7.968850208130897e-4,7,bp,NAC,9314/3725/4088/1969/7472/7474/8842,KLF4/JUN/SMAD3/EPHA2/WNT2/WNT5A/PROM1
GO:1904646,cellular response to amyloid-beta,3/53,28/18493,6.921875767419902e-5,0.0013949339470275023,8.082725583900671e-4,3,bp,NAC,3479/4804/781,IGF1/NGFR/CACNA2D1
GO:0030856,regulation of epithelial cell differentiation,5/53,151/18493,7.107320470383617e-5,0.0014084340065476867,8.160949557659786e-4,5,bp,NAC,6772/6424/2810/8842/3280,STAT1/SFRP4/SFN/PROM1/HES1
GO:0097696,STAT cascade,5/53,151/18493,7.107320470383617e-5,0.0014084340065476867,8.160949557659786e-4,5,bp,NAC,3479/6772/9021/8835/3280,IGF1/STAT1/SOCS3/SOCS2/HES1
GO:0003151,outflow tract morphogenesis,4/53,78/18493,7.329617817821113e-5,0.001429374599490572,8.282286533279441e-4,4,bp,NAC,3725/64321/7474/3280,JUN/SOX17/WNT5A/HES1
GO:0030509,BMP signaling pathway,5/53,152/18493,7.333208626486534e-5,0.001429374599490572,8.282286533279441e-4,5,bp,NAC,6424/353500/4093/7474/3280,SFRP4/BMP8A/SMAD9/WNT5A/HES1
R-HSA-3000178,ECM proteoglycans,5/45,76/10554,1.6539563645270803e-5,0.0014554816007838307,0.0011664744886664671,5,re,NAC,3679/1277/1278/8516/1281,ITGA7/COL1A1/COL1A2/ITGA8/COL3A1
GO:0045682,regulation of epidermis development,4/53,81/18493,8.494973627025214e-5,0.0016423615678915413,9.516406057146775e-4,4,bp,NAC,6424/2810/7474/3280,SFRP4/SFN/WNT5A/HES1
R-HSA-216083,Integrin cell surface interactions,5/45,85/10554,2.854161694354698e-5,0.001674441527354756,0.0013419567264685247,5,re,NAC,3679/1277/1278/8516/1281,ITGA7/COL1A1/COL1A2/ITGA8/COL3A1
R-HSA-8875878,MET promotes cell motility,4/45,41/10554,2.6028765878456228e-5,0.001674441527354756,0.0013419567264685247,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
GO:0032602,chemokine production,4/53,82/18493,8.91174536723697e-5,0.0017090427809104446,9.90277986902648e-4,4,bp,NAC,9314/7097/1969/7474,KLF4/TLR2/EPHA2/WNT5A
GO:1904645,response to amyloid-beta,3/53,31/18493,9.43997701551973e-5,0.0017958612274324734,0.0010405835716476065,3,bp,NAC,3479/4804/781,IGF1/NGFR/CACNA2D1
GO:0045926,negative regulation of growth,6/53,260/18493,9.620687264391945e-5,0.0018157138345019084,0.0010520868528896457,6,bp,NAC,4088/8835/3303/64321/7474/1026,SMAD3/SOCS2/HSPA1A/SOX17/WNT5A/CDKN1A
GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/53,84/18493,9.789627584717369e-5,0.001833049952477,0.0010621319940650673,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0034614,cellular response to reactive oxygen species,5/53,162/18493,9.909901796808948e-5,0.0018410739431884123,0.0010667813694097792,5,bp,NAC,2353/9314/3725/80310/3082,FOS/KLF4/JUN/PDGFD/HGF
GO:0005667,transcription factor complex,7/53,356/19659,4.534166883202124e-5,0.0018816792565288815,0.0014795702460975353,7,cc,NAC,2353/9314/3164/3725/4088/4093/64321,FOS/KLF4/NR4A1/JUN/SMAD3/SMAD9/SOX17
GO:0061448,connective tissue development,6/53,263/18493,1.0245880217061476e-4,0.0018887366787730382,0.0010943987926669502,6,bp,NAC,80310/7704/4088/353500/1277/7474,PDGFD/ZBTB16/SMAD3/BMP8A/COL1A1/WNT5A
GO:0061036,positive regulation of cartilage development,3/53,32/18493,1.0395455619813052e-4,0.001901568727993495,0.0011018341219704688,3,bp,NAC,7704/4088/7474,ZBTB16/SMAD3/WNT5A
GO:0071772,response to BMP,5/53,165/18493,1.0804307909535453e-4,0.001946412440066311,0.001127818106346245,5,bp,NAC,6424/353500/4093/7474/3280,SFRP4/BMP8A/SMAD9/WNT5A/HES1
GO:0071773,cellular response to BMP stimulus,5/53,165/18493,1.0804307909535453e-4,0.001946412440066311,0.001127818106346245,5,bp,NAC,6424/353500/4093/7474/3280,SFRP4/BMP8A/SMAD9/WNT5A/HES1
GO:0007093,mitotic cell cycle checkpoint,5/53,166/18493,1.1115815729667736e-4,0.0019874744214398404,0.001151610826286907,5,bp,NAC,1647/51776/2810/1026/324,GADD45A/MAP3K20/SFN/CDKN1A/APC
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,4/53,87/18493,1.1222014401864225e-4,0.0019914888244502334,0.001153936909036942,4,bp,NAC,1647/2810/1026/324,GADD45A/SFN/CDKN1A/APC
GO:0060674,placenta blood vessel development,3/53,33/18493,1.1411872445692168e-4,0.001995399461459998,0.0011562028662082857,3,bp,NAC,9021/7472/3280,SOCS3/WNT2/HES1
GO:0060795,cell fate commitment involved in formation of primary germ layer,3/53,33/18493,1.1411872445692168e-4,0.001995399461459998,0.0011562028662082857,3,bp,NAC,9314/2114/64321,KLF4/ETS2/SOX17
hsa05169,Epstein-Barr virus infection,7/50,201/7852,2.5470288298132606e-4,0.002050358207999675,0.0011930819255441065,7,kg,NAC,3725/6772/4616/1647/7097/1026/3280,JUN/STAT1/GADD45B/GADD45A/TLR2/CDKN1A/HES1
hsa05205,Proteoglycans in cancer,7/50,201/7852,2.5470288298132606e-4,0.002050358207999675,0.0011930819255441065,7,kg,NAC,3479/2318/7097/3082/7472/7474/1026,IGF1/FLNC/TLR2/HGF/WNT2/WNT5A/CDKN1A
GO:0008013,beta-catenin binding,4/52,82/17632,9.925274306824464e-5,0.0020743823301263126,0.0013581954314601896,4,mf,NAC,9314/4088/64321/324,KLF4/SMAD3/SOX17/APC
GO:0050821,protein stabilization,5/53,169/18493,1.2091884098733032e-4,0.002098868641371325,0.0012161564567991965,5,bp,NAC,3479/4088/3303/64321/1026,IGF1/SMAD3/HSPA1A/SOX17/CDKN1A
GO:0001656,metanephros development,4/53,89/18493,1.2257695666332955e-4,0.0021122319054014327,0.0012238995901777147,4,bp,NAC,10252/6772/8516/3280,SPRY1/STAT1/ITGA8/HES1
GO:0010464,regulation of mesenchymal cell proliferation,3/53,34/18493,1.2490933911155975e-4,0.0021216743457663505,0.0012293708638874566,3,bp,NAC,6772/7472/7474,STAT1/WNT2/WNT5A
GO:0048333,mesodermal cell differentiation,3/53,34/18493,1.2490933911155975e-4,0.0021216743457663505,0.0012293708638874566,3,bp,NAC,9314/64321/8516,KLF4/SOX17/ITGA8
GO:0045639,positive regulation of myeloid cell differentiation,4/53,91/18493,1.3360993619411147e-4,0.002221849148738441,0.0012874155795222079,4,bp,NAC,2353/3725/6772/3303,FOS/JUN/STAT1/HSPA1A
GO:1904029,regulation of cyclin-dependent protein kinase activity,4/53,91/18493,1.3360993619411147e-4,0.002221849148738441,0.0012874155795222079,4,bp,NAC,1647/2810/1026/324,GADD45A/SFN/CDKN1A/APC
GO:2000117,negative regulation of cysteine-type endopeptidase activity,4/53,91/18493,1.3360993619411147e-4,0.002221849148738441,0.0012874155795222079,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0043062,extracellular structure organization,7/53,402/18493,1.4171231305142086e-4,0.002340221391918603,0.001356004515967178,7,bp,NAC,5320/3679/4088/1277/1278/8516/1281,PLA2G2A/ITGA7/SMAD3/COL1A1/COL1A2/ITGA8/COL3A1
GO:0030099,myeloid cell differentiation,7/53,405/18493,1.483643227317173e-4,0.0024331748928001634,0.0014098649615667366,7,bp,NAC,2353/3725/6772/7704/7097/1969/3303,FOS/JUN/STAT1/ZBTB16/TLR2/EPHA2/HSPA1A
GO:0048562,embryonic organ morphogenesis,6/53,284/18493,1.5584574278528713e-4,0.0025383642215302243,0.0014708152653636689,6,bp,NAC,4088/1969/64321/7474/8516/3280,SMAD3/EPHA2/SOX17/WNT5A/ITGA8/HES1
hsa05146,Amoebiasis,5/50,96/7852,3.373624653594581e-4,0.0025864455677558455,0.0015050255346863047,5,kg,NAC,3554/7097/1277/1278/1281,IL1R1/TLR2/COL1A1/COL1A2/COL3A1
GO:0045684,positive regulation of epidermis development,3/53,37/18493,1.6120822003890613e-4,0.0026078445391327807,0.0015110745437230803,3,bp,NAC,6424/2810/7474,SFRP4/SFN/WNT5A
GO:0043434,response to peptide hormone,7/53,417/18493,1.7756119954026717e-4,0.0027836686146567678,0.0016129530417359611,7,bp,NAC,3164/6772/9021/7097/8835/1277/324,NR4A1/STAT1/SOCS3/TLR2/SOCS2/COL1A1/APC
GO:0048661,positive regulation of smooth muscle cell proliferation,4/53,98/18493,1.7793003760631989e-4,0.0027836686146567678,0.0016129530417359611,4,bp,NAC,3725/3479/80310/6772,JUN/IGF1/PDGFD/STAT1
GO:0051591,response to cAMP,4/53,98/18493,1.7793003760631989e-4,0.0027836686146567678,0.0016129530417359611,4,bp,NAC,2353/3725/6772/1277,FOS/JUN/STAT1/COL1A1
GO:1903708,positive regulation of hemopoiesis,5/53,183/18493,1.7546462823861506e-4,0.0027836686146567678,0.0016129530417359611,5,bp,NAC,2353/3725/6772/7704/3303,FOS/JUN/STAT1/ZBTB16/HSPA1A
GO:2000379,positive regulation of reactive oxygen species metabolic process,4/53,98/18493,1.7793003760631989e-4,0.0027836686146567678,0.0016129530417359611,4,bp,NAC,9314/1647/4088/1026,KLF4/GADD45A/SMAD3/CDKN1A
GO:0030308,negative regulation of cell growth,5/53,184/18493,1.799769652396312e-4,0.0027972890414368822,0.0016208451840294274,5,bp,NAC,4088/3303/64321/7474/1026,SMAD3/HSPA1A/SOX17/WNT5A/CDKN1A
GO:0040019,positive regulation of embryonic development,3/53,39/18493,1.8884572292024595e-4,0.002897258897447386,0.0016787711463674157,3,bp,NAC,3479/7472/3280,IGF1/WNT2/HES1
GO:1901342,regulation of vasculature development,7/53,421/18493,1.8826907094641822e-4,0.002897258897447386,0.0016787711463674157,7,bp,NAC,9314/80310/6772/4804/1969/3082/7474,KLF4/PDGFD/STAT1/NGFR/EPHA2/HGF/WNT5A
GO:0001819,positive regulation of cytokine production,7/53,422/18493,1.91026220785087e-4,0.002911925339916262,0.001687269386016727,7,bp,NAC,6772/3554/4088/7097/3303/3082/7474,STAT1/IL1R1/SMAD3/TLR2/HSPA1A/HGF/WNT5A
GO:0043235,receptor complex,7/53,396/19659,8.85298473941997e-5,0.00293919093348743,0.002311094963553845,7,cc,NAC,3977/3953/3679/4088/7097/1969/8516,LIFR/LEPR/ITGA7/SMAD3/TLR2/EPHA2/ITGA8
GO:0001823,mesonephros development,4/53,101/18493,1.9984170806886924e-4,0.003007744188530197,0.0017427901123394398,4,bp,NAC,10252/7704/4088/3280,SPRY1/ZBTB16/SMAD3/HES1
GO:0031099,regeneration,5/53,188/18493,1.9891975550051928e-4,0.003007744188530197,0.0017427901123394398,5,bp,NAC,9314/3725/3479/3082/1026,KLF4/JUN/IGF1/HGF/CDKN1A
GO:0001046,core promoter sequence-specific DNA binding,3/52,38/17632,1.8974937931720654e-4,0.003050586175176628,0.001997361887549543,3,mf,NAC,2353/6772/1647,FOS/STAT1/GADD45A
GO:0030020,extracellular matrix structural constituent conferring tensile strength,3/52,37/17632,1.7513306871666653e-4,0.003050586175176628,0.001997361887549543,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0031625,ubiquitin protein ligase binding,6/52,286/17632,1.880362605213437e-4,0.003050586175176628,0.001997361887549543,6,mf,NAC,3725/4804/4088/3303/1026/324,JUN/NGFR/SMAD3/HSPA1A/CDKN1A/APC
GO:0051427,hormone receptor binding,5/52,185/17632,2.0994675232165942e-4,0.0031342050882304873,0.0020521111129184755,5,mf,NAC,3164/6772/4088/2114/8835,NR4A1/STAT1/SMAD3/ETS2/SOCS2
GO:0007265,Ras protein signal transduction,7/53,430/18493,2.142832686322316e-4,0.003184785080046542,0.0018453736752604684,7,bp,NAC,3725/3479/10252/4804/1278/1281/1026,JUN/IGF1/SPRY1/NGFR/COL1A2/COL3A1/CDKN1A
GO:1901991,negative regulation of mitotic cell cycle phase transition,5/53,191/18493,2.1409781517473385e-4,0.003184785080046542,0.0018453736752604684,5,bp,NAC,9314/1647/2810/1026/324,KLF4/GADD45A/SFN/CDKN1A/APC
GO:0001709,cell fate determination,3/53,41/18493,2.1938570644284953e-4,0.0032403677634850695,0.0018775801878632892,3,bp,NAC,9314/64321/3280,KLF4/SOX17/HES1
GO:0030278,regulation of ossification,5/53,193/18493,2.246967478712617e-4,0.003298326336036175,0.0019111633720824014,5,bp,NAC,3479/7704/4088/3082/7474,IGF1/ZBTB16/SMAD3/HGF/WNT5A
R-HSA-3000480,Scavenging by Class A Receptors,3/45,19/10554,6.692258159839625e-5,0.0033652498175193546,0.0026970303561458945,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0032526,response to retinoic acid,4/53,105/18493,2.3200284647815632e-4,0.003384679563957397,0.001961199393218642,4,bp,NAC,9314/1277/7472/7474,KLF4/COL1A1/WNT2/WNT5A
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,4/53,106/18493,2.4059221353072726e-4,0.003488587096195545,0.0020214069801779335,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
hsa05213,Endometrial cancer,4/50,58/7852,4.7930305049741337e-4,0.0035076268695492523,0.002041051267668411,4,kg,NAC,4616/1647/1026/324,GADD45B/GADD45A/CDKN1A/APC
hsa04630,JAK-STAT signaling pathway,6/50,162/7852,5.271781479919889e-4,0.0035853884097335658,0.0020862998919011925,6,kg,NAC,3977/6772/3953/9021/8835/1026,LIFR/STAT1/LEPR/SOCS3/SOCS2/CDKN1A
hsa04659,Th17 cell differentiation,5/50,107/7852,5.567373307039698e-4,0.0035853884097335658,0.0020862998919011925,5,kg,NAC,2353/3725/6772/3554/4088,FOS/JUN/STAT1/IL1R1/SMAD3
hsa05161,Hepatitis B,6/50,163/7852,5.446940606608965e-4,0.0035853884097335658,0.0020862998919011925,6,kg,NAC,2353/3725/6772/4088/7097/1026,FOS/JUN/STAT1/SMAD3/TLR2/CDKN1A
GO:0048593,camera-type eye morphogenesis,4/53,108/18493,2.5845431996661514e-4,0.003724874987155217,0.002158320286036997,4,bp,NAC,1969/7472/7474/8842,EPHA2/WNT2/WNT5A/PROM1
GO:0043200,response to amino acid,4/53,111/18493,2.8700882188557436e-4,0.004062541538356523,0.002353975863710632,4,bp,NAC,80310/1277/1278/1281,PDGFD/COL1A1/COL1A2/COL3A1
GO:0050679,positive regulation of epithelial cell proliferation,5/53,203/18493,2.83821094054556e-4,0.004062541538356523,0.002353975863710632,5,bp,NAC,3164/3725/3479/7472/7474,NR4A1/JUN/IGF1/WNT2/WNT5A
GO:1903829,positive regulation of cellular protein localization,6/53,318/18493,2.868394202221206e-4,0.004062541538356523,0.002353975863710632,6,bp,NAC,3479/4804/4088/1969/2810/324,IGF1/NGFR/SMAD3/EPHA2/SFN/APC
GO:0010463,mesenchymal cell proliferation,3/53,45/18493,2.8968087768294434e-4,0.004076101343964743,0.002361832880018525,3,bp,NAC,6772/7472/7474,STAT1/WNT2/WNT5A
GO:0001102,RNA polymerase II activating transcription factor binding,3/52,44/17632,2.942014047407653e-4,0.004099206239387997,0.002683942639740315,3,mf,NAC,2353/3725/4088,FOS/JUN/SMAD3
GO:0050769,positive regulation of neurogenesis,7/53,453/18493,2.941872829836072e-4,0.00411516093491187,0.002384465346288185,7,bp,NAC,4804/7097/8835/3082/7474/3981/3280,NGFR/TLR2/SOCS2/HGF/WNT5A/LIG4/HES1
GO:0001938,positive regulation of endothelial cell proliferation,4/53,112/18493,2.9701087295925496e-4,0.004130361730392446,0.0023932732083943664,4,bp,NAC,3164/3725/7472/7474,NR4A1/JUN/WNT2/WNT5A
GO:0000982,"transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding",7/52,447/17632,3.205948784353541e-4,0.004187770599561813,0.0027419298813550026,7,mf,NAC,2353/9314/3164/3725/6772/2114/3280,FOS/KLF4/NR4A1/JUN/STAT1/ETS2/HES1
GO:0051216,cartilage development,5/53,206/18493,3.0367274517789904e-4,0.00419845225600607,0.002432727193622215,5,bp,NAC,7704/4088/353500/1277/7474,ZBTB16/SMAD3/BMP8A/COL1A1/WNT5A
GO:0001961,positive regulation of cytokine-mediated signaling pathway,3/53,46/18493,3.092651559560744e-4,0.0042024716620774,0.002435056175317302,3,bp,NAC,3554/3303/7474,IL1R1/HSPA1A/WNT5A
GO:0032757,positive regulation of interleukin-8 production,3/53,46/18493,3.092651559560744e-4,0.0042024716620774,0.002435056175317302,3,bp,NAC,7097/3303/7474,TLR2/HSPA1A/WNT5A
GO:1900744,regulation of p38MAPK cascade,3/53,46/18493,3.092651559560744e-4,0.0042024716620774,0.002435056175317302,3,bp,NAC,4616/1647/3082,GADD45B/GADD45A/HGF
GO:0032147,activation of protein kinase activity,6/53,323/18493,3.1180177722373416e-4,0.004212867194534317,0.0024410797032647616,6,bp,NAC,3479/4616/1647/51776/3082/7474,IGF1/GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0070372,regulation of ERK1 and ERK2 cascade,6/53,324/18493,3.1699309778379306e-4,0.004245160511212666,0.002459791558221141,6,bp,NAC,9314/5320/3725/10252/80310/1969,KLF4/PLA2G2A/JUN/SPRY1/PDGFD/EPHA2
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,4/53,114/18493,3.1776222497723066e-4,0.004245160511212666,0.002459791558221141,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
GO:0005788,endoplasmic reticulum lumen,6/53,301/19659,1.5368906047224097e-4,0.004252064006398667,0.003343411140097874,6,cc,NAC,80310/1277/7474/1278/3486/1281,PDGFD/COL1A1/WNT5A/COL1A2/IGFBP3/COL3A1
GO:0001047,core promoter binding,3/52,47/17632,3.5796008781271483e-4,0.004390465140594515,0.0028746435068108134,3,mf,NAC,2353/6772/1647,FOS/STAT1/GADD45A
GO:0005072,"transforming growth factor beta receptor, cytoplasmic mediator activity",2/52,10/17632,3.7812618435742234e-4,0.004390465140594515,0.0028746435068108134,2,mf,NAC,4088/4093,SMAD3/SMAD9
GO:1901988,negative regulation of cell cycle phase transition,5/53,211/18493,3.3908171016317157e-4,0.004504672104849285,0.0026101614737053316,5,bp,NAC,9314/1647/2810/1026/324,KLF4/GADD45A/SFN/CDKN1A/APC
GO:0044798,nuclear transcription factor complex,5/53,198/19659,1.9097902742884894e-4,0.004528931221884132,0.003561112691906356,5,cc,NAC,2353/9314/3725/4088/64321,FOS/KLF4/JUN/SMAD3/SOX17
hsa05321,Inflammatory bowel disease (IBD),4/50,65/7852,7.40242141461997e-4,0.004583807106745443,0.0026672692546606375,4,kg,NAC,3725/6772/4088/7097,JUN/STAT1/SMAD3/TLR2
GO:0060711,labyrinthine layer development,3/53,48/18493,3.5095281284920735e-4,0.004636476605307862,0.0026865335205825294,3,bp,NAC,9021/7472/3280,SOCS3/WNT2/HES1
GO:0007440,foregut morphogenesis,2/53,10/18493,3.573637012238383e-4,0.0046437753087993855,0.002690762639643396,2,bp,NAC,4088/64321,SMAD3/SOX17
GO:0048570,notochord morphogenesis,2/53,10/18493,3.573637012238383e-4,0.0046437753087993855,0.002690762639643396,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0090009,primitive streak formation,2/53,10/18493,3.573637012238383e-4,0.0046437753087993855,0.002690762639643396,2,bp,NAC,2114/7474,ETS2/WNT5A
GO:0045599,negative regulation of fat cell differentiation,3/53,49/18493,3.730860565677006e-4,0.004795668337935092,0.0027787746688314094,3,bp,NAC,4088/862/7474,SMAD3/RUNX1T1/WNT5A
GO:0048546,digestive tract morphogenesis,3/53,49/18493,3.730860565677006e-4,0.004795668337935092,0.0027787746688314094,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0000075,cell cycle checkpoint,5/53,216/18493,3.7753754463393236e-4,0.0048267972104273716,0.0027968118048999294,5,bp,NAC,1647/51776/2810/1026/324,GADD45A/MAP3K20/SFN/CDKN1A/APC
GO:1902807,negative regulation of cell cycle G1/S phase transition,4/53,121/18493,3.9861655850962626e-4,0.005069038375058242,0.002937174641649878,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
GO:0051101,regulation of DNA binding,4/53,122/18493,4.1125998465490267e-4,0.005202001295262546,0.0030142179166476354,4,bp,NAC,9314/3725/3479/3280,KLF4/JUN/IGF1/HES1
R-HSA-6783589,Interleukin-6 family signaling,3/45,24/10554,1.377150764602747e-4,0.005386189657112966,0.004316683098403932,3,re,NAC,3977/6772/9021,LIFR/STAT1/SOCS3
R-HSA-982772,Growth hormone receptor signaling,3/45,24/10554,1.377150764602747e-4,0.005386189657112966,0.004316683098403932,3,re,NAC,6772/9021/8835,STAT1/SOCS3/SOCS2
GO:0000185,activation of MAPKKK activity,2/53,11/18493,4.35975961372319e-4,0.0054565833481230236,0.0031617314871820812,2,bp,NAC,4616/1647,GADD45B/GADD45A
GO:0002328,pro-B cell differentiation,2/53,11/18493,4.35975961372319e-4,0.0054565833481230236,0.0031617314871820812,2,bp,NAC,3981/3280,LIG4/HES1
GO:0030199,collagen fibril organization,3/53,52/18493,4.448196908358901e-4,0.005509277212540347,0.003192264118992216,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0038066,p38MAPK cascade,3/53,52/18493,4.448196908358901e-4,0.005509277212540347,0.003192264118992216,3,bp,NAC,4616/1647/3082,GADD45B/GADD45A/HGF
GO:0002020,protease binding,4/52,125/17632,5.009421365589832e-4,0.005510363502148815,0.0036078935043029267,4,mf,NAC,3554/1277/1278/1281,IL1R1/COL1A1/COL1A2/COL3A1
GO:0050839,cell adhesion molecule binding,7/52,486/17632,5.294827322956405e-4,0.005533094552489443,0.003622776589391225,7,mf,NAC,3479/6772/1969/3303/2810/1281/8842,IGF1/STAT1/EPHA2/HSPA1A/SFN/COL3A1/PROM1
GO:0030198,extracellular matrix organization,6/53,348/18493,4.6338203754870723e-4,0.005709442928968009,0.0033082469983706456,6,bp,NAC,3679/4088/1277/1278/8516/1281,ITGA7/SMAD3/COL1A1/COL1A2/ITGA8/COL3A1
GO:0010823,negative regulation of mitochondrion organization,3/53,53/18493,4.705570143140115e-4,0.0057679617527769044,0.003342154811378411,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0044420,extracellular matrix component,3/53,49/19659,3.122777034065171e-4,0.0058377520694071336,0.004590242591036681,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:1990909,Wnt signalosome,2/53,10/19659,3.165046302690615e-4,0.0058377520694071336,0.004590242591036681,2,cc,NAC,7472/324,WNT2/APC
hsa04917,Prolactin signaling pathway,4/50,70/7852,9.793475352596818e-4,0.005839813080622547,0.003398125950803575,4,kg,NAC,2353/6772/9021/8835,FOS/STAT1/SOCS3/SOCS2
GO:0009913,epidermal cell differentiation,6/53,351/18493,4.8487374868005386e-4,0.005912973201852144,0.003426179417123836,6,bp,NAC,9314/6424/1969/2810/7474/3280,KLF4/SFRP4/EPHA2/SFN/WNT5A/HES1
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,3/53,54/18493,4.972311211942182e-4,0.005971795990908337,0.003460263358018244,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0061005,cell differentiation involved in kidney development,3/53,54/18493,4.972311211942182e-4,0.005971795990908337,0.003460263358018244,3,bp,NAC,6772/8842/3280,STAT1/PROM1/HES1
GO:0090183,regulation of kidney development,3/53,54/18493,4.972311211942182e-4,0.005971795990908337,0.003460263358018244,3,bp,NAC,80310/6772/8842,PDGFD/STAT1/PROM1
GO:0046425,regulation of JAK-STAT cascade,4/53,129/18493,5.079270824093648e-4,0.006069601014921958,0.003516934942469499,4,bp,NAC,3479/9021/8835/3280,IGF1/SOCS3/SOCS2/HES1
GO:0003306,Wnt signaling pathway involved in heart development,2/53,12/18493,5.222108289989998e-4,0.006117326853988283,0.0035445889300476582,2,bp,NAC,64321/7474,SOX17/WNT5A
GO:0021903,rostrocaudal neural tube patterning,2/53,12/18493,5.222108289989998e-4,0.006117326853988283,0.0035445889300476582,2,bp,NAC,64321/3280,SOX17/HES1
GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,2/53,12/18493,5.222108289989998e-4,0.006117326853988283,0.0035445889300476582,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:1904953,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,2/53,12/18493,5.222108289989998e-4,0.006117326853988283,0.0035445889300476582,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0031102,neuron projection regeneration,3/53,55/18493,5.248560426365274e-4,0.006118174849949324,0.003545080287983563,3,bp,NAC,9314/3725/3082,KLF4/JUN/HGF
hsa04110,Cell cycle,5/50,124/7852,0.0010872717393148887,0.00625181250106061,0.0036378640901889143,5,kg,NAC,4616/1647/4088/2810/1026,GADD45B/GADD45A/SMAD3/SFN/CDKN1A
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",3/53,56/18493,5.534456740288994e-4,0.006369803018385029,0.003690882276599533,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0032872,regulation of stress-activated MAPK cascade,5/53,235/18493,5.544782274203957e-4,0.006369803018385029,0.003690882276599533,5,bp,NAC,4616/1647/51776/3082/7474,GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0060688,regulation of morphogenesis of a branching structure,3/53,56/18493,5.534456740288994e-4,0.006369803018385029,0.003690882276599533,3,bp,NAC,3082/7472/7474,HGF/WNT2/WNT5A
GO:0090090,negative regulation of canonical Wnt signaling pathway,4/53,133/18493,5.699051775919528e-4,0.0064843756570031755,0.0037572695918804645,4,bp,NAC,6424/64321/7474/324,SFRP4/SOX17/WNT5A/APC
GO:1904892,regulation of STAT cascade,4/53,133/18493,5.699051775919528e-4,0.0064843756570031755,0.0037572695918804645,4,bp,NAC,3479/9021/8835/3280,IGF1/SOCS3/SOCS2/HES1
GO:0070302,regulation of stress-activated protein kinase signaling cascade,5/53,237/18493,5.761987822892202e-4,0.006524765258494122,0.0037806727118626033,5,bp,NAC,4616/1647/51776/3082/7474,GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,3/53,57/18493,5.830137757477116e-4,0.0065396545223021605,0.0037893000618359216,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,3/53,57/18493,5.830137757477116e-4,0.0065396545223021605,0.0037893000618359216,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:1905330,regulation of morphogenesis of an epithelium,4/53,134/18493,5.862028232537473e-4,0.006544555463368127,0.003792139835132964,4,bp,NAC,6772/3082/7472/7474,STAT1/HGF/WNT2/WNT5A
hsa04380,Osteoclast differentiation,5/50,128/7852,0.0012534850156384568,0.006586911886923442,0.00383285490641508,5,kg,NAC,2353/3725/6772/9021/3554,FOS/JUN/STAT1/SOCS3/IL1R1
hsa05140,Leishmaniasis,4/50,74/7852,0.0012062619737402038,0.006586911886923442,0.00383285490641508,4,kg,NAC,2353/3725/6772/7097,FOS/JUN/STAT1/TLR2
hsa05214,Glioma,4/50,75/7852,0.0012682873819542032,0.006586911886923442,0.00383285490641508,4,kg,NAC,3479/4616/1647/1026,IGF1/GADD45B/GADD45A/CDKN1A
GO:0001947,heart looping,3/53,58/18493,6.135739739148516e-4,0.006609219850684031,0.0038296085983557165,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0002693,positive regulation of cellular extravasation,2/53,13/18493,6.160256231822976e-4,0.006609219850684031,0.0038296085983557165,2,bp,NAC,80310/3554,PDGFD/IL1R1
GO:0014065,phosphatidylinositol 3-kinase signaling,4/53,136/18493,6.197880684199071e-4,0.006609219850684031,0.0038296085983557165,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0014745,negative regulation of muscle adaptation,2/53,13/18493,6.160256231822976e-4,0.006609219850684031,0.0038296085983557165,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:0043388,positive regulation of DNA binding,3/53,58/18493,6.135739739148516e-4,0.006609219850684031,0.0038296085983557165,3,bp,NAC,9314/3479/3280,KLF4/IGF1/HES1
GO:0043568,positive regulation of insulin-like growth factor receptor signaling pathway,2/53,13/18493,6.160256231822976e-4,0.006609219850684031,0.0038296085983557165,2,bp,NAC,3479/3486,IGF1/IGFBP3
GO:0045604,regulation of epidermal cell differentiation,3/53,58/18493,6.135739739148516e-4,0.006609219850684031,0.0038296085983557165,3,bp,NAC,6424/2810/3280,SFRP4/SFN/HES1
GO:0070208,protein heterotrimerization,2/53,13/18493,6.160256231822976e-4,0.006609219850684031,0.0038296085983557165,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0072006,nephron development,4/53,136/18493,6.197880684199071e-4,0.006609219850684031,0.0038296085983557165,4,bp,NAC,80310/6772/8842/3280,PDGFD/STAT1/PROM1/HES1
GO:0072182,regulation of nephron tubule epithelial cell differentiation,2/53,13/18493,6.160256231822976e-4,0.006609219850684031,0.0038296085983557165,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0051098,regulation of binding,6/53,369/18493,6.307011088678482e-4,0.0066955680218202815,0.0038796416894173566,6,bp,NAC,9314/3725/3479/4088/7474/3280,KLF4/JUN/IGF1/SMAD3/WNT5A/HES1
GO:0001889,liver development,4/53,137/18493,6.370831755362263e-4,0.006699311580865227,0.003881810835887116,4,bp,NAC,3725/4088/3082/3280,JUN/SMAD3/HGF/HES1
GO:0046683,response to organophosphorus,4/53,137/18493,6.370831755362263e-4,0.006699311580865227,0.003881810835887116,4,bp,NAC,2353/3725/6772/1277,FOS/JUN/STAT1/COL1A1
GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,3/53,59/18493,6.451397611514453e-4,0.006699311580865227,0.003881810835887116,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,3/53,59/18493,6.451397611514453e-4,0.006699311580865227,0.003881810835887116,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,3/53,59/18493,6.451397611514453e-4,0.006699311580865227,0.003881810835887116,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
hsa05220,Chronic myeloid leukemia,4/50,76/7852,0.0013325150231427547,0.006704216210186985,0.003901113061174513,4,kg,NAC,4616/1647/4088/1026,GADD45B/GADD45A/SMAD3/CDKN1A
GO:0032835,glomerulus development,3/53,60/18493,6.777244973282028e-4,0.006916862037109298,0.004007867029602971,3,bp,NAC,80310/8842/3280,PDGFD/PROM1/HES1
GO:0035019,somatic stem cell population maintenance,3/53,60/18493,6.777244973282028e-4,0.006916862037109298,0.004007867029602971,3,bp,NAC,9314/3981/3280,KLF4/LIG4/HES1
GO:0050728,negative regulation of inflammatory response,4/53,139/18493,6.726971612144434e-4,0.006916862037109298,0.004007867029602971,4,bp,NAC,9314/9021/4088/3082,KLF4/SOCS3/SMAD3/HGF
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,5/53,245/18493,6.695418067901737e-4,0.006916862037109298,0.004007867029602971,5,bp,NAC,3479/80310/9021/3082/3280,IGF1/PDGFD/SOCS3/HGF/HES1
R-HSA-3000170,Syndecan interactions,3/45,27/10554,1.9724776224124436e-4,0.006943121230891802,0.0055644631874372085,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
hsa04068,FoxO signaling pathway,5/50,132/7852,0.0014378434132211147,0.007014933016018166,0.0040819159099419215,5,kg,NAC,3479/4616/1647/4088/1026,IGF1/GADD45B/GADD45A/SMAD3/CDKN1A
GO:0046330,positive regulation of JNK cascade,4/53,140/18493,6.910235730652744e-4,0.007022453233971036,0.004069050189574649,4,bp,NAC,4616/1647/51776/7474,GADD45B/GADD45A/MAP3K20/WNT5A
GO:0009880,embryonic pattern specification,3/53,61/18493,7.113414103124488e-4,0.00713742562752322,0.004135669136571156,3,bp,NAC,7704/4088/7474,ZBTB16/SMAD3/WNT5A
GO:0042733,embryonic digit morphogenesis,3/53,61/18493,7.113414103124488e-4,0.00713742562752322,0.004135669136571156,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0045637,regulation of myeloid cell differentiation,5/53,248/18493,7.073179605493397e-4,0.00713742562752322,0.004135669136571156,5,bp,NAC,2353/3725/6772/7704/3303,FOS/JUN/STAT1/ZBTB16/HSPA1A
GO:0051770,positive regulation of nitric-oxide synthase biosynthetic process,2/53,14/18493,7.173778370443623e-4,0.007167749985258376,0.004153240109204203,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0014706,striated muscle tissue development,6/53,379/18493,7.252841477254532e-4,0.007216425536782961,0.00418144439274441,6,bp,NAC,2353/3479/4088/64321/7472/7474,FOS/IGF1/SMAD3/SOX17/WNT2/WNT5A
GO:0044344,cellular response to fibroblast growth factor stimulus,4/53,142/18493,7.287340960280576e-4,0.007220540334811337,0.004183828647810209,4,bp,NAC,3164/10252/1277/7474,NR4A1/SPRY1/COL1A1/WNT5A
GO:0001085,RNA polymerase II transcription factor binding,4/52,140/17632,7.670327871096622e-4,0.0072868114775417915,0.0047710173360888085,4,mf,NAC,2353/9314/3725/4088,FOS/KLF4/JUN/SMAD3
GO:0046935,1-phosphatidylinositol-3-kinase regulator activity,2/52,14/17632,7.588992131214474e-4,0.0072868114775417915,0.0047710173360888085,2,mf,NAC,9021/8835,SOCS3/SOCS2
GO:0045765,regulation of angiogenesis,6/53,381/18493,7.454549584854548e-4,0.007337115779546802,0.004251376457627713,6,bp,NAC,9314/6772/4804/1969/3082/7474,KLF4/STAT1/NGFR/EPHA2/HGF/WNT5A
GO:0090596,sensory organ morphogenesis,5/53,251/18493,7.466703190287326e-4,0.007337115779546802,0.004251376457627713,5,bp,NAC,1969/7472/7474/8516/8842,EPHA2/WNT2/WNT5A/ITGA8/PROM1
GO:0004860,protein kinase inhibitor activity,3/52,62/17632,8.093038903490109e-4,0.007354109264475796,0.004815080354479241,3,mf,NAC,9021/2810/1026,SOCS3/SFN/CDKN1A
GO:0031571,mitotic G1 DNA damage checkpoint,3/53,63/18493,7.817240226145449e-4,0.007587509084805664,0.0043964629241780425,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0043550,regulation of lipid kinase activity,3/53,63/18493,7.817240226145449e-4,0.007587509084805664,0.0043964629241780425,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0044819,mitotic G1/S transition checkpoint,3/53,63/18493,7.817240226145449e-4,0.007587509084805664,0.0043964629241780425,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0005161,platelet-derived growth factor receptor binding,2/52,15/17632,8.740012012277115e-4,0.007611093794024654,0.004983340182438707,2,mf,NAC,80310/3554,PDGFD/IL1R1
GO:0048592,eye morphogenesis,4/53,145/18493,7.880008118704916e-4,0.007617341181414752,0.004413748663836002,4,bp,NAC,1969/7472/7474/8842,EPHA2/WNT2/WNT5A/PROM1
hsa05216,Thyroid cancer,3/50,37/7852,0.0016211135085892332,0.0076764492612607805,0.004466845271344947,3,kg,NAC,4616/1647/1026,GADD45B/GADD45A/CDKN1A
GO:0051091,positive regulation of DNA-binding transcription factor activity,5/53,255/18493,8.016640052932981e-4,0.00771804455298568,0.0044720996502404745,5,bp,NAC,4088/7097/3303/7472/7474,SMAD3/TLR2/HSPA1A/WNT2/WNT5A
GO:0000077,DNA damage checkpoint,4/53,146/18493,8.084917680650993e-4,0.007722186035180853,0.004474499367027461,4,bp,NAC,1647/51776/2810/1026,GADD45A/MAP3K20/SFN/CDKN1A
GO:0018108,peptidyl-tyrosine phosphorylation,6/53,387/18493,8.08588865752747e-4,0.007722186035180853,0.004474499367027461,6,bp,NAC,3479/80310/9021/1969/3082/3280,IGF1/PDGFD/SOCS3/EPHA2/HGF/HES1
GO:0042074,cell migration involved in gastrulation,2/53,15/18493,8.262251371342874e-4,0.007734158058594102,0.004481436367889727,2,bp,NAC,64321/7474,SOX17/WNT5A
GO:0044783,G1 DNA damage checkpoint,3/53,64/18493,8.185155243266666e-4,0.007734158058594102,0.004481436367889727,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0061371,determination of heart left/right asymmetry,3/53,64/18493,8.185155243266666e-4,0.007734158058594102,0.004481436367889727,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0072160,nephron tubule epithelial cell differentiation,2/53,15/18493,8.262251371342874e-4,0.007734158058594102,0.004481436367889727,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0098727,maintenance of cell number,4/53,147/18493,8.293567304211505e-4,0.007734158058594102,0.004481436367889727,4,bp,NAC,9314/3479/3981/3280,KLF4/IGF1/LIG4/HES1
GO:2000484,positive regulation of interleukin-8 secretion,2/53,15/18493,8.262251371342874e-4,0.007734158058594102,0.004481436367889727,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0018212,peptidyl-tyrosine modification,6/53,390/18493,8.416699645410856e-4,0.007787903407310124,0.004512578265755811,6,bp,NAC,3479/80310/9021/1969/3082/3280,IGF1/PDGFD/SOCS3/EPHA2/HGF/HES1
GO:0045787,positive regulation of cell cycle,6/53,390/18493,8.416699645410856e-4,0.007787903407310124,0.004512578265755811,6,bp,NAC,3479/1647/2810/7474/1026/3280,IGF1/GADD45A/SFN/WNT5A/CDKN1A/HES1
GO:0071774,response to fibroblast growth factor,4/53,148/18493,8.50599490645e-4,0.007840021661836472,0.00454277736945861,4,bp,NAC,3164/10252/1277/7474,NR4A1/SPRY1/COL1A1/WNT5A
GO:0032868,response to insulin,5/53,259/18493,8.596335512679345e-4,0.007892697239054627,0.0045732994050385134,5,bp,NAC,6772/9021/7097/8835/324,STAT1/SOCS3/TLR2/SOCS2/APC
hsa04512,ECM-receptor interaction,4/50,82/7852,0.0017664587667364953,0.007899996151238216,0.0045969248608055,4,kg,NAC,3679/1277/1278/8516,ITGA7/COL1A1/COL1A2/ITGA8
hsa05162,Measles,5/50,138/7852,0.0017509914045938664,0.007899996151238216,0.0045969248608055,5,kg,NAC,2353/3725/6772/7097/3303,FOS/JUN/STAT1/TLR2/HSPA1A
GO:0016202,regulation of striated muscle tissue development,4/53,149/18493,8.722238423244867e-4,0.00797749345018319,0.00462243323725811,4,bp,NAC,3479/4088/64321/7472,IGF1/SMAD3/SOX17/WNT2
GO:0005159,insulin-like growth factor receptor binding,2/52,16/17632,9.969747469746792e-4,0.008014143158373383,0.005247235510393049,2,mf,NAC,3479/8835,IGF1/SOCS2
GO:0019210,kinase inhibitor activity,3/52,66/17632,9.711184032276726e-4,0.008014143158373383,0.005247235510393049,3,mf,NAC,9021/2810/1026,SOCS3/SFN/CDKN1A
GO:0000187,activation of MAPK activity,4/53,150/18493,8.942335807117361e-4,0.00806504515192664,0.004673163695220209,4,bp,NAC,3479/51776/3082/7474,IGF1/MAP3K20/HGF/WNT5A
GO:0030858,positive regulation of epithelial cell differentiation,3/53,66/18493,8.953624558909306e-4,0.00806504515192664,0.004673163695220209,3,bp,NAC,6424/2810/8842,SFRP4/SFN/PROM1
GO:0048754,branching morphogenesis of an epithelial tube,4/53,150/18493,8.942335807117361e-4,0.00806504515192664,0.004673163695220209,4,bp,NAC,10252/1969/7472/7474,SPRY1/EPHA2/WNT2/WNT5A
GO:0050918,positive chemotaxis,3/53,66/18493,8.953624558909306e-4,0.00806504515192664,0.004673163695220209,3,bp,NAC,4088/3082/7474,SMAD3/HGF/WNT5A
GO:0035257,nuclear hormone receptor binding,4/52,152/17632,0.0010420340521336054,0.00806611544058976,0.005281264201846733,4,mf,NAC,3164/6772/4088/2114,NR4A1/STAT1/SMAD3/ETS2
GO:0014074,response to purine-containing compound,4/53,151/18493,9.166325025078703e-4,0.008194556732946298,0.004748207145954896,4,bp,NAC,2353/3725/6772/1277,FOS/JUN/STAT1/COL1A1
GO:1901861,regulation of muscle tissue development,4/53,151/18493,9.166325025078703e-4,0.008194556732946298,0.004748207145954896,4,bp,NAC,3479/4088/64321/7472,IGF1/SMAD3/SOX17/WNT2
GO:0046824,positive regulation of nucleocytoplasmic transport,3/53,67/18493,9.354429160311336e-4,0.008331397956262306,0.0048274976427547965,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0060572,morphogenesis of an epithelial bud,2/53,16/18493,9.425253628133006e-4,0.008363154152126974,0.004845898271494936,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0031647,regulation of protein stability,5/53,265/18493,9.523883428087625e-4,0.008419254569513894,0.004878404776899511,5,bp,NAC,3479/4088/3303/64321/1026,IGF1/SMAD3/HSPA1A/SOX17/CDKN1A
GO:0048634,regulation of muscle organ development,4/53,153/18493,9.62613089097534e-4,0.008478125651384947,0.004912516700306715,4,bp,NAC,3479/4088/64321/7472,IGF1/SMAD3/SOX17/WNT2
GO:0061035,regulation of cartilage development,3/53,68/18493,9.76644514008023e-4,0.00856996551406302,0.004965731865746756,3,bp,NAC,7704/4088/7474,ZBTB16/SMAD3/WNT5A
hsa05410,Hypertrophic cardiomyopathy (HCM),4/50,85/7852,0.00201652338138165,0.00877460174060664,0.0051058486754755866,4,kg,NAC,3479/3679/781/8516,IGF1/ITGA7/CACNA2D1/ITGA8
GO:0034504,protein localization to nucleus,5/53,269/18493,0.0010182407285787291,0.008902119310883154,0.005158193164510667,5,bp,NAC,3479/4804/7704/4088/1277,IGF1/NGFR/ZBTB16/SMAD3/COL1A1
GO:0006266,DNA ligation,2/53,17/18493,0.0010662365256419845,0.009087851103858922,0.0052658125337308355,2,bp,NAC,4255/3981,MGMT/LIG4
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,3/53,70/18493,0.0010624597913856612,0.009087851103858922,0.0052658125337308355,3,bp,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,3/53,70/18493,0.0010624597913856612,0.009087851103858922,0.0052658125337308355,3,bp,NAC,3479/9021/3280,IGF1/SOCS3/HES1
GO:0048339,paraxial mesoderm development,2/53,17/18493,0.0010662365256419845,0.009087851103858922,0.0052658125337308355,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0048662,negative regulation of smooth muscle cell proliferation,3/53,70/18493,0.0010624597913856612,0.009087851103858922,0.0052658125337308355,3,bp,NAC,9314/3486/1026,KLF4/IGFBP3/CDKN1A
GO:0070102,interleukin-6-mediated signaling pathway,2/53,17/18493,0.0010662365256419845,0.009087851103858922,0.0052658125337308355,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:1904948,midbrain dopaminergic neuron differentiation,2/53,17/18493,0.0010662365256419845,0.009087851103858922,0.0052658125337308355,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0031570,DNA integrity checkpoint,4/53,158/18493,0.0010846412199666108,0.009211702932430715,0.005337576529835691,4,bp,NAC,1647/51776/2810/1026,GADD45A/MAP3K20/SFN/CDKN1A
GO:0043588,skin development,6/53,412/18493,0.0011174406761738538,0.009456490846766634,0.005479415040687676,6,bp,NAC,1969/2810/1277/7474/1278/1281,EPHA2/SFN/COL1A1/WNT5A/COL1A2/COL3A1
GO:0090288,negative regulation of cellular response to growth factor stimulus,4/53,160/18493,0.001136362953509162,0.00958252164342123,0.005552441605612144,4,bp,NAC,10252/4088/3303/7474,SPRY1/SMAD3/HSPA1A/WNT5A
GO:0072593,reactive oxygen species metabolic process,5/53,276/18493,0.0011415653594423483,0.009592376059201074,0.005558151592003102,5,bp,NAC,9314/1647/4088/7097/1026,KLF4/GADD45A/SMAD3/TLR2/CDKN1A
GO:0001756,somitogenesis,3/53,72/18493,0.001152904373847328,0.00965354436974981,0.005593594608473509,3,bp,NAC,4088/7474/3280,SMAD3/WNT5A/HES1
GO:0001710,mesodermal cell fate commitment,2/53,18/18493,0.0011973168087694693,0.009701572841589158,0.0056214239518570285,2,bp,NAC,9314/64321,KLF4/SOX17
GO:0021915,neural tube development,4/53,161/18493,0.0011628626965146497,0.009701572841589158,0.0056214239518570285,4,bp,NAC,1969/64321/7474/3280,EPHA2/SOX17/WNT5A/HES1
GO:0036342,post-anal tail morphogenesis,2/53,18/18493,0.0011973168087694693,0.009701572841589158,0.0056214239518570285,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0050680,negative regulation of epithelial cell proliferation,4/53,162/18493,0.0011897934225538027,0.009701572841589158,0.0056214239518570285,4,bp,NAC,6772/4804/2810/7474,STAT1/NGFR/SFN/WNT5A
GO:0051767,nitric-oxide synthase biosynthetic process,2/53,18/18493,0.0011973168087694693,0.009701572841589158,0.0056214239518570285,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0051769,regulation of nitric-oxide synthase biosynthetic process,2/53,18/18493,0.0011973168087694693,0.009701572841589158,0.0056214239518570285,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0052548,regulation of endopeptidase activity,6/53,417/18493,0.0011888283377655467,0.009701572841589158,0.0056214239518570285,6,bp,NAC,9314/4804/4088/3082/4255/2810,KLF4/NGFR/SMAD3/HGF/MGMT/SFN
GO:0072401,signal transduction involved in DNA integrity checkpoint,3/53,73/18493,0.0011998921381635942,0.009701572841589158,0.0056214239518570285,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0072422,signal transduction involved in DNA damage checkpoint,3/53,73/18493,0.0011998921381635942,0.009701572841589158,0.0056214239518570285,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:1903706,regulation of hemopoiesis,6/53,418/18493,0.00120351723644609,0.009701572841589158,0.0056214239518570285,6,bp,NAC,2353/3725/6772/7704/3303/3280,FOS/JUN/STAT1/ZBTB16/HSPA1A/HES1
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,2/53,18/18493,0.0011973168087694693,0.009701572841589158,0.0056214239518570285,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0035051,cardiocyte differentiation,4/53,163/18493,0.001217158929593822,0.009778391670858476,0.005665935415498979,4,bp,NAC,3479/10252/64321/3280,IGF1/SPRY1/SOX17/HES1
GO:0007492,endoderm development,3/53,74/18493,0.001248072363137794,0.009893053598472246,0.005732374467885518,3,bp,NAC,3679/4088/64321,ITGA7/SMAD3/SOX17
GO:0030178,negative regulation of Wnt signaling pathway,4/53,164/18493,0.0012449630144186908,0.009893053598472246,0.005732374467885518,4,bp,NAC,6424/64321/7474/324,SFRP4/SOX17/WNT5A/APC
GO:0048015,phosphatidylinositol-mediated signaling,4/53,164/18493,0.0012449630144186908,0.009893053598472246,0.005732374467885518,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0072395,signal transduction involved in cell cycle checkpoint,3/53,74/18493,0.001248072363137794,0.009893053598472246,0.005732374467885518,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/50,89/7852,0.0023867530608628557,0.010112295863129466,0.0058842388481106424,4,kg,NAC,2353/3725/6772/7097,FOS/JUN/STAT1/TLR2
GO:0005126,cytokine receptor binding,5/52,281/17632,0.001398261819363313,0.010180357500286051,0.006665557668280972,5,mf,NAC,3977/6772/4088/8835/353500,LIFR/STAT1/SMAD3/SOCS2/BMP8A
GO:0008083,growth factor activity,4/52,166/17632,0.00144293781606219,0.010180357500286051,0.006665557668280972,4,mf,NAC,3479/80310/3082/353500,IGF1/PDGFD/HGF/BMP8A
GO:0033613,activating transcription factor binding,3/52,76/17632,0.0014612953349692898,0.010180357500286051,0.006665557668280972,3,mf,NAC,2353/3725/4088,FOS/JUN/SMAD3
GO:0002320,lymphoid progenitor cell differentiation,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,3981/3280,LIG4/HES1
GO:0002374,cytokine secretion involved in immune response,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0035994,response to muscle stretch,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,2353/3725,FOS/JUN
GO:0044342,type B pancreatic cell proliferation,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,3164/3486,NR4A1/IGFBP3
GO:0046426,negative regulation of JAK-STAT cascade,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0048017,inositol lipid-mediated signaling,4/53,167/18493,0.0013310446817155106,0.010187020197127422,0.005902708794670355,4,bp,NAC,9314/3479/80310/3082,KLF4/IGF1/PDGFD/HGF
GO:0051403,stress-activated MAPK cascade,5/53,284/18493,0.001295727027720235,0.010187020197127422,0.005902708794670355,5,bp,NAC,4616/1647/51776/3082/7474,GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0072111,cell proliferation involved in kidney development,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,80310/6772,PDGFD/STAT1
GO:0090068,positive regulation of cell cycle process,5/53,286/18493,0.0013365644665701245,0.010187020197127422,0.005902708794670355,5,bp,NAC,3479/1647/2810/7474/1026,IGF1/GADD45A/SFN/WNT5A/CDKN1A
GO:0090201,negative regulation of release of cytochrome c from mitochondria,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,3479/3082,IGF1/HGF
GO:1905331,negative regulation of morphogenesis of an epithelium,2/53,19/18493,0.0013357245663246228,0.010187020197127422,0.005902708794670355,2,bp,NAC,6772/7474,STAT1/WNT5A
GO:2000045,regulation of G1/S transition of mitotic cell cycle,4/53,166/18493,0.0013019020975043912,0.010187020197127422,0.005902708794670355,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
hsa05166,Human T-cell leukemia virus 1 infection,6/50,219/7852,0.002505946841998349,0.010345062604147031,0.006019683372141783,6,kg,NAC,2353/3725/3554/4088/2114/1026,FOS/JUN/IL1R1/SMAD3/ETS2/CDKN1A
hsa05414,Dilated cardiomyopathy (DCM),4/50,91/7852,0.002588374408848864,0.010418206995616679,0.0060622453259881305,4,kg,NAC,3479/3679/781/8516,IGF1/ITGA7/CACNA2D1/ITGA8
GO:0030324,lung development,4/53,169/18493,0.0013906948861315883,0.010565726642878328,0.006122144294421554,4,bp,NAC,10252/7472/7474/3280,SPRY1/WNT2/WNT5A/HES1
GO:0046209,nitric oxide metabolic process,3/53,77/18493,0.0013998817608869582,0.010601652316526072,0.006142960861552225,3,bp,NAC,9314/4088/7097,KLF4/SMAD3/TLR2
GO:0023019,signal transduction involved in regulation of gene expression,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,4088/64321,SMAD3/SOX17
GO:0030903,notochord development,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0032682,negative regulation of chemokine production,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,9314/1969,KLF4/EPHA2
GO:0032874,positive regulation of stress-activated MAPK cascade,4/53,171/18493,0.0014521903805508958,0.01085567659276868,0.006290151237189236,4,bp,NAC,4616/1647/51776/7474,GADD45B/GADD45A/MAP3K20/WNT5A
GO:0060039,pericardium development,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0060602,branch elongation of an epithelium,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0060716,labyrinthine layer blood vessel development,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,7472/3280,WNT2/HES1
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,4/53,172/18493,0.0014836395679772164,0.01085567659276868,0.006290151237189236,4,bp,NAC,4616/1647/51776/7474,GADD45B/GADD45A/MAP3K20/WNT5A
GO:0072234,metanephric nephron tubule development,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,6772/3280,STAT1/HES1
GO:1900182,positive regulation of protein localization to nucleus,3/53,78/18493,0.0014529451841953107,0.01085567659276868,0.006290151237189236,3,bp,NAC,3479/4804/4088,IGF1/NGFR/SMAD3
GO:1904893,negative regulation of STAT cascade,2/53,20/18493,0.0014814183228092097,0.01085567659276868,0.006290151237189236,2,bp,NAC,9021/8835,SOCS3/SOCS2
R-HSA-6806834,Signaling by MET,4/45,79/10554,3.432063130161801e-4,0.010982602016517764,0.008801846113716389,4,re,NAC,3082/1277/1278/1281,HGF/COL1A1/COL1A2/COL3A1
GO:0030323,respiratory tube development,4/53,173/18493,0.0015155614202108224,0.011055230236997962,0.006405779460949198,4,bp,NAC,10252/7472/7474/3280,SPRY1/WNT2/WNT5A/HES1
hsa04390,Hippo signaling pathway,5/50,154/7852,0.0028297026240282582,0.01111175908459877,0.006465816008691014,5,kg,NAC,4088/353500/7472/7474/324,SMAD3/BMP8A/WNT2/WNT5A/APC
GO:0060326,cell chemotaxis,5/53,295/18493,0.0015322285116742909,0.01114262813688521,0.006456420800842257,5,bp,NAC,3164/80310/1969/3082/7474,NR4A1/PDGFD/EPHA2/HGF/WNT5A
hsa04934,Cushing syndrome,5/50,155/7852,0.002910141659147316,0.011155543026731378,0.006491293425165693,5,kg,NAC,3164/7472/7474/1026/324,NR4A1/WNT2/WNT5A/CDKN1A/APC
GO:0042116,macrophage activation,3/53,80/18493,0.0015628285014573202,0.011227813221950173,0.0065057799599543085,3,bp,NAC,3725/7097/7474,JUN/TLR2/WNT5A
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,3/53,80/18493,0.0015628285014573202,0.011227813221950173,0.0065057799599543085,3,bp,NAC,3479/9021/3280,IGF1/SOCS3/HES1
GO:0071277,cellular response to calcium ion,3/53,80/18493,0.0015628285014573202,0.011227813221950173,0.0065057799599543085,3,bp,NAC,2353/3725/7474,FOS/JUN/WNT5A
GO:2001057,reactive nitrogen species metabolic process,3/53,80/18493,0.0015628285014573202,0.011227813221950173,0.0065057799599543085,3,bp,NAC,9314/4088/7097,KLF4/SMAD3/TLR2
GO:0032103,positive regulation of response to external stimulus,5/53,297/18493,0.0015784334508639826,0.01130576730769443,0.006550949230123506,5,bp,NAC,5320/80310/4088/7097/7474,PLA2G2A/PDGFD/SMAD3/TLR2/WNT5A
GO:0051961,negative regulation of nervous system development,5/53,298/18493,0.0016019175786644625,0.01140526946725776,0.006608604193103629,5,bp,NAC,4804/7097/7474/1281/3280,NGFR/TLR2/WNT5A/COL3A1/HES1
GO:0052547,regulation of peptidase activity,6/53,442/18493,0.0015998642596993728,0.01140526946725776,0.006608604193103629,6,bp,NAC,9314/4804/4088/3082/4255/2810,KLF4/NGFR/SMAD3/HGF/MGMT/SFN
GO:0010821,regulation of mitochondrion organization,4/53,176/18493,0.001614200697504712,0.01145841569751106,0.006639398941189846,4,bp,NAC,3479/3303/3082/2810,IGF1/HSPA1A/HGF/SFN
GO:1901216,positive regulation of neuron death,3/53,81/18493,0.001619669992426053,0.011463021553539149,0.006642067732098069,3,bp,NAC,2353/3725/7474,FOS/JUN/WNT5A
GO:0032332,positive regulation of chondrocyte differentiation,2/53,21/18493,0.0016343567724930459,0.011464602964567737,0.0066429840558714405,2,bp,NAC,7704/4088,ZBTB16/SMAD3
GO:0048745,smooth muscle tissue development,2/53,21/18493,0.0016343567724930459,0.011464602964567737,0.0066429840558714405,2,bp,NAC,8516/1281,ITGA8/COL3A1
GO:0055093,response to hyperoxia,2/53,21/18493,0.0016343567724930459,0.011464602964567737,0.0066429840558714405,2,bp,NAC,1277/1026,COL1A1/CDKN1A
GO:0016525,negative regulation of angiogenesis,4/53,178/18493,0.0016823926559672339,0.01166393509005855,0.006758483924078899,4,bp,NAC,9314/6772/4804/1969,KLF4/STAT1/NGFR/EPHA2
GO:0060415,muscle tissue morphogenesis,3/53,82/18493,0.0016777922407331537,0.01166393509005855,0.006758483924078899,3,bp,NAC,7472/7474/1281,WNT2/WNT5A/COL3A1
GO:0071158,positive regulation of cell cycle arrest,3/53,82/18493,0.0016777922407331537,0.01166393509005855,0.006758483924078899,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0071346,cellular response to interferon-gamma,4/53,178/18493,0.0016823926559672339,0.01166393509005855,0.006758483924078899,4,bp,NAC,6772/9021/7097/7474,STAT1/SOCS3/TLR2/WNT5A
GO:0007260,tyrosine phosphorylation of STAT protein,3/53,83/18493,0.0017372057525573811,0.01197413124516363,0.006938222212349694,3,bp,NAC,3479/9021/3280,IGF1/SOCS3/HES1
GO:0014910,regulation of smooth muscle cell migration,3/53,83/18493,0.0017372057525573811,0.01197413124516363,0.006938222212349694,3,bp,NAC,3479/80310/3486,IGF1/PDGFD/IGFBP3
GO:0010948,negative regulation of cell cycle process,5/53,304/18493,0.0017482733346125831,0.012010377923377726,0.006959224780532711,5,bp,NAC,9314/1647/2810/1026/324,KLF4/GADD45A/SFN/CDKN1A/APC
GO:2000181,negative regulation of blood vessel morphogenesis,4/53,180/18493,0.0017525656599714345,0.012010377923377726,0.006959224780532711,4,bp,NAC,9314/6772/4804/1969,KLF4/STAT1/NGFR/EPHA2
GO:0001759,organ induction,2/53,22/18493,0.0017944987788111124,0.012054570892691598,0.006984831702241292,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,2/53,22/18493,0.0017944987788111124,0.012054570892691598,0.006984831702241292,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0042110,T cell activation,6/53,451/18493,0.0017717191036556795,0.012054570892691598,0.006984831702241292,6,bp,NAC,3479/7704/3953/4088/3981/3280,IGF1/ZBTB16/LEPR/SMAD3/LIG4/HES1
GO:0051099,positive regulation of binding,4/53,181/18493,0.0017884044342742099,0.012054570892691598,0.006984831702241292,4,bp,NAC,9314/3479/7474/3280,KLF4/IGF1/WNT5A/HES1
GO:0072012,glomerulus vasculature development,2/53,22/18493,0.0017944987788111124,0.012054570892691598,0.006984831702241292,2,bp,NAC,80310/3280,PDGFD/HES1
GO:1905809,negative regulation of synapse organization,2/53,22/18493,0.0017944987788111124,0.012054570892691598,0.006984831702241292,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:2000050,regulation of non-canonical Wnt signaling pathway,2/53,22/18493,0.0017944987788111124,0.012054570892691598,0.006984831702241292,2,bp,NAC,6424/7474,SFRP4/WNT5A
GO:0071375,cellular response to peptide hormone stimulus,5/53,307/18493,0.001825032705925779,0.012225148661102823,0.0070836703100277095,5,bp,NAC,3164/6772/9021/8835/324,NR4A1/STAT1/SOCS3/SOCS2/APC
hsa01522,Endocrine resistance,4/50,98/7852,0.003386160974837678,0.012390270839746958,0.0072097685827883585,4,kg,NAC,2353/3725/3479/1026,FOS/JUN/IGF1/CDKN1A
hsa04218,Cellular senescence,5/50,160/7852,0.003337448012385658,0.012390270839746958,0.0072097685827883585,5,kg,NAC,4616/1647/4088/3486/1026,GADD45B/GADD45A/SMAD3/IGFBP3/CDKN1A
GO:0046427,positive regulation of JAK-STAT cascade,3/53,85/18493,0.0018599480135626128,0.01242403476475251,0.0071989117378872276,3,bp,NAC,3479/9021/3280,IGF1/SOCS3/HES1
GO:0001667,ameboidal-type cell migration,6/53,456/18493,0.0018730815586266417,0.012476716936734324,0.007229437594699321,6,bp,NAC,9314/3164/3725/1969/64321/7474,KLF4/NR4A1/JUN/EPHA2/SOX17/WNT5A
GO:0002691,regulation of cellular extravasation,2/53,23/18493,0.00196180337376261,0.01253955683485761,0.0072658491863258,2,bp,NAC,80310/3554,PDGFD/IL1R1
GO:0008544,epidermis development,6/53,458/18493,0.0019148396075838153,0.01253955683485761,0.0072658491863258,6,bp,NAC,9314/6424/1969/2810/7474/3280,KLF4/SFRP4/EPHA2/SFN/WNT5A/HES1
GO:0031098,stress-activated protein kinase signaling cascade,5/53,313/18493,0.001985947422669873,0.01253955683485761,0.0072658491863258,5,bp,NAC,4616/1647/51776/3082/7474,GADD45B/GADD45A/MAP3K20/HGF/WNT5A
GO:0045606,positive regulation of epidermal cell differentiation,2/53,23/18493,0.00196180337376261,0.01253955683485761,0.0072658491863258,2,bp,NAC,6424/2810,SFRP4/SFN
GO:0045844,positive regulation of striated muscle tissue development,3/53,86/18493,0.0019232971992000389,0.01253955683485761,0.0072658491863258,3,bp,NAC,3479/64321/7472,IGF1/SOX17/WNT2
GO:0046328,regulation of JNK cascade,4/53,184/18493,0.001898974767904433,0.01253955683485761,0.0072658491863258,4,bp,NAC,4616/1647/51776/7474,GADD45B/GADD45A/MAP3K20/WNT5A
GO:0048636,positive regulation of muscle organ development,3/53,86/18493,0.0019232971992000389,0.01253955683485761,0.0072658491863258,3,bp,NAC,3479/64321/7472,IGF1/SOX17/WNT2
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/53,186/18493,0.0019752706745038997,0.01253955683485761,0.0072658491863258,4,bp,NAC,3479/9021/3082/3280,IGF1/SOCS3/HGF/HES1
GO:0051346,negative regulation of hydrolase activity,6/53,458/18493,0.0019148396075838153,0.01253955683485761,0.0072658491863258,6,bp,NAC,9314/10252/4804/3953/3082/2810,KLF4/SPRY1/NGFR/LEPR/HGF/SFN
GO:0051412,response to corticosterone,2/53,23/18493,0.00196180337376261,0.01253955683485761,0.0072658491863258,2,bp,NAC,2353/1026,FOS/CDKN1A
GO:0071248,cellular response to metal ion,4/53,184/18493,0.001898974767904433,0.01253955683485761,0.0072658491863258,4,bp,NAC,2353/3725/7474/3981,FOS/JUN/WNT5A/LIG4
GO:0071478,cellular response to radiation,4/53,186/18493,0.0019752706745038997,0.01253955683485761,0.0072658491863258,4,bp,NAC,1647/51776/4255/1026,GADD45A/MAP3K20/MGMT/CDKN1A
GO:0072170,metanephric tubule development,2/53,23/18493,0.00196180337376261,0.01253955683485761,0.0072658491863258,2,bp,NAC,6772/3280,STAT1/HES1
GO:0072243,metanephric nephron epithelium development,2/53,23/18493,0.00196180337376261,0.01253955683485761,0.0072658491863258,2,bp,NAC,6772/3280,STAT1/HES1
GO:1901863,positive regulation of muscle tissue development,3/53,87/18493,0.0019879785225993775,0.01253955683485761,0.0072658491863258,3,bp,NAC,3479/64321/7472,IGF1/SOX17/WNT2
GO:1902806,regulation of cell cycle G1/S phase transition,4/53,185/18493,0.0019368620007047207,0.01253955683485761,0.0072658491863258,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
GO:1903725,regulation of phospholipid metabolic process,3/53,86/18493,0.0019232971992000389,0.01253955683485761,0.0072658491863258,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:1904705,regulation of vascular smooth muscle cell proliferation,3/53,87/18493,0.0019879785225993775,0.01253955683485761,0.0072658491863258,3,bp,NAC,3725/3479/1026,JUN/IGF1/CDKN1A
GO:1990874,vascular smooth muscle cell proliferation,3/53,87/18493,0.0019879785225993775,0.01253955683485761,0.0072658491863258,3,bp,NAC,3725/3479/1026,JUN/IGF1/CDKN1A
GO:2000377,regulation of reactive oxygen species metabolic process,4/53,185/18493,0.0019368620007047207,0.01253955683485761,0.0072658491863258,4,bp,NAC,9314/1647/4088/1026,KLF4/GADD45A/SMAD3/CDKN1A
GO:0001892,embryonic placenta development,3/53,88/18493,0.0020540019180341654,0.012819990973977022,0.0074283423420547666,3,bp,NAC,9021/7472/3280,SOCS3/WNT2/HES1
GO:0030510,regulation of BMP signaling pathway,3/53,88/18493,0.0020540019180341654,0.012819990973977022,0.0074283423420547666,3,bp,NAC,6424/7474/3280,SFRP4/WNT5A/HES1
GO:0048644,muscle organ morphogenesis,3/53,88/18493,0.0020540019180341654,0.012819990973977022,0.0074283423420547666,3,bp,NAC,7472/7474/1281,WNT2/WNT5A/COL3A1
GO:1904894,positive regulation of STAT cascade,3/53,88/18493,0.0020540019180341654,0.012819990973977022,0.0074283423420547666,3,bp,NAC,3479/9021/3280,IGF1/SOCS3/HES1
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",6/52,449/17632,0.0019929151473188945,0.01301622705592653,0.008522334511561064,6,mf,NAC,2353/9314/3164/3725/4088/64321,FOS/KLF4/NR4A1/JUN/SMAD3/SOX17
GO:0019887,protein kinase regulator activity,4/52,180/17632,0.0019408555768426975,0.01301622705592653,0.008522334511561064,4,mf,NAC,9021/2810/1026/324,SOCS3/SFN/CDKN1A/APC
GO:0002040,sprouting angiogenesis,4/53,189/18493,0.002093662520442863,0.013033323229353739,0.007551954365554444,4,bp,NAC,9314/3164/4804/1969,KLF4/NR4A1/NGFR/EPHA2
GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,2/53,24/18493,0.0021362297573120238,0.01309266588373194,0.007586339534241562,2,bp,NAC,3479/3486,IGF1/IGFBP3
GO:0061437,renal system vasculature development,2/53,24/18493,0.0021362297573120238,0.01309266588373194,0.007586339534241562,2,bp,NAC,80310/3280,PDGFD/HES1
GO:0061440,kidney vasculature development,2/53,24/18493,0.0021362297573120238,0.01309266588373194,0.007586339534241562,2,bp,NAC,80310/3280,PDGFD/HES1
GO:1901654,response to ketone,4/53,190/18493,0.0021341941097464835,0.01309266588373194,0.007586339534241562,4,bp,NAC,2353/9314/7097/1026,FOS/KLF4/TLR2/CDKN1A
GO:2000482,regulation of interleukin-8 secretion,2/53,24/18493,0.0021362297573120238,0.01309266588373194,0.007586339534241562,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:2000679,positive regulation of transcription regulatory region DNA binding,2/53,24/18493,0.0021362297573120238,0.01309266588373194,0.007586339534241562,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0071214,cellular response to abiotic stimulus,5/53,319/18493,0.0021570358762450933,0.013152387983873927,0.007620944566814649,5,bp,NAC,1647/51776/4255/1277/1026,GADD45A/MAP3K20/MGMT/COL1A1/CDKN1A
GO:0104004,cellular response to environmental stimulus,5/53,319/18493,0.0021570358762450933,0.013152387983873927,0.007620944566814649,5,bp,NAC,1647/51776/4255/1277/1026,GADD45A/MAP3K20/MGMT/COL1A1/CDKN1A
GO:0014909,smooth muscle cell migration,3/53,90/18493,0.002190114100791538,0.013319926679494314,0.007718022231622354,3,bp,NAC,3479/80310/3486,IGF1/PDGFD/IGFBP3
GO:1901343,negative regulation of vasculature development,4/53,192/18493,0.0022168809485034477,0.013448323713115303,0.007792419875378663,4,bp,NAC,9314/6772/4804/1969,KLF4/STAT1/NGFR/EPHA2
GO:0061053,somite development,3/53,91/18493,0.0022602221973119087,0.013676357214269005,0.007924550304757704,3,bp,NAC,4088/7474/3280,SMAD3/WNT5A/HES1
GO:0032496,response to lipopolysaccharide,5/53,324/18493,0.002307652974048144,0.013813481934264555,0.008004005069254264,5,bp,NAC,2353/3725/55970/7097/7474,FOS/JUN/GNG12/TLR2/WNT5A
GO:0060330,regulation of response to interferon-gamma,2/53,25/18493,0.0023177372967920764,0.013813481934264555,0.008004005069254264,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:0060334,regulation of interferon-gamma-mediated signaling pathway,2/53,25/18493,0.0023177372967920764,0.013813481934264555,0.008004005069254264,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:0060444,branching involved in mammary gland duct morphogenesis,2/53,25/18493,0.0023177372967920764,0.013813481934264555,0.008004005069254264,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0060541,respiratory system development,4/53,194/18493,0.002301757254373318,0.013813481934264555,0.008004005069254264,4,bp,NAC,10252/7472/7474/3280,SPRY1/WNT2/WNT5A/HES1
GO:0060571,morphogenesis of an epithelial fold,2/53,25/18493,0.0023177372967920764,0.013813481934264555,0.008004005069254264,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0030901,midbrain development,3/53,92/18493,0.0023317109855653215,0.013862021809185837,0.008032130737118438,3,bp,NAC,7472/7474/3280,WNT2/WNT5A/HES1
GO:0010721,negative regulation of cell development,5/53,326/18493,0.002370000334076592,0.014054515696843232,0.00814366829585578,5,bp,NAC,3479/4804/7474/1281/3280,IGF1/NGFR/WNT5A/COL3A1/HES1
GO:0072080,nephron tubule development,3/53,93/18493,0.002404589844382134,0.014224165795872426,0.008241969380194327,3,bp,NAC,6772/8842/3280,STAT1/PROM1/HES1
GO:0000983,"transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding",2/52,24/17632,0.0022587036830183705,0.014305123325783013,0.009366235368178252,2,mf,NAC,6772/4088,STAT1/SMAD3
GO:0002573,myeloid leukocyte differentiation,4/53,197/18493,0.0024332412866501624,0.014324324819231118,0.008300004952580027,4,bp,NAC,2353/3725/7097/1969,FOS/JUN/TLR2/EPHA2
GO:0071496,cellular response to external stimulus,5/53,328/18493,0.0024335690609627297,0.014324324819231118,0.008300004952580027,5,bp,NAC,2353/3725/1647/1277/1026,FOS/JUN/GADD45A/COL1A1/CDKN1A
GO:0031667,response to nutrient levels,6/53,481/18493,0.0024476670712959597,0.014371734063066154,0.008327475494025762,6,bp,NAC,3725/6772/4255/353500/1277/1026,JUN/STAT1/MGMT/BMP8A/COL1A1/CDKN1A
GO:0032102,negative regulation of response to external stimulus,5/53,329/18493,0.0024658158334622832,0.014412587303952147,0.008351147262570654,5,bp,NAC,9314/9021/4088/3082/7474,KLF4/SOCS3/SMAD3/HGF/WNT5A
GO:0034341,response to interferon-gamma,4/53,198/18493,0.0024781958341198356,0.014412587303952147,0.008351147262570654,4,bp,NAC,6772/9021/7097/7474,STAT1/SOCS3/TLR2/WNT5A
GO:0050830,defense response to Gram-positive bacterium,3/53,94/18493,0.002478868043446774,0.014412587303952147,0.008351147262570654,3,bp,NAC,5320/7097/1969,PLA2G2A/TLR2/EPHA2
GO:0070301,cellular response to hydrogen peroxide,3/53,94/18493,0.002478868043446774,0.014412587303952147,0.008351147262570654,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2/53,26/18493,0.002506285526308689,0.014465890731946754,0.008382033096418176,2,bp,NAC,1026/324,CDKN1A/APC
GO:0045992,negative regulation of embryonic development,2/53,26/18493,0.002506285526308689,0.014465890731946754,0.008382033096418176,2,bp,NAC,64321/7474,SOX17/WNT5A
GO:0072273,metanephric nephron morphogenesis,2/53,26/18493,0.002506285526308689,0.014465890731946754,0.008382033096418176,2,bp,NAC,6772/3280,STAT1/HES1
hsa05142,Chagas disease (American trypanosomiasis),4/50,103/7852,0.004049205640760446,0.01448715795916515,0.008429925193629935,4,kg,NAC,2353/3725/4088/7097,FOS/JUN/SMAD3/TLR2
GO:0031348,negative regulation of defense response,4/53,199/18493,0.002523719734661544,0.014531248254298188,0.008419903485846723,4,bp,NAC,9314/9021/4088/3082,KLF4/SOCS3/SMAD3/HGF
GO:0002367,cytokine production involved in immune response,3/53,95/18493,0.002554554743938461,0.014567700674066332,0.00844102526774062,3,bp,NAC,3554/7097/7474,IL1R1/TLR2/WNT5A
GO:0061326,renal tubule development,3/53,95/18493,0.002554554743938461,0.014567700674066332,0.00844102526774062,3,bp,NAC,6772/8842/3280,STAT1/PROM1/HES1
GO:1990823,response to leukemia inhibitory factor,3/53,95/18493,0.002554554743938461,0.014567700674066332,0.00844102526774062,3,bp,NAC,9314/9021/64321,KLF4/SOCS3/SOX17
GO:1990830,cellular response to leukemia inhibitory factor,3/53,95/18493,0.002554554743938461,0.014567700674066332,0.00844102526774062,3,bp,NAC,9314/9021/64321,KLF4/SOCS3/SOX17
GO:0035258,steroid hormone receptor binding,3/52,90/17632,0.0023722315136797123,0.014582246657619409,0.009547681014809989,3,mf,NAC,3164/4088/2114,NR4A1/SMAD3/ETS2
hsa04620,Toll-like receptor signaling pathway,4/50,104/7852,0.004191631794512192,0.01467071128079267,0.008536732945345196,4,kg,NAC,2353/3725/6772/7097,FOS/JUN/STAT1/TLR2
GO:0051783,regulation of nuclear division,4/53,201/18493,0.002616490149432847,0.014885199941031843,0.008624995229432377,4,bp,NAC,3479/3303/7474/324,IGF1/HSPA1A/WNT5A/APC
GO:0004896,cytokine receptor activity,3/52,92/17632,0.0025253209422697216,0.0149150653145166,0.009765593003712708,3,mf,NAC,3977/3953/3554,LIFR/LEPR/IL1R1
GO:0045296,cadherin binding,5/52,323/17632,0.002569102159438266,0.0149150653145166,0.009765593003712708,5,mf,NAC,6772/1969/3303/2810/8842,STAT1/EPHA2/HSPA1A/SFN/PROM1
GO:0001657,ureteric bud development,3/53,96/18493,0.002631658999169006,0.014935763961870876,0.008654293756845195,3,bp,NAC,10252/4088/3280,SPRY1/SMAD3/HES1
GO:0002064,epithelial cell development,4/53,202/18493,0.0026637439229168663,0.015022916638479518,0.008704793005962417,4,bp,NAC,1969/2810/7474/1026,EPHA2/SFN/WNT5A/CDKN1A
GO:0035883,enteroendocrine cell differentiation,2/53,27/18493,0.0027018341461477976,0.015022916638479518,0.008704793005962417,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0051450,myoblast proliferation,2/53,27/18493,0.0027018341461477976,0.015022916638479518,0.008704793005962417,2,bp,NAC,3479/3082,IGF1/HGF
GO:0060914,heart formation,2/53,27/18493,0.0027018341461477976,0.015022916638479518,0.008704793005962417,2,bp,NAC,64321/3280,SOX17/HES1
GO:0070997,neuron death,5/53,335/18493,0.0026658811581544975,0.015022916638479518,0.008704793005962417,5,bp,NAC,2353/3725/4804/7474/3981,FOS/JUN/NGFR/WNT5A/LIG4
GO:0072163,mesonephric epithelium development,3/53,97/18493,0.0027101897552177096,0.015022916638479518,0.008704793005962417,3,bp,NAC,10252/4088/3280,SPRY1/SMAD3/HES1
GO:0072164,mesonephric tubule development,3/53,97/18493,0.0027101897552177096,0.015022916638479518,0.008704793005962417,3,bp,NAC,10252/4088/3280,SPRY1/SMAD3/HES1
GO:0072207,metanephric epithelium development,2/53,27/18493,0.0027018341461477976,0.015022916638479518,0.008704793005962417,2,bp,NAC,6772/3280,STAT1/HES1
GO:0090263,positive regulation of canonical Wnt signaling pathway,3/53,97/18493,0.0027101897552177096,0.015022916638479518,0.008704793005962417,3,bp,NAC,6424/4088/1277,SFRP4/SMAD3/COL1A1
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,2/53,27/18493,0.0027018341461477976,0.015022916638479518,0.008704793005962417,2,bp,NAC,1026/324,CDKN1A/APC
GO:0002237,response to molecule of bacterial origin,5/53,337/18493,0.0027351203823114726,0.015125851788689958,0.008764437161433826,5,bp,NAC,2353/3725/55970/7097/7474,FOS/JUN/GNG12/TLR2/WNT5A
GO:0032869,cellular response to insulin stimulus,4/53,204/18493,0.002760006694891543,0.015228064780631297,0.008823662873642765,4,bp,NAC,6772/9021/8835/324,STAT1/SOCS3/SOCS2/APC
GO:0031589,cell-substrate adhesion,5/53,338/18493,0.0027702262115546113,0.015249069284900153,0.00883583360361839,5,bp,NAC,3679/4088/1277/8516/1281,ITGA7/SMAD3/COL1A1/ITGA8/COL3A1
GO:0044773,mitotic DNA damage checkpoint,3/53,98/18493,0.0027901558515633306,0.015323303960779676,0.008878847720180869,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0048018,receptor ligand activity,6/52,478/17632,0.0027246502265955153,0.01539059182049899,0.010076942516569475,6,mf,NAC,3479/80310/3082/353500/7472/7474,IGF1/PDGFD/HGF/BMP8A/WNT2/WNT5A
GO:0001702,gastrulation with mouth forming second,2/53,28/18493,0.0029043430221842295,0.015720974027246447,0.009109271391999293,2,bp,NAC,2114/7474,ETS2/WNT5A
GO:0007229,integrin-mediated signaling pathway,3/53,99/18493,0.002871566021713236,0.015720974027246447,0.009109271391999293,3,bp,NAC,3679/8516/1281,ITGA7/ITGA8/COL3A1
GO:0033598,mammary gland epithelial cell proliferation,2/53,28/18493,0.0029043430221842295,0.015720974027246447,0.009109271391999293,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0036296,response to increased oxygen levels,2/53,28/18493,0.0029043430221842295,0.015720974027246447,0.009109271391999293,2,bp,NAC,1277/1026,COL1A1/CDKN1A
GO:0070570,regulation of neuron projection regeneration,2/53,28/18493,0.0029043430221842295,0.015720974027246447,0.009109271391999293,2,bp,NAC,9314/3082,KLF4/HGF
GO:0071241,cellular response to inorganic substance,4/53,207/18493,0.002908842965512379,0.015720974027246447,0.009109271391999293,4,bp,NAC,2353/3725/7474/3981,FOS/JUN/WNT5A/LIG4
GO:0072606,interleukin-8 secretion,2/53,28/18493,0.0029043430221842295,0.015720974027246447,0.009109271391999293,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0009266,response to temperature stimulus,4/53,208/18493,0.002959653977598387,0.01595931328509969,0.00924737333017374,4,bp,NAC,2353/3479/3303/1026,FOS/IGF1/HSPA1A/CDKN1A
GO:0010631,epithelial cell migration,5/53,346/18493,0.0030629754679626403,0.016479085209989048,0.00954854700538961,5,bp,NAC,9314/3164/3725/1969/7474,KLF4/NR4A1/JUN/EPHA2/WNT5A
GO:0060441,epithelial tube branching involved in lung morphogenesis,2/53,29/18493,0.0031137721852923577,0.01660213062023593,0.00961984373506655,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0061311,cell surface receptor signaling pathway involved in heart development,2/53,29/18493,0.0031137721852923577,0.01660213062023593,0.00961984373506655,2,bp,NAC,64321/7474,SOX17/WNT5A
GO:0070306,lens fiber cell differentiation,2/53,29/18493,0.0031137721852923577,0.01660213062023593,0.00961984373506655,2,bp,NAC,4088/1969,SMAD3/EPHA2
GO:0090162,establishment of epithelial cell polarity,2/53,29/18493,0.0031137721852923577,0.01660213062023593,0.00961984373506655,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0035282,segmentation,3/53,102/18493,0.003124546733622271,0.01662230902137307,0.009631535792562235,3,bp,NAC,4088/7474/3280,SMAD3/WNT5A/HES1
GO:0045732,positive regulation of protein catabolic process,4/53,212/18493,0.003168987817935199,0.016821100515736393,0.009746722400557276,4,bp,NAC,3303/64321/7474/324,HSPA1A/SOX17/WNT5A/APC
GO:0090132,epithelium migration,5/53,349/18493,0.0031783286150235943,0.016833107898721843,0.009753679889968083,5,bp,NAC,9314/3164/3725/1969/7474,KLF4/NR4A1/JUN/EPHA2/WNT5A
GO:0014812,muscle cell migration,3/53,103/18493,0.0032118184364933267,0.01693504266514663,0.009812744388772937,3,bp,NAC,3479/80310/3486,IGF1/PDGFD/IGFBP3
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/53,103/18493,0.0032118184364933267,0.01693504266514663,0.009812744388772937,3,bp,NAC,353500/8516/3280,BMP8A/ITGA8/HES1
GO:0007254,JNK cascade,4/53,213/18493,0.003222861478494821,0.016955673884647533,0.009824698824754825,4,bp,NAC,4616/1647/51776/7474,GADD45B/GADD45A/MAP3K20/WNT5A
GO:0019898,extrinsic component of membrane,5/53,287/19659,0.001036491657179804,0.017205761509184746,0.013528943735820597,5,cc,NAC,55970/9021/8835/7472/324,GNG12/SOCS3/SOCS2/WNT2/APC
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",3/53,104/18493,0.0033005763129530267,0.01728804068767026,0.010017283546616074,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,3/53,104/18493,0.0033005763129530267,0.01728804068767026,0.010017283546616074,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:0003209,cardiac atrium morphogenesis,2/53,30/18493,0.0033300818307588163,0.01732808444976907,0.010040486275396271,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0010165,response to X-ray,2/53,30/18493,0.0033300818307588163,0.01732808444976907,0.010040486275396271,2,bp,NAC,3981/1026,LIG4/CDKN1A
GO:0032733,positive regulation of interleukin-10 production,2/53,30/18493,0.0033300818307588163,0.01732808444976907,0.010040486275396271,2,bp,NAC,7097/3082,TLR2/HGF
R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,8/45,455/10554,5.922544930595823e-4,0.01737279846308108,0.013923175801751583,8,re,NAC,3479/10252/80310/6772/3082/1277/1278/1281,IGF1/SPRY1/PDGFD/STAT1/HGF/COL1A1/COL1A2/COL3A1
GO:0090130,tissue migration,5/53,355/18493,0.003418423982004162,0.01774893499826615,0.01028434151331521,5,bp,NAC,9314/3164/3725/1969/7474,KLF4/NR4A1/JUN/EPHA2/WNT5A
GO:0043502,regulation of muscle adaptation,3/53,106/18493,0.003482582927912313,0.018042662750709107,0.010454537444415131,3,bp,NAC,9314/3479/4088,KLF4/IGF1/SMAD3
GO:0003401,axis elongation,2/53,31/18493,0.003553232317696997,0.018249646763463197,0.010574471078470773,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0045648,positive regulation of erythrocyte differentiation,2/53,31/18493,0.003553232317696997,0.018249646763463197,0.010574471078470773,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0048011,neurotrophin TRK receptor signaling pathway,2/53,31/18493,0.003553232317696997,0.018249646763463197,0.010574471078470773,2,bp,NAC,10252/4804,SPRY1/NGFR
GO:1900745,positive regulation of p38MAPK cascade,2/53,31/18493,0.003553232317696997,0.018249646763463197,0.010574471078470773,2,bp,NAC,4616/1647,GADD45B/GADD45A
GO:0044774,mitotic DNA integrity checkpoint,3/53,107/18493,0.0035758475835369202,0.01828680764225978,0.010596003365817385,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0071156,regulation of cell cycle arrest,3/53,107/18493,0.0035758475835369202,0.01828680764225978,0.010596003365817385,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0051054,positive regulation of DNA metabolic process,4/53,220/18493,0.0036176218164435895,0.018460739655585527,0.010696785538117594,4,bp,NAC,9314/3725/3082/4255,KLF4/JUN/HGF/MGMT
GO:0007160,cell-matrix adhesion,4/53,222/18493,0.003736186705822532,0.019024950720441074,0.011023708774758695,4,bp,NAC,3679/4088/8516/1281,ITGA7/SMAD3/ITGA8/COL3A1
GO:0072009,nephron epithelium development,3/53,109/18493,0.003766938629701136,0.019140555686814744,0.011090694256137623,3,bp,NAC,6772/8842/3280,STAT1/PROM1/HES1
GO:0048713,regulation of oligodendrocyte differentiation,2/53,32/18493,0.0037831841684635875,0.01914130202682215,0.011091126711128415,2,bp,NAC,7097/3280,TLR2/HES1
GO:0060317,cardiac epithelial to mesenchymal transition,2/53,32/18493,0.0037831841684635875,0.01914130202682215,0.011091126711128415,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0045088,regulation of innate immune response,5/53,365/18493,0.0038472998372078315,0.01942437157724039,0.01125514691452688,5,bp,NAC,6772/9021/7097/3303/7474,STAT1/SOCS3/TLR2/HSPA1A/WNT5A
GO:0097191,extrinsic apoptotic signaling pathway,4/53,224/18493,0.003857369578651154,0.01943395097040772,0.011260697543386178,4,bp,NAC,3479/4088/3303/3082,IGF1/SMAD3/HSPA1A/HGF
R-HSA-1059683,Interleukin-6 signaling,2/45,11/10554,9.541425453492453e-4,0.01957738265852046,0.01569000763302477,2,re,NAC,6772/9021,STAT1/SOCS3
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/45,42/10554,7.403327539204869e-4,0.01957738265852046,0.01569000763302477,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-2586552,Signaling by Leptin,2/45,11/10554,9.541425453492453e-4,0.01957738265852046,0.01569000763302477,2,re,NAC,3953/9021,LEPR/SOCS3
R-HSA-450341,Activation of the AP-1 family of transcription factors,2/45,10/10554,7.827840729564919e-4,0.01957738265852046,0.01569000763302477,2,re,NAC,2353/3725,FOS/JUN
R-HSA-5663202,Diseases of signal transduction,7/45,378/10554,0.0010011161586743417,0.01957738265852046,0.01569000763302477,7,re,NAC,3164/6772/4088/3082/1026/324/3280,NR4A1/STAT1/SMAD3/HGF/CDKN1A/APC/HES1
R-HSA-8948216,Collagen chain trimerization,3/45,44/10554,8.490246817673232e-4,0.01957738265852046,0.01569000763302477,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0001774,microglial cell activation,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,3725/7097,JUN/TLR2
GO:0002065,columnar/cuboidal epithelial cell differentiation,3/53,111/18493,0.003964162878613329,0.019791547838275195,0.011467901429906703,3,bp,NAC,7474/1026/3280,WNT5A/CDKN1A/HES1
GO:0002269,leukocyte activation involved in inflammatory response,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,3725/7097,JUN/TLR2
GO:0003338,metanephros morphogenesis,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,6772/3280,STAT1/HES1
GO:0010092,specification of animal organ identity,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0010906,regulation of glucose metabolic process,3/53,111/18493,0.003964162878613329,0.019791547838275195,0.011467901429906703,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0031128,developmental induction,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0046854,phosphatidylinositol phosphorylation,3/53,111/18493,0.003964162878613329,0.019791547838275195,0.011467901429906703,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0060603,mammary gland duct morphogenesis,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0071354,cellular response to interleukin-6,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:0097009,energy homeostasis,2/53,33/18493,0.004019898068076922,0.019791547838275195,0.011467901429906703,2,bp,NAC,3953/353500,LEPR/BMP8A
GO:0046822,regulation of nucleocytoplasmic transport,3/53,112/18493,0.004065093667759768,0.019972712276720515,0.01157287431730652,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:1904018,positive regulation of vasculature development,4/53,228/18493,0.00410769887959852,0.020140428733371712,0.011670054982950545,4,bp,NAC,9314/80310/3082/7474,KLF4/PDGFD/HGF/WNT5A
R-HSA-430116,GP1b-IX-V activation signalling,2/45,12/10554,0.0011418680842031081,0.02048051675012217,0.016413811271030927,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,3/45,49/10554,0.0011636657244387596,0.02048051675012217,0.016413811271030927,3,re,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0003230,cardiac atrium development,2/53,34/18493,0.004263334863637255,0.020732536412534544,0.012013142474440141,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0032148,activation of protein kinase B activity,2/53,34/18493,0.004263334863637255,0.020732536412534544,0.012013142474440141,2,bp,NAC,3479/7474,IGF1/WNT5A
GO:0046627,negative regulation of insulin receptor signaling pathway,2/53,34/18493,0.004263334863637255,0.020732536412534544,0.012013142474440141,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:1900077,negative regulation of cellular response to insulin stimulus,2/53,34/18493,0.004263334863637255,0.020732536412534544,0.012013142474440141,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0042176,regulation of protein catabolic process,5/53,375/18493,0.004313605193593914,0.02084909176903725,0.012080678644446802,5,bp,NAC,4088/3303/64321/7474/324,SMAD3/HSPA1A/SOX17/WNT5A/APC
GO:0097305,response to alcohol,4/53,231/18493,0.004302520978779442,0.02084909176903725,0.012080678644446802,4,bp,NAC,2353/9314/4255/1026,FOS/KLF4/MGMT/CDKN1A
GO:1901990,regulation of mitotic cell cycle phase transition,5/53,375/18493,0.004313605193593914,0.02084909176903725,0.012080678644446802,5,bp,NAC,9314/1647/2810/1026/324,KLF4/GADD45A/SFN/CDKN1A/APC
GO:0046488,phosphatidylinositol metabolic process,4/53,233/18493,0.004435822013544812,0.02139631794768674,0.012397760255642489,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
GO:0007368,determination of left/right symmetry,3/53,116/18493,0.0044844441330284856,0.02155220347509035,0.01248808567522167,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0035909,aorta morphogenesis,2/53,35/18493,0.004513455563748946,0.02155220347509035,0.01248808567522167,2,bp,NAC,1281/3280,COL3A1/HES1
GO:0051385,response to mineralocorticoid,2/53,35/18493,0.004513455563748946,0.02155220347509035,0.01248808567522167,2,bp,NAC,2353/1026,FOS/CDKN1A
GO:0071542,dopaminergic neuron differentiation,2/53,35/18493,0.004513455563748946,0.02155220347509035,0.01248808567522167,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0110111,negative regulation of animal organ morphogenesis,2/53,35/18493,0.004513455563748946,0.02155220347509035,0.01248808567522167,2,bp,NAC,6772/7474,STAT1/WNT5A
hsa05167,Kaposi sarcoma-associated herpesvirus infection,5/50,186/7852,0.0063176820296346504,0.021641421420663377,0.012592916027715206,5,kg,NAC,2353/3725/6772/55970/1026,FOS/JUN/STAT1/GNG12/CDKN1A
GO:0003705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",3/52,108/17632,0.003971873396393271,0.021845303680162992,0.014303145194768014,3,mf,NAC,3725/7704/64321,JUN/ZBTB16/SOX17
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,3/53,117/18493,0.0045932239444902035,0.02188915138276093,0.01268332484619276,3,bp,NAC,4088/3303/8516,SMAD3/HSPA1A/ITGA8
GO:0010742,macrophage derived foam cell differentiation,2/53,36/18493,0.004770221337944515,0.022596785541099715,0.013093352340887756,2,bp,NAC,5320/6772,PLA2G2A/STAT1
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,2/53,36/18493,0.004770221337944515,0.022596785541099715,0.013093352340887756,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0090077,foam cell differentiation,2/53,36/18493,0.004770221337944515,0.022596785541099715,0.013093352340887756,2,bp,NAC,5320/6772,PLA2G2A/STAT1
GO:0034329,cell junction assembly,4/53,238/18493,0.004781237637665772,0.02260394254944176,0.013097499356920575,4,bp,NAC,2318/4088/1969/324,FLNC/SMAD3/EPHA2/APC
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,3/53,119/18493,0.004815562384943058,0.02272104633213213,0.013165353303864796,3,bp,NAC,4088/3303/8516,SMAD3/HSPA1A/ITGA8
GO:0030291,protein serine/threonine kinase inhibitor activity,2/52,33/17632,0.004248392970115778,0.022767028993697373,0.014906642000406239,2,mf,NAC,2810/1026,SFN/CDKN1A
GO:0042826,histone deacetylase binding,3/52,112/17632,0.004397731589246859,0.022978147553814835,0.015044871226370835,3,mf,NAC,9314/3303/3280,KLF4/HSPA1A/HES1
GO:0022612,gland morphogenesis,3/53,120/18493,0.0049291344042350855,0.023164983425436825,0.013422585677436505,3,bp,NAC,1969/3082/7474,EPHA2/HGF/WNT5A
GO:0043500,muscle adaptation,3/53,120/18493,0.0049291344042350855,0.023164983425436825,0.013422585677436505,3,bp,NAC,9314/3479/4088,KLF4/IGF1/SMAD3
GO:0022407,regulation of cell-cell adhesion,5/53,388/18493,0.004978658937916238,0.02335157979164658,0.01353070601003292,5,bp,NAC,9314/3479/7704/7474/3280,KLF4/IGF1/ZBTB16/WNT5A/HES1
GO:0002687,positive regulation of leukocyte migration,3/53,121/18493,0.005044317061329793,0.02338281865856189,0.013548806880641634,3,bp,NAC,80310/3554/7474,PDGFD/IL1R1/WNT5A
GO:0045667,regulation of osteoblast differentiation,3/53,121/18493,0.005044317061329793,0.02338281865856189,0.013548806880641634,3,bp,NAC,3479/4088/3082,IGF1/SMAD3/HGF
GO:0048009,insulin-like growth factor receptor signaling pathway,2/53,37/18493,0.005033593516110548,0.02338281865856189,0.013548806880641634,2,bp,NAC,3479/3486,IGF1/IGFBP3
GO:0070741,response to interleukin-6,2/53,37/18493,0.005033593516110548,0.02338281865856189,0.013548806880641634,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:0071276,cellular response to cadmium ion,2/53,37/18493,0.005033593516110548,0.02338281865856189,0.013548806880641634,2,bp,NAC,2353/3725,FOS/JUN
GO:1900180,regulation of protein localization to nucleus,3/53,121/18493,0.005044317061329793,0.02338281865856189,0.013548806880641634,3,bp,NAC,3479/4804/4088,IGF1/NGFR/SMAD3
GO:0048545,response to steroid hormone,5/53,390/18493,0.005087099636927401,0.0235352586315435,0.013637135827847572,5,bp,NAC,2353/3164/7097/1277/1026,FOS/NR4A1/TLR2/COL1A1/CDKN1A
GO:2001233,regulation of apoptotic signaling pathway,5/53,391/18493,0.005141946436669842,0.023742812866797837,0.01375739986837164,5,bp,NAC,3479/4088/3303/3082/2810,IGF1/SMAD3/HSPA1A/HGF/SFN
GO:0032570,response to progesterone,2/53,38/18493,0.005303533587915553,0.02420691530146485,0.014026316732157712,2,bp,NAC,2353/7097,FOS/TLR2
GO:0032675,regulation of interleukin-6 production,3/53,123/18493,0.005279540050571226,0.02420691530146485,0.014026316732157712,3,bp,NAC,7097/3082/7474,TLR2/HGF/WNT5A
GO:0032731,positive regulation of interleukin-1 beta production,2/53,38/18493,0.005303533587915553,0.02420691530146485,0.014026316732157712,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0045687,positive regulation of glial cell differentiation,2/53,38/18493,0.005303533587915553,0.02420691530146485,0.014026316732157712,2,bp,NAC,7097/3280,TLR2/HES1
GO:0070374,positive regulation of ERK1 and ERK2 cascade,4/53,245/18493,0.005294654452387676,0.02420691530146485,0.014026316732157712,4,bp,NAC,5320/3725/80310/1969,PLA2G2A/JUN/PDGFD/EPHA2
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/53,123/18493,0.005279540050571226,0.02420691530146485,0.014026316732157712,3,bp,NAC,4088/3303/7474,SMAD3/HSPA1A/WNT5A
GO:0009855,determination of bilateral symmetry,3/53,124/18493,0.005399593034829386,0.024598146047556092,0.014253009240959201,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0007611,learning or memory,4/53,247/18493,0.005447874178870346,0.024770640147903786,0.01435295823717678,4,bp,NAC,2353/3725/7097/8516,FOS/JUN/TLR2/ITGA8
GO:0009799,specification of symmetry,3/53,125/18493,0.005521281962231818,0.024792167501569515,0.014365431924020405,3,bp,NAC,4088/64321/7474,SMAD3/SOX17/WNT5A
GO:0021537,telencephalon development,4/53,248/18493,0.005525588215236267,0.024792167501569515,0.014365431924020405,4,bp,NAC,55970/7474/1281/3280,GNG12/WNT5A/COL3A1/HES1
GO:0030326,embryonic limb morphogenesis,3/53,125/18493,0.005521281962231818,0.024792167501569515,0.014365431924020405,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0035113,embryonic appendage morphogenesis,3/53,125/18493,0.005521281962231818,0.024792167501569515,0.014365431924020405,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0045785,positive regulation of cell adhesion,5/53,397/18493,0.005479907094003082,0.024792167501569515,0.014365431924020405,5,bp,NAC,3479/7704/4088/7474/3280,IGF1/ZBTB16/SMAD3/WNT5A/HES1
GO:0046834,lipid phosphorylation,3/53,125/18493,0.005521281962231818,0.024792167501569515,0.014365431924020405,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0048706,embryonic skeletal system development,3/53,125/18493,0.005521281962231818,0.024792167501569515,0.014365431924020405,3,bp,NAC,4088/1277/7474,SMAD3/COL1A1/WNT5A
GO:0007257,activation of JUN kinase activity,2/53,39/18493,0.005580003202239635,0.024942194764898215,0.01445236286452648,2,bp,NAC,51776/7474,MAP3K20/WNT5A
GO:0038179,neurotrophin signaling pathway,2/53,39/18493,0.005580003202239635,0.024942194764898215,0.01445236286452648,2,bp,NAC,10252/4804,SPRY1/NGFR
GO:0005581,collagen trimer,3/53,87/19659,0.0016715099958884696,0.025224605392498725,0.019834185597145476,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0010951,negative regulation of endopeptidase activity,4/53,250/18493,0.005683240426415816,0.025355995748624408,0.014692133342901755,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0022409,positive regulation of cell-cell adhesion,4/53,251/18493,0.005763184881596164,0.02566177587963518,0.01486931283539571,4,bp,NAC,3479/7704/7474/3280,IGF1/ZBTB16/WNT5A/HES1
GO:0051222,positive regulation of protein transport,5/53,402/18493,0.005773360006562161,0.02566177587963518,0.01486931283539571,5,bp,NAC,3479/4088/7097/2810/7474,IGF1/SMAD3/TLR2/SFN/WNT5A
GO:0021532,neural tube patterning,2/53,40/18493,0.005862964166605972,0.025914737524514876,0.015015887485985558,2,bp,NAC,64321/3280,SOX17/HES1
GO:0061900,glial cell activation,2/53,40/18493,0.005862964166605972,0.025914737524514876,0.015015887485985558,2,bp,NAC,3725/7097,JUN/TLR2
GO:0090184,positive regulation of kidney development,2/53,40/18493,0.005862964166605972,0.025914737524514876,0.015015887485985558,2,bp,NAC,80310/8842,PDGFD/PROM1
GO:0030010,establishment of cell polarity,3/53,128/18493,0.0058962249550246785,0.02596522767231238,0.015045143208825159,3,bp,NAC,10252/7474/3280,SPRY1/WNT5A/HES1
GO:0035270,endocrine system development,3/53,128/18493,0.0058962249550246785,0.02596522767231238,0.015045143208825159,3,bp,NAC,4088/7474/3280,SMAD3/WNT5A/HES1
GO:0043491,protein kinase B signaling,4/53,253/18493,0.005925326099890187,0.0260451487348223,0.01509145221277606,4,bp,NAC,9314/3479/1969/3082,KLF4/IGF1/EPHA2/HGF
R-HSA-877312,Regulation of IFNG signaling,2/45,14/10554,0.0015658754345082761,0.026247054902233963,0.021035319120211428,2,re,NAC,6772/9021,STAT1/SOCS3
R-HSA-2214320,Anchoring fibril formation,2/45,15/10554,0.0018018868314153556,0.026427673527425213,0.021180073281548917,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-75892,Platelet Adhesion to exposed collagen,2/45,15/10554,0.0018018868314153556,0.026427673527425213,0.021180073281548917,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-8878166,Transcriptional regulation by RUNX2,4/45,121/10554,0.0017038771136692473,0.026427673527425213,0.021180073281548917,4,re,NAC,6772/1277/1026/3280,STAT1/COL1A1/CDKN1A/HES1
GO:0003206,cardiac chamber morphogenesis,3/53,129/18493,0.006024517761515512,0.026432293794988723,0.015315777335062744,3,bp,NAC,7472/7474/3280,WNT2/WNT5A/HES1
GO:0009896,positive regulation of catabolic process,5/53,407/18493,0.006077787553109153,0.02661690386978557,0.015422746742308584,5,bp,NAC,3479/3303/64321/7474/324,IGF1/HSPA1A/SOX17/WNT5A/APC
GO:0017145,stem cell division,2/53,41/18493,0.006152378446614339,0.02670683251096884,0.01547485448048259,2,bp,NAC,7704/64321,ZBTB16/SOX17
GO:0042770,signal transduction in response to DNA damage,3/53,130/18493,0.006154476121114771,0.02670683251096884,0.01547485448048259,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0050921,positive regulation of chemotaxis,3/53,130/18493,0.006154476121114771,0.02670683251096884,0.01547485448048259,3,bp,NAC,80310/4088/7474,PDGFD/SMAD3/WNT5A
GO:0072210,metanephric nephron development,2/53,41/18493,0.006152378446614339,0.02670683251096884,0.01547485448048259,2,bp,NAC,6772/3280,STAT1/HES1
GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,2/53,41/18493,0.006152378446614339,0.02670683251096884,0.01547485448048259,2,bp,NAC,3303/2810,HSPA1A/SFN
R-HSA-186797,Signaling by PDGF,3/45,58/10554,0.0018974596996501033,0.026716232571073455,0.021411334716051694,3,re,NAC,80310/6772/1281,PDGFD/STAT1/COL3A1
R-HSA-3000171,Non-integrin membrane-ECM interactions,3/45,59/10554,0.0019931834095282537,0.026984636928997895,0.021626443471804535,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0042056,chemoattractant activity,2/52,37/17632,0.005318612769046673,0.027111952895872066,0.017751467521850257,2,mf,NAC,3082/7474,HGF/WNT5A
GO:0031668,cellular response to extracellular stimulus,4/53,258/18493,0.006343961838254887,0.027478945813060332,0.01592224340192819,4,bp,NAC,2353/3725/1277/1026,FOS/JUN/COL1A1/CDKN1A
GO:0008286,insulin receptor signaling pathway,3/53,132/18493,0.006419412044594672,0.027628538769846354,0.01600892269033194,3,bp,NAC,9021/8835/324,SOCS3/SOCS2/APC
GO:0032635,interleukin-6 production,3/53,132/18493,0.006419412044594672,0.027628538769846354,0.01600892269033194,3,bp,NAC,7097/3082/7474,TLR2/HGF/WNT5A
GO:0042307,positive regulation of protein import into nucleus,2/53,42/18493,0.006448208165376252,0.027628538769846354,0.01600892269033194,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0045429,positive regulation of nitric oxide biosynthetic process,2/53,42/18493,0.006448208165376252,0.027628538769846354,0.01600892269033194,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:1901987,regulation of cell cycle phase transition,5/53,412/18493,0.006393404124138967,0.027628538769846354,0.01600892269033194,5,bp,NAC,9314/1647/2810/1026/324,KLF4/GADD45A/SFN/CDKN1A/APC
GO:1904407,positive regulation of nitric oxide metabolic process,2/53,42/18493,0.006448208165376252,0.027628538769846354,0.01600892269033194,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:0050729,positive regulation of inflammatory response,3/53,133/18493,0.006554400664602431,0.02803303018061975,0.016243298882931814,3,bp,NAC,5320/7097/7474,PLA2G2A/TLR2/WNT5A
hsa05223,Non-small cell lung cancer,3/50,66/7852,0.008389967862551787,0.028141350538975783,0.016375156573840113,3,kg,NAC,4616/1647/1026,GADD45B/GADD45A/CDKN1A
GO:0010466,negative regulation of peptidase activity,4/53,261/18493,0.006604373650013148,0.028196051238296705,0.016337758873414366,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0005719,nuclear euchromatin,2/53,25/19659,0.0020560878183915926,0.028442548154417033,0.022364463989522586,2,cc,NAC,9314/3725,KLF4/JUN
GO:0010675,regulation of cellular carbohydrate metabolic process,3/53,134/18493,0.006691076951045522,0.028515019694599016,0.016522580133783417,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,3/45,61/10554,0.0021935496191670192,0.028597387627658916,0.022918958983889324,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0010470,regulation of gastrulation,2/53,43/18493,0.0067504156029521145,0.028665157685393083,0.016609575233579546,2,bp,NAC,9314/64321,KLF4/SOX17
GO:0021983,pituitary gland development,2/53,43/18493,0.0067504156029521145,0.028665157685393083,0.016609575233579546,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0000082,G1/S transition of mitotic cell cycle,4/53,263/18493,0.006781877803493223,0.028747424985217266,0.016657243727878097,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
GO:0005109,frizzled binding,2/52,39/17632,0.005895355834051866,0.029010986037880736,0.018994853613319044,2,mf,NAC,7472/7474,WNT2/WNT5A
GO:0019955,cytokine binding,3/52,125/17632,0.005968767462339099,0.029010986037880736,0.018994853613319044,3,mf,NAC,3977/3953/3554,LIFR/LEPR/IL1R1
GO:0035850,epithelial cell differentiation involved in kidney development,2/53,44/18493,0.007058963195790171,0.029762791630476994,0.017245581977023767,2,bp,NAC,6772/8842,STAT1/PROM1
GO:0043542,endothelial cell migration,4/53,266/18493,0.007054037958150636,0.029762791630476994,0.017245581977023767,4,bp,NAC,9314/3164/1969/7474,KLF4/NR4A1/EPHA2/WNT5A
GO:1904591,positive regulation of protein import,2/53,44/18493,0.007058963195790171,0.029762791630476994,0.017245581977023767,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0002440,production of molecular mediator of immune response,4/53,268/18493,0.007239448338412764,0.03046974893583284,0.01765521727989252,4,bp,NAC,3554/7097/7474/3981,IL1R1/TLR2/WNT5A/LIG4
R-HSA-1442490,Collagen degradation,3/45,64/10554,0.002516870341144888,0.030557665472831598,0.02448999505597748,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-2243919,Crosslinking of collagen fibrils,2/45,18/10554,0.002604346489161784,0.030557665472831598,0.02448999505597748,2,re,NAC,1277/1278,COL1A1/COL1A2
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,2/45,18/10554,0.002604346489161784,0.030557665472831598,0.02448999505597748,2,re,NAC,1647/2810,GADD45A/SFN
GO:0005942,phosphatidylinositol 3-kinase complex,2/53,27/19659,0.0023973431920675434,0.030612228452554787,0.024070490349504082,2,cc,NAC,9021/8835,SOCS3/SOCS2
GO:0014911,positive regulation of smooth muscle cell migration,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,3479/80310,IGF1/PDGFD
GO:0031018,endocrine pancreas development,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0032653,regulation of interleukin-10 production,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,7097/3082,TLR2/HGF
GO:0032732,positive regulation of interleukin-1 production,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0035987,endodermal cell differentiation,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,3679/64321,ITGA7/SOX17
GO:0060412,ventricular septum morphogenesis,2/53,45/18493,0.007373813536167249,0.030709156898433832,0.017793938462241556,2,bp,NAC,7474/3280,WNT5A/HES1
hsa04015,Rap1 signaling pathway,5/50,206/7852,0.009624976093026169,0.030992423019544264,0.018034165732196402,5,kg,NAC,3479/80310/4804/1969/3082,IGF1/PDGFD/NGFR/EPHA2/HGF
hsa05211,Renal cell carcinoma,3/50,69/7852,0.009479194585519731,0.030992423019544264,0.018034165732196402,3,kg,NAC,3725/3082/1026,JUN/HGF/CDKN1A
GO:0021700,developmental maturation,4/53,271/18493,0.007523577505331175,0.03127808969873695,0.018123597634299795,4,bp,NAC,3479/7474/1026/3280,IGF1/WNT5A/CDKN1A/HES1
GO:0007612,learning,3/53,141/18493,0.007695501406724872,0.03160604895542616,0.0183136284726895,3,bp,NAC,2353/3725/7097,FOS/JUN/TLR2
GO:0030857,negative regulation of epithelial cell differentiation,2/53,46/18493,0.007694929371631396,0.03160604895542616,0.0183136284726895,2,bp,NAC,6772/3280,STAT1/HES1
GO:0031103,axon regeneration,2/53,46/18493,0.007694929371631396,0.03160604895542616,0.0183136284726895,2,bp,NAC,9314/3725,KLF4/JUN
GO:0031952,regulation of protein autophosphorylation,2/53,46/18493,0.007694929371631396,0.03160604895542616,0.0183136284726895,2,bp,NAC,3725/80310,JUN/PDGFD
GO:0060443,mammary gland morphogenesis,2/53,46/18493,0.007694929371631396,0.03160604895542616,0.0183136284726895,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0071236,cellular response to antibiotic,3/53,141/18493,0.007695501406724872,0.03160604895542616,0.0183136284726895,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0090102,cochlea development,2/53,46/18493,0.007694929371631396,0.03160604895542616,0.0183136284726895,2,bp,NAC,7474/3280,WNT5A/HES1
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,3/45,67/10554,0.0028682472075379326,0.03193153643762637,0.025591063891399125,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",2/45,19/10554,0.0029028669488751243,0.03193153643762637,0.025591063891399125,2,re,NAC,9314/3479,KLF4/IGF1
GO:1902107,positive regulation of leukocyte differentiation,3/53,142/18493,0.007845863291128399,0.032168039493626434,0.018639265060049138,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0002067,glandular epithelial cell differentiation,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0002720,positive regulation of cytokine production involved in immune response,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0009948,anterior/posterior axis specification,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,2114/7474,ETS2/WNT5A
GO:0032613,interleukin-10 production,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,7097/3082,TLR2/HGF
GO:0045646,regulation of erythrocyte differentiation,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0055023,positive regulation of cardiac muscle tissue growth,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0090199,regulation of release of cytochrome c from mitochondria,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,3479/3082,IGF1/HGF
GO:0150076,neuroinflammatory response,2/53,47/18493,0.008022273604446274,0.03244382080165517,0.01879906220590794,2,bp,NAC,3725/7097,JUN/TLR2
GO:0019827,stem cell population maintenance,3/53,144/18493,0.00815178910493686,0.03285585507040653,0.01903780898904969,3,bp,NAC,9314/3981/3280,KLF4/LIG4/HES1
GO:1904951,positive regulation of establishment of protein localization,5/53,437/18493,0.008146725914273534,0.03285585507040653,0.01903780898904969,5,bp,NAC,3479/4088/7097/2810/7474,IGF1/SMAD3/TLR2/SFN/WNT5A
hsa04210,Apoptosis,4/50,136/7852,0.010713014795079795,0.033169141961689366,0.01930077564295753,4,kg,NAC,2353/3725/4616/1647,FOS/JUN/GADD45B/GADD45A
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),3/50,72/7852,0.010647487391396357,0.033169141961689366,0.01930077564295753,3,kg,NAC,3679/781/8516,ITGA7/CACNA2D1/ITGA8
GO:0009408,response to heat,3/53,145/18493,0.00830736209704389,0.03340880876357956,0.01935820931854528,3,bp,NAC,3479/3303/1026,IGF1/HSPA1A/CDKN1A
GO:0050768,negative regulation of neurogenesis,4/53,279/18493,0.0083170793894193,0.03340880876357956,0.01935820931854528,4,bp,NAC,4804/7474/1281/3280,NGFR/WNT5A/COL3A1/HES1
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,2/53,48/18493,0.00835580929103746,0.03350778160891582,0.019415557578713123,2,bp,NAC,3725/3479,JUN/IGF1
GO:0035326,enhancer binding,3/52,133/17632,0.007082477935327715,0.03364177019280665,0.022026845253411555,3,mf,NAC,3725/7704/4088,JUN/ZBTB16/SMAD3
GO:0035107,appendage morphogenesis,3/53,146/18493,0.008464681054994492,0.033716937267633,0.01953674953890116,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0035108,limb morphogenesis,3/53,146/18493,0.008464681054994492,0.033716937267633,0.01953674953890116,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0051092,positive regulation of NF-kappaB transcription factor activity,3/53,146/18493,0.008464681054994492,0.033716937267633,0.01953674953890116,3,bp,NAC,7097/3303/7474,TLR2/HSPA1A/WNT5A
GO:0051592,response to calcium ion,3/53,146/18493,0.008464681054994492,0.033716937267633,0.01953674953890116,3,bp,NAC,2353/3725/7474,FOS/JUN/WNT5A
hsa04810,Regulation of actin cytoskeleton,5/50,214/7852,0.011231962198499984,0.034119734225632026,0.019853915306186666,5,kg,NAC,80310/55970/3679/8516/324,PDGFD/GNG12/ITGA7/ITGA8/APC
GO:0044843,cell cycle G1/S phase transition,4/53,282/18493,0.008628292236805954,0.03431116879452267,0.019881067660586157,4,bp,NAC,9314/1647/2810/1026,KLF4/GADD45A/SFN/CDKN1A
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,2/45,20/10554,0.0032166857360023463,0.03431131451735836,0.027498302304581463,2,re,NAC,4088/3280,SMAD3/HES1
GO:0010718,positive regulation of epithelial to mesenchymal transition,2/53,49/18493,0.008695499641440424,0.034348668018846056,0.019902795996932187,2,bp,NAC,4088/1277,SMAD3/COL1A1
GO:0032330,regulation of chondrocyte differentiation,2/53,49/18493,0.008695499641440424,0.034348668018846056,0.019902795996932187,2,bp,NAC,7704/4088,ZBTB16/SMAD3
GO:0060324,face development,2/53,49/18493,0.008695499641440424,0.034348668018846056,0.019902795996932187,2,bp,NAC,1277/7474,COL1A1/WNT5A
GO:0072132,mesenchyme morphogenesis,2/53,49/18493,0.008695499641440424,0.034348668018846056,0.019902795996932187,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0042133,neurotransmitter metabolic process,3/53,148/18493,0.00878457412184839,0.03464298053359117,0.020073330759360294,3,bp,NAC,9314/4088/7097,KLF4/SMAD3/TLR2
GO:0010632,regulation of epithelial cell migration,4/53,284/18493,0.00883996318504662,0.034803696115961694,0.020166454878400186,4,bp,NAC,9314/3725/1969/7474,KLF4/JUN/EPHA2/WNT5A
GO:0001890,placenta development,3/53,149/18493,0.008947156661838622,0.0351094695410103,0.020343630485229736,3,bp,NAC,9021/7472/3280,SOCS3/WNT2/HES1
GO:0050890,cognition,4/53,285/18493,0.008947065459657637,0.0351094695410103,0.020343630485229736,4,bp,NAC,2353/3725/7097/8516,FOS/JUN/TLR2/ITGA8
GO:0001706,endoderm formation,2/53,50/18493,0.009041308018750496,0.03536222116544191,0.020490083442770778,2,bp,NAC,3679/64321,ITGA7/SOX17
GO:0060425,lung morphogenesis,2/53,50/18493,0.009041308018750496,0.03536222116544191,0.020490083442770778,2,bp,NAC,10252/7472,SPRY1/WNT2
GO:0031214,biomineral tissue development,3/53,150/18493,0.009111502030841214,0.035519921031705586,0.020581460152495512,3,bp,NAC,3479/4088/1277,IGF1/SMAD3/COL1A1
GO:1990845,adaptive thermogenesis,3/53,150/18493,0.009111502030841214,0.035519921031705586,0.020581460152495512,3,bp,NAC,3953/353500/324,LEPR/BMP8A/APC
GO:0034330,cell junction organization,4/53,287/18493,0.009163816943621977,0.0356071187776684,0.02063198551634188,4,bp,NAC,2318/4088/1969/324,FLNC/SMAD3/EPHA2/APC
GO:0097193,intrinsic apoptotic signaling pathway,4/53,287/18493,0.009163816943621977,0.0356071187776684,0.02063198551634188,4,bp,NAC,1969/3303/2810/1026,EPHA2/HSPA1A/SFN/CDKN1A
GO:0060421,positive regulation of heart growth,2/53,51/18493,0.009393197938574441,0.03632036536248784,0.021045265043378596,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0097345,mitochondrial outer membrane permeabilization,2/53,51/18493,0.009393197938574441,0.03632036536248784,0.021045265043378596,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:2000677,regulation of transcription regulatory region DNA binding,2/53,51/18493,0.009393197938574441,0.03632036536248784,0.021045265043378596,2,bp,NAC,9314/3479,KLF4/IGF1
GO:0030168,platelet activation,3/53,152/18493,0.009445497268030806,0.03646329951846958,0.02112808599427944,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",4/52,267/17632,0.007874732851891159,0.036573759245450053,0.02394655604083861,4,mf,NAC,7704/2114/51513/3280,ZBTB16/ETS2/ETV7/HES1
GO:1990841,promoter-specific chromatin binding,2/52,46/17632,0.00812688632590839,0.03692433135032291,0.024176092045036405,2,mf,NAC,9314/6772,KLF4/STAT1
GO:0000791,euchromatin,2/53,33/19659,0.003569179208041452,0.03739156324765477,0.02940110236340641,2,cc,NAC,9314/3725,KLF4/JUN
GO:0008305,integrin complex,2/53,32/19659,0.0033586432571153088,0.03739156324765477,0.02940110236340641,2,cc,NAC,3679/8516,ITGA7/ITGA8
GO:0016607,nuclear speck,5/53,382/19659,0.0036040060961594956,0.03739156324765477,0.02940110236340641,5,cc,NAC,1647/7704/3303/79882/23451,GADD45A/ZBTB16/HSPA1A/ZC3H14/SF3B1
GO:0000186,activation of MAPKK activity,2/53,52/18493,0.009751133068483983,0.03746073414677691,0.02170603381795006,2,bp,NAC,4616/51776,GADD45B/MAP3K20
GO:0002763,positive regulation of myeloid leukocyte differentiation,2/53,52/18493,0.009751133068483983,0.03746073414677691,0.02170603381795006,2,bp,NAC,2353/3725,FOS/JUN
GO:0021879,forebrain neuron differentiation,2/53,52/18493,0.009751133068483983,0.03746073414677691,0.02170603381795006,2,bp,NAC,7474/3280,WNT5A/HES1
GO:1903037,regulation of leukocyte cell-cell adhesion,4/53,293/18493,0.009834636043824847,0.037720587922928206,0.021856602005716003,4,bp,NAC,9314/3479/7704/3280,KLF4/IGF1/ZBTB16/HES1
GO:0045216,cell-cell junction organization,3/53,155/18493,0.009959809420289237,0.038077856593967535,0.022063615723741097,3,bp,NAC,4088/1969/324,SMAD3/EPHA2/APC
GO:0071695,anatomical structure maturation,3/53,155/18493,0.009959809420289237,0.038077856593967535,0.022063615723741097,3,bp,NAC,3479/7474/1026,IGF1/WNT5A/CDKN1A
GO:0001664,G protein-coupled receptor binding,4/52,274/17632,0.008608092188764542,0.03827853760535722,0.02506275441297627,4,mf,NAC,6772/3303/7472/7474,STAT1/HSPA1A/WNT2/WNT5A
GO:0010332,response to gamma radiation,2/53,53/18493,0.010115077227471037,0.0384243668481248,0.02226439564614022,2,bp,NAC,51776/3981,MAP3K20/LIG4
GO:0032722,positive regulation of chemokine production,2/53,53/18493,0.010115077227471037,0.0384243668481248,0.02226439564614022,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0046579,positive regulation of Ras protein signal transduction,2/53,53/18493,0.010115077227471037,0.0384243668481248,0.02226439564614022,2,bp,NAC,3479/1281,IGF1/COL3A1
GO:0070830,bicellular tight junction assembly,2/53,53/18493,0.010115077227471037,0.0384243668481248,0.02226439564614022,2,bp,NAC,1969/324,EPHA2/APC
GO:2001236,regulation of extrinsic apoptotic signaling pathway,3/53,156/18493,0.010134813569278143,0.03843793726912827,0.0222722588133721,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
GO:1901214,regulation of neuron death,4/53,296/18493,0.010181741120145903,0.038554427362590696,0.022339757167735484,4,bp,NAC,2353/3725/7474/3981,FOS/JUN/WNT5A/LIG4
GO:0098636,protein complex involved in cell adhesion,2/53,35/19659,0.004008263560132542,0.039139514763647174,0.030775522071605894,2,cc,NAC,3679/8516,ITGA7/ITGA8
GO:0045123,cellular extravasation,2/53,54/18493,0.01048499438540475,0.039471013073429644,0.022870858356477983,2,bp,NAC,80310/3554,PDGFD/IL1R1
GO:0070206,protein trimerization,2/53,54/18493,0.01048499438540475,0.039471013073429644,0.022870858356477983,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0090316,positive regulation of intracellular protein transport,3/53,158/18493,0.010490193550213429,0.039471013073429644,0.022870858356477983,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0120192,tight junction assembly,2/53,54/18493,0.01048499438540475,0.039471013073429644,0.022870858356477983,2,bp,NAC,1969/324,EPHA2/APC
GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2/53,55/18493,0.010860848662490348,0.04060864484182712,0.02353004121019508,2,bp,NAC,4804/1969,NGFR/EPHA2
GO:0051898,negative regulation of protein kinase B signaling,2/53,55/18493,0.010860848662490348,0.04060864484182712,0.02353004121019508,2,bp,NAC,9314/1969,KLF4/EPHA2
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,2/53,55/18493,0.010860848662490348,0.04060864484182712,0.02353004121019508,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:2000242,negative regulation of reproductive process,2/53,55/18493,0.010860848662490348,0.04060864484182712,0.02353004121019508,2,bp,NAC,3479/7474,IGF1/WNT5A
hsa01521,EGFR tyrosine kinase inhibitor resistance,3/50,79/7852,0.013686703533325515,0.04080665312713718,0.023744963244950706,3,kg,NAC,3479/80310/3082,IGF1/PDGFD/HGF
GO:0048871,multicellular organismal homeostasis,5/53,471/18493,0.011035134246317815,0.041195524706034166,0.023870099526448023,5,bp,NAC,3953/353500/2810/324/8842,LEPR/BMP8A/SFN/APC/PROM1
GO:0006109,regulation of carbohydrate metabolic process,3/53,162/18493,0.011222535613565631,0.041705257166648,0.02416545599182959,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0006644,phospholipid metabolic process,5/53,473/18493,0.011224291247541932,0.041705257166648,0.02416545599182959,5,bp,NAC,9314/5320/9021/8835/3082,KLF4/PLA2G2A/SOCS3/SOCS2/HGF
GO:0051302,regulation of cell division,3/53,162/18493,0.011222535613565631,0.041705257166648,0.02416545599182959,3,bp,NAC,80310/64321/2810,PDGFD/SOX17/SFN
GO:0035904,aorta development,2/53,56/18493,0.01124260432872966,0.0417081327515119,0.02416712220429777,2,bp,NAC,1281/3280,COL3A1/HES1
GO:0002066,columnar/cuboidal epithelial cell development,2/53,57/18493,0.011630225803383557,0.042878568930924184,0.024845313058554187,2,bp,NAC,7474/1026,WNT5A/CDKN1A
GO:0046626,regulation of insulin receptor signaling pathway,2/53,57/18493,0.011630225803383557,0.042878568930924184,0.024845313058554187,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0120193,tight junction organization,2/53,57/18493,0.011630225803383557,0.042878568930924184,0.024845313058554187,2,bp,NAC,1969/324,EPHA2/APC
GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,2/53,57/18493,0.011630225803383557,0.042878568930924184,0.024845313058554187,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0050900,leukocyte migration,5/53,478/18493,0.01170690795206553,0.04309446921054463,0.02497041308335307,5,bp,NAC,80310/3554/1277/7474/1278,PDGFD/IL1R1/COL1A1/WNT5A/COL1A2
GO:0005160,transforming growth factor beta receptor binding,2/52,51/17632,0.009917947970272236,0.0431843984538937,0.02827485166963576,2,mf,NAC,4088/353500,SMAD3/BMP8A
GO:0031960,response to corticosteroid,3/53,166/18493,0.011983824914248726,0.04404565014850614,0.025521559932891215,3,bp,NAC,2353/1277/1026,FOS/COL1A1/CDKN1A
R-HSA-3700989,Transcriptional Regulation by TP53,6/45,365/10554,0.004276480341701881,0.04427414941997242,0.035482870946628615,6,re,NAC,2353/3725/1647/2810/3486/1026,FOS/JUN/GADD45A/SFN/IGFBP3/CDKN1A
GO:0003205,cardiac chamber development,3/53,167/18493,0.012178692845331641,0.04469279565771395,0.025896538230245486,3,bp,NAC,7472/7474/3280,WNT2/WNT5A/HES1
GO:0034113,heterotypic cell-cell adhesion,2/53,59/18493,0.012422924598060022,0.04544879183721036,0.02633458833823574,2,bp,NAC,9314/3679,KLF4/ITGA7
GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,2/53,59/18493,0.012422924598060022,0.04544879183721036,0.02633458833823574,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0005201,extracellular matrix structural constituent,3/52,155/17632,0.010749184014744336,0.04584856038941972,0.03001920347834079,3,mf,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0043901,negative regulation of multi-organism process,3/53,169/18493,0.012573903187341877,0.04593047892396157,0.02661369435238179,3,bp,NAC,3725/3479/6772,JUN/IGF1/STAT1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,2/45,25/10554,0.005010732568217294,0.04641520694769704,0.03719879025712562,2,re,NAC,3164/1026,NR4A1/CDKN1A
R-HSA-76002,"Platelet activation, signaling and aggregation",5/45,262/10554,0.0049279714384519715,0.04641520694769704,0.03719879025712562,5,re,NAC,3479/55970/3082/1277/1278,IGF1/GNG12/HGF/COL1A1/COL1A2
R-HSA-8940973,RUNX2 regulates osteoblast differentiation,2/45,24/10554,0.00462235623683417,0.04641520694769704,0.03719879025712562,2,re,NAC,1277/3280,COL1A1/HES1
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,2/45,25/10554,0.005010732568217294,0.04641520694769704,0.03719879025712562,2,re,NAC,6772/3280,STAT1/HES1
hsa04921,Oxytocin signaling pathway,4/50,153/7852,0.01594135618867731,0.0466646972068554,0.027153697622818766,4,kg,NAC,2353/3725/781/1026,FOS/JUN/CACNA2D1/CDKN1A
GO:0051057,positive regulation of small GTPase mediated signal transduction,2/53,60/18493,0.01282793149808526,0.046786535433200535,0.027109722846292556,2,bp,NAC,3479/1281,IGF1/COL3A1
R-HSA-3238698,WNT ligand biogenesis and trafficking,2/45,26/10554,0.0054136390458508635,0.047640023603487604,0.0381804016917903,2,re,NAC,7472/7474,WNT2/WNT5A
R-HSA-912694,Regulation of IFNA signaling,2/45,26/10554,0.0054136390458508635,0.047640023603487604,0.0381804016917903,2,re,NAC,6772/9021,STAT1/SOCS3
GO:0001077,"proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific",4/52,298/17632,0.011459057890414607,0.04789886198193305,0.031361632121134714,4,mf,NAC,2353/9314/3164/3725,FOS/KLF4/NR4A1/JUN
GO:0035794,positive regulation of mitochondrial membrane permeability,2/53,61/18493,0.013238663365467394,0.04792097199363395,0.027767054286958016,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0045669,positive regulation of osteoblast differentiation,2/53,61/18493,0.013238663365467394,0.04792097199363395,0.027767054286958016,2,bp,NAC,3479/3082,IGF1/HGF
GO:0050878,regulation of body fluid levels,5/53,493/18493,0.013239730277467414,0.04792097199363395,0.027767054286958016,5,bp,NAC,8835/2810/1277/1278/1281,SOCS2/SFN/COL1A1/COL1A2/COL3A1
GO:0055025,positive regulation of cardiac muscle tissue development,2/53,61/18493,0.013238663365467394,0.04792097199363395,0.027767054286958016,2,bp,NAC,3479/7472,IGF1/WNT2
GO:1900076,regulation of cellular response to insulin stimulus,2/53,61/18493,0.013238663365467394,0.04792097199363395,0.027767054286958016,2,bp,NAC,9021/8835,SOCS3/SOCS2
GO:0001824,blastocyst development,2/53,62/18493,0.013655085357759231,0.049051046798718204,0.02842185837701834,2,bp,NAC,3479/64321,IGF1/SOX17
GO:0043297,apical junction assembly,2/53,62/18493,0.013655085357759231,0.049051046798718204,0.02842185837701834,2,bp,NAC,1969/324,EPHA2/APC
GO:0045428,regulation of nitric oxide biosynthetic process,2/53,62/18493,0.013655085357759231,0.049051046798718204,0.02842185837701834,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:0045685,regulation of glial cell differentiation,2/53,62/18493,0.013655085357759231,0.049051046798718204,0.02842185837701834,2,bp,NAC,7097/3280,TLR2/HES1
GO:0046622,positive regulation of organ growth,2/53,62/18493,0.013655085357759231,0.049051046798718204,0.02842185837701834,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0021953,central nervous system neuron differentiation,3/53,175/18493,0.013803517287742055,0.04936054753421144,0.02860119371532149,3,bp,NAC,7472/7474/3280,WNT2/WNT5A/HES1
GO:0048736,appendage development,3/53,175/18493,0.013803517287742055,0.04936054753421144,0.02860119371532149,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
GO:0060173,limb development,3/53,175/18493,0.013803517287742055,0.04936054753421144,0.02860119371532149,3,bp,NAC,7704/51776/7474,ZBTB16/MAP3K20/WNT5A
hsa05132,Salmonella infection,3/50,86/7852,0.017172502781311834,0.04937094549627152,0.028728435104074315,3,kg,NAC,2353/3725/2318,FOS/JUN/FLNC
GO:0032729,positive regulation of interferon-gamma production,2/53,63/18493,0.014077162778583651,0.04996342251861481,0.02895052015265672,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0046686,response to cadmium ion,2/53,63/18493,0.014077162778583651,0.04996342251861481,0.02895052015265672,2,bp,NAC,2353/3725,FOS/JUN
GO:0055001,muscle cell development,3/53,176/18493,0.014014892719942728,0.04996342251861481,0.02895052015265672,3,bp,NAC,3479/2318/3280,IGF1/FLNC/HES1
GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,2/53,63/18493,0.014077162778583651,0.04996342251861481,0.02895052015265672,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:1905710,positive regulation of membrane permeability,2/53,63/18493,0.014077162778583651,0.04996342251861481,0.02895052015265672,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0007088,regulation of mitotic nuclear division,3/53,177/18493,0.01422811413021534,0.050398467391493465,0.029202600068817208,3,bp,NAC,3479/3303/324,IGF1/HSPA1A/APC
GO:0007159,leukocyte cell-cell adhesion,4/53,327/18493,0.014242123669925824,0.050398467391493465,0.029202600068817208,4,bp,NAC,9314/3479/7704/3280,KLF4/IGF1/ZBTB16/HES1
GO:0021872,forebrain generation of neurons,2/53,64/18493,0.014504861077108083,0.05094912797837965,0.029521671693904197,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0032651,regulation of interleukin-1 beta production,2/53,64/18493,0.014504861077108083,0.05094912797837965,0.029521671693904197,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0042306,regulation of protein import into nucleus,2/53,64/18493,0.014504861077108083,0.05094912797837965,0.029521671693904197,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0051785,positive regulation of nuclear division,2/53,64/18493,0.014504861077108083,0.05094912797837965,0.029521671693904197,2,bp,NAC,3479/7474,IGF1/WNT5A
GO:1905207,regulation of cardiocyte differentiation,2/53,64/18493,0.014504861077108083,0.05094912797837965,0.029521671693904197,2,bp,NAC,3479/64321,IGF1/SOX17
GO:0002685,regulation of leukocyte migration,3/53,180/18493,0.014878875136105946,0.0521857891941887,0.030238235604972345,3,bp,NAC,80310/3554/7474,PDGFD/IL1R1/WNT5A
GO:0032481,positive regulation of type I interferon production,2/53,65/18493,0.014938145847520845,0.052316510788519247,0.03031398017890829,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0043409,negative regulation of MAPK cascade,3/53,182/18493,0.015321982912661528,0.053424743938869666,0.030956128465309374,3,bp,NAC,9314/10252/1844,KLF4/SPRY1/DUSP2
GO:0043534,blood vessel endothelial cell migration,3/53,182/18493,0.015321982912661528,0.053424743938869666,0.030956128465309374,3,bp,NAC,9314/3164/1969,KLF4/NR4A1/EPHA2
GO:0048638,regulation of developmental growth,4/53,334/18493,0.01528261108233146,0.053424743938869666,0.030956128465309374,4,bp,NAC,3479/8835/7472/7474,IGF1/SOCS2/WNT2/WNT5A
GO:0014015,positive regulation of gliogenesis,2/53,66/18493,0.015376982828509292,0.05345974439502207,0.03097640892969939,2,bp,NAC,7097/3280,TLR2/HES1
GO:2000573,positive regulation of DNA biosynthetic process,2/53,66/18493,0.015376982828509292,0.05345974439502207,0.03097640892969939,2,bp,NAC,9314/3082,KLF4/HGF
GO:0048839,inner ear development,3/53,183/18493,0.015546322540364976,0.0539695693445079,0.031271818986304656,3,bp,NAC,7474/8516/3280,WNT5A/ITGA8/HES1
hsa04974,Protein digestion and absorption,3/50,90/7852,0.019367645038906887,0.05470510265375454,0.03183232517936682,3,kg,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:1904589,regulation of protein import,2/53,67/18493,0.015821337902739405,0.05484422963952523,0.03177862715158184,2,bp,NAC,3479/4088,IGF1/SMAD3
hsa05323,Rheumatoid arthritis,3/50,91/7852,0.019939665628567953,0.05534976148619725,0.03220744538915695,3,kg,NAC,2353/3725/7097,FOS/JUN/TLR2
hsa04658,Th1 and Th2 cell differentiation,3/50,92/7852,0.02052099865701576,0.05599797938609385,0.032584636582950986,3,kg,NAC,2353/3725/6772,FOS/JUN/STAT1
R-HSA-1474290,Collagen formation,3/45,90/10554,0.006570949780944867,0.056414007875429106,0.045212183345140544,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
hsa05222,Small cell lung cancer,3/50,93/7852,0.02111165099329077,0.0566495968319969,0.03296380593689262,3,kg,NAC,4616/1647/1026,GADD45B/GADD45A/CDKN1A
GO:0001540,amyloid-beta binding,2/52,61/17632,0.013971104373167486,0.05725413360768636,0.037486967358344135,2,mf,NAC,4804/7097,NGFR/TLR2
hsa04350,TGF-beta signaling pathway,3/50,94/7852,0.021711628199504104,0.05730446131344526,0.03334486470674488,3,kg,NAC,4088/353500/4093,SMAD3/BMP8A/SMAD9
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,3/45,95/10554,0.007628365855909517,0.05734444333016909,0.04595786726221685,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,3/45,98/10554,0.008308427868859726,0.05734444333016909,0.04595786726221685,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,3/45,95/10554,0.007628365855909517,0.05734444333016909,0.04595786726221685,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,3/45,98/10554,0.008308427868859726,0.05734444333016909,0.04595786726221685,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
R-HSA-2219528,PI3K/AKT Signaling in Cancer,3/45,97/10554,0.008077902925628625,0.05734444333016909,0.04595786726221685,3,re,NAC,3164/3082/1026,NR4A1/HGF/CDKN1A
R-HSA-2871796,FCERI mediated MAPK activation,2/45,32/10554,0.008129246198184892,0.05734444333016909,0.04595786726221685,2,re,NAC,2353/3725,FOS/JUN
R-HSA-373080,Class B/2 (Secretin family receptors),3/45,95/10554,0.007628365855909517,0.05734444333016909,0.04595786726221685,3,re,NAC,55970/7472/7474,GNG12/WNT2/WNT5A
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/45,31/10554,0.007641764014898924,0.05734444333016909,0.04595786726221685,2,re,NAC,2353/3725,FOS/JUN
R-HSA-8878159,Transcriptional regulation by RUNX3,3/45,96/10554,0.007851220616231565,0.05734444333016909,0.04595786726221685,3,re,NAC,4088/1026/3280,SMAD3/CDKN1A/HES1
R-HSA-8941326,RUNX2 regulates bone development,2/45,32/10554,0.008129246198184892,0.05734444333016909,0.04595786726221685,2,re,NAC,1277/3280,COL1A1/HES1
GO:0040014,regulation of multicellular organism growth,2/53,69/18493,0.016726466578372526,0.057729372312583266,0.03345037774209707,2,bp,NAC,3479/8835,IGF1/SOCS2
GO:0050771,negative regulation of axonogenesis,2/53,69/18493,0.016726466578372526,0.057729372312583266,0.03345037774209707,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0055008,cardiac muscle tissue morphogenesis,2/53,69/18493,0.016726466578372526,0.057729372312583266,0.03345037774209707,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0071897,DNA biosynthetic process,3/53,189/18493,0.01693146673271353,0.05835221433390258,0.033811273765250976,3,bp,NAC,9314/3082/3981,KLF4/HGF/LIG4
GO:0048678,response to axon injury,2/53,70/18493,0.017187172660342732,0.05914775193385676,0.03427223552805033,2,bp,NAC,9314/3725,KLF4/JUN
R-HSA-1474244,Extracellular matrix organization,5/45,301/10554,0.008767676950528852,0.05935042858819531,0.04756553487331442,5,re,NAC,3679/1277/1278/8516/1281,ITGA7/COL1A1/COL1A2/ITGA8/COL3A1
hsa04960,Aldosterone-regulated sodium reabsorption,2/50,37/7852,0.02296640311796856,0.05963856293536996,0.03470305394735487,2,kg,NAC,3479/2810,IGF1/SFN
hsa05215,Prostate cancer,3/50,97/7852,0.02356754548260418,0.06022817178887735,0.035046141152076396,3,kg,NAC,3479/80310/1026,IGF1/PDGFD/CDKN1A
GO:0006305,DNA alkylation,2/53,71/18493,0.017653261795660326,0.06046465352074705,0.03503529346140405,2,bp,NAC,2353/4255,FOS/MGMT
GO:0006306,DNA methylation,2/53,71/18493,0.017653261795660326,0.06046465352074705,0.03503529346140405,2,bp,NAC,2353/4255,FOS/MGMT
GO:0031110,regulation of microtubule polymerization or depolymerization,2/53,71/18493,0.017653261795660326,0.06046465352074705,0.03503529346140405,2,bp,NAC,3303/324,HSPA1A/APC
GO:0070482,response to oxygen levels,4/53,349/18493,0.01767154507860353,0.06046465352074705,0.03503529346140405,4,bp,NAC,4088/7097/1277/1026,SMAD3/TLR2/COL1A1/CDKN1A
GO:0003281,ventricular septum development,2/53,72/18493,0.0181247005791407,0.06183721374059768,0.035830601915117694,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0048844,artery morphogenesis,2/53,72/18493,0.0181247005791407,0.06183721374059768,0.035830601915117694,2,bp,NAC,1281/3280,COL3A1/HES1
R-HSA-2559583,Cellular Senescence,4/45,195/10554,0.009324143474624288,0.06192638685033489,0.04962999903077079,4,re,NAC,2353/3725/2114/1026,FOS/JUN/ETS2/CDKN1A
hsa05231,Choline metabolism in cancer,3/50,99/7852,0.024851493025161243,0.06251703714142125,0.036378007882226164,3,kg,NAC,2353/3725/80310,FOS/JUN/PDGFD
GO:0035265,organ growth,3/53,195/18493,0.01838387787705633,0.06263160686481369,0.036290900529432575,3,bp,NAC,3479/3953/7472,IGF1/LEPR/WNT2
GO:0006809,nitric oxide biosynthetic process,2/53,73/18493,0.018601455746492176,0.06301176889623702,0.03651117944543149,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:0032611,interleukin-1 beta production,2/53,73/18493,0.018601455746492176,0.06301176889623702,0.03651117944543149,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0032760,positive regulation of tumor necrosis factor production,2/53,73/18493,0.018601455746492176,0.06301176889623702,0.03651117944543149,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0046902,regulation of mitochondrial membrane permeability,2/53,73/18493,0.018601455746492176,0.06301176889623702,0.03651117944543149,2,bp,NAC,3303/2810,HSPA1A/SFN
R-HSA-114604,GPVI-mediated activation cascade,2/45,35/10554,0.009673225953656325,0.0630551025127227,0.05053459172670361,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0045666,positive regulation of neuron differentiation,4/53,356/18493,0.018862075693309402,0.0638037211930153,0.036970063760637883,4,bp,NAC,4804/8835/3082/7474,NGFR/SOCS2/HGF/WNT5A
GO:0010611,regulation of cardiac muscle hypertrophy,2/53,74/18493,0.019083494173807558,0.0642783982228249,0.03724510790743119,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0043507,positive regulation of JUN kinase activity,2/53,74/18493,0.019083494173807558,0.0642783982228249,0.03724510790743119,2,bp,NAC,51776/7474,MAP3K20/WNT5A
GO:0055021,regulation of cardiac muscle tissue growth,2/53,74/18493,0.019083494173807558,0.0642783982228249,0.03724510790743119,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0010038,response to metal ion,4/53,358/18493,0.019211196311551017,0.06461700824450965,0.03744131016425264,4,bp,NAC,2353/3725/7474/3981,FOS/JUN/WNT5A/LIG4
GO:0007163,establishment or maintenance of cell polarity,3/53,199/18493,0.019389651317449384,0.06494167722942906,0.037629434506362115,3,bp,NAC,10252/7474/3280,SPRY1/WNT5A/HES1
GO:0007266,Rho protein signal transduction,3/53,199/18493,0.019389651317449384,0.06494167722942906,0.037629434506362115,3,bp,NAC,4804/1278/1281,NGFR/COL1A2/COL3A1
GO:0045861,negative regulation of proteolysis,4/53,359/18493,0.019387259414149958,0.06494167722942906,0.037629434506362115,4,bp,NAC,9314/4804/3082/2810,KLF4/NGFR/HGF/SFN
GO:0001937,negative regulation of endothelial cell proliferation,2/53,75/18493,0.01957078287705754,0.06527254092797032,0.037821148277948365,2,bp,NAC,6772/4804,STAT1/NGFR
GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,2/53,75/18493,0.01957078287705754,0.06527254092797032,0.037821148277948365,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0070373,negative regulation of ERK1 and ERK2 cascade,2/53,75/18493,0.01957078287705754,0.06527254092797032,0.037821148277948365,2,bp,NAC,9314/10252,KLF4/SPRY1
R-HSA-1266695,Interleukin-7 signaling,2/45,36/10554,0.010214665849150008,0.06537386143456006,0.05239292722626224,2,re,NAC,8835/3082,SOCS2/HGF
GO:0045766,positive regulation of angiogenesis,3/53,200/18493,0.019645790931999182,0.06543093954663033,0.03791292986877036,3,bp,NAC,9314/3082/7474,KLF4/HGF/WNT5A
GO:0043687,post-translational protein modification,4/53,361/18493,0.019742398931403355,0.06566073378863942,0.03804608053177327,4,bp,NAC,7704/9021/8835/3486,ZBTB16/SOCS3/SOCS2/IGFBP3
GO:0010507,negative regulation of autophagy,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,3953/3082,LEPR/HGF
GO:0014743,regulation of muscle hypertrophy,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0021536,diencephalon development,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0043407,negative regulation of MAP kinase activity,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,10252/1844,SPRY1/DUSP2
GO:0051145,smooth muscle cell differentiation,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,8516/3280,ITGA8/HES1
GO:0060411,cardiac septum morphogenesis,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0072088,nephron epithelium morphogenesis,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,6772/3280,STAT1/HES1
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,2/53,76/18493,0.020063289011585446,0.0659896283119643,0.03823665329572011,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0050870,positive regulation of T cell activation,3/53,202/18493,0.020163711144111026,0.06622832196228733,0.03837496058104295,3,bp,NAC,3479/7704/3280,IGF1/ZBTB16/HES1
GO:0001570,vasculogenesis,2/53,77/18493,0.020560979871604088,0.06716210183334412,0.038916024655768884,2,bp,NAC,1969/64321,EPHA2/SOX17
GO:0002718,regulation of cytokine production involved in immune response,2/53,77/18493,0.020560979871604088,0.06716210183334412,0.038916024655768884,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0031016,pancreas development,2/53,77/18493,0.020560979871604088,0.06716210183334412,0.038916024655768884,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0032652,regulation of interleukin-1 production,2/53,77/18493,0.020560979871604088,0.06716210183334412,0.038916024655768884,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0006006,glucose metabolic process,3/53,204/18493,0.020689157063769816,0.06748808710239318,0.0391049116980358,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0006650,glycerophospholipid metabolic process,4/53,367/18493,0.020832032151790955,0.06786105816021766,0.039321023917367505,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
GO:0031100,animal organ regeneration,2/53,78/18493,0.02106382288969378,0.06833529444978419,0.03959581268415188,2,bp,NAC,3082/1026,HGF/CDKN1A
GO:0071260,cellular response to mechanical stimulus,2/53,78/18493,0.02106382288969378,0.06833529444978419,0.03959581268415188,2,bp,NAC,1647/1277,GADD45A/COL1A1
GO:0072028,nephron morphogenesis,2/53,78/18493,0.02106382288969378,0.06833529444978419,0.03959581268415188,2,bp,NAC,6772/3280,STAT1/HES1
GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,2/53,79/18493,0.02157178563630248,0.06981532784259084,0.0404533947793154,2,bp,NAC,4088/3303,SMAD3/HSPA1A
GO:0031346,positive regulation of cell projection organization,4/53,371/18493,0.02157874935420701,0.06981532784259084,0.0404533947793154,4,bp,NAC,4804/3082/7474/324,NGFR/HGF/WNT5A/APC
GO:0002696,positive regulation of leukocyte activation,4/53,372/18493,0.021767978386485913,0.07023643501094098,0.04069739871157619,4,bp,NAC,3479/7704/7474/3280,IGF1/ZBTB16/WNT5A/HES1
GO:0060348,bone development,3/53,208/18493,0.02176264326650458,0.07023643501094098,0.04069739871157619,3,bp,NAC,3479/6424/1277,IGF1/SFRP4/COL1A1
GO:0042692,muscle cell differentiation,4/53,373/18493,0.0219582300223262,0.07075429673860664,0.04099746555302382,4,bp,NAC,3479/2318/8516/3280,IGF1/FLNC/ITGA8/HES1
GO:0051701,interaction with host,3/53,209/18493,0.02203572442461064,0.07087414248066122,0.041066908285239935,3,bp,NAC,4088/1969/3303,SMAD3/EPHA2/HSPA1A
GO:0060420,regulation of heart growth,2/53,80/18493,0.02208483581924725,0.07087414248066122,0.041066908285239935,2,bp,NAC,3479/7472,IGF1/WNT2
GO:1903671,negative regulation of sprouting angiogenesis,2/53,80/18493,0.02208483581924725,0.07087414248066122,0.041066908285239935,2,bp,NAC,9314/4804,KLF4/NGFR
GO:0030900,forebrain development,4/53,374/18493,0.022149505590177768,0.07089034225227825,0.04107629498837246,4,bp,NAC,55970/7474/1281/3280,GNG12/WNT5A/COL3A1/HES1
GO:0051271,negative regulation of cellular component movement,4/53,374/18493,0.022149505590177768,0.07089034225227825,0.04107629498837246,4,bp,NAC,9314/7474/3486/1281,KLF4/WNT5A/IGFBP3/COL3A1
GO:0043583,ear development,3/53,210/18493,0.022310690056480426,0.07121452477088651,0.041264137455221304,3,bp,NAC,7474/8516/3280,WNT5A/ITGA8/HES1
GO:0050920,regulation of chemotaxis,3/53,210/18493,0.022310690056480426,0.07121452477088651,0.041264137455221304,3,bp,NAC,80310/4088/7474,PDGFD/SMAD3/WNT5A
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),3/45,110/10554,0.011379425980278744,0.07152782044746639,0.05732492787057713,3,re,NAC,2353/3725/1026,FOS/JUN/CDKN1A
GO:0032755,positive regulation of interleukin-6 production,2/53,81/18493,0.0226029412832174,0.07176207526233774,0.04158140698437436,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0043620,regulation of DNA-templated transcription in response to stress,2/53,81/18493,0.0226029412832174,0.07176207526233774,0.04158140698437436,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0090559,regulation of membrane permeability,2/53,81/18493,0.0226029412832174,0.07176207526233774,0.04158140698437436,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,2/53,81/18493,0.0226029412832174,0.07176207526233774,0.04158140698437436,2,bp,NAC,4088/3303,SMAD3/HSPA1A
GO:0009798,axis specification,2/53,82/18493,0.02312607000927952,0.07322742274576124,0.04243047956009096,2,bp,NAC,2114/7474,ETS2/WNT5A
GO:0110110,positive regulation of animal organ morphogenesis,2/53,82/18493,0.02312607000927952,0.07322742274576124,0.04243047956009096,2,bp,NAC,10252/7472,SPRY1/WNT2
R-HSA-76009,Platelet Aggregation (Plug Formation),2/45,39/10554,0.011917675307240683,0.07359687207278456,0.05898313910139434,2,re,NAC,1277/1278,COL1A1/COL1A2
GO:0032388,positive regulation of intracellular transport,3/53,214/18493,0.02342940106592094,0.07399085754948206,0.042872839862012325,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:1903039,positive regulation of leukocyte cell-cell adhesion,3/53,214/18493,0.02342940106592094,0.07399085754948206,0.042872839862012325,3,bp,NAC,3479/7704/3280,IGF1/ZBTB16/HES1
GO:0046849,bone remodeling,2/53,83/18493,0.023654190114383754,0.07460167651459491,0.04322676931415376,2,bp,NAC,3953/1969,LEPR/EPHA2
GO:0007584,response to nutrient,3/53,216/18493,0.024000066869839895,0.07559226359798579,0.04380074943551123,3,bp,NAC,6772/4255/1277,STAT1/MGMT/COL1A1
GO:0010639,negative regulation of organelle organization,4/53,384/18493,0.02411885878255999,0.07576571490743415,0.04390125307150251,4,bp,NAC,3479/3303/3082/324,IGF1/HSPA1A/HGF/APC
GO:0050867,positive regulation of cell activation,4/53,384/18493,0.02411885878255999,0.07576571490743415,0.04390125307150251,4,bp,NAC,3479/7704/7474/3280,IGF1/ZBTB16/WNT5A/HES1
GO:0001708,cell fate specification,2/53,84/18493,0.024187269850872113,0.07588037955854075,0.043967693701974175,2,bp,NAC,64321/324,SOX17/APC
GO:0045665,negative regulation of neuron differentiation,3/53,217/18493,0.024288227300921103,0.07609671214965795,0.044093044222877374,3,bp,NAC,4804/7474/3280,NGFR/WNT5A/HES1
GO:0040013,negative regulation of locomotion,4/53,386/18493,0.024525141652186944,0.07673787743276388,0.044464557372178276,4,bp,NAC,9314/7474/3486/1281,KLF4/WNT5A/IGFBP3/COL3A1
GO:0072331,signal transduction by p53 class mediator,3/53,218/18493,0.024578272603100183,0.07680306471770333,0.044502329120213215,3,bp,NAC,1647/2810/1026,GADD45A/SFN/CDKN1A
GO:0045445,myoblast differentiation,2/53,85/18493,0.024725277605987972,0.07716103693837191,0.0447097504990168,2,bp,NAC,3479/3486,IGF1/IGFBP3
R-HSA-195721,Signaling by WNT,5/45,330/10554,0.012715504979022768,0.07716996125200025,0.061846739280909294,5,re,NAC,55970/64321/7472/7474/324,GNG12/SOX17/WNT2/WNT5A/APC
GO:0001618,virus receptor activity,2/52,74/17632,0.020126001456267893,0.0793647981954715,0.0519638567887751,2,mf,NAC,1969/3303,EPHA2/HSPA1A
GO:0104005,hijacked molecular function,2/52,74/17632,0.020126001456267893,0.0793647981954715,0.0519638567887751,2,mf,NAC,1969/3303,EPHA2/HSPA1A
GO:0006112,energy reserve metabolic process,2/53,87/18493,0.025815951392653316,0.07993532866110623,0.046317270248058116,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0010594,regulation of endothelial cell migration,3/53,222/18493,0.025757298368456766,0.07993532866110623,0.046317270248058116,3,bp,NAC,9314/1969/7474,KLF4/EPHA2/WNT5A
GO:0032612,interleukin-1 production,2/53,87/18493,0.025815951392653316,0.07993532866110623,0.046317270248058116,2,bp,NAC,4088/7474,SMAD3/WNT5A
GO:0046578,regulation of Ras protein signal transduction,3/53,222/18493,0.025757298368456766,0.07993532866110623,0.046317270248058116,3,bp,NAC,3479/10252/1281,IGF1/SPRY1/COL3A1
GO:0048709,oligodendrocyte differentiation,2/53,87/18493,0.025815951392653316,0.07993532866110623,0.046317270248058116,2,bp,NAC,7097/3280,TLR2/HES1
GO:2001234,negative regulation of apoptotic signaling pathway,3/53,222/18493,0.025757298368456766,0.07993532866110623,0.046317270248058116,3,bp,NAC,3479/3303/3082,IGF1/HSPA1A/HGF
hsa04668,TNF signaling pathway,3/50,110/7852,0.03257922725619094,0.08069623981918063,0.046956295154671965,3,kg,NAC,2353/3725/9021,FOS/JUN/SOCS3
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2/53,88/18493,0.026368554868807233,0.08122334647412383,0.04706359193246343,2,bp,NAC,4804/4088,NGFR/SMAD3
GO:0010717,regulation of epithelial to mesenchymal transition,2/53,88/18493,0.026368554868807233,0.08122334647412383,0.04706359193246343,2,bp,NAC,4088/1277,SMAD3/COL1A1
GO:0043506,regulation of JUN kinase activity,2/53,88/18493,0.026368554868807233,0.08122334647412383,0.04706359193246343,2,bp,NAC,51776/7474,MAP3K20/WNT5A
GO:0048738,cardiac muscle tissue development,3/53,224/18493,0.02635811374605758,0.08122334647412383,0.04706359193246343,3,bp,NAC,3479/7472/7474,IGF1/WNT2/WNT5A
GO:0019897,extrinsic component of plasma membrane,3/53,162/19659,0.009519675129273866,0.08170976513691977,0.0642486422129236,3,cc,NAC,55970/7472/324,GNG12/WNT2/APC
GO:0031012,extracellular matrix,5/53,490/19659,0.010123775188888875,0.08170976513691977,0.0642486422129236,5,cc,NAC,1277/7472/7474/1278/1281,COL1A1/WNT2/WNT5A/COL1A2/COL3A1
GO:0031256,leading edge membrane,3/53,167/19659,0.010336777517321176,0.08170976513691977,0.0642486422129236,3,cc,NAC,1969/8516/324,EPHA2/ITGA8/APC
GO:0090575,RNA polymerase II transcription factor complex,3/53,161/19659,0.009360981836085185,0.08170976513691977,0.0642486422129236,3,cc,NAC,2353/3725/4088,FOS/JUN/SMAD3
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,2/45,42/10554,0.013736282039016296,0.08195205555480908,0.0656792789733518,2,re,NAC,64321/324,SOX17/APC
GO:0033273,response to vitamin,2/53,89/18493,0.02692596125182848,0.08261927207335241,0.04787243908814055,2,bp,NAC,4255/1277,MGMT/COL1A1
GO:0060337,type I interferon signaling pathway,2/53,89/18493,0.02692596125182848,0.08261927207335241,0.04787243908814055,2,bp,NAC,6772/7474,STAT1/WNT5A
GO:0071357,cellular response to type I interferon,2/53,89/18493,0.02692596125182848,0.08261927207335241,0.04787243908814055,2,bp,NAC,6772/7474,STAT1/WNT5A
GO:0000012,single strand break repair,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3981,LIG4
GO:0002702,positive regulation of production of molecular mediator of immune response,2/53,91/18493,0.02805505908827939,0.08308170340270393,0.04814038765620799,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0003263,cardioblast proliferation,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3280,HES1
GO:0003266,regulation of secondary heart field cardioblast proliferation,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3280,HES1
GO:0006307,DNA dealkylation involved in DNA repair,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,4255,MGMT
GO:0031053,primary miRNA processing,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,4088,SMAD3
GO:0031669,cellular response to nutrient levels,3/53,228/18493,0.02758233224220795,0.08308170340270393,0.04814038765620799,3,bp,NAC,3725/1277/1026,JUN/COL1A1/CDKN1A
GO:0032621,interleukin-18 production,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7097,TLR2
GO:0038063,collagen-activated tyrosine kinase receptor signaling pathway,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,1277,COL1A1
GO:0045073,regulation of chemokine biosynthetic process,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:0048525,negative regulation of viral process,2/53,91/18493,0.02805505908827939,0.08308170340270393,0.04814038765620799,2,bp,NAC,3725/6772,JUN/STAT1
GO:0051402,neuron apoptotic process,3/53,230/18493,0.0282057262623337,0.08308170340270393,0.04814038765620799,3,bp,NAC,3725/4804/3981,JUN/NGFR/LIG4
GO:0051481,negative regulation of cytosolic calcium ion concentration,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,4088,SMAD3
GO:0051593,response to folic acid,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,4255,MGMT
GO:0051896,regulation of protein kinase B signaling,3/53,228/18493,0.02758233224220795,0.08308170340270393,0.04814038765620799,3,bp,NAC,9314/1969/3082,KLF4/EPHA2/HGF
GO:0051899,membrane depolarization,2/53,90/18493,0.027488139596170198,0.08308170340270393,0.04814038765620799,2,bp,NAC,3725/781,JUN/CACNA2D1
GO:0060068,vagina development,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:0060281,regulation of oocyte development,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3479,IGF1
GO:0060333,interferon-gamma-mediated signaling pathway,2/53,90/18493,0.027488139596170198,0.08308170340270393,0.04814038765620799,2,bp,NAC,6772/9021,STAT1/SOCS3
GO:0060513,prostatic bud formation,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:0070391,response to lipoteichoic acid,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7097,TLR2
GO:0071104,response to interleukin-9,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,6772,STAT1
GO:0071223,cellular response to lipoteichoic acid,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7097,TLR2
GO:0072203,cell proliferation involved in metanephros development,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,6772,STAT1
GO:0072672,neutrophil extravasation,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3554,IL1R1
GO:0090193,positive regulation of glomerulus development,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,80310,PDGFD
GO:0090630,activation of GTPase activity,2/53,91/18493,0.02805505908827939,0.08308170340270393,0.04814038765620799,2,bp,NAC,1969/7474,EPHA2/WNT5A
GO:0098722,asymmetric stem cell division,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7704,ZBTB16
GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:1900376,regulation of secondary metabolite biosynthetic process,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:1904779,regulation of protein localization to centrosome,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,324,APC
GO:1905879,regulation of oogenesis,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,3479,IGF1
GO:2000035,regulation of stem cell division,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,64321,SOX17
GO:2000049,positive regulation of cell-cell adhesion mediated by cadherin,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,7474,WNT5A
GO:2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/53,10/18493,0.0282994868613079,0.08308170340270393,0.04814038765620799,1,bp,NAC,4088,SMAD3
hsa04930,Type II diabetes mellitus,2/50,46/7852,0.034423925554322096,0.08381954033421293,0.04877371094962374,2,kg,NAC,9021/8835,SOCS3/SOCS2
hsa05145,Toxoplasmosis,3/50,113/7852,0.03488142361734327,0.08381954033421293,0.04877371094962374,3,kg,NAC,6772/7097/3303,STAT1/TLR2/HSPA1A
GO:0043255,regulation of carbohydrate biosynthetic process,2/53,92/18493,0.028626689046117496,0.0839386763892323,0.04863694718848441,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0033157,regulation of intracellular protein transport,3/53,232/18493,0.028836636201942954,0.08445014887711864,0.0489333118853297,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0044728,DNA methylation or demethylation,2/53,93/18493,0.02920299891868306,0.08531293787300775,0.049433241412848994,2,bp,NAC,2353/4255,FOS/MGMT
GO:0055006,cardiac cell development,2/53,93/18493,0.02920299891868306,0.08531293787300775,0.049433241412848994,2,bp,NAC,3479/10252,IGF1/SPRY1
GO:0030217,T cell differentiation,3/53,234/18493,0.029475055733484943,0.08600206445917448,0.04983254498564003,3,bp,NAC,7704/3953/3981,ZBTB16/LEPR/LIG4
GO:0003334,keratinocyte development,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,2810,SFN
GO:0009629,response to gravity,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,2353,FOS
GO:0010454,negative regulation of cell fate commitment,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,64321,SOX17
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,2/53,96/18493,0.030959704470305063,0.08615632010279038,0.04992192599466718,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0019042,viral latency,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3981,LIG4
GO:0030316,osteoclast differentiation,2/53,95/18493,0.030369536856323102,0.08615632010279038,0.04992192599466718,2,bp,NAC,2353/1969,FOS/EPHA2
GO:0032490,detection of molecule of bacterial origin,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,7097,TLR2
GO:0032649,regulation of interferon-gamma production,2/53,95/18493,0.030369536856323102,0.08615632010279038,0.04992192599466718,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0033197,response to vitamin E,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,1277,COL1A1
GO:0034115,negative regulation of heterotypic cell-cell adhesion,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9314,KLF4
GO:0034340,response to type I interferon,2/53,94/18493,0.02978395828553606,0.08615632010279038,0.04992192599466718,2,bp,NAC,6772/7474,STAT1/WNT5A
GO:0035630,bone mineralization involved in bone maturation,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3479,IGF1
GO:0040015,negative regulation of multicellular organism growth,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,8835,SOCS2
GO:0042033,chemokine biosynthetic process,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,7474,WNT5A
GO:0042035,regulation of cytokine biosynthetic process,2/53,94/18493,0.02978395828553606,0.08615632010279038,0.04992192599466718,2,bp,NAC,9314/7474,KLF4/WNT5A
GO:0042472,inner ear morphogenesis,2/53,96/18493,0.030959704470305063,0.08615632010279038,0.04992192599466718,2,bp,NAC,7474/8516,WNT5A/ITGA8
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9021,SOCS3
GO:0044341,sodium-dependent phosphate transport,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,6424,SFRP4
GO:0048705,skeletal system morphogenesis,3/53,236/18493,0.030120977837198287,0.08615632010279038,0.04992192599466718,3,bp,NAC,6424/4088/1277,SFRP4/SMAD3/COL1A1
GO:0050755,chemokine metabolic process,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,7474,WNT5A
GO:0051052,regulation of DNA metabolic process,4/53,412/18493,0.030188284290494305,0.08615632010279038,0.04992192599466718,4,bp,NAC,9314/3725/3082/4255,KLF4/JUN/HGF/MGMT
GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,10252,SPRY1
GO:0051798,positive regulation of hair follicle development,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,7474,WNT5A
GO:0060340,positive regulation of type I interferon-mediated signaling pathway,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,7474,WNT5A
GO:0060840,artery development,2/53,94/18493,0.02978395828553606,0.08615632010279038,0.04992192599466718,2,bp,NAC,1281/3280,COL3A1/HES1
GO:0060992,response to fungicide,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9314,KLF4
GO:0060993,kidney morphogenesis,2/53,94/18493,0.02978395828553606,0.08615632010279038,0.04992192599466718,2,bp,NAC,6772/3280,STAT1/HES1
GO:0061307,cardiac neural crest cell differentiation involved in heart development,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3280,HES1
GO:0061308,cardiac neural crest cell development involved in heart development,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3280,HES1
GO:0061469,regulation of type B pancreatic cell proliferation,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3164,NR4A1
GO:0070106,interleukin-27-mediated signaling pathway,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,6772,STAT1
GO:0070587,regulation of cell-cell adhesion involved in gastrulation,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9314,KLF4
GO:0070757,interleukin-35-mediated signaling pathway,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,6772,STAT1
GO:0071356,cellular response to tumor necrosis factor,3/53,235/18493,0.029797079429308065,0.08615632010279038,0.04992192599466718,3,bp,NAC,6772/3303/1277,STAT1/HSPA1A/COL1A1
GO:0072173,metanephric tubule morphogenesis,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3280,HES1
GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9314,KLF4
GO:0090084,negative regulation of inclusion body assembly,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,3303,HSPA1A
GO:0097237,cellular response to toxic substance,3/53,235/18493,0.029797079429308065,0.08615632010279038,0.04992192599466718,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0120162,positive regulation of cold-induced thermogenesis,2/53,96/18493,0.030959704470305063,0.08615632010279038,0.04992192599466718,2,bp,NAC,3953/324,LEPR/APC
GO:1901201,regulation of extracellular matrix assembly,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,4088,SMAD3
GO:1903426,regulation of reactive oxygen species biosynthetic process,2/53,94/18493,0.02978395828553606,0.08615632010279038,0.04992192599466718,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,9314,KLF4
GO:1905902,regulation of mesoderm formation,1/53,11/18493,0.031085837951301154,0.08615632010279038,0.04992192599466718,1,bp,NAC,64321,SOX17
GO:0000280,nuclear division,4/53,416/18493,0.031123002991504313,0.08615890700092811,0.04992342493214773,4,bp,NAC,3479/3303/7474/324,IGF1/HSPA1A/WNT5A/APC
GO:0042102,positive regulation of T cell proliferation,2/53,97/18493,0.03155443109588588,0.08715033350292291,0.05049789144142628,2,bp,NAC,3479/3280,IGF1/HES1
GO:0055024,regulation of cardiac muscle tissue development,2/53,97/18493,0.03155443109588588,0.08715033350292291,0.05049789144142628,2,bp,NAC,3479/7472,IGF1/WNT2
hsa04060,Cytokine-cytokine receptor interaction,5/50,294/7852,0.038153111777331036,0.09017484121884217,0.05247179384424292,5,kg,NAC,3977/4804/3953/3554/353500,LIFR/NGFR/LEPR/IL1R1/BMP8A
hsa05144,Malaria,2/50,49/7852,0.03864636052236093,0.09017484121884217,0.05247179384424292,2,kg,NAC,7097/3082,TLR2/HGF
GO:0003264,regulation of cardioblast proliferation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3280,HES1
GO:0010935,regulation of macrophage cytokine production,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0016045,detection of bacterium,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7097,TLR2
GO:0019318,hexose metabolic process,3/53,244/18493,0.032779527933931824,0.09038094627353992,0.05236981925194271,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0021889,olfactory bulb interneuron differentiation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0031349,positive regulation of defense response,4/53,427/18493,0.03378159874686003,0.09038094627353992,0.05236981925194271,4,bp,NAC,5320/7097/3303/7474,PLA2G2A/TLR2/HSPA1A/WNT5A
GO:0031953,negative regulation of protein autophosphorylation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3725,JUN
GO:0033160,"positive regulation of protein import into nucleus, translocation",1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3479,IGF1
GO:0036005,response to macrophage colony-stimulating factor,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7097,TLR2
GO:0036006,cellular response to macrophage colony-stimulating factor stimulus,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7097,TLR2
GO:0042635,positive regulation of hair cycle,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0043455,regulation of secondary metabolic process,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0043922,negative regulation by host of viral transcription,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3725,JUN
GO:0048505,regulation of timing of cell differentiation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3280,HES1
GO:0048715,negative regulation of oligodendrocyte differentiation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3280,HES1
GO:0048853,forebrain morphogenesis,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0050714,positive regulation of protein secretion,3/53,246/18493,0.033462834100970805,0.09038094627353992,0.05236981925194271,3,bp,NAC,3479/7097/7474,IGF1/TLR2/WNT5A
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,324,APC
GO:0055017,cardiac muscle tissue growth,2/53,100/18493,0.03336566665355209,0.09038094627353992,0.05236981925194271,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0060019,radial glial cell differentiation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3280,HES1
GO:0060670,branching involved in labyrinthine layer morphogenesis,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,9021,SOCS3
GO:0060707,trophoblast giant cell differentiation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,9021,SOCS3
GO:0060900,embryonic camera-type eye formation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:0061430,bone trabecula morphogenesis,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,1277,COL1A1
GO:0070586,cell-cell adhesion involved in gastrulation,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,9314,KLF4
GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,3082,HGF
GO:1901387,positive regulation of voltage-gated calcium channel activity,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,781,CACNA2D1
GO:1901722,regulation of cell proliferation involved in kidney development,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,80310,PDGFD
GO:2000052,positive regulation of non-canonical Wnt signaling pathway,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,7474,WNT5A
GO:2001223,negative regulation of neuron migration,1/53,12/18493,0.03386434950787387,0.09038094627353992,0.05236981925194271,1,bp,NAC,1281,COL3A1
GO:0002042,cell migration involved in sprouting angiogenesis,2/53,101/18493,0.03397833157602076,0.09048205205798138,0.0524284034101623,2,bp,NAC,9314/3164,KLF4/NR4A1
GO:0007631,feeding behavior,2/53,101/18493,0.03397833157602076,0.09048205205798138,0.0524284034101623,2,bp,NAC,2353/3953,FOS/LEPR
GO:0048608,reproductive structure development,4/53,428/18493,0.03402971723041703,0.09051752525048289,0.05244895779420216,4,bp,NAC,9021/7472/7474/3280,SOCS3/WNT2/WNT5A/HES1
GO:0006352,"DNA-templated transcription, initiation",3/53,248/18493,0.03415358676357368,0.0907455076243332,0.05258105859866857,3,bp,NAC,3164/3725/1026,NR4A1/JUN/CDKN1A
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,2/53,102/18493,0.03459540727286873,0.09161233685398869,0.05308332917616361,2,bp,NAC,1969/2810,EPHA2/SFN
GO:0035567,non-canonical Wnt signaling pathway,2/53,102/18493,0.03459540727286873,0.09161233685398869,0.05308332917616361,2,bp,NAC,6424/7474,SFRP4/WNT5A
GO:0042136,neurotransmitter biosynthetic process,2/53,102/18493,0.03459540727286873,0.09161233685398869,0.05308332917616361,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:0061458,reproductive system development,4/53,431/18493,0.03478051665223416,0.09200007630590971,0.05330799870941341,4,bp,NAC,9021/7472/7474/3280,SOCS3/WNT2/WNT5A/HES1
GO:0003157,endocardium development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,64321,SOX17
GO:0003337,mesenchymal to epithelial transition involved in metanephros morphogenesis,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,6772,STAT1
GO:0007183,SMAD protein complex assembly,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,4088,SMAD3
GO:0007494,midgut development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,7474,WNT5A
GO:0010839,negative regulation of keratinocyte proliferation,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,2810,SFN
GO:0030282,bone mineralization,2/53,104/18493,0.03584267404940426,0.09297559514002947,0.0538732477704832,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0031274,positive regulation of pseudopodium assembly,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,324,APC
GO:0031643,positive regulation of myelination,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3082,HGF
GO:0033151,V(D)J recombination,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3981,LIG4
GO:0034605,cellular response to heat,2/53,104/18493,0.03584267404940426,0.09297559514002947,0.0538732477704832,2,bp,NAC,3303/1026,HSPA1A/CDKN1A
GO:0038065,collagen-activated signaling pathway,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,1277,COL1A1
GO:0040034,"regulation of development, heterochronic",1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3280,HES1
GO:0042089,cytokine biosynthetic process,2/53,105/18493,0.036472806973203716,0.09297559514002947,0.0538732477704832,2,bp,NAC,9314/7474,KLF4/WNT5A
GO:0042659,regulation of cell fate specification,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,64321,SOX17
GO:0045414,regulation of interleukin-8 biosynthetic process,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,9314,KLF4
GO:0045605,negative regulation of epidermal cell differentiation,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3280,HES1
GO:0050708,regulation of protein secretion,4/53,438/18493,0.0365700301549933,0.09297559514002947,0.0538732477704832,4,bp,NAC,3479/7097/353500/7474,IGF1/TLR2/BMP8A/WNT5A
GO:0051963,regulation of synapse assembly,2/53,104/18493,0.03584267404940426,0.09297559514002947,0.0538732477704832,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0055062,phosphate ion homeostasis,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,6424,SFRP4
GO:0060576,intestinal epithelial cell development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,1026,CDKN1A
GO:0060601,lateral sprouting from an epithelium,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,7474,WNT5A
GO:0060712,spongiotrophoblast layer development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,9021,SOCS3
GO:0061029,eyelid development in camera-type eye,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3725,JUN
GO:0070243,regulation of thymocyte apoptotic process,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,7474,WNT5A
GO:0070307,lens fiber cell development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,1969,EPHA2
GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3303,HSPA1A
GO:0071285,cellular response to lithium ion,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,3981,LIG4
GO:0072109,glomerular mesangium development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,80310,PDGFD
GO:0072505,divalent inorganic anion homeostasis,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,6424,SFRP4
GO:0072506,trivalent inorganic anion homeostasis,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,6424,SFRP4
GO:0090179,planar cell polarity pathway involved in neural tube closure,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,7474,WNT5A
GO:0090192,regulation of glomerulus development,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,80310,PDGFD
GO:0090257,regulation of muscle system process,3/53,252/18493,0.03555738465115474,0.09297559514002947,0.0538732477704832,3,bp,NAC,9314/3479/4088,KLF4/IGF1/SMAD3
GO:0098543,detection of other organism,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,7097,TLR2
GO:0098703,calcium ion import across plasma membrane,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,781,CACNA2D1
GO:0098903,regulation of membrane repolarization during action potential,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,781,CACNA2D1
GO:1902656,calcium ion import into cytosol,1/53,13/18493,0.03663504316493171,0.09297559514002947,0.0538732477704832,1,bp,NAC,781,CACNA2D1
GO:2000278,regulation of DNA biosynthetic process,2/53,104/18493,0.03584267404940426,0.09297559514002947,0.0538732477704832,2,bp,NAC,9314/3082,KLF4/HGF
GO:0001818,negative regulation of cytokine production,3/53,256/18493,0.036990821691398404,0.09377364857063235,0.05433566729182319,3,bp,NAC,9314/1969/3082,KLF4/EPHA2/HGF
GO:0031109,microtubule polymerization or depolymerization,2/53,106/18493,0.03710723435869009,0.09377364857063235,0.05433566729182319,2,bp,NAC,3303/324,HSPA1A/APC
GO:0032609,interferon-gamma production,2/53,106/18493,0.03710723435869009,0.09377364857063235,0.05433566729182319,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0042107,cytokine metabolic process,2/53,106/18493,0.03710723435869009,0.09377364857063235,0.05433566729182319,2,bp,NAC,9314/7474,KLF4/WNT5A
GO:0031253,cell projection membrane,4/53,334/19659,0.012466065902982612,0.09406213363159609,0.07396134794114087,4,cc,NAC,1969/8516/324/8842,EPHA2/ITGA8/APC/PROM1
GO:0034612,response to tumor necrosis factor,3/53,257/18493,0.03735379945475327,0.09429653408004594,0.05463864508467095,3,bp,NAC,6772/3303/1277,STAT1/HSPA1A/COL1A1
GO:0051219,phosphoprotein binding,2/52,82/17632,0.024379542786559318,0.09435786004427588,0.061780517782703936,2,mf,NAC,9021/2810,SOCS3/SFN
GO:0003300,cardiac muscle hypertrophy,2/53,107/18493,0.037745927440121604,0.09488352584842406,0.054978768242037596,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0007249,I-kappaB kinase/NF-kappaB signaling,3/53,258/18493,0.03771862107377087,0.09488352584842406,0.054978768242037596,3,bp,NAC,6772/7097/7474,STAT1/TLR2/WNT5A
GO:0048640,negative regulation of developmental growth,2/53,107/18493,0.037745927440121604,0.09488352584842406,0.054978768242037596,2,bp,NAC,8835/7474,SOCS2/WNT5A
GO:0060419,heart growth,2/53,107/18493,0.037745927440121604,0.09488352584842406,0.054978768242037596,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0003279,cardiac septum development,2/53,109/18493,0.03903599624770807,0.09638714249370212,0.05585001528230538,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0007501,mesodermal cell fate specification,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,64321,SOX17
GO:0010421,hydrogen peroxide-mediated programmed cell death,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3082,HGF
GO:0010934,macrophage cytokine production,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0014897,striated muscle hypertrophy,2/53,109/18493,0.03903599624770807,0.09638714249370212,0.05585001528230538,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0020027,hemoglobin metabolic process,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,9314,KLF4
GO:0021984,adenohypophysis development,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3280,HES1
GO:0030100,regulation of endocytosis,3/53,260/18493,0.038453788502146445,0.09638714249370212,0.05585001528230538,3,bp,NAC,6424/7097/7474,SFRP4/TLR2/WNT5A
GO:0031272,regulation of pseudopodium assembly,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,324,APC
GO:0034374,low-density lipoprotein particle remodeling,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,5320,PLA2G2A
GO:0034392,negative regulation of smooth muscle cell apoptotic process,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3479,IGF1
GO:0042228,interleukin-8 biosynthetic process,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,9314,KLF4
GO:0045198,establishment of epithelial cell apical/basal polarity,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0045836,positive regulation of meiotic nuclear division,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0046620,regulation of organ growth,2/53,108/18493,0.038388857575818,0.09638714249370212,0.05585001528230538,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0048711,positive regulation of astrocyte differentiation,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3280,HES1
GO:0060911,cardiac cell fate commitment,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,64321,SOX17
GO:0061051,positive regulation of cell growth involved in cardiac muscle cell development,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3479,IGF1
GO:0070234,positive regulation of T cell apoptotic process,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0071850,mitotic cell cycle arrest,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,1647,GADD45A
GO:0086069,bundle of His cell to Purkinje myocyte communication,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,781,CACNA2D1
GO:0090036,regulation of protein kinase C signaling,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0090178,regulation of establishment of planar polarity involved in neural tube closure,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0090399,replicative senescence,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,1026,CDKN1A
GO:0097468,programmed cell death in response to reactive oxygen species,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,3082,HGF
GO:1904469,positive regulation of tumor necrosis factor secretion,1/53,14/18493,0.039397940497846284,0.09638714249370212,0.05585001528230538,1,bp,NAC,7474,WNT5A
GO:0098802,plasma membrane receptor complex,3/53,184/19659,0.013413584954610615,0.09681109141153749,0.07612286198497556,3,cc,NAC,3679/7097/8516,ITGA7/TLR2/ITGA8
GO:0031093,platelet alpha granule lumen,2/53,67/19659,0.014098761779695865,0.0975164356428964,0.07667747634571435,2,cc,NAC,3479/3082,IGF1/HGF
GO:0002244,hematopoietic progenitor cell differentiation,2/53,111/18493,0.04034278574312121,0.09799299744345479,0.05678050270173181,2,bp,NAC,3981/3280,LIG4/HES1
GO:0002793,positive regulation of peptide secretion,3/53,265/18493,0.04032384178929502,0.09799299744345479,0.05678050270173181,3,bp,NAC,3479/7097/7474,IGF1/TLR2/WNT5A
GO:0014896,muscle hypertrophy,2/53,111/18493,0.04034278574312121,0.09799299744345479,0.05678050270173181,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0021987,cerebral cortex development,2/53,111/18493,0.04034278574312121,0.09799299744345479,0.05678050270173181,2,bp,NAC,55970/1281,GNG12/COL3A1
GO:0030218,erythrocyte differentiation,2/53,111/18493,0.04034278574312121,0.09799299744345479,0.05678050270173181,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0060349,bone morphogenesis,2/53,111/18493,0.04034278574312121,0.09799299744345479,0.05678050270173181,2,bp,NAC,6424/1277,SFRP4/COL1A1
GO:1902105,regulation of leukocyte differentiation,3/53,265/18493,0.04032384178929502,0.09799299744345479,0.05678050270173181,3,bp,NAC,2353/3725/7704,FOS/JUN/ZBTB16
GO:0006304,DNA modification,2/53,112/18493,0.04100238014449147,0.09929089611364636,0.05753254969357846,2,bp,NAC,2353/4255,FOS/MGMT
GO:0014013,regulation of gliogenesis,2/53,112/18493,0.04100238014449147,0.09929089611364636,0.05753254969357846,2,bp,NAC,7097/3280,TLR2/HES1
GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,2/53,112/18493,0.04100238014449147,0.09929089611364636,0.05753254969357846,2,bp,NAC,3725/4088,JUN/SMAD3
GO:0045927,positive regulation of growth,3/53,267/18493,0.041084674812808315,0.09938896918093405,0.05758937659149338,3,bp,NAC,3479/2810/7472,IGF1/SFN/WNT2
GO:0001711,endodermal cell fate commitment,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,64321,SOX17
GO:0002070,epithelial cell maturation,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,1026,CDKN1A
GO:0002761,regulation of myeloid leukocyte differentiation,2/53,114/18493,0.04233382811344258,0.09977189618807379,0.05781125762922784,2,bp,NAC,2353/3725,FOS/JUN
GO:0003012,muscle system process,4/53,456/18493,0.041414399973574136,0.09977189618807379,0.05781125762922784,4,bp,NAC,9314/3479/4088/781,KLF4/IGF1/SMAD3/CACNA2D1
GO:0007351,tripartite regional subdivision,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,7474,WNT5A
GO:0008543,fibroblast growth factor receptor signaling pathway,2/53,113/18493,0.04166607023685423,0.09977189618807379,0.05781125762922784,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0008595,"anterior/posterior axis specification, embryo",1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,7474,WNT5A
GO:0010820,positive regulation of T cell chemotaxis,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,7474,WNT5A
GO:0010976,positive regulation of neuron projection development,3/53,269/18493,0.041852803601582056,0.09977189618807379,0.05781125762922784,3,bp,NAC,4804/3082/7474,NGFR/HGF/WNT5A
GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,9314,KLF4
GO:0032479,regulation of type I interferon production,2/53,113/18493,0.04166607023685423,0.09977189618807379,0.05781125762922784,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0032606,type I interferon production,2/53,114/18493,0.04233382811344258,0.09977189618807379,0.05781125762922784,2,bp,NAC,6772/7097,STAT1/TLR2
GO:0033689,negative regulation of osteoblast proliferation,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,4088,SMAD3
GO:0034616,response to laminar fluid shear stress,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,9314,KLF4
GO:0035729,cellular response to hepatocyte growth factor stimulus,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,3082,HGF
GO:0042552,myelination,2/53,114/18493,0.04233382811344258,0.09977189618807379,0.05781125762922784,2,bp,NAC,7097/3082,TLR2/HGF
GO:0045721,negative regulation of gluconeogenesis,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,3953,LEPR
GO:0046486,glycerolipid metabolic process,4/53,459/18493,0.042255853620262324,0.09977189618807379,0.05781125762922784,4,bp,NAC,5320/9021/8835/3082,PLA2G2A/SOCS3/SOCS2/HGF
GO:0048285,organelle fission,4/53,458/18493,0.04197428683571472,0.09977189618807379,0.05781125762922784,4,bp,NAC,3479/3303/7474/324,IGF1/HSPA1A/WNT5A/APC
GO:0048569,post-embryonic animal organ development,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,9314,KLF4
GO:0060026,convergent extension,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,7474,WNT5A
GO:0060253,negative regulation of glial cell proliferation,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,3280,HES1
GO:0072075,metanephric mesenchyme development,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,6772,STAT1
GO:0072089,stem cell proliferation,2/53,114/18493,0.04233382811344258,0.09977189618807379,0.05781125762922784,2,bp,NAC,64321/7474,SOX17/WNT5A
GO:0090177,establishment of planar polarity involved in neural tube closure,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,7474,WNT5A
GO:1902514,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,1/53,15/18493,0.04215306302361155,0.09977189618807379,0.05781125762922784,1,bp,NAC,781,CACNA2D1
GO:1903409,reactive oxygen species biosynthetic process,2/53,115/18493,0.04300562598841273,0.10125483029747076,0.05867052049904354,2,bp,NAC,9314/4088,KLF4/SMAD3
hsa04611,Platelet activation,3/50,124/7852,0.04402651626432052,0.10126098740793718,0.05892270597781243,3,kg,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0005125,cytokine activity,3/52,219/17632,0.026747437331164584,0.10164026185842541,0.06654864790528989,3,mf,NAC,353500/7472/7474,BMP8A/WNT2/WNT5A
GO:0007272,ensheathment of neurons,2/53,116/18493,0.04368143619640194,0.1025414168559169,0.05941601286547529,2,bp,NAC,7097/3082,TLR2/HGF
GO:0008366,axon ensheathment,2/53,116/18493,0.04368143619640194,0.1025414168559169,0.05941601286547529,2,bp,NAC,7097/3082,TLR2/HGF
GO:0042471,ear morphogenesis,2/53,116/18493,0.04368143619640194,0.1025414168559169,0.05941601286547529,2,bp,NAC,7474/8516,WNT5A/ITGA8
R-HSA-157118,Signaling by NOTCH,4/45,235/10554,0.0174860526882208,0.10258484243756202,0.0822151249200557,4,re,NAC,3725/6772/4088/3280,JUN/STAT1/SMAD3/HES1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,3/45,130/10554,0.017785270911889823,0.10262976001615111,0.08225112345792016,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
hsa05170,Human immunodeficiency virus 1 infection,4/50,212/7852,0.04528906051115252,0.10269772876472615,0.059758730696702365,4,kg,NAC,2353/3725/55970/7097,FOS/JUN/GNG12/TLR2
GO:0002791,regulation of peptide secretion,4/53,465/18493,0.04396798503773399,0.1031122962719245,0.05974679997341825,4,bp,NAC,3479/7097/353500/7474,IGF1/TLR2/BMP8A/WNT5A
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,3/45,132/10554,0.018516302851042967,0.10345616831058928,0.08291343632547227,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-9012852,Signaling by NOTCH3,2/45,49/10554,0.01841201533077091,0.10345616831058928,0.08291343632547227,2,re,NAC,6772/3280,STAT1/HES1
GO:0001832,blastocyst growth,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,3479,IGF1
GO:0001946,lymphangiogenesis,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,1969,EPHA2
GO:0002062,chondrocyte differentiation,2/53,117/18493,0.04436123119208737,0.10366332793589621,0.06006608661329208,2,bp,NAC,7704/4088,ZBTB16/SMAD3
GO:0002739,regulation of cytokine secretion involved in immune response,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,7474,WNT5A
GO:0010819,regulation of T cell chemotaxis,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,7474,WNT5A
GO:0031269,pseudopodium assembly,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,324,APC
GO:0033158,"regulation of protein import into nucleus, translocation",1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,3479,IGF1
GO:0034134,toll-like receptor 2 signaling pathway,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,7097,TLR2
GO:0038095,Fc-epsilon receptor signaling pathway,2/53,117/18493,0.04436123119208737,0.10366332793589621,0.06006608661329208,2,bp,NAC,2353/3725,FOS/JUN
GO:0048012,hepatocyte growth factor receptor signaling pathway,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,3082,HGF
GO:0072283,metanephric renal vesicle morphogenesis,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,6772,STAT1
GO:0090083,regulation of inclusion body assembly,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,3303,HSPA1A
GO:1900363,regulation of mRNA polyadenylation,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,79882,ZC3H14
GO:1901841,regulation of high voltage-gated calcium channel activity,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,781,CACNA2D1
GO:2000047,regulation of cell-cell adhesion mediated by cadherin,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,7474,WNT5A
GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/53,16/18493,0.04490043220099793,0.10366332793589621,0.06006608661329208,1,bp,NAC,4088,SMAD3
GO:0140014,mitotic nuclear division,3/53,277/18493,0.04499791811175513,0.10378763265737506,0.06013811303107609,3,bp,NAC,3479/3303/324,IGF1/HSPA1A/APC
GO:0043488,regulation of mRNA stability,2/53,118/18493,0.04504498354974675,0.10379551441986219,0.060142679994510916,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:0044262,cellular carbohydrate metabolic process,3/53,278/18493,0.045399186209184594,0.10451042091523811,0.060556921330639064,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0033209,tumor necrosis factor-mediated signaling pathway,2/53,119/18493,0.04573266596282032,0.10507466633776494,0.06088386447529297,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:1905477,positive regulation of protein localization to membrane,2/53,119/18493,0.04573266596282032,0.10507466633776494,0.06088386447529297,2,bp,NAC,1969/2810,EPHA2/SFN
GO:0009897,external side of plasma membrane,4/53,359/19659,0.015862194144973432,0.10532496912262358,0.0828173504832297,4,cc,NAC,3977/3953/3554/7472,LIFR/LEPR/IL1R1/WNT2
hsa05134,Legionellosis,2/50,55/7852,0.047644369912241365,0.10653810494265083,0.061993405295167864,2,kg,NAC,7097/3303,TLR2/HSPA1A
GO:0034101,erythrocyte homeostasis,2/53,120/18493,0.0464242512434743,0.10656068480403659,0.06174491452723824,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0010744,positive regulation of macrophage derived foam cell differentiation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,5320,PLA2G2A
GO:0021783,preganglionic parasympathetic fiber development,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3280,HES1
GO:0022010,central nervous system myelination,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7097,TLR2
GO:0031268,pseudopodium organization,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,324,APC
GO:0032291,axon ensheathment in central nervous system,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7097,TLR2
GO:0035728,response to hepatocyte growth factor,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3082,HGF
GO:0036149,phosphatidylinositol acyl-chain remodeling,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,5320,PLA2G2A
GO:0038092,nodal signaling pathway,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,4088,SMAD3
GO:0042249,establishment of planar polarity of embryonic epithelium,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7474,WNT5A
GO:0043923,positive regulation by host of viral transcription,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3725,JUN
GO:0044320,cellular response to leptin stimulus,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3953,LEPR
GO:0045683,negative regulation of epidermis development,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3280,HES1
GO:0045725,positive regulation of glycogen biosynthetic process,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3479,IGF1
GO:0046718,viral entry into host cell,2/53,121/18493,0.047119712322165816,0.1065739276634269,0.06175258789404002,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0048714,positive regulation of oligodendrocyte differentiation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7097,TLR2
GO:0048820,hair follicle maturation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7474,WNT5A
GO:0060644,mammary gland epithelial cell differentiation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,4255,MGMT
GO:0060850,regulation of transcription involved in cell fate commitment,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,64321,SOX17
GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7474,WNT5A
GO:0061318,renal filtration cell differentiation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,8842,PROM1
GO:0061577,calcium ion transmembrane transport via high voltage-gated calcium channel,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,781,CACNA2D1
GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3479,IGF1
GO:0072112,glomerular visceral epithelial cell differentiation,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,8842,PROM1
GO:0072148,epithelial cell fate commitment,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3280,HES1
GO:0090185,negative regulation of kidney development,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,6772,STAT1
GO:0106058,positive regulation of calcineurin-mediated signaling,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,3479,IGF1
GO:0140058,neuron projection arborization,1/53,17/18493,0.04764006943070764,0.1065739276634269,0.06175258789404002,1,bp,NAC,7474,WNT5A
GO:0001206,"distal enhancer DNA-binding transcription repressor activity, RNA polymerase II-specific",1/52,10/17632,0.029110831639231782,0.10673971601051653,0.06988749978024252,1,mf,NAC,7704,ZBTB16
GO:0071723,lipopeptide binding,1/52,10/17632,0.029110831639231782,0.10673971601051653,0.06988749978024252,1,mf,NAC,7097,TLR2
GO:0010975,regulation of neuron projection development,4/53,478/18493,0.04781127032835953,0.10685639176770578,0.061916257281185834,4,bp,NAC,9314/4804/3082/7474,KLF4/NGFR/HGF/WNT5A
GO:0007043,cell-cell junction assembly,2/53,123/18493,0.04852215418434364,0.10824172856507429,0.06271896892199648,2,bp,NAC,1969/324,EPHA2/APC
GO:0050715,positive regulation of cytokine secretion,2/53,123/18493,0.04852215418434364,0.10824172856507429,0.06271896892199648,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0043087,regulation of GTPase activity,4/53,481/18493,0.04872414250969978,0.10859045069172078,0.06292103047915654,4,bp,NAC,3725/10252/1969/7474,JUN/SPRY1/EPHA2/WNT5A
GO:0005996,monosaccharide metabolic process,3/53,287/18493,0.04909121348782804,0.10920384066796547,0.06327644966330256,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0009895,negative regulation of catabolic process,3/53,287/18493,0.04909121348782804,0.10920384066796547,0.06327644966330256,3,bp,NAC,3953/4088/3082,LEPR/SMAD3/HGF
GO:0005035,death receptor activity,1/52,11/17632,0.03197578662474776,0.10955638368151281,0.07173170424878704,1,mf,NAC,4804,NGFR
GO:0035325,Toll-like receptor binding,1/52,11/17632,0.03197578662474776,0.10955638368151281,0.07173170424878704,1,mf,NAC,7097,TLR2
GO:0042301,phosphate ion binding,1/52,11/17632,0.03197578662474776,0.10955638368151281,0.07173170424878704,1,mf,NAC,55970,GNG12
GO:0045295,gamma-catenin binding,1/52,11/17632,0.03197578662474776,0.10955638368151281,0.07173170424878704,1,mf,NAC,324,APC
GO:0002726,positive regulation of T cell cytokine production,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,3554,IL1R1
GO:0007221,positive regulation of transcription of Notch receptor target,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,6772,STAT1
GO:0007252,I-kappaB phosphorylation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7097,TLR2
GO:0010224,response to UV-B,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,1026,CDKN1A
GO:0030540,female genitalia development,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7474,WNT5A
GO:0031293,membrane protein intracellular domain proteolysis,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,4804,NGFR
GO:0032717,negative regulation of interleukin-8 production,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,9314,KLF4
GO:0035089,establishment of apical/basal cell polarity,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7474,WNT5A
GO:0036148,phosphatidylglycerol acyl-chain remodeling,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,5320,PLA2G2A
GO:0043931,ossification involved in bone maturation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,3479,IGF1
GO:0045655,regulation of monocyte differentiation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,3725,JUN
GO:0050765,negative regulation of phagocytosis,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7097,TLR2
GO:0060219,camera-type eye photoreceptor cell differentiation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,8842,PROM1
GO:0060749,mammary gland alveolus development,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,8835,SOCS2
GO:0061323,cell proliferation involved in heart morphogenesis,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,3280,HES1
GO:0061377,mammary gland lobule development,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,8835,SOCS2
GO:0070230,positive regulation of lymphocyte apoptotic process,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7474,WNT5A
GO:0070242,thymocyte apoptotic process,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7474,WNT5A
GO:0072311,glomerular epithelial cell differentiation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,8842,PROM1
GO:0098581,detection of external biotic stimulus,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7097,TLR2
GO:1905276,regulation of epithelial tube formation,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,7474,WNT5A
GO:2000136,regulation of cell proliferation involved in heart morphogenesis,1/53,18/18493,0.05037199605552778,0.10979340661782315,0.06361806438968197,1,bp,NAC,3280,HES1
GO:0003231,cardiac ventricle development,2/53,126/18493,0.050654215478026475,0.11000522776871868,0.06374080082743251,2,bp,NAC,7474/3280,WNT5A/HES1
GO:0042476,odontogenesis,2/53,126/18493,0.050654215478026475,0.11000522776871868,0.06374080082743251,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,2/53,126/18493,0.050654215478026475,0.11000522776871868,0.06374080082743251,2,bp,NAC,4804/4088,NGFR/SMAD3
GO:0043487,regulation of RNA stability,2/53,126/18493,0.050654215478026475,0.11000522776871868,0.06374080082743251,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:0000790,nuclear chromatin,4/53,369/19659,0.017369046569613886,0.11002720113060589,0.08651473012171929,4,cc,NAC,9314/3725/6772/4088,KLF4/JUN/STAT1/SMAD3
GO:0016528,sarcoplasm,2/53,76/19659,0.017895990545339514,0.11002720113060589,0.08651473012171929,2,cc,NAC,2318/781,FLNC/CACNA2D1
GO:0030258,lipid modification,3/53,291/18493,0.05077836960213239,0.11017423623528359,0.06383873012792096,3,bp,NAC,9021/8835/3082,SOCS3/SOCS2/HGF
GO:0032355,response to estradiol,2/53,127/18493,0.051372369454372215,0.11126001326274784,0.06446786656674647,2,bp,NAC,8835/1277,SOCS2/COL1A1
GO:0032680,regulation of tumor necrosis factor production,2/53,127/18493,0.051372369454372215,0.11126001326274784,0.06446786656674647,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0000980,RNA polymerase II distal enhancer sequence-specific DNA binding,2/52,100/17632,0.03514227332906341,0.11128386554203412,0.07286276766791457,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0003714,transcription corepressor activity,3/52,238/17632,0.03306319283381438,0.11128386554203412,0.07286276766791457,3,mf,NAC,3303/862/3280,HSPA1A/RUNX1T1/HES1
GO:0004861,cyclin-dependent protein serine/threonine kinase inhibitor activity,1/52,12/17632,0.03483244964588761,0.11128386554203412,0.07286276766791457,1,mf,NAC,1026,CDKN1A
GO:0031994,insulin-like growth factor I binding,1/52,12/17632,0.03483244964588761,0.11128386554203412,0.07286276766791457,1,mf,NAC,3486,IGFBP3
GO:0070410,co-SMAD binding,1/52,12/17632,0.03483244964588761,0.11128386554203412,0.07286276766791457,1,mf,NAC,4088,SMAD3
GO:0002076,osteoblast development,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,4088,SMAD3
GO:0002576,platelet degranulation,2/53,128/18493,0.05209421301785391,0.11206918687413689,0.06493672950212263,2,bp,NAC,3479/3082,IGF1/HGF
GO:0007350,blastoderm segmentation,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7474,WNT5A
GO:0008015,blood circulation,4/53,492/18493,0.05215449431394149,0.11206918687413689,0.06493672950212263,4,bp,NAC,6772/4088/781/1278,STAT1/SMAD3/CACNA2D1/COL1A2
GO:0008356,asymmetric cell division,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7704,ZBTB16
GO:0010560,positive regulation of glycoprotein biosynthetic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3479,IGF1
GO:0010612,regulation of cardiac muscle adaptation,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,4088,SMAD3
GO:0030859,polarized epithelial cell differentiation,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7474,WNT5A
GO:0032288,myelin assembly,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7097,TLR2
GO:0032640,tumor necrosis factor production,2/53,129/18493,0.05281972002976472,0.11206918687413689,0.06493672950212263,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0036303,lymph vessel morphogenesis,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,1969,EPHA2
GO:0042438,melanin biosynthetic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7474,WNT5A
GO:0042789,mRNA transcription by RNA polymerase II,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,64321,SOX17
GO:0045821,positive regulation of glycolytic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3479,IGF1
GO:0048486,parasympathetic nervous system development,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3280,HES1
GO:0051051,negative regulation of transport,4/53,495/18493,0.05311268864892863,0.11206918687413689,0.06493672950212263,4,bp,NAC,6424/7097/3303/353500,SFRP4/TLR2/HSPA1A/BMP8A
GO:0051797,regulation of hair follicle development,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,7474,WNT5A
GO:0061564,axon development,4/53,493/18493,0.05247281549215389,0.11206918687413689,0.06493672950212263,4,bp,NAC,9314/3725/4804/7474,KLF4/JUN/NGFR/WNT5A
GO:0070875,positive regulation of glycogen metabolic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3479,IGF1
GO:0071636,positive regulation of transforming growth factor beta production,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,4088,SMAD3
GO:0072074,kidney mesenchyme development,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,6772,STAT1
GO:0072077,renal vesicle morphogenesis,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,6772,STAT1
GO:1901673,regulation of mitotic spindle assembly,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3303,HSPA1A
GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3303,HSPA1A
GO:1902850,microtubule cytoskeleton organization involved in mitosis,2/53,129/18493,0.05281972002976472,0.11206918687413689,0.06493672950212263,2,bp,NAC,10252/3303,SPRY1/HSPA1A
GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,4088,SMAD3
GO:1905288,vascular associated smooth muscle cell apoptotic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3479,IGF1
GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3479,IGF1
GO:2000737,negative regulation of stem cell differentiation,1/53,19/18493,0.05309623336048319,0.11206918687413689,0.06493672950212263,1,bp,NAC,3280,HES1
R-HSA-202733,Cell surface interactions at the vascular wall,3/45,137/10554,0.02041657859343339,0.11229118226388365,0.08999412932631824,3,re,NAC,7102/1277/1278,TSPAN7/COL1A1/COL1A2
GO:0007006,mitochondrial membrane organization,2/53,131/18493,0.05428162041582324,0.11423158703436077,0.06618969829931312,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0030216,keratinocyte differentiation,3/53,299/18493,0.05423713272271839,0.11423158703436077,0.06618969829931312,3,bp,NAC,1969/2810/7474,EPHA2/SFN/WNT5A
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,2/53,131/18493,0.05428162041582324,0.11423158703436077,0.06618969829931312,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0002089,lens morphogenesis in camera-type eye,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,1969,EPHA2
GO:0002700,regulation of production of molecular mediator of immune response,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0002827,positive regulation of T-helper 1 type immune response,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,3554,IL1R1
GO:0003013,circulatory system process,4/53,500/18493,0.05473119947172749,0.11481214923752191,0.06652609594613616,4,bp,NAC,6772/4088/781/1278,STAT1/SMAD3/CACNA2D1/COL1A2
GO:0003323,type B pancreatic cell development,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,7474,WNT5A
GO:0006582,melanin metabolic process,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,7474,WNT5A
GO:0030260,entry into host cell,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0030813,positive regulation of nucleotide catabolic process,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,3479,IGF1
GO:0032946,positive regulation of mononuclear cell proliferation,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,3479/3280,IGF1/HES1
GO:0035458,cellular response to interferon-beta,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,6772,STAT1
GO:0044409,entry into host,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0050671,positive regulation of lymphocyte proliferation,2/53,132/18493,0.055017962083072906,0.11481214923752191,0.06652609594613616,2,bp,NAC,3479/3280,IGF1/HES1
GO:0051131,chaperone-mediated protein complex assembly,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,3303,HSPA1A
GO:0051197,positive regulation of coenzyme metabolic process,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,3479,IGF1
GO:0051291,protein heterooligomerization,2/53,132/18493,0.055017962083072906,0.11481214923752191,0.06652609594613616,2,bp,NAC,1277/1278,COL1A1/COL1A2
GO:0051806,entry into cell of other organism involved in symbiotic interaction,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0051828,entry into other organism involved in symbiotic interaction,2/53,133/18493,0.055757863784118254,0.11481214923752191,0.06652609594613616,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0060231,mesenchymal to epithelial transition,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,6772,STAT1
GO:0060575,intestinal epithelial cell differentiation,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,1026,CDKN1A
GO:0061162,establishment of monopolar cell polarity,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,7474,WNT5A
GO:0061436,establishment of skin barrier,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,2810,SFN
GO:0070977,bone maturation,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,3479,IGF1
GO:0072087,renal vesicle development,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,6772,STAT1
GO:0140131,positive regulation of lymphocyte chemotaxis,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,7474,WNT5A
GO:1902473,regulation of protein localization to synapse,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,7474,WNT5A
GO:1903055,positive regulation of extracellular matrix organization,1/53,20/18493,0.05581280257299215,0.11481214923752191,0.06652609594613616,1,bp,NAC,4088,SMAD3
GO:0017017,MAP kinase tyrosine/serine/threonine phosphatase activity,1/52,13/17632,0.03768084423263085,0.11581318300911542,0.07582832430715188,1,mf,NAC,1844,DUSP2
GO:0072542,protein phosphatase activator activity,1/52,13/17632,0.03768084423263085,0.11581318300911542,0.07582832430715188,1,mf,NAC,3486,IGFBP3
GO:0050863,regulation of T cell activation,3/53,305/18493,0.056904347478925775,0.11695638574320266,0.06776854009908916,3,bp,NAC,3479/7704/3280,IGF1/ZBTB16/HES1
R-HSA-1474228,Degradation of the extracellular matrix,3/45,140/10554,0.02160669845025094,0.11700858237674357,0.09377482080432797,3,re,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0033135,regulation of peptidyl-serine phosphorylation,2/53,135/18493,0.05724824511713107,0.11746016124981681,0.06806044490107134,2,bp,NAC,3082/7474,HGF/WNT5A
GO:0071706,tumor necrosis factor superfamily cytokine production,2/53,135/18493,0.05724824511713107,0.11746016124981681,0.06806044490107134,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0009595,detection of biotic stimulus,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,7097,TLR2
GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,3554,IL1R1
GO:0036120,cellular response to platelet-derived growth factor stimulus,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,80310,PDGFD
GO:0036150,phosphatidylserine acyl-chain remodeling,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,5320,PLA2G2A
GO:0046827,positive regulation of protein export from nucleus,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,2810,SFN
GO:0050434,positive regulation of viral transcription,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,3725,JUN
GO:0060713,labyrinthine layer morphogenesis,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,9021,SOCS3
GO:0061339,establishment or maintenance of monopolar cell polarity,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,7474,WNT5A
GO:0071498,cellular response to fluid shear stress,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,9314,KLF4
GO:0072010,glomerular epithelium development,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,8842,PROM1
GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,4093,SMAD9
GO:1904886,beta-catenin destruction complex disassembly,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,324,APC
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,9314,KLF4
GO:2000178,negative regulation of neural precursor cell proliferation,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,7474,WNT5A
GO:2000380,regulation of mesoderm development,1/53,21/18493,0.05852172486301721,0.11853889414331767,0.06868549972714924,1,bp,NAC,64321,SOX17
GO:0045089,positive regulation of innate immune response,3/53,309/18493,0.05871694582459556,0.11883310397522402,0.06885597499161979,3,bp,NAC,7097/3303/7474,TLR2/HSPA1A/WNT5A
GO:0033549,MAP kinase phosphatase activity,1/52,14/17632,0.04052099384951646,0.11928010865561889,0.07809828317920149,1,mf,NAC,1844,DUSP2
GO:0035497,cAMP response element binding,1/52,14/17632,0.04052099384951646,0.11928010865561889,0.07809828317920149,1,mf,NAC,3725,JUN
GO:0047485,protein N-terminus binding,2/52,107/17632,0.03974182714659711,0.11928010865561889,0.07809828317920149,2,mf,NAC,1647/3303,GADD45A/HSPA1A
GO:0007568,aging,3/53,311/18493,0.05963350379170351,0.12058543538832563,0.06987133589629423,3,bp,NAC,2353/3725/1026,FOS/JUN/CDKN1A
GO:0070665,positive regulation of leukocyte proliferation,2/53,139/18493,0.060270610582014425,0.12177018858456269,0.07055782252100067,2,bp,NAC,3479/3280,IGF1/HES1
GO:0007398,ectoderm development,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,2114,ETS2
GO:0010842,retina layer formation,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,8842,PROM1
GO:0032069,regulation of nuclease activity,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,3303,HSPA1A
GO:0032727,positive regulation of interferon-alpha production,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,6772,STAT1
GO:0033561,regulation of water loss via skin,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,2810,SFN
GO:0034123,positive regulation of toll-like receptor signaling pathway,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,7097,TLR2
GO:0036119,response to platelet-derived growth factor,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,80310,PDGFD
GO:0044321,response to leptin,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,3953,LEPR
GO:0045663,positive regulation of myoblast differentiation,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,3486,IGFBP3
GO:0060065,uterus development,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,7474,WNT5A
GO:0061013,regulation of mRNA catabolic process,2/53,140/18493,0.061034722802597995,0.12203549434549192,0.07071154977568456,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:0070841,inclusion body assembly,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,3303,HSPA1A
GO:0071425,hematopoietic stem cell proliferation,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,7474,WNT5A
GO:0071677,positive regulation of mononuclear cell migration,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,80310,PDGFD
GO:0097150,neuronal stem cell population maintenance,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,3280,HES1
GO:1904467,regulation of tumor necrosis factor secretion,1/53,22/18493,0.061223021343217776,0.12203549434549192,0.07071154977568456,1,bp,NAC,7474,WNT5A
GO:0045807,positive regulation of endocytosis,2/53,141/18493,0.061802193614049455,0.12308678091642346,0.07132070126138654,2,bp,NAC,6424/7474,SFRP4/WNT5A
GO:0106106,cold-induced thermogenesis,2/53,142/18493,0.06257299833294834,0.12430959902736104,0.07202924400283989,2,bp,NAC,3953/324,LEPR/APC
GO:0120161,regulation of cold-induced thermogenesis,2/53,142/18493,0.06257299833294834,0.12430959902736104,0.07202924400283989,2,bp,NAC,3953/324,LEPR/APC
GO:2000241,regulation of reproductive process,2/53,142/18493,0.06257299833294834,0.12430959902736104,0.07202924400283989,2,bp,NAC,3479/7474,IGF1/WNT5A
GO:0000132,establishment of mitotic spindle orientation,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,10252,SPRY1
GO:0002021,response to dietary excess,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,353500,BMP8A
GO:0006297,"nucleotide-excision repair, DNA gap filling",1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3981,LIG4
GO:0010226,response to lithium ion,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3981,LIG4
GO:0034505,tooth mineralization,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,1277,COL1A1
GO:0042742,defense response to bacterium,3/53,319/18493,0.06336750184668372,0.12489231197890283,0.07236688786701952,3,bp,NAC,5320/7097/1969,PLA2G2A/TLR2/EPHA2
GO:0045686,negative regulation of glial cell differentiation,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3280,HES1
GO:0051446,positive regulation of meiotic cell cycle,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,7474,WNT5A
GO:0060396,growth hormone receptor signaling pathway,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,8835,SOCS2
GO:0060445,branching involved in salivary gland morphogenesis,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3082,HGF
GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3479,IGF1
GO:0061351,neural precursor cell proliferation,2/53,143/18493,0.06334711238495104,0.12489231197890283,0.07236688786701952,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0072215,regulation of metanephros development,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,6772,STAT1
GO:0086012,membrane depolarization during cardiac muscle cell action potential,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,781,CACNA2D1
GO:1903020,positive regulation of glycoprotein metabolic process,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,3479,IGF1
GO:1903670,regulation of sprouting angiogenesis,2/53,143/18493,0.06334711238495104,0.12489231197890283,0.07236688786701952,2,bp,NAC,9314/4804,KLF4/NGFR
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,1026,CDKN1A
GO:1904861,excitatory synapse assembly,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,7474,WNT5A
GO:1990774,tumor necrosis factor secretion,1/53,23/18493,0.06391671306910207,0.12489231197890283,0.07236688786701952,1,bp,NAC,7474,WNT5A
GO:2001056,positive regulation of cysteine-type endopeptidase activity,2/53,143/18493,0.06334711238495104,0.12489231197890283,0.07236688786701952,2,bp,NAC,4804/4088,NGFR/SMAD3
GO:0051056,regulation of small GTPase mediated signal transduction,3/53,321/18493,0.06431780536727151,0.12557285809800628,0.07276121962298714,3,bp,NAC,3479/10252/1281,IGF1/SPRY1/COL3A1
GO:0005924,cell-substrate adherens junction,4/53,405/19659,0.023524459918560035,0.1260807107560093,0.0991376546210853,4,cc,NAC,2318/1969/3303/8516,FLNC/EPHA2/HSPA1A/ITGA8
GO:0005925,focal adhesion,4/53,402/19659,0.022966933964986495,0.1260807107560093,0.0991376546210853,4,cc,NAC,2318/1969/3303/8516,FLNC/EPHA2/HSPA1A/ITGA8
GO:0017053,transcriptional repressor complex,2/53,84/19659,0.02159279344016499,0.1260807107560093,0.0991376546210853,2,cc,NAC,3725/7704,JUN/ZBTB16
GO:0030055,cell-substrate junction,4/53,409/19659,0.024280640547908933,0.1260807107560093,0.0991376546210853,4,cc,NAC,2318/1969/3303/8516,FLNC/EPHA2/HSPA1A/ITGA8
GO:0031091,platelet alpha granule,2/53,91/19659,0.025064237680411487,0.1260807107560093,0.0991376546210853,2,cc,NAC,3479/3082,IGF1/HGF
GO:0032587,ruffle membrane,2/53,91/19659,0.025064237680411487,0.1260807107560093,0.0991376546210853,2,cc,NAC,1969/324,EPHA2/APC
hsa04915,Estrogen signaling pathway,3/50,138/7852,0.05722598132109309,0.12621072592734228,0.07344069700904521,3,kg,NAC,2353/3725/3303,FOS/JUN/HSPA1A
hsa04213,Longevity regulating pathway - multiple species,2/50,62/7852,0.059001193134685735,0.12665589459579205,0.0736997359857829,2,kg,NAC,3479/3303,IGF1/HSPA1A
hsa05418,Fluid shear stress and atherosclerosis,3/50,139/7852,0.0582337625935507,0.12665589459579205,0.0736997359857829,3,kg,NAC,2353/3725/3554,FOS/JUN/IL1R1
GO:0002092,positive regulation of receptor internalization,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,6424,SFRP4
GO:0002262,myeloid cell homeostasis,2/53,146/18493,0.06568906642384545,0.12803678935421955,0.07418890587608934,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0007026,negative regulation of microtubule depolymerization,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,324,APC
GO:0009267,cellular response to starvation,2/53,146/18493,0.06568906642384545,0.12803678935421955,0.07418890587608934,2,bp,NAC,3725/1026,JUN/CDKN1A
GO:0030325,adrenal gland development,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,4088,SMAD3
GO:0030336,negative regulation of cell migration,3/53,324/18493,0.06575574937644642,0.12803678935421955,0.07418890587608934,3,bp,NAC,9314/3486/1281,KLF4/IGFBP3/COL3A1
GO:0030878,thyroid gland development,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,4088,SMAD3
GO:0032897,negative regulation of viral transcription,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,3725,JUN
GO:0035264,multicellular organism growth,2/53,147/18493,0.06647617423228806,0.12803678935421955,0.07418890587608934,2,bp,NAC,3479/8835,IGF1/SOCS2
GO:0043524,negative regulation of neuron apoptotic process,2/53,147/18493,0.06647617423228806,0.12803678935421955,0.07418890587608934,2,bp,NAC,3725/3981,JUN/LIG4
GO:0045672,positive regulation of osteoclast differentiation,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,2353,FOS
GO:0046058,cAMP metabolic process,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,1969,EPHA2
GO:0048679,regulation of axon regeneration,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,9314,KLF4
GO:0048799,animal organ maturation,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,3479,IGF1
GO:0062009,secondary palate development,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,7474,WNT5A
GO:0071378,cellular response to growth hormone stimulus,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,8835,SOCS2
GO:0090103,cochlea morphogenesis,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,7474,WNT5A
GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,2810,SFN
GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/53,24/18493,0.0666028210391798,0.12803678935421955,0.07418890587608934,1,bp,NAC,2810,SFN
GO:0010977,negative regulation of neuron projection development,2/53,148/18493,0.06726647012421194,0.12920813082017446,0.074867621284409,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0001158,enhancer sequence-specific DNA binding,2/52,119/17632,0.048122054780211906,0.12961229327408155,0.0848632491847424,2,mf,NAC,3725/7704,JUN/ZBTB16
GO:0005005,transmembrane-ephrin receptor activity,1/52,17/17632,0.04899220654857628,0.12961229327408155,0.0848632491847424,1,mf,NAC,1969,EPHA2
GO:0019211,phosphatase activator activity,1/52,16/17632,0.04617665170574614,0.12961229327408155,0.0848632491847424,1,mf,NAC,3486,IGFBP3
GO:0042834,peptidoglycan binding,1/52,17/17632,0.04899220654857628,0.12961229327408155,0.0848632491847424,1,mf,NAC,7097,TLR2
GO:0047498,calcium-dependent phospholipase A2 activity,1/52,16/17632,0.04617665170574614,0.12961229327408155,0.0848632491847424,1,mf,NAC,5320,PLA2G2A
GO:0051010,microtubule plus-end binding,1/52,17/17632,0.04899220654857628,0.12961229327408155,0.0848632491847424,1,mf,NAC,324,APC
GO:0070696,transmembrane receptor protein serine/threonine kinase binding,1/52,17/17632,0.04899220654857628,0.12961229327408155,0.0848632491847424,1,mf,NAC,353500,BMP8A
GO:0071837,HMG box domain binding,1/52,16/17632,0.04617665170574614,0.12961229327408155,0.0848632491847424,1,mf,NAC,3725,JUN
R-HSA-1257604,PIP3 activates AKT signaling,4/45,260/10554,0.024329717600350218,0.1297584938685345,0.10399305130612214,4,re,NAC,3164/3725/3082/1026,NR4A1/JUN/HGF/CDKN1A
GO:0016331,morphogenesis of embryonic epithelium,2/53,149/18493,0.06805993017131907,0.13052138221564255,0.07562856417169497,2,bp,NAC,7472/7474,WNT2/WNT5A
GO:0051384,response to glucocorticoid,2/53,149/18493,0.06805993017131907,0.13052138221564255,0.07562856417169497,2,bp,NAC,2353/1026,FOS/CDKN1A
GO:0001945,lymph vessel development,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,1969,EPHA2
GO:0002068,glandular epithelial cell development,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,7474,WNT5A
GO:0002230,positive regulation of defense response to virus by host,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,6772,STAT1
GO:0003309,type B pancreatic cell differentiation,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,7474,WNT5A
GO:0009299,mRNA transcription,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,64321,SOX17
GO:0031116,positive regulation of microtubule polymerization,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,3303,HSPA1A
GO:0034114,regulation of heterotypic cell-cell adhesion,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,9314,KLF4
GO:0050927,positive regulation of positive chemotaxis,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,4088,SMAD3
GO:0051894,positive regulation of focal adhesion assembly,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,4088,SMAD3
GO:0055083,monovalent inorganic anion homeostasis,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,6424,SFRP4
GO:0060343,trabecula formation,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,1277,COL1A1
GO:0085029,extracellular matrix assembly,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,4088,SMAD3
GO:1901032,negative regulation of response to reactive oxygen species,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,3082,HGF
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,3082,HGF
GO:1903707,negative regulation of hemopoiesis,2/53,150/18493,0.06885653055159574,0.13117124905412245,0.07600511930053841,2,bp,NAC,7704/3280,ZBTB16/HES1
GO:2001039,negative regulation of cellular response to drug,1/53,25/18493,0.0692813661951126,0.13117124905412245,0.07600511930053841,1,bp,NAC,3082,HGF
GO:0051251,positive regulation of lymphocyte activation,3/53,333/18493,0.07015858681721274,0.13272642756669203,0.07690624305466774,3,bp,NAC,3479/7704/3280,IGF1/ZBTB16/HES1
GO:0000188,inactivation of MAPK activity,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,1844,DUSP2
GO:0001958,endochondral ossification,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,1277,COL1A1
GO:0006817,phosphate ion transport,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,6424,SFRP4
GO:0007596,blood coagulation,3/53,334/18493,0.07065595215619959,0.13315387897680583,0.07715392305813769,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0031114,regulation of microtubule depolymerization,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,324,APC
GO:0031954,positive regulation of protein autophosphorylation,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,80310,PDGFD
GO:0033137,negative regulation of peptidyl-serine phosphorylation,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3082,HGF
GO:0036075,replacement ossification,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,1277,COL1A1
GO:0036152,phosphatidylethanolamine acyl-chain remodeling,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,5320,PLA2G2A
GO:0042026,protein refolding,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3303,HSPA1A
GO:0042129,regulation of T cell proliferation,2/53,153/18493,0.07126493705731397,0.13315387897680583,0.07715392305813769,2,bp,NAC,3479/3280,IGF1/HES1
GO:0043032,positive regulation of macrophage activation,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:0048596,embryonic camera-type eye morphogenesis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:0048843,negative regulation of axon extension involved in axon guidance,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:0050926,regulation of positive chemotaxis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,4088,SMAD3
GO:0051194,positive regulation of cofactor metabolic process,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3479,IGF1
GO:0060037,pharyngeal system development,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3280,HES1
GO:0060259,regulation of feeding behavior,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3953,LEPR
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,781,CACNA2D1
GO:0060669,embryonic placenta morphogenesis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,9021,SOCS3
GO:0060706,cell differentiation involved in embryonic placenta development,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,9021,SOCS3
GO:0060740,prostate gland epithelium morphogenesis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:0070528,protein kinase C signaling,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:0072202,cell differentiation involved in metanephros development,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,6772,STAT1
GO:0090169,regulation of spindle assembly,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3303,HSPA1A
GO:1901623,regulation of lymphocyte chemotaxis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,7474,WNT5A
GO:1902624,positive regulation of neutrophil migration,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,3554,IL1R1
GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/53,26/18493,0.07195236942186523,0.13315387897680583,0.07715392305813769,1,bp,NAC,4804,NGFR
GO:0042277,peptide binding,3/52,285/17632,0.05171642629816573,0.13510916370395795,0.08846230814159929,3,mf,NAC,4804/3953/7097,NGFR/LEPR/TLR2
GO:0007599,hemostasis,3/53,339/18493,0.07316697916827902,0.13519120160230577,0.07833441764305178,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:2000146,negative regulation of cell motility,3/53,339/18493,0.07316697916827902,0.13519120160230577,0.07833441764305178,3,bp,NAC,9314/3486/1281,KLF4/IGFBP3/COL3A1
GO:0002724,regulation of T cell cytokine production,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3554,IL1R1
GO:0002825,regulation of T-helper 1 type immune response,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3554,IL1R1
GO:0006606,protein import into nucleus,2/53,157/18493,0.07451868363158454,0.13586255358407087,0.07872342200059704,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0010818,T cell chemotaxis,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,7474,WNT5A
GO:0031440,regulation of mRNA 3'-end processing,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,79882,ZC3H14
GO:0035902,response to immobilization stress,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,2353,FOS
GO:0036151,phosphatidylcholine acyl-chain remodeling,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,5320,PLA2G2A
GO:0040001,establishment of mitotic spindle localization,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,10252,SPRY1
GO:0042104,positive regulation of activated T cell proliferation,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3479,IGF1
GO:0042634,regulation of hair cycle,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,7474,WNT5A
GO:0043921,modulation by host of viral transcription,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3725,JUN
GO:0044550,secondary metabolite biosynthetic process,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,7474,WNT5A
GO:0045931,positive regulation of mitotic cell cycle,2/53,157/18493,0.07451868363158454,0.13586255358407087,0.07872342200059704,2,bp,NAC,3479/3280,IGF1/HES1
GO:0048710,regulation of astrocyte differentiation,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3280,HES1
GO:0050817,coagulation,3/53,340/18493,0.07367399771661724,0.13586255358407087,0.07872342200059704,3,bp,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
GO:0052472,modulation by host of symbiont transcription,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3725,JUN
GO:0060122,inner ear receptor cell stereocilium organization,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3280,HES1
GO:1903792,negative regulation of anion transport,1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,6424,SFRP4
GO:2000144,"positive regulation of DNA-templated transcription, initiation",1/53,27/18493,0.07461585154785388,0.13586255358407087,0.07872342200059704,1,bp,NAC,3725,JUN
GO:1902903,regulation of supramolecular fiber organization,3/53,343/18493,0.07520460969209136,0.13682981013603157,0.07928388361208683,3,bp,NAC,4088/3303/324,SMAD3/HSPA1A/APC
GO:0043535,regulation of blood vessel endothelial cell migration,2/53,158/18493,0.07533956170955086,0.13697054873494796,0.07936543238194277,2,bp,NAC,9314/1969,KLF4/EPHA2
GO:0005178,integrin binding,2/52,126/17632,0.05328219727967776,0.13748122507966234,0.09001540800985197,2,mf,NAC,3479/1281,IGF1/COL3A1
GO:0030098,lymphocyte differentiation,3/53,344/18493,0.07571798603704848,0.13755337723155178,0.07970314319689314,3,bp,NAC,7704/3953/3981,ZBTB16/LEPR/LIG4
GO:0001505,regulation of neurotransmitter levels,3/53,346/18493,0.0767494735291303,0.13784877696522876,0.07987430793124894,3,bp,NAC,9314/4088/7097,KLF4/SMAD3/TLR2
GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,2810,SFN
GO:0005979,regulation of glycogen biosynthetic process,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,3479,IGF1
GO:0007020,microtubule nucleation,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,3303,HSPA1A
GO:0010962,regulation of glucan biosynthetic process,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,3479,IGF1
GO:0032647,regulation of interferon-alpha production,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,6772,STAT1
GO:0033688,regulation of osteoblast proliferation,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,4088,SMAD3
GO:0034368,protein-lipid complex remodeling,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,5320,PLA2G2A
GO:0034369,plasma lipoprotein particle remodeling,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,5320,PLA2G2A
GO:0035025,positive regulation of Rho protein signal transduction,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,1281,COL3A1
GO:0035116,embryonic hindlimb morphogenesis,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7704,ZBTB16
GO:0035456,response to interferon-beta,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,6772,STAT1
GO:0043433,negative regulation of DNA-binding transcription factor activity,2/53,160/18493,0.07699008704485374,0.13784877696522876,0.07987430793124894,2,bp,NAC,9314/6424,KLF4/SFRP4
GO:0048643,positive regulation of skeletal muscle tissue development,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,64321,SOX17
GO:0048730,epidermis morphogenesis,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,9314,KLF4
GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,3725,JUN
GO:0060338,regulation of type I interferon-mediated signaling pathway,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7474,WNT5A
GO:0060512,prostate gland morphogenesis,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7474,WNT5A
GO:0061082,myeloid leukocyte cytokine production,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7474,WNT5A
GO:0071480,cellular response to gamma radiation,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,51776,MAP3K20
GO:1902668,negative regulation of axon guidance,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7474,WNT5A
GO:1903034,regulation of response to wounding,2/53,160/18493,0.07699008704485374,0.13784877696522876,0.07987430793124894,2,bp,NAC,9314/4088,KLF4/SMAD3
GO:2000108,positive regulation of leukocyte apoptotic process,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,7474,WNT5A
GO:2000781,positive regulation of double-strand break repair,1/53,28/18493,0.0772718333451009,0.13784877696522876,0.07987430793124894,1,bp,NAC,4255,MGMT
GO:0007519,skeletal muscle tissue development,2/53,161/18493,0.07781968884300909,0.13861814237353978,0.08032010462881838,2,bp,NAC,2353/64321,FOS/SOX17
GO:0035821,modification of morphology or physiology of other organism,2/53,161/18493,0.07781968884300909,0.13861814237353978,0.08032010462881838,2,bp,NAC,3725/4088,JUN/SMAD3
GO:0005003,ephrin receptor activity,1/52,19/17632,0.054598884086653254,0.13916057041598207,0.09111495418825319,1,mf,NAC,1969,EPHA2
hsa05221,Acute myeloid leukemia,2/50,66/7852,0.06587049006354646,0.13954143289777604,0.0811976955076958,2,kg,NAC,7704/862,ZBTB16/RUNX1T1
GO:0051480,regulation of cytosolic calcium ion concentration,3/53,350/18493,0.07883127592206297,0.14031495070558814,0.08130329355655566,3,bp,NAC,4088/781/7474,SMAD3/CACNA2D1/WNT5A
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,7474,WNT5A
GO:0021884,forebrain neuron development,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,7474,WNT5A
GO:0030307,positive regulation of cell growth,2/53,163/18493,0.07948745781529619,0.14046604426375847,0.08139084234485408,2,bp,NAC,3479/2810,IGF1/SFN
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,8516,ITGA8
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,3303,HSPA1A
GO:0032607,interferon-alpha production,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,6772,STAT1
GO:0042036,negative regulation of cytokine biosynthetic process,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,9314,KLF4
GO:0045862,positive regulation of proteolysis,3/53,352/18493,0.07988152640168203,0.14046604426375847,0.08139084234485408,3,bp,NAC,4804/4088/3303,NGFR/SMAD3/HSPA1A
GO:0046471,phosphatidylglycerol metabolic process,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,5320,PLA2G2A
GO:0050686,negative regulation of mRNA processing,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,79882,ZC3H14
GO:0050718,positive regulation of interleukin-1 beta secretion,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,7474,WNT5A
GO:0051294,establishment of spindle orientation,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,10252,SPRY1
GO:0055002,striated muscle cell development,2/53,163/18493,0.07948745781529619,0.14046604426375847,0.08139084234485408,2,bp,NAC,3479/2318,IGF1/FLNC
GO:0071295,cellular response to vitamin,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,1277,COL1A1
GO:0071539,protein localization to centrosome,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,324,APC
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,8516,ITGA8
GO:2000727,positive regulation of cardiac muscle cell differentiation,1/53,29/18493,0.07992033552937983,0.14046604426375847,0.08139084234485408,1,bp,NAC,3479,IGF1
GO:0008329,signaling pattern recognition receptor activity,1/52,20/17632,0.05739005299754274,0.1406014181273439,0.09205834478244627,1,mf,NAC,7097,TLR2
GO:0030506,ankyrin binding,1/52,20/17632,0.05739005299754274,0.1406014181273439,0.09205834478244627,1,mf,NAC,2318,FLNC
GO:0038187,pattern recognition receptor activity,1/52,20/17632,0.05739005299754274,0.1406014181273439,0.09205834478244627,1,mf,NAC,7097,TLR2
GO:0070851,growth factor receptor binding,2/52,132/17632,0.05785512899019893,0.1406014181273439,0.09205834478244627,2,mf,NAC,80310/3554,PDGFD/IL1R1
GO:0007416,synapse assembly,2/53,165/18493,0.0811664979552254,0.14244570637455795,0.08253792645048753,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0010634,positive regulation of epithelial cell migration,2/53,165/18493,0.0811664979552254,0.14244570637455795,0.08253792645048753,2,bp,NAC,3725/7474,JUN/WNT5A
GO:0035690,cellular response to drug,3/53,355/18493,0.08146849723834433,0.14276498631745235,0.08272292819686827,3,bp,NAC,9314/80310/3082,KLF4/PDGFD/HGF
GO:0062012,regulation of small molecule metabolic process,3/53,355/18493,0.08146849723834433,0.14276498631745235,0.08272292819686827,3,bp,NAC,3479/3953/3486,IGF1/LEPR/IGFBP3
GO:0102567,"phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)",1/52,21/17632,0.06017313937297619,0.14291120601081847,0.09357067127376681,1,mf,NAC,5320,PLA2G2A
GO:0102568,"phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)",1/52,21/17632,0.06017313937297619,0.14291120601081847,0.09357067127376681,1,mf,NAC,5320,PLA2G2A
GO:0001825,blastocyst formation,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,64321,SOX17
GO:0006658,phosphatidylserine metabolic process,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,5320,PLA2G2A
GO:0006913,nucleocytoplasmic transport,3/53,357/18493,0.08253415998749047,0.14309836639369705,0.08291610004397745,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0010743,regulation of macrophage derived foam cell differentiation,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,5320,PLA2G2A
GO:0010837,regulation of keratinocyte proliferation,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,2810,SFN
GO:0034367,protein-containing complex remodeling,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,5320,PLA2G2A
GO:0038111,interleukin-7-mediated signaling pathway,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,8835,SOCS2
GO:0046685,response to arsenic-containing substance,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,1026,CDKN1A
GO:0050482,arachidonic acid secretion,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,5320,PLA2G2A
GO:0099625,ventricular cardiac muscle cell membrane repolarization,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,781,CACNA2D1
GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,3303,HSPA1A
GO:1903963,arachidonate transport,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,5320,PLA2G2A
GO:1905508,protein localization to microtubule organizing center,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,324,APC
GO:2000406,positive regulation of T cell migration,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,7474,WNT5A
GO:2001171,positive regulation of ATP biosynthetic process,1/53,30/18493,0.08256137876036684,0.14309836639369705,0.08291610004397745,1,bp,NAC,3479,IGF1
hsa04932,Non-alcoholic fatty liver disease (NAFLD),3/50,149/7852,0.06877189402961259,0.14325197192898353,0.08335681923294891,3,kg,NAC,3725/3953/9021,JUN/LEPR/SOCS3
hsa05031,Amphetamine addiction,2/50,68/7852,0.06940157646248891,0.14325197192898353,0.08335681923294891,2,kg,NAC,2353/3725,FOS/JUN
hsa04920,Adipocytokine signaling pathway,2/50,69/7852,0.0711903042797119,0.14508403783586857,0.084422879159152045,2,kg,NAC,3953/9021,LEPR/SOCS3
R-HSA-168898,Toll-like Receptor Cascades,3/45,155/10554,0.02812036343245523,0.1455642342385918,0.11666033126777092,3,re,NAC,2353/3725/7097,FOS/JUN/TLR2
R-HSA-4086398,Ca2+ pathway,2/45,61/10554,0.027744319985037364,0.1455642342385918,0.11666033126777092,2,re,NAC,55970/7474,GNG12/WNT5A
GO:0006691,leukotriene metabolic process,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,7097,TLR2
GO:0021543,pallium development,2/53,169/18493,0.08455768215751336,0.14564606117913337,0.0843923217579946,2,bp,NAC,55970/1281,GNG12/COL3A1
GO:0021772,olfactory bulb development,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,7474,WNT5A
GO:0030431,sleep,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,2353,FOS
GO:0032728,positive regulation of interferon-beta production,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,7097,TLR2
GO:0033687,osteoblast proliferation,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,4088,SMAD3
GO:0040020,regulation of meiotic nuclear division,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,7474,WNT5A
GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,7474,WNT5A
GO:0048469,cell maturation,2/53,169/18493,0.08455768215751336,0.14564606117913337,0.0843923217579946,2,bp,NAC,1026/3280,CDKN1A/HES1
GO:0051085,chaperone cofactor-dependent protein refolding,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,3303,HSPA1A
GO:0051169,nuclear transport,3/53,360/18493,0.08414409463050679,0.14564606117913337,0.0843923217579946,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0051204,protein insertion into mitochondrial membrane,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,2810,SFN
GO:0060325,face morphogenesis,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,1277,COL1A1
GO:0086011,membrane repolarization during action potential,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,781,CACNA2D1
GO:0098760,response to interleukin-7,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,8835,SOCS2
GO:0098761,cellular response to interleukin-7,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,8835,SOCS2
GO:0099623,regulation of cardiac muscle cell membrane repolarization,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,781,CACNA2D1
GO:1902622,regulation of neutrophil migration,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,3554,IL1R1
GO:1903393,positive regulation of adherens junction organization,1/53,31/18493,0.08519498364178912,0.14564606117913337,0.0843923217579946,1,bp,NAC,4088,SMAD3
GO:0048771,tissue remodeling,2/53,170/18493,0.08541224681453478,0.14570324456597109,0.08442545577303183,2,bp,NAC,3953/1969,LEPR/EPHA2
GO:0060538,skeletal muscle organ development,2/53,170/18493,0.08541224681453478,0.14570324456597109,0.08442545577303183,2,bp,NAC,2353/64321,FOS/SOX17
GO:2001235,positive regulation of apoptotic signaling pathway,2/53,170/18493,0.08541224681453478,0.14570324456597109,0.08442545577303183,2,bp,NAC,4088/2810,SMAD3/SFN
GO:0005158,insulin receptor binding,1/52,22/17632,0.06294816616035959,0.14617963030572395,0.09571066199820756,1,mf,NAC,3479,IGF1
GO:0070840,dynein complex binding,1/52,22/17632,0.06294816616035959,0.14617963030572395,0.09571066199820756,1,mf,NAC,324,APC
GO:0001659,temperature homeostasis,2/53,171/18493,0.08626947540854055,0.1469547367632589,0.08515061326329332,2,bp,NAC,3953/324,LEPR/APC
GO:0010950,positive regulation of endopeptidase activity,2/53,171/18493,0.08626947540854055,0.1469547367632589,0.08515061326329332,2,bp,NAC,4804/4088,NGFR/SMAD3
hsa04150,mTOR signaling pathway,3/50,153/7852,0.07321603465349036,0.14734726974014936,0.08573983005474531,3,kg,NAC,3479/7472/7474,IGF1/WNT2/WNT5A
GO:0033612,receptor serine/threonine kinase binding,1/52,23/17632,0.06571515624324764,0.147682447901492,0.0966946271830469,1,mf,NAC,353500,BMP8A
GO:0044183,protein binding involved in protein folding,1/52,23/17632,0.06571515624324764,0.147682447901492,0.0966946271830469,1,mf,NAC,3303,HSPA1A
GO:0051787,misfolded protein binding,1/52,23/17632,0.06571515624324764,0.147682447901492,0.0966946271830469,1,mf,NAC,3303,HSPA1A
GO:0008608,attachment of spindle microtubules to kinetochore,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,324,APC
GO:0010921,regulation of phosphatase activity,2/53,172/18493,0.08712934635848309,0.1481125843800729,0.08582150987274376,2,bp,NAC,4088/3486,SMAD3/IGFBP3
GO:0021988,olfactory lobe development,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,7474,WNT5A
GO:0030513,positive regulation of BMP signaling pathway,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,3280,HES1
GO:0032735,positive regulation of interleukin-12 production,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,7097,TLR2
GO:0035510,DNA dealkylation,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,4255,MGMT
GO:0035767,endothelial cell chemotaxis,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,3164,NR4A1
GO:0042491,inner ear auditory receptor cell differentiation,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,3280,HES1
GO:0048841,regulation of axon extension involved in axon guidance,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,7474,WNT5A
GO:0086019,cell-cell signaling involved in cardiac conduction,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,781,CACNA2D1
GO:0099068,postsynapse assembly,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,7474,WNT5A
GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,2810,SFN
GO:1901890,positive regulation of cell junction assembly,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,4088,SMAD3
GO:1903205,regulation of hydrogen peroxide-induced cell death,1/53,32/18493,0.08782117072157392,0.1481125843800729,0.08582150987274376,1,bp,NAC,3082,HGF
hsa04662,B cell receptor signaling pathway,2/50,71/7852,0.07481283701841708,0.14821000625748706,0.08624184738095031,2,kg,NAC,2353/3725,FOS/JUN
hsa05160,Hepatitis C,3/50,155/7852,0.07548584169635987,0.14821000625748706,0.08624184738095031,3,kg,NAC,6772/9021/1026,STAT1/SOCS3/CDKN1A
GO:0030877,beta-catenin destruction complex,1/53,12/19659,0.03188496567375554,0.15064534814599942,0.11845290532722846,1,cc,NAC,324,APC
GO:0061695,"transferase complex, transferring phosphorus-containing groups",3/53,259/19659,0.032670075501542044,0.15064534814599942,0.11845290532722846,3,cc,NAC,9021/8835/1026,SOCS3/SOCS2/CDKN1A
GO:1990454,L-type voltage-gated calcium channel complex,1/53,12/19659,0.03188496567375554,0.15064534814599942,0.11845290532722846,1,cc,NAC,781,CACNA2D1
GO:0070507,regulation of microtubule cytoskeleton organization,2/53,175/18493,0.08972459899463354,0.1511084252190075,0.08755740277618557,2,bp,NAC,3303/324,HSPA1A/APC
GO:0120032,regulation of plasma membrane bounded cell projection assembly,2/53,175/18493,0.08972459899463354,0.1511084252190075,0.08755740277618557,2,bp,NAC,1969/324,EPHA2/APC
GO:0003299,muscle hypertrophy in response to stress,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,4088,SMAD3
GO:0014887,cardiac muscle adaptation,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,4088,SMAD3
GO:0014898,cardiac muscle hypertrophy in response to stress,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,4088,SMAD3
GO:0043900,regulation of multi-organism process,3/53,371/18493,0.09016291981336368,0.1514550887675809,0.08775827152262558,3,bp,NAC,3725/3479/6772,JUN/IGF1/STAT1
GO:0046326,positive regulation of glucose import,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,3479,IGF1
GO:0060251,regulation of glial cell proliferation,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,3280,HES1
GO:0070873,regulation of glycogen metabolic process,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,3479,IGF1
GO:1905332,positive regulation of morphogenesis of an epithelium,1/53,33/18493,0.09043996049199532,0.1514550887675809,0.08775827152262558,1,bp,NAC,7472,WNT2
GO:0008143,poly(A) binding,1/52,24/17632,0.06847413244151823,0.15224567744975862,0.0996823876528261,1,mf,NAC,79882,ZC3H14
GO:0008217,regulation of blood pressure,2/53,177/18493,0.09146758791923326,0.15263854320837664,0.08844400560389759,2,bp,NAC,4088/1278,SMAD3/COL1A2
GO:0050792,regulation of viral process,2/53,177/18493,0.09146758791923326,0.15263854320837664,0.08844400560389759,2,bp,NAC,3725/6772,JUN/STAT1
GO:0060491,regulation of cell projection assembly,2/53,177/18493,0.09146758791923326,0.15263854320837664,0.08844400560389759,2,bp,NAC,1969/324,EPHA2/APC
GO:1903532,positive regulation of secretion by cell,3/53,373/18493,0.09127649581171834,0.15263854320837664,0.08844400560389759,3,bp,NAC,3479/7097/7474,IGF1/TLR2/WNT5A
GO:1905475,regulation of protein localization to membrane,2/53,177/18493,0.09146758791923326,0.15263854320837664,0.08844400560389759,2,bp,NAC,1969/2810,EPHA2/SFN
GO:0007094,mitotic spindle assembly checkpoint,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,324,APC
GO:0010922,positive regulation of phosphatase activity,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,4088,SMAD3
GO:0014904,myotube cell development,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,3479,IGF1
GO:0030224,monocyte differentiation,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,3725,JUN
GO:0031577,spindle checkpoint,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,324,APC
GO:0031641,regulation of myelination,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,3082,HGF
GO:0042098,T cell proliferation,2/53,178/18493,0.0923428652405745,0.15355736705135545,0.08897640364314298,2,bp,NAC,3479/3280,IGF1/HES1
GO:0043403,skeletal muscle tissue regeneration,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,3479,IGF1
GO:0048048,embryonic eye morphogenesis,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,7474,WNT5A
GO:0048854,brain morphogenesis,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,7474,WNT5A
GO:0050716,positive regulation of interleukin-1 secretion,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,7474,WNT5A
GO:0051170,import into nucleus,2/53,178/18493,0.0923428652405745,0.15355736705135545,0.08897640364314298,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0071173,spindle assembly checkpoint,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,324,APC
GO:0071174,mitotic spindle checkpoint,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,324,APC
GO:0071634,regulation of transforming growth factor beta production,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,4088,SMAD3
GO:1903131,mononuclear cell differentiation,1/53,34/18493,0.09305137338982472,0.15355736705135545,0.08897640364314298,1,bp,NAC,3725,JUN
GO:0002221,pattern recognition receptor signaling pathway,2/53,179/18493,0.09322063656180694,0.15362347452805053,0.08901470858183266,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0031345,negative regulation of cell projection organization,2/53,179/18493,0.09322063656180694,0.15362347452805053,0.08901470858183266,2,bp,NAC,4804/7474,NGFR/WNT5A
R-HSA-450294,MAP kinase activation,2/45,64/10554,0.0303199419723517,0.15467564600388112,0.12396253926148369,2,re,NAC,2353/3725,FOS/JUN
hsa03450,Non-homologous end-joining,1/50,13/7852,0.07974997436728448,0.15469573341123857,0.09001582395292733,1,kg,NAC,3981,LIG4
GO:0032591,dendritic spine membrane,1/53,13/19659,0.03449656524719136,0.1547683738117234,0.12169485321911035,1,cc,NAC,8516,ITGA8
GO:0048639,positive regulation of developmental growth,2/53,180/18493,0.09410088107220808,0.15485944303786214,0.08973087111529442,2,bp,NAC,3479/7472,IGF1/WNT2
GO:0050770,regulation of axonogenesis,2/53,180/18493,0.09410088107220808,0.15485944303786214,0.08973087111529442,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0007223,"Wnt signaling pathway, calcium modulating pathway",1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,7474,WNT5A
GO:0007435,salivary gland morphogenesis,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3082,HGF
GO:0010614,negative regulation of cardiac muscle hypertrophy,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,4088,SMAD3
GO:0030501,positive regulation of bone mineralization,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,4088,SMAD3
GO:0031111,negative regulation of microtubule polymerization or depolymerization,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,324,APC
GO:0032885,regulation of polysaccharide biosynthetic process,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3479,IGF1
GO:0060428,lung epithelium development,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,7472,WNT2
GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3303,HSPA1A
GO:1901099,negative regulation of signal transduction in absence of ligand,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3303,HSPA1A
GO:2001024,negative regulation of response to drug,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3082,HGF
GO:2001038,regulation of cellular response to drug,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3082,HGF
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/53,35/18493,0.09565542979647434,0.15612121623611255,0.0904619857700285,1,bp,NAC,3303,HSPA1A
R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,2/45,65/10554,0.031198961111762524,0.1568862044477201,0.12573415906695273,2,re,NAC,2353/3725,FOS/JUN
GO:0000578,embryonic axis specification,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,7474,WNT5A
GO:0002755,MyD88-dependent toll-like receptor signaling pathway,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,7097,TLR2
GO:0010453,regulation of cell fate commitment,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,64321,SOX17
GO:0010591,regulation of lamellipodium assembly,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,1969,EPHA2
GO:0030212,hyaluronan metabolic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3082,HGF
GO:0033120,positive regulation of RNA splicing,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3303,HSPA1A
GO:0034390,smooth muscle cell apoptotic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3479,IGF1
GO:0034391,regulation of smooth muscle cell apoptotic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3479,IGF1
GO:0034405,response to fluid shear stress,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,9314,KLF4
GO:0035137,hindlimb morphogenesis,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,7704,ZBTB16
GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3303,HSPA1A
GO:0036474,cell death in response to hydrogen peroxide,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3082,HGF
GO:0042594,response to starvation,2/53,183/18493,0.09675624704922176,0.15722988747692637,0.0911043879010653,2,bp,NAC,3725/1026,JUN/CDKN1A
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,324,APC
GO:0050691,regulation of defense response to virus by host,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,6772,STAT1
GO:0050707,regulation of cytokine secretion,2/53,184/18493,0.0976461780972933,0.15722988747692637,0.0911043879010653,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0051084,'de novo' posttranslational protein folding,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3303,HSPA1A
GO:0051973,positive regulation of telomerase activity,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,9314,KLF4
GO:0060236,regulation of mitotic spindle organization,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3303,HSPA1A
GO:0060416,response to growth hormone,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,8835,SOCS2
GO:0070232,regulation of T cell apoptotic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,7474,WNT5A
GO:0070884,regulation of calcineurin-NFAT signaling cascade,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3479,IGF1
GO:0071604,transforming growth factor beta production,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,4088,SMAD3
GO:0106056,regulation of calcineurin-mediated signaling,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3479,IGF1
GO:1901385,regulation of voltage-gated calcium channel activity,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,781,CACNA2D1
GO:1901532,regulation of hematopoietic progenitor cell differentiation,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3280,HES1
GO:1903580,positive regulation of ATP metabolic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,3479,IGF1
GO:1904037,positive regulation of epithelial cell apoptotic process,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,6424,SFRP4
GO:2000403,positive regulation of lymphocyte migration,1/53,36/18493,0.09825215003814658,0.15722988747692637,0.0911043879010653,1,bp,NAC,7474,WNT5A
GO:0002369,T cell cytokine production,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3554,IL1R1
GO:0003298,physiological muscle hypertrophy,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3479,IGF1
GO:0003301,physiological cardiac muscle hypertrophy,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3479,IGF1
GO:0006367,transcription initiation from RNA polymerase II promoter,2/53,186/18493,0.09943313159137102,0.15891399359169098,0.09208021672857489,2,bp,NAC,3164/1026,NR4A1/CDKN1A
GO:0014741,negative regulation of muscle hypertrophy,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,4088,SMAD3
GO:0014912,negative regulation of smooth muscle cell migration,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3486,IGFBP3
GO:0019216,regulation of lipid metabolic process,3/53,388/18493,0.09981189205677692,0.15891399359169098,0.09208021672857489,3,bp,NAC,9314/9021/8835,KLF4/SOCS3/SOCS2
GO:0031076,embryonic camera-type eye development,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,7474,WNT5A
GO:0038093,Fc receptor signaling pathway,2/53,187/18493,0.1003301136340271,0.15891399359169098,0.09208021672857489,2,bp,NAC,2353/3725,FOS/JUN
GO:0045494,photoreceptor cell maintenance,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,8842,PROM1
GO:0045740,positive regulation of DNA replication,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3725,JUN
GO:0048846,axon extension involved in axon guidance,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,7474,WNT5A
GO:0051293,establishment of spindle localization,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,10252,SPRY1
GO:0060045,positive regulation of cardiac muscle cell proliferation,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,7472,WNT2
GO:0060323,head morphogenesis,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,1277,COL1A1
GO:0061049,cell growth involved in cardiac muscle cell development,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3479,IGF1
GO:0061756,leukocyte adhesion to vascular endothelial cell,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,9314,KLF4
GO:0086010,membrane depolarization during action potential,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,781,CACNA2D1
GO:1901021,positive regulation of calcium ion transmembrane transporter activity,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,781,CACNA2D1
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3082,HGF
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,324,APC
GO:1902284,neuron projection extension involved in neuron projection guidance,1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,7474,WNT5A
GO:2000142,"regulation of DNA-templated transcription, initiation",1/53,37/18493,0.10084155438598053,0.15891399359169098,0.09208021672857489,1,bp,NAC,3725,JUN
GO:0007219,Notch signaling pathway,2/53,189/18493,0.10213098799436462,0.1607329513240232,0.09313418320709416,2,bp,NAC,6772/3280,STAT1/HES1
GO:0010952,positive regulation of peptidase activity,2/53,189/18493,0.10213098799436462,0.1607329513240232,0.09313418320709416,2,bp,NAC,4804/4088,NGFR/SMAD3
hsa05133,Pertussis,2/50,76/7852,0.08412035371145545,0.16123067794695628,0.0938184396030017,2,kg,NAC,2353/3725,FOS/JUN
GO:0000060,"protein import into nucleus, translocation",1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,3479,IGF1
GO:0007431,salivary gland development,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,3082,HGF
GO:0010559,regulation of glycoprotein biosynthetic process,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,3479,IGF1
GO:0019048,modulation by virus of host morphology or physiology,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,4088,SMAD3
GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,7474,WNT5A
GO:0046676,negative regulation of insulin secretion,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,353500,BMP8A
GO:0060306,regulation of membrane repolarization,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,781,CACNA2D1
GO:0086091,regulation of heart rate by cardiac conduction,1/53,38/18493,0.10342366305619877,0.1619101189912052,0.09381627451617351,1,bp,NAC,781,CACNA2D1
GO:0042622,photoreceptor outer segment membrane,1/53,14/19659,0.037101252310303146,0.16207389167132427,0.1274392046115676,1,cc,NAC,8842,PROM1
GO:0034764,positive regulation of transmembrane transport,2/53,192/18493,0.1048492770237881,0.16403393471221586,0.095046886166301,2,bp,NAC,3479/781,IGF1/CACNA2D1
GO:0007623,circadian rhythm,2/53,193/18493,0.10575982181499619,0.16485573838324058,0.09552306739128943,2,bp,NAC,3725/4804,JUN/NGFR
GO:0010677,negative regulation of cellular carbohydrate metabolic process,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,3953,LEPR
GO:0014003,oligodendrocyte development,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,7097,TLR2
GO:0046825,regulation of protein export from nucleus,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,2810,SFN
GO:0060119,inner ear receptor cell development,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,3280,HES1
GO:1903053,regulation of extracellular matrix organization,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,4088,SMAD3
GO:2000816,negative regulation of mitotic sister chromatid separation,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,324,APC
GO:2000826,regulation of heart morphogenesis,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,3280,HES1
GO:2001222,regulation of neuron migration,1/53,39/18493,0.10599849621025015,0.16485573838324058,0.09552306739128943,1,bp,NAC,1281,COL3A1
GO:0001968,fibronectin binding,1/52,27/17632,0.07670320497588468,0.1652677303088649,0.10820853659104732,1,mf,NAC,3486,IGFBP3
GO:0004709,MAP kinase kinase kinase activity,1/52,27/17632,0.07670320497588468,0.1652677303088649,0.10820853659104732,1,mf,NAC,51776,MAP3K20
GO:0051019,mitogen-activated protein kinase binding,1/52,27/17632,0.07670320497588468,0.1652677303088649,0.10820853659104732,1,mf,NAC,1844,DUSP2
GO:0010001,glial cell differentiation,2/53,194/18493,0.1066725582265648,0.1657956493220726,0.09606768401690632,2,bp,NAC,7097/3280,TLR2/HES1
GO:0006458,'de novo' protein folding,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3303,HSPA1A
GO:0006654,phosphatidic acid biosynthetic process,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,5320,PLA2G2A
GO:0010828,positive regulation of glucose transmembrane transport,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3479,IGF1
GO:0014014,negative regulation of gliogenesis,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3280,HES1
GO:0030225,macrophage differentiation,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,7097,TLR2
GO:0030810,positive regulation of nucleotide biosynthetic process,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3479,IGF1
GO:0032881,regulation of polysaccharide metabolic process,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3479,IGF1
GO:0035315,hair cell differentiation,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3280,HES1
GO:0043616,keratinocyte proliferation,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,2810,SFN
GO:0046006,regulation of activated T cell proliferation,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3479,IGF1
GO:0090224,regulation of spindle organization,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3303,HSPA1A
GO:1900373,positive regulation of purine nucleotide biosynthetic process,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,3479,IGF1
GO:1905819,negative regulation of chromosome separation,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,324,APC
GO:2000404,regulation of T cell migration,1/53,40/18493,0.1085660739549591,0.16720862944617404,0.09688641314906019,1,bp,NAC,7474,WNT5A
GO:0005520,insulin-like growth factor binding,1/52,28/17632,0.07943035256698117,0.1676862998636269,0.10979208754606648,1,mf,NAC,3486,IGFBP3
GO:0043425,bHLH transcription factor binding,1/52,28/17632,0.07943035256698117,0.1676862998636269,0.10979208754606648,1,mf,NAC,4088,SMAD3
GO:0051047,positive regulation of secretion,3/53,404/18493,0.10926125907833452,0.16817040394063396,0.09744369826846529,3,bp,NAC,3479/7097/7474,IGF1/TLR2/WNT5A
R-HSA-2262752,Cellular responses to stress,5/45,426/10554,0.03397630613539611,0.1684459121078793,0.13499851807688892,5,re,NAC,2353/3725/2114/3303/1026,FOS/JUN/ETS2/HSPA1A/CDKN1A
GO:0043547,positive regulation of GTPase activity,3/53,405/18493,0.10986325761588968,0.16898759806635555,0.09791720856485302,3,bp,NAC,3725/1969/7474,JUN/EPHA2/WNT5A
GO:0006110,regulation of glycolytic process,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,3479,IGF1
GO:0007019,microtubule depolymerization,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,324,APC
GO:0021575,hindbrain morphogenesis,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,3280,HES1
GO:0032715,negative regulation of interleukin-6 production,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,3082,HGF
GO:0035088,establishment or maintenance of apical/basal cell polarity,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,7474,WNT5A
GO:0035136,forelimb morphogenesis,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,7704,ZBTB16
GO:0035886,vascular smooth muscle cell differentiation,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,3280,HES1
GO:0046473,phosphatidic acid metabolic process,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,5320,PLA2G2A
GO:0048863,stem cell differentiation,2/53,199/18493,0.11126843776008334,0.16939586747341753,0.0981537738580424,2,bp,NAC,64321/3280,SOX17/HES1
GO:0050919,negative chemotaxis,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,7474,WNT5A
GO:0061245,establishment or maintenance of bipolar cell polarity,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,7474,WNT5A
GO:0071222,cellular response to lipopolysaccharide,2/53,199/18493,0.11126843776008334,0.16939586747341753,0.0981537738580424,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0097529,myeloid leukocyte migration,2/53,199/18493,0.11126843776008334,0.16939586747341753,0.0981537738580424,2,bp,NAC,80310/3554,PDGFD/IL1R1
GO:0099622,cardiac muscle cell membrane repolarization,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,781,CACNA2D1
GO:1904706,negative regulation of vascular smooth muscle cell proliferation,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,1026,CDKN1A
GO:1905209,positive regulation of cardiocyte differentiation,1/53,41/18493,0.11112641634266762,0.16939586747341753,0.0981537738580424,1,bp,NAC,3479,IGF1
GO:0035035,histone acetyltransferase binding,1/52,29/17632,0.08214959942374744,0.16999273544121996,0.11130221912545253,1,mf,NAC,6772,STAT1
GO:0051721,protein phosphatase 2A binding,1/52,29/17632,0.08214959942374744,0.16999273544121996,0.11130221912545253,1,mf,NAC,6772,STAT1
R-HSA-909733,Interferon alpha/beta signaling,2/45,69/10554,0.03481481146003954,0.17020574491574889,0.13640891039898537,2,re,NAC,6772/9021,STAT1/SOCS3
GO:0033218,amide binding,3/52,348/17632,0.08308318735010614,0.17023907996247237,0.11146351244080288,3,mf,NAC,4804/3953/7097,NGFR/LEPR/TLR2
GO:1902905,positive regulation of supramolecular fiber organization,2/53,200/18493,0.11219391904117515,0.17069554669220377,0.09890685256079623,2,bp,NAC,4088/3303,SMAD3/HSPA1A
GO:0009187,cyclic nucleotide metabolic process,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,1969,EPHA2
GO:0010799,regulation of peptidyl-threonine phosphorylation,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:0030517,negative regulation of axon extension,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:0030811,regulation of nucleotide catabolic process,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,3479,IGF1
GO:0033048,negative regulation of mitotic sister chromatid segregation,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,324,APC
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,10252,SPRY1
GO:0042088,T-helper 1 type immune response,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,3554,IL1R1
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,6772,STAT1
GO:0044331,cell-cell adhesion mediated by cadherin,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:0046189,phenol-containing compound biosynthetic process,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:0050706,regulation of interleukin-1 beta secretion,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:0051653,spindle localization,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,10252,SPRY1
GO:0071675,regulation of mononuclear cell migration,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,80310,PDGFD
GO:0099054,presynapse assembly,1/53,42/18493,0.1136795433713822,0.17131175800833134,0.09926390652600849,1,bp,NAC,7474,WNT5A
GO:1901215,negative regulation of neuron death,2/53,201/18493,0.11312145781906811,0.17131175800833134,0.09926390652600849,2,bp,NAC,3725/3981,JUN/LIG4
R-HSA-9006925,Intracellular signaling by second messengers,4/45,293/10554,0.03556901733215563,0.17151087809477783,0.1374548903391162,4,re,NAC,3164/3725/3082/1026,NR4A1/JUN/HGF/CDKN1A
GO:0043523,regulation of neuron apoptotic process,2/53,202/18493,0.11405103528581764,0.17176273711822315,0.09952521928544736,2,bp,NAC,3725/3981,JUN/LIG4
GO:0070717,poly-purine tract binding,1/52,30/17632,0.08486096798762688,0.17219361465450503,0.11274323800093505,1,mf,NAC,79882,ZC3H14
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",2/53,203/18493,0.11498263272062428,0.17305613962635732,0.10027466104683358,2,bp,NAC,3725/6772,JUN/STAT1
GO:0010613,positive regulation of cardiac muscle hypertrophy,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3479,IGF1
GO:0010907,positive regulation of glucose metabolic process,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3479,IGF1
GO:0014009,glial cell proliferation,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3280,HES1
GO:0014742,positive regulation of muscle hypertrophy,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3479,IGF1
GO:0031113,regulation of microtubule polymerization,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3303,HSPA1A
GO:0031648,protein destabilization,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,64321,SOX17
GO:0032886,regulation of microtubule-based process,2/53,204/18493,0.11591623148950392,0.1737172718504907,0.1006577437263921,2,bp,NAC,3303/324,HSPA1A/APC
GO:0032924,activin receptor signaling pathway,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,4088,SMAD3
GO:0045912,negative regulation of carbohydrate metabolic process,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3953,LEPR
GO:1902667,regulation of axon guidance,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,7474,WNT5A
GO:1903573,negative regulation of response to endoplasmic reticulum stress,1/53,43/18493,0.1162254749849162,0.1737172718504907,0.1006577437263921,1,bp,NAC,3303,HSPA1A
GO:0050670,regulation of lymphocyte proliferation,2/53,205/18493,0.11685181304496073,0.1745437257669074,0.10113661946300823,2,bp,NAC,3479/3280,IGF1/HES1
GO:0005164,tumor necrosis factor receptor binding,1/52,31/17632,0.08756448063758948,0.17489684305488906,0.11451316845699111,1,mf,NAC,6772,STAT1
GO:0030674,"protein binding, bridging",2/52,168/17632,0.08786683502757585,0.17489684305488906,0.11451316845699111,2,mf,NAC,8835/1278,SOCS2/COL1A2
GO:0001078,"proximal promoter DNA-binding transcription repressor activity, RNA polymerase II-specific",2/52,169/17632,0.08875673714589087,0.17500149116501124,0.11458168648426825,2,mf,NAC,2114/3280,ETS2/HES1
GO:0071004,U2-type prespliceosome,1/53,16/19659,0.04228996064161061,0.17550333666268406,0.137998818935782,1,cc,NAC,23451,SF3B1
GO:0071010,prespliceosome,1/53,16/19659,0.04228996064161061,0.17550333666268406,0.137998818935782,1,cc,NAC,23451,SF3B1
GO:0032944,regulation of mononuclear cell proliferation,2/53,206/18493,0.11778935892565918,0.17561322603461915,0.10175632458913572,2,bp,NAC,3479/3280,IGF1/HES1
GO:0035303,regulation of dephosphorylation,2/53,206/18493,0.11778935892565918,0.17561322603461915,0.10175632458913572,2,bp,NAC,4088/3486,SMAD3/IGFBP3
GO:0071219,cellular response to molecule of bacterial origin,2/53,206/18493,0.11778935892565918,0.17561322603461915,0.10175632458913572,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0006378,mRNA polyadenylation,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,79882,ZC3H14
GO:0032309,icosanoid secretion,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,5320,PLA2G2A
GO:0033046,negative regulation of sister chromatid segregation,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,324,APC
GO:0033173,calcineurin-NFAT signaling cascade,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3479,IGF1
GO:0033628,regulation of cell adhesion mediated by integrin,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,1969,EPHA2
GO:0046782,regulation of viral transcription,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3725,JUN
GO:0046850,regulation of bone remodeling,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3953,LEPR
GO:0050798,activated T cell proliferation,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3479,IGF1
GO:0050850,positive regulation of calcium-mediated signaling,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3479,IGF1
GO:0070169,positive regulation of biomineral tissue development,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,4088,SMAD3
GO:0071364,cellular response to epidermal growth factor stimulus,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,1277,COL1A1
GO:0099172,presynapse organization,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,7474,WNT5A
GO:1901031,regulation of response to reactive oxygen species,1/53,44/18493,0.11876423107303535,0.17563516261920278,0.10176903539840487,1,bp,NAC,3082,HGF
GO:0097718,disordered domain specific binding,1/52,32/17632,0.09026015969030499,0.1763025549091004,0.11543355395710428,1,mf,NAC,3303,HSPA1A
GO:0001754,eye photoreceptor cell differentiation,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,8842,PROM1
GO:0002699,positive regulation of immune effector process,2/53,209/18493,0.1206135991914259,0.17750245368582537,0.10285100786806493,2,bp,NAC,3554/7474,IL1R1/WNT5A
GO:0006111,regulation of gluconeogenesis,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3953,LEPR
GO:0010810,regulation of cell-substrate adhesion,2/53,209/18493,0.1206135991914259,0.17750245368582537,0.10285100786806493,2,bp,NAC,4088/1277,SMAD3/COL1A1
GO:0016051,carbohydrate biosynthetic process,2/53,209/18493,0.1206135991914259,0.17750245368582537,0.10285100786806493,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0032386,regulation of intracellular transport,3/53,422/18493,0.12029468623359028,0.17750245368582537,0.10285100786806493,3,bp,NAC,3479/4088/2810,IGF1/SMAD3/SFN
GO:0034198,cellular response to amino acid starvation,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,1026,CDKN1A
GO:0048483,autonomic nervous system development,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3280,HES1
GO:0048538,thymus development,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3280,HES1
GO:0048599,oocyte development,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3479,IGF1
GO:0048701,embryonic cranial skeleton morphogenesis,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,4088,SMAD3
GO:0051985,negative regulation of chromosome segregation,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,324,APC
GO:0071827,plasma lipoprotein particle organization,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,5320,PLA2G2A
GO:0090278,negative regulation of peptide hormone secretion,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,353500,BMP8A
GO:0098868,bone growth,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3953,LEPR
GO:1900034,regulation of cellular response to heat,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3303,HSPA1A
GO:1903018,regulation of glycoprotein metabolic process,1/53,45/18493,0.12129583147160061,0.17750245368582537,0.10285100786806493,1,bp,NAC,3479,IGF1
GO:0050663,cytokine secretion,2/53,210/18493,0.1215588194715696,0.1777779044916313,0.10301061350960357,2,bp,NAC,7097/7474,TLR2/WNT5A
R-HSA-448424,Interleukin-17 signaling,2/45,72/10554,0.037628759666095773,0.1789908567900772,0.14344961010688004,2,re,NAC,2353/3725,FOS/JUN
GO:0002711,positive regulation of T cell mediated immunity,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3554,IL1R1
GO:0005978,glycogen biosynthetic process,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3479,IGF1
GO:0009250,glucan biosynthetic process,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3479,IGF1
GO:0035196,production of miRNAs involved in gene silencing by miRNA,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,4088,SMAD3
GO:0043631,RNA polyadenylation,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,79882,ZC3H14
GO:0044003,modification by symbiont of host morphology or physiology,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,4088,SMAD3
GO:0045981,positive regulation of nucleotide metabolic process,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3479,IGF1
GO:0048806,genitalia development,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,7474,WNT5A
GO:0060351,cartilage development involved in endochondral bone morphogenesis,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,1277,COL1A1
GO:0071715,icosanoid transport,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,5320,PLA2G2A
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,9314,KLF4
GO:1900544,positive regulation of purine nucleotide metabolic process,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3479,IGF1
GO:1901571,fatty acid derivative transport,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,5320,PLA2G2A
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/53,46/18493,0.12382029596271127,0.17953942914593132,0.10403130129344612,1,bp,NAC,3303,HSPA1A
GO:0001530,lipopolysaccharide binding,1/52,33/17632,0.09294802740031072,0.17987164561726796,0.117770405088113,1,mf,NAC,7097,TLR2
R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,2810,SFN
R-HSA-112308,Presynaptic depolarization and calcium channel opening,1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,781,CACNA2D1
R-HSA-1502540,Signaling by Activin,1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,4088,SMAD3
R-HSA-162594,Early Phase of HIV Life Cycle,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,3981,LIG4
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/45,85/10554,0.05076870017474767,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/45,85/10554,0.05076870017474767,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/45,94/10554,0.06069273017742229,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
R-HSA-193692,Regulated proteolysis of p75NTR,1/45,11/10554,0.045935741548446596,0.180720645181595,0.1448359237699386,1,re,NAC,4804,NGFR
R-HSA-193697,p75NTR regulates axonogenesis,1/45,10/10554,0.04184650527543732,0.180720645181595,0.1448359237699386,1,re,NAC,4804,NGFR
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,1026,CDKN1A
R-HSA-209543,p75NTR recruits signalling complexes,1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,4804,NGFR
R-HSA-209560,NF-kB is activated and signals survival,1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,4804,NGFR
R-HSA-2197563,NOTCH2 intracellular domain regulates transcription,1/45,12/10554,0.050007911863377386,0.180720645181595,0.1448359237699386,1,re,NAC,3280,HES1
R-HSA-2980736,Peptide hormone metabolism,2/45,89/10554,0.055100719566793896,0.180720645181595,0.1448359237699386,2,re,NAC,9314/3479,KLF4/IGF1
R-HSA-3371568,Attenuation phase,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,3303,HSPA1A
R-HSA-3772470,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,7474,WNT5A
R-HSA-4839735,"AXIN mutants destabilize the destruction complex, activating WNT signaling",1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-4839743,phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-4839744,truncated APC mutants destabilize the destruction complex,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-4839748,AMER1 mutants destabilize the destruction complex,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5099900,WNT5A-dependent internalization of FZD4,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,7474,WNT5A
R-HSA-5140745,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,7474,WNT5A
R-HSA-5339716,Misspliced GSK3beta mutants stabilize beta-catenin,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5358747,S33 mutants of beta-catenin aren't phosphorylated,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5358749,S37 mutants of beta-catenin aren't phosphorylated,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5358751,S45 mutants of beta-catenin aren't phosphorylated,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5358752,T41 mutants of beta-catenin aren't phosphorylated,1/45,15/10554,0.062122721781173285,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5467337,APC truncation mutants have impaired AXIN binding,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5467340,AXIN missense mutants destabilize the destruction complex,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5467348,Truncations of AMER1 destabilize the destruction complex,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,324,APC
R-HSA-5602498,MyD88 deficiency (TLR2/4),1/45,10/10554,0.04184650527543732,0.180720645181595,0.1448359237699386,1,re,NAC,7097,TLR2
R-HSA-5603041,IRAK4 deficiency (TLR2/4),1/45,11/10554,0.045935741548446596,0.180720645181595,0.1448359237699386,1,re,NAC,7097,TLR2
R-HSA-6803211,TP53 Regulates Transcription of Death Receptors and Ligands,1/45,12/10554,0.050007911863377386,0.180720645181595,0.1448359237699386,1,re,NAC,3486,IGFBP3
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,1026,CDKN1A
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/45,13/10554,0.054063085830949764,0.180720645181595,0.1448359237699386,1,re,NAC,2810,SFN
R-HSA-877300,Interferon gamma signaling,2/45,92/10554,0.058432912408988014,0.180720645181595,0.1448359237699386,2,re,NAC,6772/9021,STAT1/SOCS3
R-HSA-8851805,MET activates RAS signaling,1/45,11/10554,0.045935741548446596,0.180720645181595,0.1448359237699386,1,re,NAC,3082,HGF
R-HSA-8875555,MET activates RAP1 and RAC1,1/45,11/10554,0.045935741548446596,0.180720645181595,0.1448359237699386,1,re,NAC,3082,HGF
R-HSA-8875656,MET receptor recycling,1/45,10/10554,0.04184650527543732,0.180720645181595,0.1448359237699386,1,re,NAC,3082,HGF
R-HSA-8941856,RUNX3 regulates NOTCH signaling,1/45,14/10554,0.058101332784522564,0.180720645181595,0.1448359237699386,1,re,NAC,3280,HES1
R-HSA-8984722,Interleukin-35 Signalling,1/45,12/10554,0.050007911863377386,0.180720645181595,0.1448359237699386,1,re,NAC,6772,STAT1
R-HSA-9013694,Signaling by NOTCH4,2/45,82/10554,0.047605844682328154,0.180720645181595,0.1448359237699386,2,re,NAC,4088/3280,SMAD3/HES1
R-HSA-9020956,Interleukin-27 signaling,1/45,11/10554,0.045935741548446596,0.180720645181595,0.1448359237699386,1,re,NAC,6772,STAT1
R-HSA-9020958,Interleukin-21 signaling,1/45,10/10554,0.04184650527543732,0.180720645181595,0.1448359237699386,1,re,NAC,6772,STAT1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/45,93/10554,0.059559040666612405,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/45,94/10554,0.06069273017742229,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/45,85/10554,0.05076870017474767,0.180720645181595,0.1448359237699386,2,re,NAC,2353/3725,FOS/JUN
GO:0017038,protein import,2/53,214/18493,0.12535825449567642,0.18154806893466416,0.1051951760592605,2,bp,NAC,3479/4088,IGF1/SMAD3
GO:0050807,regulation of synapse organization,2/53,214/18493,0.12535825449567642,0.18154806893466416,0.1051951760592605,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,3981,LIG4
GO:0002208,somatic diversification of immunoglobulins involved in immune response,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,3981,LIG4
GO:0007595,lactation,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,8835,SOCS2
GO:0030850,prostate gland development,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,7474,WNT5A
GO:0045190,isotype switching,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,3981,LIG4
GO:0046580,negative regulation of Ras protein signal transduction,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,10252,SPRY1
GO:0046638,positive regulation of alpha-beta T cell differentiation,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,7704,ZBTB16
GO:0051205,protein insertion into membrane,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,2810,SFN
GO:0060042,retina morphogenesis in camera-type eye,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,8842,PROM1
GO:0097720,calcineurin-mediated signaling,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,3479,IGF1
GO:1901185,negative regulation of ERBB signaling pathway,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,10252,SPRY1
GO:1990928,response to amino acid starvation,1/53,47/18493,0.1263376442748475,0.18163900730688473,0.1052478688702192,1,bp,NAC,1026,CDKN1A
GO:0004713,protein tyrosine kinase activity,2/52,177/17632,0.09597244797023646,0.18242524085365994,0.11944236369164338,2,mf,NAC,1969/3082,EPHA2/HGF
GO:0004857,enzyme inhibitor activity,3/52,371/17632,0.09618532282905472,0.18242524085365994,0.11944236369164338,3,mf,NAC,9021/2810/1026,SOCS3/SFN/CDKN1A
GO:0019902,phosphatase binding,2/52,178/17632,0.09688613270218302,0.18242524085365994,0.11944236369164338,2,mf,NAC,6772/4088,STAT1/SMAD3
GO:0070663,regulation of leukocyte proliferation,2/53,216/18493,0.12726885508300395,0.18286727334585098,0.10595956832797086,2,bp,NAC,3479/3280,IGF1/HES1
GO:0004623,phospholipase A2 activity,1/52,35/17632,0.0983004175007024,0.1834356005147036,0.12010389356288827,1,mf,NAC,5320,PLA2G2A
GO:0009409,response to cold,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,2353,FOS
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,353500,BMP8A
GO:0019083,viral transcription,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,3725,JUN
GO:0043470,regulation of carbohydrate catabolic process,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,3479,IGF1
GO:0043525,positive regulation of neuron apoptotic process,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,3725,JUN
GO:0050702,interleukin-1 beta secretion,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,7474,WNT5A
GO:0051445,regulation of meiotic cell cycle,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,7474,WNT5A
GO:0051972,regulation of telomerase activity,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,9314,KLF4
GO:0061383,trabecula morphogenesis,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,1277,COL1A1
GO:0070849,response to epidermal growth factor,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,1277,COL1A1
GO:0072698,protein localization to microtubule cytoskeleton,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,324,APC
GO:1902743,regulation of lamellipodium organization,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,1969,EPHA2
GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,4804,NGFR
GO:2000725,regulation of cardiac muscle cell differentiation,1/53,48/18493,0.12884789608301317,0.1835831617048564,0.10637437858955208,1,bp,NAC,3479,IGF1
R-HSA-1482922,Acyl chain remodelling of PI,1/45,17/10554,0.07011520075706046,0.18418321392899464,0.14761094896223256,1,re,NAC,5320,PLA2G2A
R-HSA-166166,MyD88-independent TLR4 cascade ,2/45,100/10554,0.06764911878499988,0.18418321392899464,0.14761094896223256,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/45,98/10554,0.06530147592197273,0.18418321392899464,0.14761094896223256,2,re,NAC,2353/3725,FOS/JUN
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/45,99/10554,0.06647175769059582,0.18418321392899464,0.14761094896223256,2,re,NAC,2353/3725,FOS/JUN
R-HSA-193639,p75NTR signals via NF-kB,1/45,16/10554,0.06612732160277346,0.18418321392899464,0.14761094896223256,1,re,NAC,4804,NGFR
R-HSA-196299,Beta-catenin phosphorylation cascade,1/45,17/10554,0.07011520075706046,0.18418321392899464,0.14761094896223256,1,re,NAC,324,APC
R-HSA-205043,NRIF signals cell death from the nucleus,1/45,16/10554,0.06612732160277346,0.18418321392899464,0.14761094896223256,1,re,NAC,4804,NGFR
R-HSA-210744,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,1/45,16/10554,0.06612732160277346,0.18418321392899464,0.14761094896223256,1,re,NAC,3280,HES1
R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,1/45,17/10554,0.07011520075706046,0.18418321392899464,0.14761094896223256,1,re,NAC,7102,TSPAN7
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/45,17/10554,0.07011520075706046,0.18418321392899464,0.14761094896223256,1,re,NAC,3977,LIFR
R-HSA-6803157,Antimicrobial peptides,2/45,97/10554,0.06413835249231736,0.18418321392899464,0.14761094896223256,2,re,NAC,5320/7097,PLA2G2A/TLR2
R-HSA-9006936,Signaling by TGF-beta family members,2/45,102/10554,0.07002476547861439,0.18418321392899464,0.14761094896223256,2,re,NAC,4088/4093,SMAD3/SMAD9
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/45,100/10554,0.06764911878499988,0.18418321392899464,0.14761094896223256,2,re,NAC,2353/3725,FOS/JUN
GO:0002683,negative regulation of immune system process,3/53,437/18493,0.1297962914800291,0.18482370128114325,0.10709318975566222,3,bp,NAC,7704/1281/3280,ZBTB16/COL3A1/HES1
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,1/52,36/17632,0.10096498409102872,0.18510247083355263,0.12119527176208435,1,mf,NAC,1026,CDKN1A
GO:0017147,Wnt-protein binding,1/52,36/17632,0.10096498409102872,0.18510247083355263,0.12119527176208435,1,mf,NAC,6424,SFRP4
GO:0002697,regulation of immune effector process,3/53,439/18493,0.13108333154068993,0.1855928977178344,0.10753888854528143,3,bp,NAC,6772/3554/7474,STAT1/IL1R1/WNT5A
GO:0021545,cranial nerve development,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,3280,HES1
GO:0031050,dsRNA processing,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,4088,SMAD3
GO:0032648,regulation of interferon-beta production,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,7097,TLR2
GO:0034260,negative regulation of GTPase activity,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,10252,SPRY1
GO:0035272,exocrine system development,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,3082,HGF
GO:0050704,regulation of interleukin-1 secretion,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,7474,WNT5A
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,9021,SOCS3
GO:0050803,regulation of synapse structure or activity,2/53,220/18493,0.13111111934896202,0.1855928977178344,0.10753888854528143,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0051495,positive regulation of cytoskeleton organization,2/53,220/18493,0.13111111934896202,0.1855928977178344,0.10753888854528143,2,bp,NAC,4088/3303,SMAD3/HSPA1A
GO:0070918,production of small RNA involved in gene silencing by RNA,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,4088,SMAD3
GO:0071825,protein-lipid complex subunit organization,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,5320,PLA2G2A
GO:0086009,membrane repolarization,1/53,49/18493,0.13135107100887944,0.1855928977178344,0.10753888854528143,1,bp,NAC,781,CACNA2D1
GO:0070160,tight junction,2/53,127/19659,0.04606919998605754,0.18652407799233053,0.14666446208655032,2,cc,NAC,1969/324,EPHA2/APC
GO:0097472,cyclin-dependent protein kinase activity,1/52,37/17632,0.1036218277388612,0.18669794825363784,0.12223990568105225,1,mf,NAC,1026,CDKN1A
GO:0140097,"catalytic activity, acting on DNA",2/52,185/17632,0.10335152925963921,0.18669794825363784,0.12223990568105225,2,mf,NAC,4255/3981,MGMT/LIG4
R-HSA-112315,Transmission across Chemical Synapses,3/45,227/10554,0.07207940922133158,0.18794038552524975,0.15062207930851354,3,re,NAC,7102/55970/781,TSPAN7/GNG12/CACNA2D1
GO:0008022,protein C-terminus binding,2/52,187/17632,0.10522050371458873,0.1879579938149491,0.12306491662524999,2,mf,NAC,7704/3981,ZBTB16/LIG4
GO:0001954,positive regulation of cell-matrix adhesion,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,4088,SMAD3
GO:0009994,oocyte differentiation,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,3479,IGF1
GO:0010171,body morphogenesis,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,1277,COL1A1
GO:0016447,somatic recombination of immunoglobulin gene segments,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,3981,LIG4
GO:0032655,regulation of interleukin-12 production,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,7097,TLR2
GO:0045668,negative regulation of osteoblast differentiation,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,4088,SMAD3
GO:0070231,T cell apoptotic process,1/53,50/18493,0.13384718862092282,0.18833645830802037,0.10912860162241544,1,bp,NAC,7474,WNT5A
GO:0031965,nuclear membrane,3/53,302/19659,0.047895605470975426,0.18876137333587892,0.1484236543668293,3,cc,NAC,3164/4088/1844,NR4A1/SMAD3/DUSP2
GO:0042383,sarcolemma,2/53,133/19659,0.050033135101076334,0.18876137333587892,0.1484236543668293,2,cc,NAC,2318/781,FLNC/CACNA2D1
GO:0043034,costamere,1/53,19/19659,0.050021626464863966,0.18876137333587892,0.1484236543668293,1,cc,NAC,2318,FLNC
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/45,18/10554,0.0740864274787012,0.19035344870440016,0.1525559935788853,1,re,NAC,6772,STAT1
R-HSA-446353,Cell-extracellular matrix interactions,1/45,18/10554,0.0740864274787012,0.19035344870440016,0.1525559935788853,1,re,NAC,2318,FLNC
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,324,APC
GO:0030514,negative regulation of BMP signaling pathway,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,7474,WNT5A
GO:0032608,interferon-beta production,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,7097,TLR2
GO:0045840,positive regulation of mitotic nuclear division,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,3479,IGF1
GO:0048260,positive regulation of receptor-mediated endocytosis,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,6424,SFRP4
GO:0051496,positive regulation of stress fiber assembly,1/53,51/18493,0.1363362684345697,0.1911601688310181,0.11076475631880076,1,bp,NAC,4088,SMAD3
GO:0006874,cellular calcium ion homeostasis,3/53,448/18493,0.13693167732893935,0.19165599098776795,0.11105205267716715,3,bp,NAC,4088/781/7474,SMAD3/CACNA2D1/WNT5A
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,2/53,226/18493,0.13692510363430735,0.19165599098776795,0.11105205267716715,2,bp,NAC,6772/7474,STAT1/WNT5A
GO:0048588,developmental cell growth,2/53,226/18493,0.13692510363430735,0.19165599098776795,0.11105205267716715,2,bp,NAC,3479/7474,IGF1/WNT5A
hsa04012,ErbB signaling pathway,2/50,85/7852,0.10169694107651293,0.1926259707449245,0.1120870310316985,2,kg,NAC,3725/1026,JUN/CDKN1A
GO:0046777,protein autophosphorylation,2/53,227/18493,0.1378997849511683,0.19278406150139815,0.11170569541203586,2,bp,NAC,3725/80310,JUN/PDGFD
GO:0060560,developmental growth involved in morphogenesis,2/53,227/18493,0.1378997849511683,0.19278406150139815,0.11170569541203586,2,bp,NAC,10252/7474,SPRY1/WNT5A
GO:0042805,actinin binding,1/52,39/17632,0.10891243393157568,0.19290422620084166,0.12630344702145263,1,mf,NAC,8842,PROM1
GO:0002090,regulation of receptor internalization,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,6424,SFRP4
GO:0032615,interleukin-12 production,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,7097,TLR2
GO:0032964,collagen biosynthetic process,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,1277,COL1A1
GO:0043030,regulation of macrophage activation,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,7474,WNT5A
GO:0045839,negative regulation of mitotic nuclear division,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,324,APC
GO:0048641,regulation of skeletal muscle tissue development,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,64321,SOX17
GO:2001169,regulation of ATP biosynthetic process,1/53,52/18493,0.13881832991233622,0.19327282700909576,0.11198890290598307,1,bp,NAC,3479,IGF1
R-HSA-1482925,Acyl chain remodelling of PG,1/45,19/10554,0.07804106973035863,0.1934539193315932,0.1550408205169467,1,re,NAC,5320,PLA2G2A
R-HSA-201681,TCF dependent signaling in response to WNT,3/45,233/10554,0.07663350841197855,0.1934539193315932,0.1550408205169467,3,re,NAC,64321/7474/324,SOX17/WNT5A/APC
R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,1/45,19/10554,0.07804106973035863,0.1934539193315932,0.1550408205169467,1,re,NAC,55970,GNG12
R-HSA-5686938,Regulation of TLR by endogenous ligand,1/45,19/10554,0.07804106973035863,0.1934539193315932,0.1550408205169467,1,re,NAC,7097,TLR2
R-HSA-8951664,Neddylation,3/45,234/10554,0.07740483708382766,0.1934539193315932,0.1550408205169467,3,re,NAC,7704/9021/8835,ZBTB16/SOCS3/SOCS2
GO:0071216,cellular response to biotic stimulus,2/53,229/18493,0.13985386899725735,0.19460064392947804,0.11275828555782692,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0043392,negative regulation of DNA binding,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,3725,JUN
GO:0044380,protein localization to cytoskeleton,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,324,APC
GO:0045661,regulation of myoblast differentiation,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,3486,IGFBP3
GO:0045747,positive regulation of Notch signaling pathway,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,3280,HES1
GO:0051058,negative regulation of small GTPase mediated signal transduction,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,10252,SPRY1
GO:0060563,neuroepithelial cell differentiation,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,3280,HES1
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,1/53,53/18493,0.1412933924639681,0.19580168256370406,0.11345420852369911,1,bp,NAC,324,APC
GO:0001784,phosphotyrosine residue binding,1/52,40/17632,0.11154624018608339,0.19590894284782712,0.1282707759769203,1,mf,NAC,9021,SOCS3
GO:0001221,transcription cofactor binding,1/52,41/17632,0.11417241091768449,0.1972068915850914,0.1291206039086471,1,mf,NAC,9314,KLF4
GO:0060090,molecular adaptor activity,2/52,196/17632,0.11374400602255494,0.1972068915850914,0.1291206039086471,2,mf,NAC,8835/1278,SOCS2/COL1A2
GO:0002381,immunoglobulin production involved in immunoglobulin mediated immune response,1/53,54/18493,0.1437614754465827,0.1984387334190334,0.11498220620845236,1,bp,NAC,3981,LIG4
GO:0002758,innate immune response-activating signal transduction,2/53,233/18493,0.14378046159839972,0.1984387334190334,0.11498220620845236,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/53,54/18493,0.1437614754465827,0.1984387334190334,0.11498220620845236,1,bp,NAC,324,APC
GO:0042593,glucose homeostasis,2/53,233/18493,0.14378046159839972,0.1984387334190334,0.11498220620845236,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0046148,pigment biosynthetic process,1/53,54/18493,0.1437614754465827,0.1984387334190334,0.11498220620845236,1,bp,NAC,7474,WNT5A
GO:0060113,inner ear receptor cell differentiation,1/53,54/18493,0.1437614754465827,0.1984387334190334,0.11498220620845236,1,bp,NAC,3280,HES1
GO:0098900,regulation of action potential,1/53,54/18493,0.1437614754465827,0.1984387334190334,0.11498220620845236,1,bp,NAC,781,CACNA2D1
GO:0033500,carbohydrate homeostasis,2/53,234/18493,0.14476585302826953,0.199682829757091,0.11570307828428673,2,bp,NAC,4804/3953,NGFR/LEPR
GO:0015026,coreceptor activity,1/52,42/17632,0.11679096782930287,0.20007633013380574,0.13099935994658649,1,mf,NAC,4804,NGFR
R-HSA-1181150,Signaling by NODAL,1/45,20/10554,0.08197919520374553,0.2003935882758224,0.16060251691961844,1,re,NAC,4088,SMAD3
R-HSA-418217,G beta:gamma signalling through PLC beta,1/45,20/10554,0.08197919520374553,0.2003935882758224,0.16060251691961844,1,re,NAC,55970,GNG12
GO:0055074,calcium ion homeostasis,3/53,461/18493,0.14553754187422327,0.20063088381269736,0.11625241331097379,3,bp,NAC,4088/781/7474,SMAD3/CACNA2D1/WNT5A
GO:0002011,morphogenesis of an epithelial sheet,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,7474,WNT5A
GO:0032922,circadian regulation of gene expression,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,4804,NGFR
GO:0046324,regulation of glucose import,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,3479,IGF1
GO:0051196,regulation of coenzyme metabolic process,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,3479,IGF1
GO:0060043,regulation of cardiac muscle cell proliferation,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,7472,WNT2
GO:0070498,interleukin-1-mediated signaling pathway,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,3554,IL1R1
GO:1900408,negative regulation of cellular response to oxidative stress,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,3082,HGF
GO:1903202,negative regulation of oxidative stress-induced cell death,1/53,55/18493,0.14622259816480643,0.2006447423173166,0.11626044340373047,1,bp,NAC,3082,HGF
GO:0006302,double-strand break repair,2/53,236/18493,0.14674101485244612,0.20123998461310086,0.11660534719957019,2,bp,NAC,4255/3981,MGMT/LIG4
GO:0010656,negative regulation of muscle cell apoptotic process,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,3479,IGF1
GO:0031663,lipopolysaccharide-mediated signaling pathway,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,7097,TLR2
GO:0035306,positive regulation of dephosphorylation,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,4088,SMAD3
GO:0044784,metaphase/anaphase transition of cell cycle,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,324,APC
GO:0045806,negative regulation of endocytosis,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,7097,TLR2
GO:0048008,platelet-derived growth factor receptor signaling pathway,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,80310,PDGFD
GO:0048016,inositol phosphate-mediated signaling,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,3479,IGF1
GO:0050701,interleukin-1 secretion,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,7474,WNT5A
GO:0055081,anion homeostasis,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,6424,SFRP4
GO:0086002,cardiac muscle cell action potential involved in contraction,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,781,CACNA2D1
GO:0086065,cell communication involved in cardiac conduction,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,781,CACNA2D1
GO:1903078,positive regulation of protein localization to plasma membrane,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,1969,EPHA2
GO:1903749,positive regulation of establishment of protein localization to mitochondrion,1/53,56/18493,0.1486767798709171,0.2023774370538299,0.11726442614468743,1,bp,NAC,2810,SFN
GO:0048020,CCR chemokine receptor binding,1/52,43/17632,0.11940193256340637,0.20288621061586937,0.13283912052411492,1,mf,NAC,6772,STAT1
GO:0010965,regulation of mitotic sister chromatid separation,1/53,57/18493,0.15112403976498023,0.20523870163399371,0.11892234094944792,1,bp,NAC,324,APC
GO:0042108,positive regulation of cytokine biosynthetic process,1/53,57/18493,0.15112403976498023,0.20523870163399371,0.11892234094944792,1,bp,NAC,7474,WNT5A
GO:0070228,regulation of lymphocyte apoptotic process,1/53,57/18493,0.15112403976498023,0.20523870163399371,0.11892234094944792,1,bp,NAC,7474,WNT5A
GO:1902883,negative regulation of response to oxidative stress,1/53,57/18493,0.15112403976498023,0.20523870163399371,0.11892234094944792,1,bp,NAC,3082,HGF
GO:0015485,cholesterol binding,1/52,44/17632,0.12200532670216901,0.20563801032865583,0.13464085289713051,1,mf,NAC,8842,PROM1
R-HSA-500657,Presynaptic function of Kainate receptors,1/45,21/10554,0.08590087132068425,0.20569460343456364,0.16485093815927948,1,re,NAC,55970,GNG12
R-HSA-6807004,Negative regulation of MET activity,1/45,21/10554,0.08590087132068425,0.20569460343456364,0.16485093815927948,1,re,NAC,3082,HGF
R-HSA-9008059,Interleukin-37 signaling,1/45,21/10554,0.08590087132068425,0.20569460343456364,0.16485093815927948,1,re,NAC,4088,SMAD3
GO:0006839,mitochondrial transport,2/53,241/18493,0.1517037209663298,0.20590836099197046,0.11931036454273355,2,bp,NAC,3303/2810,HSPA1A/SFN
GO:0006091,generation of precursor metabolites and energy,3/53,471/18493,0.15227885329736504,0.20657108564810842,0.1196943699319968,3,bp,NAC,3479/3953/862,IGF1/LEPR/RUNX1T1
GO:0051249,regulation of lymphocyte activation,3/53,472/18493,0.15295858121021125,0.20737486095660337,0.12016010490557916,3,bp,NAC,3479/7704/3280,IGF1/ZBTB16/HES1
GO:0014888,striated muscle adaptation,1/53,58/18493,0.1535643969949898,0.20784071488564926,0.12043003664526357,1,bp,NAC,4088,SMAD3
GO:0031646,positive regulation of neurological system process,1/53,58/18493,0.1535643969949898,0.20784071488564926,0.12043003664526357,1,bp,NAC,3082,HGF
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/53,58/18493,0.1535643969949898,0.20784071488564926,0.12043003664526357,1,bp,NAC,3082,HGF
GO:0008138,protein tyrosine/serine/threonine phosphatase activity,1/52,45/17632,0.12460117176763963,0.20833315919549344,0.1364054933035213,1,mf,NAC,1844,DUSP2
GO:0022604,regulation of cell morphogenesis,3/53,474/18493,0.15432102776772136,0.20874596361299283,0.12095456879704646,3,bp,NAC,4804/3679/7474,NGFR/ITGA7/WNT5A
GO:0016311,dephosphorylation,3/53,475/18493,0.15500373687008553,0.20955024802561875,0.12142059876301846,3,bp,NAC,4088/1844/3486,SMAD3/DUSP2/IGFBP3
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,3981,LIG4
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,3303,HSPA1A
GO:0016444,somatic cell DNA recombination,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,3981,LIG4
GO:0031330,negative regulation of cellular catabolic process,2/53,245/18493,0.15569836104945634,0.20982066539726243,0.12157728786021715,2,bp,NAC,3953/3082,LEPR/HGF
GO:0033619,membrane protein proteolysis,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,4804,NGFR
GO:0042490,mechanoreceptor differentiation,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,3280,HES1
GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,3303,HSPA1A
GO:0072678,T cell migration,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,7474,WNT5A
GO:2000401,regulation of lymphocyte migration,1/53,59/18493,0.15599787065700588,0.20982066539726243,0.12157728786021715,1,bp,NAC,7474,WNT5A
GO:0032813,tumor necrosis factor receptor superfamily binding,1/52,46/17632,0.12718948922189988,0.21097304164584982,0.1381339481942104,1,mf,NAC,6772,STAT1
GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,3303,HSPA1A
GO:0003407,neural retina development,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,8842,PROM1
GO:0016445,somatic diversification of immunoglobulins,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,3981,LIG4
GO:0018149,peptide cross-linking,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,1281,COL3A1
GO:0030166,proteoglycan biosynthetic process,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,3479,IGF1
GO:0051306,mitotic sister chromatid separation,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,324,APC
GO:0051784,negative regulation of nuclear division,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,324,APC
GO:0051893,regulation of focal adhesion assembly,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,4088,SMAD3
GO:0060761,negative regulation of response to cytokine stimulus,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,9314,KLF4
GO:0061077,chaperone-mediated protein folding,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,3303,HSPA1A
GO:0090109,regulation of cell-substrate junction assembly,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,4088,SMAD3
GO:0090307,mitotic spindle assembly,1/53,60/18493,0.15842447979529284,0.2116479848051721,0.12263609938027105,1,bp,NAC,3303,HSPA1A
GO:0048872,homeostasis of number of cells,2/53,248/18493,0.15870797069159828,0.21190766665054506,0.12278656794544884,2,bp,NAC,6772/3303,STAT1/HSPA1A
GO:0031258,lamellipodium membrane,1/53,22/19659,0.05769204233204184,0.21280626682205753,0.16733022882647516,1,cc,NAC,1969,EPHA2
GO:0031528,microvillus membrane,1/53,23/19659,0.06023531888937772,0.21280626682205753,0.16733022882647516,1,cc,NAC,8842,PROM1
GO:0062023,collagen-containing extracellular matrix,3/53,332/19659,0.06025237675082352,0.21280626682205753,0.16733022882647516,3,cc,NAC,1277/1278/1281,COL1A1/COL1A2/COL3A1
R-HSA-392170,ADP signalling through P2Y purinoceptor 12,1/45,22/10554,0.08980616523415319,0.21359304163798598,0.17118102619312273,1,re,NAC,55970,GNG12
GO:0045739,positive regulation of DNA repair,1/53,61/18493,0.1608442434024563,0.21403895400729772,0.12402150891751264,1,bp,NAC,4255,MGMT
GO:0045815,"positive regulation of gene expression, epigenetic",1/53,61/18493,0.1608442434024563,0.21403895400729772,0.12402150891751264,1,bp,NAC,23451,SF3B1
GO:0046034,ATP metabolic process,2/53,250/18493,0.16072063998723457,0.21403895400729772,0.12402150891751264,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0046635,positive regulation of alpha-beta T cell activation,1/53,61/18493,0.1608442434024563,0.21403895400729772,0.12402150891751264,1,bp,NAC,7704,ZBTB16
GO:0048747,muscle fiber development,1/53,61/18493,0.1608442434024563,0.21403895400729772,0.12402150891751264,1,bp,NAC,2318,FLNC
GO:0072503,cellular divalent inorganic cation homeostasis,3/53,483/18493,0.1605004400408586,0.21403895400729772,0.12402150891751264,3,bp,NAC,4088/781/7474,SMAD3/CACNA2D1/WNT5A
R-HSA-112409,RAF-independent MAPK1/3 activation,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,1844,DUSP2
R-HSA-1482801,Acyl chain remodelling of PS,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,5320,PLA2G2A
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,4088,SMAD3
R-HSA-428930,Thromboxane signalling through TP receptor,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,55970,GNG12
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,3725,JUN
R-HSA-8863678,Neurodegenerative Diseases,1/45,23/10554,0.09369514382933586,0.21416032875276766,0.17163567017267264,1,re,NAC,3725,JUN
R-HSA-1296041,Activation of G protein gated Potassium channels,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,55970,GNG12
R-HSA-1296059,G protein gated Potassium channels,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,55970,GNG12
R-HSA-182971,EGFR downregulation,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,10252,SPRY1
R-HSA-2559580,Oxidative Stress Induced Senescence,2/45,125/10554,0.09916312009566307,0.21506865233760356,0.1723636328542995,2,re,NAC,2353/3725,FOS/JUN
R-HSA-3371571,HSF1-dependent transactivation,1/45,24/10554,0.09756787372466214,0.21506865233760356,0.1723636328542995,1,re,NAC,3303,HSPA1A
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),2/45,125/10554,0.09916312009566307,0.21506865233760356,0.1723636328542995,2,re,NAC,3479/3486,IGF1/IGFBP3
R-HSA-392451,G beta:gamma signalling through PI3Kgamma,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,55970,GNG12
R-HSA-418592,ADP signalling through P2Y purinoceptor 1,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,55970,GNG12
R-HSA-5260271,Diseases of Immune System,1/45,24/10554,0.09756787372466214,0.21506865233760356,0.1723636328542995,1,re,NAC,7097,TLR2
R-HSA-5602358,Diseases associated with the TLR signaling cascade,1/45,24/10554,0.09756787372466214,0.21506865233760356,0.1723636328542995,1,re,NAC,7097,TLR2
R-HSA-8854691,Interleukin-20 family signaling,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,6772,STAT1
R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,1/45,25/10554,0.10142442127284712,0.21506865233760356,0.1723636328542995,1,re,NAC,55970,GNG12
GO:0004879,nuclear receptor activity,1/52,50/17632,0.13746791007894776,0.2160210015526322,0.14143908437089994,1,mf,NAC,3164,NR4A1
GO:0005245,voltage-gated calcium channel activity,1/52,48/17632,0.13234362684629108,0.2160210015526322,0.14143908437089994,1,mf,NAC,781,CACNA2D1
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,1/52,48/17632,0.13234362684629108,0.2160210015526322,0.14143908437089994,1,mf,NAC,1026,CDKN1A
GO:0032934,sterol binding,1/52,50/17632,0.13746791007894776,0.2160210015526322,0.14143908437089994,1,mf,NAC,8842,PROM1
GO:0045309,protein phosphorylated amino acid binding,1/52,49/17632,0.13490948964224192,0.2160210015526322,0.14143908437089994,1,mf,NAC,9021,SOCS3
GO:0070888,E-box binding,1/52,50/17632,0.13746791007894776,0.2160210015526322,0.14143908437089994,1,mf,NAC,3280,HES1
GO:0098531,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",1/52,50/17632,0.13746791007894776,0.2160210015526322,0.14143908437089994,1,mf,NAC,3164,NR4A1
GO:0002218,activation of innate immune response,2/53,252/18493,0.16273817995318213,0.21628165740265592,0.12532100816257655,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0019080,viral gene expression,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,3725,JUN
GO:0019748,secondary metabolic process,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,7474,WNT5A
GO:0032233,positive regulation of actin filament bundle assembly,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,4088,SMAD3
GO:0046530,photoreceptor cell differentiation,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,8842,PROM1
GO:0050922,negative regulation of chemotaxis,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,7474,WNT5A
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,353500,BMP8A
GO:1905818,regulation of chromosome separation,1/53,62/18493,0.1632571804195826,0.21628165740265592,0.12532100816257655,1,bp,NAC,324,APC
GO:0009150,purine ribonucleotide metabolic process,3/53,488/18493,0.16396678169345377,0.21710078333353736,0.1257956378131116,3,bp,NAC,3479/1969/3303,IGF1/EPHA2/HSPA1A
GO:0017046,peptide hormone binding,1/52,51/17632,0.14001890932112138,0.21838770185159975,0.14298867409069743,1,mf,NAC,3953,LEPR
GO:0010676,positive regulation of cellular carbohydrate metabolic process,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,3479,IGF1
GO:0046323,glucose import,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,3479,IGF1
GO:0046637,regulation of alpha-beta T cell differentiation,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,7704,ZBTB16
GO:0048247,lymphocyte chemotaxis,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,7474,WNT5A
GO:0050891,multicellular organismal water homeostasis,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,2810,SFN
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,7474,WNT5A
GO:1904377,positive regulation of protein localization to cell periphery,1/53,63/18493,0.16566330973637278,0.2184954800627257,0.12660377291935196,1,bp,NAC,1969,EPHA2
GO:0007281,germ cell development,2/53,255/18493,0.1657733637760168,0.21851943406838578,0.12661765269156613,2,bp,NAC,3479/7704,IGF1/ZBTB16
R-HSA-114608,Platelet degranulation ,2/45,129/10554,0.10453495691252666,0.22033715468987658,0.17658599717968576,2,re,NAC,3479/3082,IGF1/HGF
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,1/45,26/10554,0.10526485256192708,0.22055492917737105,0.17676052936463946,1,re,NAC,4088,SMAD3
GO:0045600,positive regulation of fat cell differentiation,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,7704,ZBTB16
GO:0045670,regulation of osteoclast differentiation,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,2353,FOS
GO:0050795,regulation of behavior,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,3953,LEPR
GO:0060038,cardiac muscle cell proliferation,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,7472,WNT2
GO:0072091,regulation of stem cell proliferation,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,64321,SOX17
GO:1901880,negative regulation of protein depolymerization,1/53,64/18493,0.16806265019128186,0.22080275257175042,0.12794068572281941,1,bp,NAC,324,APC
hsa04657,IL-17 signaling pathway,2/50,93/7852,0.11809546647264392,0.22108569886157758,0.12864744817705398,2,kg,NAC,2353/3725,FOS/JUN
GO:0031334,positive regulation of protein complex assembly,2/53,259/18493,0.16983622764217943,0.2225933632725924,0.12897822695933048,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0033627,cell adhesion mediated by integrin,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,1969,EPHA2
GO:0034121,regulation of toll-like receptor signaling pathway,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,7097,TLR2
GO:0035418,protein localization to synapse,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,7474,WNT5A
GO:0042246,tissue regeneration,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,3479,IGF1
GO:0046888,negative regulation of hormone secretion,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,353500,BMP8A
GO:0060389,pathway-restricted SMAD protein phosphorylation,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,353500,BMP8A
GO:0060675,ureteric bud morphogenesis,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,3280,HES1
GO:0090175,regulation of establishment of planar polarity,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,7474,WNT5A
GO:1904888,cranial skeletal system development,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,4088,SMAD3
GO:2001259,positive regulation of cation channel activity,1/53,65/18493,0.17045522057165297,0.2225933632725924,0.12897822695933048,1,bp,NAC,781,CACNA2D1
GO:0060627,regulation of vesicle-mediated transport,3/53,498/18493,0.170968044293226,0.22314051005998434,0.12929526256850937,3,bp,NAC,6424/7097/7474,SFRP4/TLR2/WNT5A
GO:0002709,regulation of T cell mediated immunity,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,3554,IL1R1
GO:0010812,negative regulation of cell-substrate adhesion,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,1277,COL1A1
GO:0015909,long-chain fatty acid transport,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,5320,PLA2G2A
GO:0072171,mesonephric tubule morphogenesis,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,3280,HES1
GO:1903391,regulation of adherens junction organization,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,4088,SMAD3
GO:2000243,positive regulation of reproductive process,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,7474,WNT5A
GO:2000736,regulation of stem cell differentiation,1/53,66/18493,0.172841039613855,0.22472170158652116,0.13021145915486532,1,bp,NAC,3280,HES1
R-HSA-1482788,Acyl chain remodelling of PC,1/45,28/10554,0.11289762939769465,0.2257952587953893,0.18096031506329047,1,re,NAC,5320,PLA2G2A
R-HSA-201451,Signaling by BMP,1/45,28/10554,0.11289762939769465,0.2257952587953893,0.18096031506329047,1,re,NAC,4093,SMAD9
R-HSA-202040,G-protein activation,1/45,28/10554,0.11289762939769465,0.2257952587953893,0.18096031506329047,1,re,NAC,55970,GNG12
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/45,134/10554,0.1113603673003053,0.2257952587953893,0.18096031506329047,2,re,NAC,2353/3725,FOS/JUN
R-HSA-397795,G-protein beta:gamma signalling,1/45,28/10554,0.11289762939769465,0.2257952587953893,0.18096031506329047,1,re,NAC,55970,GNG12
R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",1/45,28/10554,0.11289762939769465,0.2257952587953893,0.18096031506329047,1,re,NAC,55970,GNG12
R-HSA-5576893,Phase 2 - plateau phase,1/45,27/10554,0.10908923341628796,0.2257952587953893,0.18096031506329047,1,re,NAC,781,CACNA2D1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,2/45,134/10554,0.1113603673003053,0.2257952587953893,0.18096031506329047,2,re,NAC,3479/3082,IGF1/HGF
GO:0030032,lamellipodium assembly,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,1969,EPHA2
GO:0030104,water homeostasis,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,2810,SFN
GO:0034976,response to endoplasmic reticulum stress,2/53,264/18493,0.1749391546048555,0.22657610638179862,0.13128596487706362,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0035924,cellular response to vascular endothelial growth factor stimulus,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,3164,NR4A1
GO:0046651,lymphocyte proliferation,2/53,264/18493,0.1749391546048555,0.22657610638179862,0.13128596487706362,2,bp,NAC,3479/3280,IGF1/HES1
GO:0048663,neuron fate commitment,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,3280,HES1
GO:0061515,myeloid cell development,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,7097,TLR2
GO:0086003,cardiac muscle cell contraction,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,781,CACNA2D1
GO:1903311,regulation of mRNA metabolic process,2/53,264/18493,0.1749391546048555,0.22657610638179862,0.13128596487706362,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:1903672,positive regulation of sprouting angiogenesis,1/53,67/18493,0.17522012600341785,0.22657610638179862,0.13128596487706362,1,bp,NAC,9314,KLF4
GO:0003707,steroid hormone receptor activity,1/52,54/17632,0.14762759064370745,0.2268688709156975,0.14854169337215148,1,mf,NAC,3164,NR4A1
GO:0005070,SH3/SH2 adaptor activity,1/52,54/17632,0.14762759064370745,0.2268688709156975,0.14854169337215148,1,mf,NAC,8835,SOCS2
GO:0005686,U2 snRNP,1/53,27/19659,0.07034124885539361,0.22840039440118098,0.1795919397954752,1,cc,NAC,23451,SF3B1
GO:0005689,U12-type spliceosomal complex,1/53,27/19659,0.07034124885539361,0.22840039440118098,0.1795919397954752,1,cc,NAC,23451,SF3B1
GO:0030666,endocytic vesicle membrane,2/53,163/19659,0.07154711149916512,0.22840039440118098,0.1795919397954752,2,cc,NAC,7097/7474,TLR2/WNT5A
GO:0071005,U2-type precatalytic spliceosome,1/53,27/19659,0.07034124885539361,0.22840039440118098,0.1795919397954752,1,cc,NAC,23451,SF3B1
GO:0071011,precatalytic spliceosome,1/53,27/19659,0.07034124885539361,0.22840039440118098,0.1795919397954752,1,cc,NAC,23451,SF3B1
GO:0032943,mononuclear cell proliferation,2/53,266/18493,0.17698753837798428,0.22861290943120402,0.1324661584017733,2,bp,NAC,3479/3280,IGF1/HES1
GO:0042063,gliogenesis,2/53,266/18493,0.17698753837798428,0.22861290943120402,0.1324661584017733,2,bp,NAC,7097/3280,TLR2/HES1
GO:0031670,cellular response to nutrient,1/53,68/18493,0.1775924983751649,0.2288969979057681,0.13263076900475873,1,bp,NAC,1277,COL1A1
GO:0033047,regulation of mitotic sister chromatid segregation,1/53,68/18493,0.1775924983751649,0.2288969979057681,0.13263076900475873,1,bp,NAC,324,APC
GO:0033692,cellular polysaccharide biosynthetic process,1/53,68/18493,0.1775924983751649,0.2288969979057681,0.13263076900475873,1,bp,NAC,3479,IGF1
GO:0050688,regulation of defense response to virus,1/53,68/18493,0.1775924983751649,0.2288969979057681,0.13263076900475873,1,bp,NAC,6772,STAT1
GO:0015980,energy derivation by oxidation of organic compounds,2/53,267/18493,0.17801322036715556,0.22931497184891433,0.1328729574389044,2,bp,NAC,3479/3953,IGF1/LEPR
GO:0006260,DNA replication,2/53,268/18493,0.1790398774502162,0.23051263052334278,0.13356692194017786,2,bp,NAC,3725/3981,JUN/LIG4
GO:0001726,ruffle,2/53,167/19659,0.07461022211803814,0.23077156546272792,0.18145639896879048,2,cc,NAC,1969/324,EPHA2/APC
GO:0005834,heterotrimeric G-protein complex,1/53,30/19659,0.07785064858983592,0.23077156546272792,0.18145639896879048,1,cc,NAC,55970,GNG12
GO:0016342,catenin complex,1/53,29/19659,0.07535415190368677,0.23077156546272792,0.18145639896879048,1,cc,NAC,324,APC
GO:1905360,GTPase complex,1/53,30/19659,0.07785064858983592,0.23077156546272792,0.18145639896879048,1,cc,NAC,55970,GNG12
GO:0002200,somatic diversification of immune receptors,1/53,69/18493,0.17995817531335323,0.2310694065308607,0.13388953704966433,1,bp,NAC,3981,LIG4
GO:0030500,regulation of bone mineralization,1/53,69/18493,0.17995817531335323,0.2310694065308607,0.13388953704966433,1,bp,NAC,4088,SMAD3
GO:0033077,T cell differentiation in thymus,1/53,69/18493,0.17995817531335323,0.2310694065308607,0.13388953704966433,1,bp,NAC,3981,LIG4
GO:0042440,pigment metabolic process,1/53,69/18493,0.17995817531335323,0.2310694065308607,0.13388953704966433,1,bp,NAC,7474,WNT5A
GO:0048708,astrocyte differentiation,1/53,69/18493,0.17995817531335323,0.2310694065308607,0.13388953704966433,1,bp,NAC,3280,HES1
R-HSA-186763,Downstream signal transduction,1/45,29/10554,0.11669010580631212,0.23206167934362637,0.18598244636391106,1,re,NAC,6772,STAT1
R-HSA-114452,Activation of BH3-only proteins,1/45,30/10554,0.12046672768172428,0.23213981966967287,0.18604507078789573,1,re,NAC,2810,SFN
R-HSA-1296065,Inwardly rectifying K+ channels,1/45,31/10554,0.12422755980395173,0.23213981966967287,0.18604507078789573,1,re,NAC,55970,GNG12
R-HSA-1482839,Acyl chain remodelling of PE,1/45,30/10554,0.12046672768172428,0.23213981966967287,0.18604507078789573,1,re,NAC,5320,PLA2G2A
R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,3303,HSPA1A
R-HSA-1839124,FGFR1 mutant receptor activation,1/45,31/10554,0.12422755980395173,0.23213981966967287,0.18604507078789573,1,re,NAC,6772,STAT1
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,4088,SMAD3
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,4088,SMAD3
R-HSA-3000157,Laminin interactions,1/45,30/10554,0.12046672768172428,0.23213981966967287,0.18604507078789573,1,re,NAC,3679,ITGA7
R-HSA-3858494,Beta-catenin independent WNT signaling,2/45,145/10554,0.12677214894407107,0.23213981966967287,0.18604507078789573,2,re,NAC,55970/7474,GNG12/WNT5A
R-HSA-392518,Signal amplification,1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,55970,GNG12
R-HSA-3928663,EPHA-mediated growth cone collapse,1/45,30/10554,0.12046672768172428,0.23213981966967287,0.18604507078789573,1,re,NAC,1969,EPHA2
R-HSA-399719,Trafficking of AMPA receptors,1/45,31/10554,0.12422755980395173,0.23213981966967287,0.18604507078789573,1,re,NAC,7102,TSPAN7
R-HSA-399721,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",1/45,31/10554,0.12422755980395173,0.23213981966967287,0.18604507078789573,1,re,NAC,7102,TSPAN7
R-HSA-446652,Interleukin-1 family signaling,2/45,139/10554,0.11830130062595783,0.23213981966967287,0.18604507078789573,2,re,NAC,3554/4088,IL1R1/SMAD3
R-HSA-451326,Activation of kainate receptors upon glutamate binding,1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,55970,GNG12
R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),1/45,32/10554,0.12797266669446028,0.23213981966967287,0.18604507078789573,1,re,NAC,55970,GNG12
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,1/45,31/10554,0.12422755980395173,0.23213981966967287,0.18604507078789573,1,re,NAC,324,APC
R-HSA-5683057,MAPK family signaling cascades,3/45,293/10554,0.12860018419200628,0.23213981966967287,0.18604507078789573,3,re,NAC,3725/1844/3082,JUN/DUSP2/HGF
R-HSA-163359,Glucagon signaling in metabolic regulation,1/45,33/10554,0.13170211261717002,0.2329605208102706,0.18670280974028863,1,re,NAC,55970,GNG12
R-HSA-1980145,Signaling by NOTCH2,1/45,33/10554,0.13170211261717002,0.2329605208102706,0.18670280974028863,1,re,NAC,3280,HES1
R-HSA-2559585,Oncogene Induced Senescence,1/45,33/10554,0.13170211261717002,0.2329605208102706,0.18670280974028863,1,re,NAC,2114,ETS2
R-HSA-420092,Glucagon-type ligand receptors,1/45,33/10554,0.13170211261717002,0.2329605208102706,0.18670280974028863,1,re,NAC,55970,GNG12
GO:1901224,positive regulation of NIK/NF-kappaB signaling,1/53,70/18493,0.18231717535180259,0.23371980753993885,0.13542527027124962,1,bp,NAC,7097,TLR2
GO:1903747,regulation of establishment of protein localization to mitochondrion,1/53,70/18493,0.18231717535180259,0.23371980753993885,0.13542527027124962,1,bp,NAC,2810,SFN
GO:1904427,positive regulation of calcium ion transmembrane transport,1/53,70/18493,0.18231717535180259,0.23371980753993885,0.13542527027124962,1,bp,NAC,781,CACNA2D1
hsa04713,Circadian entrainment,2/50,97/7852,0.12653243815216283,0.23415773037354273,0.136253926140865,2,kg,NAC,2353/55970,FOS/GNG12
GO:0035914,skeletal muscle cell differentiation,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,2353,FOS
GO:0038034,signal transduction in absence of ligand,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,3303,HSPA1A
GO:0043242,negative regulation of protein complex disassembly,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,324,APC
GO:0046785,microtubule polymerization,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,3303,HSPA1A
GO:0051155,positive regulation of striated muscle cell differentiation,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,3479,IGF1
GO:0060350,endochondral bone morphogenesis,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,1277,COL1A1
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,3303,HSPA1A
GO:1903312,negative regulation of mRNA metabolic process,1/53,71/18493,0.184669516974033,0.23571879300281826,0.1365835509896371,1,bp,NAC,79882,ZC3H14
R-HSA-9018519,Estrogen-dependent gene expression,2/45,150/10554,0.13394064629272354,0.23573553747519344,0.18892680634973635,2,re,NAC,2353/3725,FOS/JUN
hsa04064,NF-kappa B signaling pathway,2/50,100/7852,0.13295365614784163,0.23644398019461277,0.13758427092069656,2,kg,NAC,4616/3554,GADD45B/IL1R1
hsa04066,HIF-1 signaling pathway,2/50,100/7852,0.13295365614784163,0.23644398019461277,0.13758427092069656,2,kg,NAC,3479/1026,IGF1/CDKN1A
hsa04660,T cell receptor signaling pathway,2/50,101/7852,0.13511084582549301,0.23644398019461277,0.13758427092069656,2,kg,NAC,2353/3725,FOS/JUN
hsa04750,Inflammatory mediator regulation of TRP channels,2/50,100/7852,0.13295365614784163,0.23644398019461277,0.13758427092069656,2,kg,NAC,3479/3554,IGF1/IL1R1
hsa04916,Melanogenesis,2/50,101/7852,0.13511084582549301,0.23644398019461277,0.13758427092069656,2,kg,NAC,7472/7474,WNT2/WNT5A
R-HSA-4791275,Signaling by WNT in cancer,1/45,34/10554,0.13541596157945757,0.2371463605769605,0.19005748993608082,1,re,NAC,324,APC
GO:0002312,B cell activation involved in immune response,1/53,72/18493,0.18701521861339787,0.23816447495600346,0.13800066297083288,1,bp,NAC,3981,LIG4
GO:0007162,negative regulation of cell adhesion,2/53,276/18493,0.1872866140318446,0.23816447495600346,0.13800066297083288,2,bp,NAC,9314/1277,KLF4/COL1A1
GO:0016579,protein deubiquitination,2/53,276/18493,0.1872866140318446,0.23816447495600346,0.13800066297083288,2,bp,NAC,4088/324,SMAD3/APC
GO:0048511,rhythmic process,2/53,276/18493,0.1872866140318446,0.23816447495600346,0.13800066297083288,2,bp,NAC,3725/4804,JUN/NGFR
GO:0061045,negative regulation of wound healing,1/53,72/18493,0.18701521861339787,0.23816447495600346,0.13800066297083288,1,bp,NAC,4088,SMAD3
GO:0070227,lymphocyte apoptotic process,1/53,72/18493,0.18701521861339787,0.23816447495600346,0.13800066297083288,1,bp,NAC,7474,WNT5A
GO:2000779,regulation of double-strand break repair,1/53,72/18493,0.18701521861339787,0.23816447495600346,0.13800066297083288,1,bp,NAC,4255,MGMT
GO:0051146,striated muscle cell differentiation,2/53,277/18493,0.18832144091126346,0.2393524246322739,0.13868900174567156,2,bp,NAC,3479/2318,IGF1/FLNC
GO:0001895,retina homeostasis,1/53,73/18493,0.18935429865321618,0.24015174517191898,0.13915215547343718,1,bp,NAC,8842,PROM1
GO:0005977,glycogen metabolic process,1/53,73/18493,0.18935429865321618,0.24015174517191898,0.13915215547343718,1,bp,NAC,3479,IGF1
GO:0031397,negative regulation of protein ubiquitination,1/53,73/18493,0.18935429865321618,0.24015174517191898,0.13915215547343718,1,bp,NAC,3303,HSPA1A
GO:1900371,regulation of purine nucleotide biosynthetic process,1/53,73/18493,0.18935429865321618,0.24015174517191898,0.13915215547343718,1,bp,NAC,3479,IGF1
GO:0000271,polysaccharide biosynthetic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0006073,cellular glucan metabolic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0006096,glycolytic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0009205,purine ribonucleoside triphosphate metabolic process,2/53,280/18493,0.19143091947591237,0.2415639385083114,0.1399704287138151,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0010827,regulation of glucose transmembrane transport,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0021954,central nervous system neuron development,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,7474,WNT5A
GO:0030808,regulation of nucleotide biosynthetic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0044042,glucan metabolic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0072078,nephron tubule morphogenesis,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3280,HES1
GO:0086001,cardiac muscle cell action potential,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,781,CACNA2D1
GO:0090398,cellular senescence,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,1026,CDKN1A
GO:1903578,regulation of ATP metabolic process,1/53,74/18493,0.19168677542690649,0.2415639385083114,0.1399704287138151,1,bp,NAC,3479,IGF1
GO:0018105,peptidyl-serine phosphorylation,2/53,282/18493,0.19350794109324632,0.24372981139816724,0.14122540972962727,2,bp,NAC,3082/7474,HGF/WNT5A
GO:0006757,ATP generation from ADP,1/53,75/18493,0.19401266721812072,0.24397785438640457,0.14136913434190768,1,bp,NAC,3479,IGF1
GO:0051193,regulation of cofactor metabolic process,1/53,75/18493,0.19401266721812072,0.24397785438640457,0.14136913434190768,1,bp,NAC,3479,IGF1
GO:1903201,regulation of oxidative stress-induced cell death,1/53,75/18493,0.19401266721812072,0.24397785438640457,0.14136913434190768,1,bp,NAC,3082,HGF
GO:0070661,leukocyte proliferation,2/53,283/18493,0.19454762430302444,0.24452127409756452,0.14168401035532383,2,bp,NAC,3479/3280,IGF1/HES1
hsa04625,C-type lectin receptor signaling pathway,2/50,104/7852,0.1416301548569783,0.24518768744057534,0.14267214241393403,2,kg,NAC,3725/6772,JUN/STAT1
GO:0034308,primary alcohol metabolic process,1/53,76/18493,0.19633199226087472,0.24637333910098158,0.14275716032189142,1,bp,NAC,3479,IGF1
GO:0051851,modification by host of symbiont morphology or physiology,1/53,76/18493,0.19633199226087472,0.24637333910098158,0.14275716032189142,1,bp,NAC,3725,JUN
GO:0070509,calcium ion import,1/53,76/18493,0.19633199226087472,0.24637333910098158,0.14275716032189142,1,bp,NAC,781,CACNA2D1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,2/45,156/10554,0.14266357575461389,0.24639503641272648,0.1974697062159411,2,re,NAC,7102/55970,TSPAN7/GNG12
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/45,36/10554,0.1427971233755574,0.24639503641272648,0.1974697062159411,1,re,NAC,9314,KLF4
R-HSA-8939211,ESR-mediated signaling,2/45,156/10554,0.14266357575461389,0.24639503641272648,0.1974697062159411,2,re,NAC,2353/3725,FOS/JUN
GO:0009167,purine ribonucleoside monophosphate metabolic process,2/53,286/18493,0.19767121177776562,0.24779237828546474,0.1435794002813835,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009199,ribonucleoside triphosphate metabolic process,2/53,286/18493,0.19767121177776562,0.24779237828546474,0.1435794002813835,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0008306,associative learning,1/53,77/18493,0.19864476873968084,0.2485752777024319,0.14403303904762227,1,bp,NAC,2353,FOS
GO:0009126,purine nucleoside monophosphate metabolic process,2/53,287/18493,0.1987138784324319,0.2485752777024319,0.14403303904762227,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0009144,purine nucleoside triphosphate metabolic process,2/53,287/18493,0.1987138784324319,0.2485752777024319,0.14403303904762227,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0021675,nerve development,1/53,77/18493,0.19864476873968084,0.2485752777024319,0.14403303904762227,1,bp,NAC,3280,HES1
GO:0030522,intracellular receptor signaling pathway,2/53,288/18493,0.1997572597668222,0.24974908713223093,0.14471318447881473,2,bp,NAC,3164/3303,NR4A1/HSPA1A
hsa04928,"Parathyroid hormone synthesis, secretion and action",2/50,106/7852,0.14601432287193708,0.25008836151470076,0.14552379323182982,2,kg,NAC,2353/1026,FOS/CDKN1A
GO:0014032,neural crest cell development,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,3280,HES1
GO:0019058,viral life cycle,2/53,289/18493,0.20080134343385134,0.25018927391092155,0.14496824379150827,2,bp,NAC,1969/3303,EPHA2/HSPA1A
GO:0034644,cellular response to UV,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,1026,CDKN1A
GO:0042866,pyruvate biosynthetic process,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,3479,IGF1
GO:0061333,renal tubule morphogenesis,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,3280,HES1
GO:0098659,inorganic cation import across plasma membrane,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,781,CACNA2D1
GO:0099587,inorganic ion import across plasma membrane,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,781,CACNA2D1
GO:1905897,regulation of response to endoplasmic reticulum stress,1/53,78/18493,0.20095101478968047,0.25018927391092155,0.14496824379150827,1,bp,NAC,3303,HSPA1A
hsa00592,alpha-Linolenic acid metabolism,1/50,25/7852,0.14781317513365344,0.25050443364756003,0.14576590123983554,1,kg,NAC,5320,PLA2G2A
GO:0031252,cell leading edge,3/53,390/19659,0.0878970873204038,0.25156752577908675,0.19780832718203398,3,cc,NAC,1969/8516/324,EPHA2/ITGA8/APC
GO:0032839,dendrite cytoplasm,1/53,34/19659,0.08777067122637772,0.25156752577908675,0.19780832718203398,1,cc,NAC,79882,ZC3H14
GO:0001736,establishment of planar polarity,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,7474,WNT5A
GO:0007045,cell-substrate adherens junction assembly,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,4088,SMAD3
GO:0007164,establishment of tissue polarity,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,7474,WNT5A
GO:0014855,striated muscle cell proliferation,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,7472,WNT2
GO:0030279,negative regulation of ossification,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,4088,SMAD3
GO:0046470,phosphatidylcholine metabolic process,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,5320,PLA2G2A
GO:0048041,focal adhesion assembly,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,4088,SMAD3
GO:1901879,regulation of protein depolymerization,1/53,79/18493,0.20325074849677516,0.25199701768786825,0.1460157125197732,1,bp,NAC,324,APC
GO:0070646,protein modification by small protein removal,2/53,292/18493,0.2039376858933607,0.25271694479125156,0.14643286296832736,2,bp,NAC,4088/324,SMAD3/APC
R-HSA-111465,Apoptotic cleavage of cellular proteins,1/45,38/10554,0.1501166590488252,0.2528280573453898,0.2026253569634105,1,re,NAC,324,APC
R-HSA-2129379,Molecules associated with elastic fibres,1/45,38/10554,0.1501166590488252,0.2528280573453898,0.2026253569634105,1,re,NAC,8516,ITGA8
R-HSA-5655302,Signaling by FGFR1 in disease,1/45,38/10554,0.1501166590488252,0.2528280573453898,0.2026253569634105,1,re,NAC,6772,STAT1
R-HSA-5689896,Ovarian tumor domain proteases,1/45,38/10554,0.1501166590488252,0.2528280573453898,0.2026253569634105,1,re,NAC,324,APC
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/45,38/10554,0.1501166590488252,0.2528280573453898,0.2026253569634105,1,re,NAC,1026,CDKN1A
GO:0010769,regulation of cell morphogenesis involved in differentiation,2/53,293/18493,0.2049844566629752,0.2538817905961224,0.14710781456789176,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0033045,regulation of sister chromatid segregation,1/53,80/18493,0.20554398789775674,0.25391356011473537,0.14712622291628905,1,bp,NAC,324,APC
GO:0045913,positive regulation of carbohydrate metabolic process,1/53,80/18493,0.20554398789775674,0.25391356011473537,0.14712622291628905,1,bp,NAC,3479,IGF1
GO:0048013,ephrin receptor signaling pathway,1/53,80/18493,0.20554398789775674,0.25391356011473537,0.14712622291628905,1,bp,NAC,1969,EPHA2
GO:0050764,regulation of phagocytosis,1/53,80/18493,0.20554398789775674,0.25391356011473537,0.14712622291628905,1,bp,NAC,7097,TLR2
GO:0051702,interaction with symbiont,1/53,80/18493,0.20554398789775674,0.25391356011473537,0.14712622291628905,1,bp,NAC,3725,JUN
GO:0032088,negative regulation of NF-kappaB transcription factor activity,1/53,81/18493,0.20783075098043846,0.2562060787099444,0.14845458679620965,1,bp,NAC,9314,KLF4
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,1/53,81/18493,0.20783075098043846,0.2562060787099444,0.14845458679620965,1,bp,NAC,3303,HSPA1A
GO:0043537,negative regulation of blood vessel endothelial cell migration,1/53,81/18493,0.20783075098043846,0.2562060787099444,0.14845458679620965,1,bp,NAC,9314,KLF4
GO:0050772,positive regulation of axonogenesis,1/53,81/18493,0.20783075098043846,0.2562060787099444,0.14845458679620965,1,bp,NAC,4804,NGFR
GO:0008180,COP9 signalosome,1/53,36/19659,0.09269134358868014,0.25644605059534836,0.20164432640344454,1,cc,NAC,3303,HSPA1A
GO:0030027,lamellipodium,2/53,188/19659,0.09134917487080275,0.25644605059534836,0.20164432640344454,2,cc,NAC,1969/324,EPHA2/APC
R-HSA-977444,GABA B receptor activation,1/45,39/10554,0.15375347441044607,0.2564986871681375,0.20556712966824417,1,re,NAC,55970,GNG12
R-HSA-991365,Activation of GABAB receptors,1/45,39/10554,0.15375347441044607,0.2564986871681375,0.20556712966824417,1,re,NAC,55970,GNG12
hsa04950,Maturity onset diabetes of the young,1/50,26/7852,0.1532570669495874,0.2570248726967039,0.14956007629948773,1,kg,NAC,3280,HES1
GO:0014031,mesenchymal cell development,1/53,82/18493,0.21011105568378574,0.258748881624051,0.14992797399224594,1,bp,NAC,3280,HES1
GO:0048864,stem cell development,1/53,82/18493,0.21011105568378574,0.258748881624051,0.14992797399224594,1,bp,NAC,3280,HES1
R-HSA-1483166,Synthesis of PA,1/45,40/10554,0.15737507152423902,0.26007523557057344,0.2084335021917275,1,re,NAC,5320,PLA2G2A
R-HSA-5675221,Negative regulation of MAPK pathway,1/45,40/10554,0.15737507152423902,0.26007523557057344,0.2084335021917275,1,re,NAC,1844,DUSP2
GO:0009161,ribonucleoside monophosphate metabolic process,2/53,300/18493,0.2123291483618735,0.2606044063558078,0.15100312864404075,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0034637,cellular carbohydrate biosynthetic process,1/53,83/18493,0.21238491989804686,0.2606044063558078,0.15100312864404075,1,bp,NAC,3479,IGF1
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/53,83/18493,0.21238491989804686,0.2606044063558078,0.15100312864404075,1,bp,NAC,10252,SPRY1
GO:0043414,macromolecule methylation,2/53,300/18493,0.2123291483618735,0.2606044063558078,0.15100312864404075,2,bp,NAC,2353/4255,FOS/MGMT
GO:0045582,positive regulation of T cell differentiation,1/53,83/18493,0.21238491989804686,0.2606044063558078,0.15100312864404075,1,bp,NAC,7704,ZBTB16
GO:0051492,regulation of stress fiber assembly,1/53,83/18493,0.21238491989804686,0.2606044063558078,0.15100312864404075,1,bp,NAC,4088,SMAD3
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1/53,83/18493,0.21238491989804686,0.2606044063558078,0.15100312864404075,1,bp,NAC,3303,HSPA1A
GO:0018209,peptidyl-serine modification,2/53,301/18493,0.2133807193921542,0.26169125874911947,0.1516328881867104,2,bp,NAC,3082/7474,HGF/WNT5A
GO:0000245,spliceosomal complex assembly,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,23451,SF3B1
GO:0002690,positive regulation of leukocyte chemotaxis,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,7474,WNT5A
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,3082,HGF
GO:0034103,regulation of tissue remodeling,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,3953,LEPR
GO:0046031,ADP metabolic process,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,3479,IGF1
GO:0051781,positive regulation of cell division,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,80310,PDGFD
GO:0070542,response to fatty acid,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,7097,TLR2
GO:0097306,cellular response to alcohol,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,9314,KLF4
GO:0097581,lamellipodium organization,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,1969,EPHA2
GO:1903035,negative regulation of response to wounding,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,4088,SMAD3
GO:2000177,regulation of neural precursor cell proliferation,1/53,84/18493,0.21465236146488054,0.2617658028530697,0.15167608159650672,1,bp,NAC,7474,WNT5A
GO:0010506,regulation of autophagy,2/53,303/18493,0.21548549216896104,0.2626471042428444,0.15218673783979608,2,bp,NAC,3953/3082,LEPR/HGF
GO:0004714,transmembrane receptor protein tyrosine kinase activity,1/52,64/17632,0.17251609405238266,0.2631814865470655,0.17231726643726275,1,mf,NAC,1969,EPHA2
GO:0000281,mitotic cytokinesis,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,324,APC
GO:0006303,double-strand break repair via nonhomologous end joining,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,3981,LIG4
GO:0048477,oogenesis,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,3479,IGF1
GO:0071674,mononuclear cell migration,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,80310,PDGFD
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,9314,KLF4
GO:1904035,regulation of epithelial cell apoptotic process,1/53,85/18493,0.21691339817748634,0.26357693452532577,0.15272551338747797,1,bp,NAC,6424,SFRP4
R-HSA-109581,Apoptosis,2/45,169/10554,0.16196186029228354,0.2639393123785427,0.21153031015983684,2,re,NAC,2810/324,SFN/APC
R-HSA-109606,Intrinsic Pathway for Apoptosis,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,2810,SFN
R-HSA-1433557,Signaling by SCF-KIT,1/45,43/10554,0.16814917452999523,0.2639393123785427,0.21153031015983684,1,re,NAC,6772,STAT1
R-HSA-1461957,Beta defensins,1/45,42/10554,0.1645728597171403,0.2639393123785427,0.21153031015983684,1,re,NAC,7097,TLR2
R-HSA-177929,Signaling by EGFR,1/45,43/10554,0.16814917452999523,0.2639393123785427,0.21153031015983684,1,re,NAC,10252,SPRY1
R-HSA-186712,Regulation of beta-cell development,1/45,42/10554,0.1645728597171403,0.2639393123785427,0.21153031015983684,1,re,NAC,3280,HES1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,4088,SMAD3
R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1/45,42/10554,0.1645728597171403,0.2639393123785427,0.21153031015983684,1,re,NAC,55970,GNG12
R-HSA-419037,NCAM1 interactions,1/45,42/10554,0.1645728597171403,0.2639393123785427,0.21153031015983684,1,re,NAC,1281,COL3A1
R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,1/45,43/10554,0.16814917452999523,0.2639393123785427,0.21153031015983684,1,re,NAC,55970,GNG12
R-HSA-451927,Interleukin-2 family signaling,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,6772,STAT1
R-HSA-5357801,Programmed Cell Death,2/45,172/10554,0.16648373174646552,0.2639393123785427,0.21153031015983684,2,re,NAC,2810/324,SFN/APC
R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,3486,IGFBP3
R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,1/45,42/10554,0.1645728597171403,0.2639393123785427,0.21153031015983684,1,re,NAC,55970,GNG12
R-HSA-69231,Cyclin D associated events in G1,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,1026,CDKN1A
R-HSA-69236,G1 Phase,1/45,44/10554,0.17171051856444963,0.2639393123785427,0.21153031015983684,1,re,NAC,1026,CDKN1A
hsa04725,Cholinergic synapse,2/50,112/7852,0.15933351648121924,0.2644607850873845,0.1538869556899459,2,kg,NAC,2353/55970,FOS/GNG12
GO:0006029,proteoglycan metabolic process,1/53,86/18493,0.2191680477807343,0.26563792947124676,0.15391972452652034,1,bp,NAC,3479,IGF1
GO:0014033,neural crest cell differentiation,1/53,86/18493,0.2191680477807343,0.26563792947124676,0.15391972452652034,1,bp,NAC,3280,HES1
GO:0048524,positive regulation of viral process,1/53,86/18493,0.2191680477807343,0.26563792947124676,0.15391972452652034,1,bp,NAC,3725,JUN
GO:0070167,regulation of biomineral tissue development,1/53,86/18493,0.2191680477807343,0.26563792947124676,0.15391972452652034,1,bp,NAC,4088,SMAD3
GO:1901019,regulation of calcium ion transmembrane transporter activity,1/53,86/18493,0.2191680477807343,0.26563792947124676,0.15391972452652034,1,bp,NAC,781,CACNA2D1
GO:0006402,mRNA catabolic process,2/53,307/18493,0.21970124074709088,0.2660130094178117,0.15413705870829778,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:0009141,nucleoside triphosphate metabolic process,2/53,307/18493,0.21970124074709088,0.2660130094178117,0.15413705870829778,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0001942,hair follicle development,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,7474,WNT5A
GO:0006094,gluconeogenesis,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,3953,LEPR
GO:0009416,response to light stimulus,2/53,308/18493,0.220756404238234,0.2670020425536189,0.15471013841914355,2,bp,NAC,2353/1026,FOS/CDKN1A
GO:0034446,substrate adhesion-dependent cell spreading,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,8516,ITGA8
GO:0055013,cardiac muscle cell development,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,3479,IGF1
GO:1900407,regulation of cellular response to oxidative stress,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,3082,HGF
GO:1901888,regulation of cell junction assembly,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,4088,SMAD3
GO:2000106,regulation of leukocyte apoptotic process,1/53,87/18493,0.22141632797129374,0.2670020425536189,0.15471013841914355,1,bp,NAC,7474,WNT5A
R-HSA-1566948,Elastic fibre formation,1/45,45/10554,0.1752569530710717,0.268219336873988,0.21496047333202387,1,re,NAC,8516,ITGA8
GO:0042379,chemokine receptor binding,1/52,66/17632,0.17740756748203823,0.2686824753894637,0.17591902191201353,1,mf,NAC,6772,STAT1
GO:0034333,adherens junction assembly,1/53,88/18493,0.22365825639775883,0.2695688462817387,0.15619743250975876,1,bp,NAC,4088,SMAD3
GO:0005518,collagen binding,1/52,67/17632,0.17984265836732471,0.2704109035882796,0.17705070494322012,1,mf,NAC,4088,SMAD3
GO:0001843,neural tube closure,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,7474,WNT5A
GO:0009791,post-embryonic development,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,9314,KLF4
GO:0022404,molting cycle process,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,7474,WNT5A
GO:0022405,hair cycle process,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,7474,WNT5A
GO:0051304,chromosome separation,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,324,APC
GO:0060021,roof of mouth development,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,7474,WNT5A
GO:0098773,skin epidermis development,1/53,89/18493,0.22589385066078105,0.2713007963996653,0.15720098379317513,1,bp,NAC,7474,WNT5A
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",1/52,68/17632,0.18227067896310567,0.2721040850234935,0.17815931026468979,1,mf,NAC,3082,HGF
R-HSA-5576892,Phase 0 - rapid depolarisation,1/45,46/10554,0.1787885390556374,0.2724396785609713,0.21834280458833824,1,re,NAC,781,CACNA2D1
GO:0001666,response to hypoxia,2/53,314/18493,0.22709683044920656,0.2726079065160087,0.15795836821276413,2,bp,NAC,4088/7097,SMAD3/TLR2
GO:0019319,hexose biosynthetic process,1/53,90/18493,0.22812312831319226,0.2732880600144943,0.15835247247088358,1,bp,NAC,3953,LEPR
GO:0045638,negative regulation of myeloid cell differentiation,1/53,90/18493,0.22812312831319226,0.2732880600144943,0.15835247247088358,1,bp,NAC,7704,ZBTB16
GO:0060606,tube closure,1/53,90/18493,0.22812312831319226,0.2732880600144943,0.15835247247088358,1,bp,NAC,7474,WNT5A
GO:1901184,regulation of ERBB signaling pathway,1/53,90/18493,0.22812312831319226,0.2732880600144943,0.15835247247088358,1,bp,NAC,10252,SPRY1
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/45,47/10554,0.18230533728008513,0.27423708855807677,0.21978331260037254,1,re,NAC,3280,HES1
R-HSA-418597,G alpha (z) signalling events,1/45,47/10554,0.18230533728008513,0.27423708855807677,0.21978331260037254,1,re,NAC,55970,GNG12
R-HSA-6783783,Interleukin-10 signaling,1/45,47/10554,0.18230533728008513,0.27423708855807677,0.21978331260037254,1,re,NAC,3554,IL1R1
GO:0030516,regulation of axon extension,1/53,91/18493,0.23034610686013568,0.2755347294333011,0.15965426976592062,1,bp,NAC,7474,WNT5A
GO:0044070,regulation of anion transport,1/53,91/18493,0.23034610686013568,0.2755347294333011,0.15965426976592062,1,bp,NAC,6424,SFRP4
GO:0046634,regulation of alpha-beta T cell activation,1/53,91/18493,0.23034610686013568,0.2755347294333011,0.15965426976592062,1,bp,NAC,7704,ZBTB16
GO:0006470,protein dephosphorylation,2/53,318/18493,0.231331977178142,0.27657488271976954,0.1602569702448667,2,bp,NAC,1844/3486,DUSP2/IGFBP3
GO:0000726,non-recombinational repair,1/53,92/18493,0.2325628037591908,0.2774883830102136,0.16078628363523956,1,bp,NAC,3981,LIG4
GO:0006165,nucleoside diphosphate phosphorylation,1/53,92/18493,0.2325628037591908,0.2774883830102136,0.16078628363523956,1,bp,NAC,3479,IGF1
GO:0010660,regulation of muscle cell apoptotic process,1/53,92/18493,0.2325628037591908,0.2774883830102136,0.16078628363523956,1,bp,NAC,3479,IGF1
GO:2001022,positive regulation of response to DNA damage stimulus,1/53,92/18493,0.2325628037591908,0.2774883830102136,0.16078628363523956,1,bp,NAC,4255,MGMT
hsa00591,Linoleic acid metabolism,1/50,29/7852,0.16938506633931238,0.27827546612887033,0.16192557362189908,1,kg,NAC,5320,PLA2G2A
GO:0032590,dendrite membrane,1/53,40/19659,0.10245468993047069,0.27881112341734643,0.21923005265536435,1,cc,NAC,8516,ITGA8
GO:0007589,body fluid secretion,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,8835,SOCS2
GO:0015908,fatty acid transport,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,5320,PLA2G2A
GO:0036473,cell death in response to oxidative stress,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,3082,HGF
GO:0048704,embryonic skeletal system morphogenesis,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,4088,SMAD3
GO:1901655,cellular response to ketone,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,9314,KLF4
GO:1903076,regulation of protein localization to plasma membrane,1/53,93/18493,0.2347732364205004,0.2792850206142821,0.16182731706613046,1,bp,NAC,1969,EPHA2
hsa05163,Human cytomegalovirus infection,3/50,225/7852,0.17194482397515168,0.2796274410100952,0.1627122736181659,3,kg,NAC,55970/3554/1026,GNG12/IL1R1/CDKN1A
GO:0009123,nucleoside monophosphate metabolic process,2/53,322/18493,0.2355728823002364,0.2800961570549811,0.16229731733211025,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,1/53,41/19659,0.10487937525763724,0.28080606923819,0.22079868475292053,1,cc,NAC,1026,CDKN1A
GO:0052813,phosphatidylinositol bisphosphate kinase activity,1/52,71/17632,0.18951252000499563,0.2809086289435751,0.18392405823553143,1,mf,NAC,3082,HGF
GO:0032092,positive regulation of protein binding,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,7474,WNT5A
GO:0045621,positive regulation of lymphocyte differentiation,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,7704,ZBTB16
GO:0046939,nucleotide phosphorylation,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,3479,IGF1
GO:0110020,regulation of actomyosin structure organization,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,4088,SMAD3
GO:1900542,regulation of purine nucleotide metabolic process,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,3479,IGF1
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,1/53,94/18493,0.23697742220689788,0.28092338484945323,0.16277664148020643,1,bp,NAC,3303,HSPA1A
hsa04722,Neurotrophin signaling pathway,2/50,119/7852,0.17515032450426554,0.28199202245186755,0.16408819874610142,2,kg,NAC,3725/4804,JUN/NGFR
GO:0001738,morphogenesis of a polarized epithelium,1/53,95/18493,0.23917537843403192,0.2826834244115944,0.1637964687507313,1,bp,NAC,7474,WNT5A
GO:0007044,cell-substrate junction assembly,1/53,95/18493,0.23917537843403192,0.2826834244115944,0.1637964687507313,1,bp,NAC,4088,SMAD3
GO:0030038,contractile actin filament bundle assembly,1/53,95/18493,0.23917537843403192,0.2826834244115944,0.1637964687507313,1,bp,NAC,4088,SMAD3
GO:0031124,mRNA 3'-end processing,1/53,95/18493,0.23917537843403192,0.2826834244115944,0.1637964687507313,1,bp,NAC,79882,ZC3H14
GO:0036293,response to decreased oxygen levels,2/53,325/18493,0.23875693752082908,0.2826834244115944,0.1637964687507313,2,bp,NAC,4088/7097,SMAD3/TLR2
GO:0043149,stress fiber assembly,1/53,95/18493,0.23917537843403192,0.2826834244115944,0.1637964687507313,1,bp,NAC,4088,SMAD3
GO:0016235,aggresome,1/53,42/19659,0.10729763364846945,0.2827207489785068,0.22230420338195842,1,cc,NAC,3303,HSPA1A
hsa04152,AMPK signaling pathway,2/50,120/7852,0.1774312786452856,0.282835998632584,0.16457929962929047,2,kg,NAC,3479/3953,IGF1/LEPR
GO:0009135,purine nucleoside diphosphate metabolic process,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3479,IGF1
GO:0009179,purine ribonucleoside diphosphate metabolic process,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3479,IGF1
GO:0010657,muscle cell apoptotic process,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3479,IGF1
GO:0014020,primary neural tube formation,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,7474,WNT5A
GO:0032414,positive regulation of ion transmembrane transporter activity,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,781,CACNA2D1
GO:0046364,monosaccharide biosynthetic process,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3953,LEPR
GO:0048259,regulation of receptor-mediated endocytosis,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,6424,SFRP4
GO:0099175,regulation of postsynapse organization,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,7474,WNT5A
GO:1902882,regulation of response to oxidative stress,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3082,HGF
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,1/53,96/18493,0.24136712237049218,0.28386301532988645,0.16447996417459232,1,bp,NAC,3303,HSPA1A
GO:0005891,voltage-gated calcium channel complex,1/53,43/19659,0.10970948181162543,0.28455896844890344,0.22374960106318342,1,cc,NAC,781,CACNA2D1
GO:0043130,ubiquitin binding,1/52,73/17632,0.19430543008993717,0.2859847527380061,0.18724763463077712,1,mf,NAC,4088,SMAD3
GO:0021782,glial cell development,1/53,97/18493,0.24355267123793622,0.2860090134339814,0.1657234290580681,1,bp,NAC,7097,TLR2
GO:0032231,regulation of actin filament bundle assembly,1/53,97/18493,0.24355267123793622,0.2860090134339814,0.1657234290580681,1,bp,NAC,4088,SMAD3
GO:0062014,negative regulation of small molecule metabolic process,1/53,97/18493,0.24355267123793622,0.2860090134339814,0.1657234290580681,1,bp,NAC,3953,LEPR
GO:0030669,clathrin-coated endocytic vesicle membrane,1/53,44/19659,0.11211493641317472,0.2863242991474923,0.22513768607665854,1,cc,NAC,7474,WNT5A
GO:0033044,regulation of chromosome organization,2/53,330/18493,0.24406930836653154,0.28647424249536624,0.16599299872800427,2,bp,NAC,3981/324,LIG4/APC
GO:0070491,repressing transcription factor binding,1/52,74/17632,0.19669144966026142,0.28747211873422823,0.18822148292847984,1,mf,NAC,6772,STAT1
GO:0006140,regulation of nucleotide metabolic process,1/53,98/18493,0.24573204221121236,0.2878575351617059,0.1667945259292077,1,bp,NAC,3479,IGF1
GO:0009185,ribonucleoside diphosphate metabolic process,1/53,98/18493,0.24573204221121236,0.2878575351617059,0.1667945259292077,1,bp,NAC,3479,IGF1
GO:0010596,negative regulation of endothelial cell migration,1/53,98/18493,0.24573204221121236,0.2878575351617059,0.1667945259292077,1,bp,NAC,9314,KLF4
GO:0061640,cytoskeleton-dependent cytokinesis,1/53,98/18493,0.24573204221121236,0.2878575351617059,0.1667945259292077,1,bp,NAC,324,APC
GO:1990391,DNA repair complex,1/53,45/19659,0.1145140140767027,0.28802009601110073,0.22647109641963534,1,cc,NAC,3981,LIG4
R-HSA-383280,Nuclear Receptor transcription pathway,1/45,50/10554,0.19276760937449944,0.2887412702120162,0.23140747732302736,1,re,NAC,3164,NR4A1
GO:0002027,regulation of heart rate,1/53,99/18493,0.24790525241848638,0.28983219776359914,0.16793871314795772,1,bp,NAC,781,CACNA2D1
GO:0008593,regulation of Notch signaling pathway,1/53,99/18493,0.24790525241848638,0.28983219776359914,0.16793871314795772,1,bp,NAC,3280,HES1
GO:0018958,phenol-containing compound metabolic process,1/53,99/18493,0.24790525241848638,0.28983219776359914,0.16793871314795772,1,bp,NAC,7474,WNT5A
GO:0044264,cellular polysaccharide metabolic process,1/53,99/18493,0.24790525241848638,0.28983219776359914,0.16793871314795772,1,bp,NAC,3479,IGF1
R-HSA-1461973,Defensins,1/45,52/10554,0.19966962171936686,0.2916336383618968,0.2337255235675489,1,re,NAC,7097,TLR2
R-HSA-2428928,IRS-related events triggered by IGF1R,1/45,52/10554,0.19966962171936686,0.2916336383618968,0.2337255235675489,1,re,NAC,3479,IGF1
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/45,51/10554,0.19622585933433867,0.2916336383618968,0.2337255235675489,1,re,NAC,1969,EPHA2
R-HSA-445717,Aquaporin-mediated transport,1/45,52/10554,0.19966962171936686,0.2916336383618968,0.2337255235675489,1,re,NAC,55970,GNG12
R-HSA-72165,mRNA Splicing - Minor Pathway,1/45,52/10554,0.19966962171936686,0.2916336383618968,0.2337255235675489,1,re,NAC,23451,SF3B1
R-HSA-75153,Apoptotic execution phase,1/45,52/10554,0.19966962171936686,0.2916336383618968,0.2337255235675489,1,re,NAC,324,APC
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/53,100/18493,0.2500723189413646,0.2919351862751915,0.16915725679882507,1,bp,NAC,3554,IL1R1
GO:0050848,regulation of calcium-mediated signaling,1/53,100/18493,0.2500723189413646,0.2919351862751915,0.16915725679882507,1,bp,NAC,3479,IGF1
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,1/53,100/18493,0.2500723189413646,0.2919351862751915,0.16915725679882507,1,bp,NAC,324,APC
R-HSA-112316,Neuronal System,3/45,368/10554,0.20641085656656083,0.2931165327523874,0.23491396763648273,3,re,NAC,7102/55970/781,TSPAN7/GNG12/CACNA2D1
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/45,54/10554,0.20651392080281838,0.2931165327523874,0.23491396763648273,1,re,NAC,3479,IGF1
R-HSA-2428924,IGF1R signaling cascade,1/45,53/10554,0.2030989558483547,0.2931165327523874,0.23491396763648273,1,re,NAC,3479,IGF1
R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),1/45,53/10554,0.2030989558483547,0.2931165327523874,0.23491396763648273,1,re,NAC,3303,HSPA1A
R-HSA-8848021,Signaling by PTK6,1/45,54/10554,0.20651392080281838,0.2931165327523874,0.23491396763648273,1,re,NAC,9021,SOCS3
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/45,54/10554,0.20651392080281838,0.2931165327523874,0.23491396763648273,1,re,NAC,9021,SOCS3
R-HSA-913531,Interferon Signaling,2/45,197/10554,0.20493781387563562,0.2931165327523874,0.23491396763648273,2,re,NAC,6772/9021,STAT1/SOCS3
R-HSA-9006931,Signaling by Nuclear Receptors,2/45,199/10554,0.20806188731346062,0.2941276479290688,0.23572431113932554,2,re,NAC,2353/3725,FOS/JUN
GO:0046632,alpha-beta T cell differentiation,1/53,101/18493,0.2522332588150177,0.2941690482894125,0.1704516330445049,1,bp,NAC,7704,ZBTB16
GO:1904659,glucose transmembrane transport,1/53,101/18493,0.2522332588150177,0.2941690482894125,0.1704516330445049,1,bp,NAC,3479,IGF1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,3/45,371/10554,0.20973690831684505,0.29530956691011784,0.23667154285858727,3,re,NAC,7704/9021/7097,ZBTB16/SOCS3/TLR2
GO:0002456,T cell mediated immunity,1/53,102/18493,0.25438808902830656,0.2961012607485624,0.17157122319501936,1,bp,NAC,3554,IL1R1
GO:0035335,peptidyl-tyrosine dephosphorylation,1/53,102/18493,0.25438808902830656,0.2961012607485624,0.17157122319501936,1,bp,NAC,1844,DUSP2
GO:1901222,regulation of NIK/NF-kappaB signaling,1/53,102/18493,0.25438808902830656,0.2961012607485624,0.17157122319501936,1,bp,NAC,7097,TLR2
GO:2001023,regulation of response to drug,1/53,102/18493,0.25438808902830656,0.2961012607485624,0.17157122319501936,1,bp,NAC,3082,HGF
GO:0006401,RNA catabolic process,2/53,340/18493,0.254710620607469,0.2963316319983177,0.17170470819609487,2,bp,NAC,3303/79882,HSPA1A/ZC3H14
GO:0019888,protein phosphatase regulator activity,1/52,80/17632,0.21086271393467015,0.29777234602936525,0.19496552497515734,1,mf,NAC,3486,IGFBP3
GO:0030295,protein kinase activator activity,1/52,80/17632,0.21086271393467015,0.29777234602936525,0.19496552497515734,1,mf,NAC,1026,CDKN1A
GO:0035004,phosphatidylinositol 3-kinase activity,1/52,79/17632,0.2085179828407101,0.29777234602936525,0.19496552497515734,1,mf,NAC,3082,HGF
GO:0035591,signaling adaptor activity,1/52,80/17632,0.21086271393467015,0.29777234602936525,0.19496552497515734,1,mf,NAC,8835,SOCS2
GO:0043178,alcohol binding,1/52,79/17632,0.2085179828407101,0.29777234602936525,0.19496552497515734,1,mf,NAC,8842,PROM1
R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,1/45,56/10554,0.21330097833353467,0.29794422370398493,0.23878305009769132,1,re,NAC,3303,HSPA1A
R-HSA-977443,GABA receptor activation,1/45,56/10554,0.21330097833353467,0.29794422370398493,0.23878305009769132,1,re,NAC,55970,GNG12
GO:0033138,positive regulation of peptidyl-serine phosphorylation,1/53,103/18493,0.25653682652390186,0.2980188439051483,0.1726823366260189,1,bp,NAC,7474,WNT5A
GO:0051983,regulation of chromosome segregation,1/53,103/18493,0.25653682652390186,0.2980188439051483,0.1726823366260189,1,bp,NAC,324,APC
GO:1901800,positive regulation of proteasomal protein catabolic process,1/53,103/18493,0.25653682652390186,0.2980188439051483,0.1726823366260189,1,bp,NAC,3303,HSPA1A
GO:0006909,phagocytosis,2/53,342/18493,0.2568408759352368,0.2982263686396451,0.17280258357279246,2,bp,NAC,3953/7097,LEPR/TLR2
GO:0019199,transmembrane receptor protein kinase activity,1/52,81/17632,0.21320063205655937,0.2990532355692679,0.19580418345003686,1,mf,NAC,1969,EPHA2
GO:0001841,neural tube formation,1/53,104/18493,0.2586794881984117,0.3000682063101575,0.1738698074720005,1,bp,NAC,7474,WNT5A
GO:0032411,positive regulation of transporter activity,1/53,104/18493,0.2586794881984117,0.3000682063101575,0.1738698074720005,1,bp,NAC,781,CACNA2D1
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,3280,HES1
R-HSA-2644603,Signaling by NOTCH1 in Cancer,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,3280,HES1
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,3280,HES1
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,3280,HES1
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,3280,HES1
R-HSA-447115,Interleukin-12 family signaling,1/45,58/10554,0.22003126225371772,0.3001976911368552,0.24058905868623556,1,re,NAC,6772,STAT1
GO:0002449,lymphocyte mediated immunity,2/53,344/18493,0.2589716193806059,0.300260609891312,0.17398129270405358,2,bp,NAC,3554/3981,IL1R1/LIG4
hsa04215,Apoptosis - multiple species,1/50,33/7852,0.1904215455787166,0.30056734155071935,0.1748969820072836,1,kg,NAC,4804,NGFR
GO:0002708,positive regulation of lymphocyte mediated immunity,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,3554,IL1R1
GO:0002821,positive regulation of adaptive immune response,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,3554,IL1R1
GO:0010927,cellular component assembly involved in morphogenesis,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,7097,TLR2
GO:0043467,regulation of generation of precursor metabolites and energy,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,3479,IGF1
GO:0051225,spindle assembly,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,3303,HSPA1A
GO:0051261,protein depolymerization,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,324,APC
GO:0061387,regulation of extent of cell growth,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,7474,WNT5A
GO:0072676,lymphocyte migration,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,7474,WNT5A
GO:0097006,regulation of plasma lipoprotein particle levels,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,5320,PLA2G2A
GO:0098739,import across plasma membrane,1/53,105/18493,0.2608160909025,0.3009319088627584,0.17437026634560257,1,bp,NAC,781,CACNA2D1
GO:0031331,positive regulation of cellular catabolic process,2/53,347/18493,0.26216848836561196,0.3023456184934167,0.17518941817886882,2,bp,NAC,3479/3303,IGF1/HSPA1A
GO:0019359,nicotinamide nucleotide biosynthetic process,1/53,106/18493,0.2629466514410128,0.3026559231010303,0.17536921930824162,1,bp,NAC,3479,IGF1
GO:0019363,pyridine nucleotide biosynthetic process,1/53,106/18493,0.2629466514410128,0.3026559231010303,0.17536921930824162,1,bp,NAC,3479,IGF1
GO:0032963,collagen metabolic process,1/53,106/18493,0.2629466514410128,0.3026559231010303,0.17536921930824162,1,bp,NAC,1277,COL1A1
GO:0043244,regulation of protein complex disassembly,1/53,106/18493,0.2629466514410128,0.3026559231010303,0.17536921930824162,1,bp,NAC,324,APC
GO:0006066,alcohol metabolic process,2/53,348/18493,0.2632342758849401,0.30284040060686385,0.17547611190048462,2,bp,NAC,3479/3953,IGF1/LEPR
R-HSA-193648,NRAGE signals death through JNK,1/45,59/10554,0.22337525931913127,0.30358336401673436,0.24330245680766988,1,re,NAC,4804,NGFR
GO:0006275,regulation of DNA replication,1/53,107/18493,0.2650711865730967,0.30451173027576034,0.1764445376171796,1,bp,NAC,3725,JUN
GO:0031623,receptor internalization,1/53,107/18493,0.2650711865730967,0.30451173027576034,0.1764445376171796,1,bp,NAC,6424,SFRP4
GO:0071887,leukocyte apoptotic process,1/53,107/18493,0.2650711865730967,0.30451173027576034,0.1764445376171796,1,bp,NAC,7474,WNT5A
GO:0022412,cellular process involved in reproduction in multicellular organism,2/53,350/18493,0.26536604356305504,0.30470326006419357,0.1765555165437694,2,bp,NAC,3479/7704,IGF1/ZBTB16
GO:0006690,icosanoid metabolic process,1/53,108/18493,0.2671897130123234,0.30605835141777704,0.17734070293739548,1,bp,NAC,7097,TLR2
GO:0007052,mitotic spindle organization,1/53,108/18493,0.2671897130123234,0.30605835141777704,0.17734070293739548,1,bp,NAC,3303,HSPA1A
GO:0008645,hexose transmembrane transport,1/53,108/18493,0.2671897130123234,0.30605835141777704,0.17734070293739548,1,bp,NAC,3479,IGF1
GO:0014902,myotube differentiation,1/53,108/18493,0.2671897130123234,0.30605835141777704,0.17734070293739548,1,bp,NAC,3479,IGF1
GO:1904019,epithelial cell apoptotic process,1/53,108/18493,0.2671897130123234,0.30605835141777704,0.17734070293739548,1,bp,NAC,6424,SFRP4
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/45,60/10554,0.22670523676845367,0.30692401285575266,0.2459797710686056,1,re,NAC,1026,CDKN1A
GO:0002688,regulation of leukocyte chemotaxis,1/53,109/18493,0.26930224742681075,0.3077370227683594,0.1783133826761908,1,bp,NAC,7474,WNT5A
GO:0005976,polysaccharide metabolic process,1/53,109/18493,0.26930224742681075,0.3077370227683594,0.1783133826761908,1,bp,NAC,3479,IGF1
GO:0006289,nucleotide-excision repair,1/53,109/18493,0.26930224742681075,0.3077370227683594,0.1783133826761908,1,bp,NAC,3981,LIG4
GO:0018107,peptidyl-threonine phosphorylation,1/53,109/18493,0.26930224742681075,0.3077370227683594,0.1783133826761908,1,bp,NAC,7474,WNT5A
GO:0072525,pyridine-containing compound biosynthetic process,1/53,109/18493,0.26930224742681075,0.3077370227683594,0.1783133826761908,1,bp,NAC,3479,IGF1
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2/53,354/18493,0.26963010021826883,0.30796367834728305,0.17844471469018347,2,bp,NAC,3554/3981,IL1R1/LIG4
GO:0015749,monosaccharide transmembrane transport,1/53,110/18493,0.27140880643934195,0.3096977647374065,0.17944950380295924,1,bp,NAC,3479,IGF1
GO:1903510,mucopolysaccharide metabolic process,1/53,110/18493,0.27140880643934195,0.3096977647374065,0.17944950380295924,1,bp,NAC,3082,HGF
R-HSA-8943724,Regulation of PTEN gene transcription,1/45,61/10554,0.23002125204817747,0.3102202326473505,0.24862147831785264,1,re,NAC,3725,JUN
GO:0045446,endothelial cell differentiation,1/53,111/18493,0.2735094066274898,0.3116460800000818,0.18057842446996905,1,bp,NAC,64321,SOX17
GO:0061337,cardiac conduction,1/53,111/18493,0.2735094066274898,0.3116460800000818,0.18057842446996905,1,bp,NAC,781,CACNA2D1
GO:1904375,regulation of protein localization to cell periphery,1/53,111/18493,0.2735094066274898,0.3116460800000818,0.18057842446996905,1,bp,NAC,1969,EPHA2
GO:0032259,methylation,2/53,358/18493,0.27389438426018475,0.3119352709629882,0.1807459916296541,2,bp,NAC,2353/4255,FOS/MGMT
GO:0007613,memory,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,8516,ITGA8
GO:0010822,positive regulation of mitochondrion organization,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,2810,SFN
GO:0034219,carbohydrate transmembrane transport,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,3479,IGF1
GO:0046717,acid secretion,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,5320,PLA2G2A
GO:0051149,positive regulation of muscle cell differentiation,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,3479,IGF1
GO:1990266,neutrophil migration,1/53,112/18493,0.275604064523733,0.31298303029486013,0.181353099312103,1,bp,NAC,3554,IL1R1
GO:0030165,PDZ domain binding,1/52,86/17632,0.22478870550886,0.3132055963423449,0.2050703980080828,1,mf,NAC,55970,GNG12
hsa05020,Prion diseases,1/50,35/7852,0.20074308800706797,0.3137828851372616,0.18258696814132908,1,kg,NAC,3303,HSPA1A
hsa04728,Dopaminergic synapse,2/50,131/7852,0.202812125497597,0.31396877120301075,0.1826951332923698,2,kg,NAC,2353/55970,FOS/GNG12
GO:0019209,kinase activator activity,1/52,87/17632,0.22708615149732114,0.3143112957810604,0.20579435130464796,1,mf,NAC,1026,CDKN1A
GO:0005635,nuclear envelope,3/53,461/19659,0.12767060771252337,0.3143636960643988,0.2471851509954689,3,cc,NAC,3164/4088/1844,NR4A1/SMAD3/DUSP2
GO:0030315,T-tubule,1/53,51/19659,0.12877548995409105,0.3143636960643988,0.2471851509954689,1,cc,NAC,781,CACNA2D1
GO:0006090,pyruvate metabolic process,1/53,113/18493,0.27769279661558033,0.3146038448555741,0.18229225484305545,1,bp,NAC,3479,IGF1
GO:0007569,cell aging,1/53,113/18493,0.27769279661558033,0.3146038448555741,0.18229225484305545,1,bp,NAC,1026,CDKN1A
GO:0042303,molting cycle,1/53,113/18493,0.27769279661558033,0.3146038448555741,0.18229225484305545,1,bp,NAC,7474,WNT5A
GO:0042633,hair cycle,1/53,113/18493,0.27769279661558033,0.3146038448555741,0.18229225484305545,1,bp,NAC,7474,WNT5A
GO:0051153,regulation of striated muscle cell differentiation,1/53,113/18493,0.27769279661558033,0.3146038448555741,0.18229225484305545,1,bp,NAC,3479,IGF1
GO:0043666,regulation of phosphoprotein phosphatase activity,1/53,114/18493,0.2797756193456874,0.31666179095861235,0.18348469937799283,1,bp,NAC,3486,IGFBP3
GO:0070252,actin-mediated cell contraction,1/53,114/18493,0.2797756193456874,0.31666179095861235,0.18348469937799283,1,bp,NAC,781,CACNA2D1
R-HSA-1226099,Signaling by FGFR in disease,1/45,63/10554,0.23661162473600017,0.31668171827784053,0.2537999416820014,1,re,NAC,6772,STAT1
R-HSA-375165,NCAM signaling for neurite out-growth,1/45,63/10554,0.23661162473600017,0.31668171827784053,0.2537999416820014,1,re,NAC,1281,COL3A1
GO:0005496,steroid binding,1/52,89/17632,0.2316610277828708,0.3185339132014473,0.2085590970344405,1,mf,NAC,8842,PROM1
GO:0006282,regulation of DNA repair,1/53,115/18493,0.2818525491119793,0.3187091591955715,0.1846710147346302,1,bp,NAC,4255,MGMT
GO:0010633,negative regulation of epithelial cell migration,1/53,115/18493,0.2818525491119793,0.3187091591955715,0.1846710147346302,1,bp,NAC,9314,KLF4
GO:0003727,single-stranded RNA binding,1/52,90/17632,0.23393849609246964,0.3195630436818703,0.20923291704176852,1,mf,NAC,79882,ZC3H14
R-HSA-4608870,Asymmetric localization of PCP proteins,1/45,64/10554,0.23988609589097876,0.31984812785463834,0.2563376144289566,1,re,NAC,7474,WNT5A
GO:0006754,ATP biosynthetic process,1/53,116/18493,0.28392360226776703,0.3202895285544355,0.18558673492884603,1,bp,NAC,3479,IGF1
GO:0009132,nucleoside diphosphate metabolic process,1/53,116/18493,0.28392360226776703,0.3202895285544355,0.18558673492884603,1,bp,NAC,3479,IGF1
GO:0018210,peptidyl-threonine modification,1/53,116/18493,0.28392360226776703,0.3202895285544355,0.18558673492884603,1,bp,NAC,7474,WNT5A
GO:0048675,axon extension,1/53,116/18493,0.28392360226776703,0.3202895285544355,0.18558673492884603,1,bp,NAC,7474,WNT5A
GO:0051928,positive regulation of calcium ion transport,1/53,116/18493,0.28392360226776703,0.3202895285544355,0.18558673492884603,1,bp,NAC,781,CACNA2D1
GO:0032182,ubiquitin-like protein binding,1/52,91/17632,0.23620934309983455,0.3205698227783469,0.2098921025494087,1,mf,NAC,4088,SMAD3
GO:1904115,axon cytoplasm,1/53,53/19659,0.13347904651094555,0.32112350320024585,0.252500408350225,1,cc,NAC,79882,ZC3H14
hsa03040,Spliceosome,2/50,134/7852,0.2098116873426261,0.32171125392536004,0.18720040274179173,2,kg,NAC,3303/23451,HSPA1A/SF3B1
GO:0001952,regulation of cell-matrix adhesion,1/53,117/18493,0.2859887951218675,0.3224662659079188,0.18684801118740466,1,bp,NAC,4088,SMAD3
GO:0010811,positive regulation of cell-substrate adhesion,1/53,118/18493,0.2880481439387236,0.32417344358082567,0.1878372084667792,1,bp,NAC,4088,SMAD3
GO:0019730,antimicrobial humoral response,1/53,118/18493,0.2880481439387236,0.32417344358082567,0.1878372084667792,1,bp,NAC,5320,PLA2G2A
GO:0046660,female sex differentiation,1/53,118/18493,0.2880481439387236,0.32417344358082567,0.1878372084667792,1,bp,NAC,7474,WNT5A
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,1/53,118/18493,0.2880481439387236,0.32417344358082567,0.1878372084667792,1,bp,NAC,3303,HSPA1A
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/45,66/10554,0.24639389048452343,0.32605507312237686,0.26131208013396234,1,re,NAC,1026,CDKN1A
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/45,66/10554,0.24639389048452343,0.32605507312237686,0.26131208013396234,1,re,NAC,1026,CDKN1A
hsa04371,Apelin signaling pathway,2/50,137/7852,0.21683760029156704,0.32626966025179716,0.18985289154893725,2,kg,NAC,55970/4088,GNG12/SMAD3
hsa04910,Insulin signaling pathway,2/50,137/7852,0.21683760029156704,0.32626966025179716,0.18985289154893725,2,kg,NAC,9021/8835,SOCS3/SOCS2
GO:0007098,centrosome cycle,1/53,119/18493,0.2901016649385193,0.3263300658579938,0.18908682936041518,1,bp,NAC,1647,GADD45A
GO:0003713,transcription coactivator activity,2/52,321/17632,0.24440710739910193,0.3274428554257199,0.21439219947289645,2,mf,NAC,3725/64321,JUN/SOX17
GO:0019208,phosphatase regulator activity,1/52,94/17632,0.24298234478291614,0.3274428554257199,0.21439219947289645,1,mf,NAC,3486,IGFBP3
GO:0007173,epidermal growth factor receptor signaling pathway,1/53,120/18493,0.29214937429730137,0.3283228790543396,0.19024153365593852,1,bp,NAC,10252,SPRY1
GO:0038061,NIK/NF-kappaB signaling,1/53,120/18493,0.29214937429730137,0.3283228790543396,0.19024153365593852,1,bp,NAC,7097,TLR2
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,1/53,121/18493,0.29419128814709383,0.33046144695974927,0.19148069322752947,1,bp,NAC,3303,HSPA1A
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/45,68/10554,0.25284719570131187,0.33209780927933497,0.2661549428434862,1,re,NAC,3303,HSPA1A
R-HSA-69615,G1/S DNA Damage Checkpoints,1/45,68/10554,0.25284719570131187,0.33209780927933497,0.2661549428434862,1,re,NAC,1026,CDKN1A
GO:0010595,positive regulation of endothelial cell migration,1/53,122/18493,0.29622742257601875,0.33243454973372943,0.1926239766285033,1,bp,NAC,7474,WNT5A
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/53,122/18493,0.29622742257601875,0.33243454973372943,0.1926239766285033,1,bp,NAC,9314,KLF4
GO:0016328,lateral plasma membrane,1/53,56/19659,0.14048770260372678,0.3331565518888378,0.26196203192273865,1,cc,NAC,324,APC
GO:0032589,neuron projection membrane,1/53,57/19659,0.14281153833101368,0.3338973994781447,0.26254456268414667,1,cc,NAC,8516,ITGA8
GO:0005637,nuclear inner membrane,1/53,58/19659,0.14512920940888585,0.33460345502604233,0.26309973635529016,1,cc,NAC,4088,SMAD3
R-HSA-5693571,Nonhomologous End-Joining (NHEJ),1/45,69/10554,0.2560535542930954,0.3350589260638274,0.2685280866779478,1,re,NAC,3981,LIG4
GO:0001838,embryonic epithelial tube formation,1/53,124/18493,0.30028241730493055,0.3368262209203419,0.19516866149560783,1,bp,NAC,7474,WNT5A
R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,1/45,70/10554,0.25924645749355424,0.3379805668064115,0.27086959301470775,1,re,NAC,2810,SFN
GO:0050808,synapse organization,2/53,384/18493,0.30158088336126454,0.33812321576288873,0.19592018477872666,2,bp,NAC,7097/7474,TLR2/WNT5A
GO:0004620,phospholipase activity,1/52,99/17632,0.2541400060966652,0.3383137660777263,0.22150989468700288,1,mf,NAC,5320,PLA2G2A
GO:0003158,endothelium development,1/53,125/18493,0.3023013095626933,0.33861164113993625,0.19620319518931287,1,bp,NAC,64321,SOX17
GO:0071482,cellular response to light stimulus,1/53,125/18493,0.3023013095626933,0.33861164113993625,0.19620319518931287,1,bp,NAC,1026,CDKN1A
GO:0004725,protein tyrosine phosphatase activity,1/52,100/17632,0.2563521044074494,0.3390986697541577,0.22202380794782425,1,mf,NAC,1844,DUSP2
R-HSA-1169408,ISG15 antiviral mechanism,1/45,71/10554,0.26242596048981426,0.3396100665162302,0.27217553177736153,1,re,NAC,6772,STAT1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/45,71/10554,0.26242596048981426,0.3396100665162302,0.27217553177736153,1,re,NAC,3082,HGF
GO:0051087,chaperone binding,1/52,101/17632,0.25855776779843787,0.33986524194889,0.22252571872755328,1,mf,NAC,3280,HES1
hsa04975,Fat digestion and absorption,1/50,41/7852,0.23094005487785885,0.3411132920672961,0.1984902451388647,1,kg,NAC,5320,PLA2G2A
hsa05219,Bladder cancer,1/50,41/7852,0.23094005487785885,0.3411132920672961,0.1984902451388647,1,kg,NAC,1026,CDKN1A
GO:0009206,purine ribonucleoside triphosphate biosynthetic process,1/53,127/18493,0.30632196343331464,0.34263105787602177,0.19853218306392478,1,bp,NAC,3479,IGF1
GO:0031644,regulation of neurological system process,1/53,127/18493,0.30632196343331464,0.34263105787602177,0.19853218306392478,1,bp,NAC,3082,HGF
GO:0045471,response to ethanol,1/53,127/18493,0.30632196343331464,0.34263105787602177,0.19853218306392478,1,bp,NAC,4255,MGMT
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/45,73/10554,0.2687449855135736,0.34399358145737424,0.27568863585698655,1,re,NAC,4088,SMAD3
R-HSA-1980143,Signaling by NOTCH1,1/45,73/10554,0.2687449855135736,0.34399358145737424,0.27568863585698655,1,re,NAC,3280,HES1
R-HSA-8939902,Regulation of RUNX2 expression and activity,1/45,73/10554,0.2687449855135736,0.34399358145737424,0.27568863585698655,1,re,NAC,6772,STAT1
GO:0009145,purine nucleoside triphosphate biosynthetic process,1/53,128/18493,0.30832375674367274,0.34438416793633336,0.19954799514349097,1,bp,NAC,3479,IGF1
GO:0042177,negative regulation of protein catabolic process,1/53,128/18493,0.30832375674367274,0.34438416793633336,0.19954799514349097,1,bp,NAC,4088,SMAD3
GO:0050709,negative regulation of protein secretion,1/53,128/18493,0.30832375674367274,0.34438416793633336,0.19954799514349097,1,bp,NAC,353500,BMP8A
R-HSA-8878171,Transcriptional regulation by RUNX1,2/45,239/10554,0.27130844196480575,0.34601656366525946,0.27730992542550703,2,re,NAC,3977/9021,LIFR/SOCS3
GO:0007224,smoothened signaling pathway,1/53,129/18493,0.3103198820305,0.34612602226478845,0.20055728526608302,1,bp,NAC,3280,HES1
GO:0032273,positive regulation of protein polymerization,1/53,129/18493,0.3103198820305,0.34612602226478845,0.20055728526608302,1,bp,NAC,3303,HSPA1A
GO:0055007,cardiac muscle cell differentiation,1/53,129/18493,0.3103198820305,0.34612602226478845,0.20055728526608302,1,bp,NAC,3479,IGF1
GO:0042562,hormone binding,1/52,104/17632,0.2651363317260125,0.3463343333171038,0.22676133634461595,1,mf,NAC,3953,LEPR
GO:0002831,regulation of response to biotic stimulus,1/53,130/18493,0.3123103550348776,0.3480196927239638,0.20165454286028453,1,bp,NAC,6772,STAT1
GO:0071347,cellular response to interleukin-1,1/53,130/18493,0.3123103550348776,0.3480196927239638,0.20165454286028453,1,bp,NAC,3554,IL1R1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/45,75/10554,0.27501106645479434,0.3494725465418325,0.2800796724677366,1,re,NAC,1026,CDKN1A
GO:0002224,toll-like receptor signaling pathway,1/53,131/18493,0.3142951914550238,0.3495762232366916,0.20255645000966288,1,bp,NAC,7097,TLR2
GO:0002705,positive regulation of leukocyte mediated immunity,1/53,131/18493,0.3142951914550238,0.3495762232366916,0.20255645000966288,1,bp,NAC,3554,IL1R1
GO:0050777,negative regulation of immune response,1/53,131/18493,0.3142951914550238,0.3495762232366916,0.20255645000966288,1,bp,NAC,1281,COL3A1
GO:0072175,epithelial tube formation,1/53,131/18493,0.3142951914550238,0.3495762232366916,0.20255645000966288,1,bp,NAC,7474,WNT5A
GO:0097553,calcium ion transmembrane import into cytosol,1/53,132/18493,0.31627440694641296,0.3516131555486536,0.20373671843353,1,bp,NAC,781,CACNA2D1
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",1/45,76/10554,0.2781243885284209,0.3521574991438998,0.2822314885483408,1,re,NAC,4804,NGFR
GO:0001508,action potential,1/53,133/18493,0.3182480171218849,0.35298217570701595,0.20452997565423575,1,bp,NAC,781,CACNA2D1
GO:0009201,ribonucleoside triphosphate biosynthetic process,1/53,133/18493,0.3182480171218849,0.35298217570701595,0.20452997565423575,1,bp,NAC,3479,IGF1
GO:0031023,microtubule organizing center organization,1/53,133/18493,0.3182480171218849,0.35298217570701595,0.20452997565423575,1,bp,NAC,1647,GADD45A
GO:0034620,cellular response to unfolded protein,1/53,133/18493,0.3182480171218849,0.35298217570701595,0.20452997565423575,1,bp,NAC,3303,HSPA1A
GO:0060048,cardiac muscle contraction,1/53,133/18493,0.3182480171218849,0.35298217570701595,0.20452997565423575,1,bp,NAC,781,CACNA2D1
GO:0007292,female gamete generation,1/53,134/18493,0.32021603755176176,0.3545036020940826,0.2054115422695561,1,bp,NAC,3479,IGF1
GO:0046631,alpha-beta T cell activation,1/53,134/18493,0.32021603755176176,0.3545036020940826,0.2054115422695561,1,bp,NAC,7704,ZBTB16
GO:0061041,regulation of wound healing,1/53,134/18493,0.32021603755176176,0.3545036020940826,0.2054115422695561,1,bp,NAC,4088,SMAD3
GO:0097530,granulocyte migration,1/53,134/18493,0.32021603755176176,0.3545036020940826,0.2054115422695561,1,bp,NAC,3554,IL1R1
GO:0002792,negative regulation of peptide secretion,1/53,135/18493,0.3221784837639605,0.35601321300683003,0.20628626259392702,1,bp,NAC,353500,BMP8A
GO:0008584,male gonad development,1/53,135/18493,0.3221784837639605,0.35601321300683003,0.20628626259392702,1,bp,NAC,7474,WNT5A
GO:0043484,regulation of RNA splicing,1/53,135/18493,0.3221784837639605,0.35601321300683003,0.20628626259392702,1,bp,NAC,3303,HSPA1A
GO:0072655,establishment of protein localization to mitochondrion,1/53,135/18493,0.3221784837639605,0.35601321300683003,0.20628626259392702,1,bp,NAC,2810,SFN
GO:0045334,clathrin-coated endocytic vesicle,1/53,63/19659,0.15662565502183756,0.35616244840582245,0.2800516398371717,1,cc,NAC,7474,WNT5A
GO:0009411,response to UV,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,1026,CDKN1A
GO:0030048,actin filament-based movement,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,781,CACNA2D1
GO:0035023,regulation of Rho protein signal transduction,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,1281,COL3A1
GO:0046546,development of primary male sexual characteristics,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,7474,WNT5A
GO:1902904,negative regulation of supramolecular fiber organization,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,324,APC
GO:1904064,positive regulation of cation transmembrane transport,1/53,136/18493,0.32413537124410596,0.3571797557082873,0.20696219743355676,1,bp,NAC,781,CACNA2D1
R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,1/45,78/10554,0.2843118652495249,0.35870170812843283,0.28747624933738036,1,re,NAC,6772,STAT1
GO:0045580,regulation of T cell differentiation,1/53,137/18493,0.32608671543564394,0.3589973191231302,0.20801535599671442,1,bp,NAC,7704,ZBTB16
GO:0050684,regulation of mRNA processing,1/53,137/18493,0.32608671543564394,0.3589973191231302,0.20801535599671442,1,bp,NAC,79882,ZC3H14
R-HSA-5673001,RAF/MAP kinase cascade,2/45,248/10554,0.2856154252475924,0.3590593917398305,0.2877629096479502,2,re,NAC,1844/3082,DUSP2/HGF
R-HSA-416482,G alpha (12/13) signalling events,1/45,79/10554,0.2873861269967346,0.35999970356886324,0.28851650884107466,1,re,NAC,55970,GNG12
GO:0035304,regulation of protein dephosphorylation,1/53,138/18493,0.3280325317399536,0.36080543962886663,0.20906304301455733,1,bp,NAC,3486,IGFBP3
GO:1903364,positive regulation of cellular protein catabolic process,1/53,138/18493,0.3280325317399536,0.36080543962886663,0.20906304301455733,1,bp,NAC,3303,HSPA1A
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/45,80/10554,0.2904474753771782,0.3612632909285043,0.28952919249054776,1,re,NAC,1026,CDKN1A
R-HSA-422356,Regulation of insulin secretion,1/45,80/10554,0.2904474753771782,0.3612632909285043,0.28952919249054776,1,re,NAC,55970,GNG12
GO:0034704,calcium channel complex,1/53,65/19659,0.16118163897508264,0.36156962256572595,0.2843033176800888,1,cc,NAC,781,CACNA2D1
GO:0005881,cytoplasmic microtubule,1/53,66/19659,0.16345056686802562,0.36177058800123,0.2844613374264586,1,cc,NAC,324,APC
GO:0016529,sarcoplasmic reticulum,1/53,67/19659,0.16571347300572759,0.3619531120914576,0.28460485668573715,1,cc,NAC,781,CACNA2D1
GO:0034332,adherens junction organization,1/53,139/18493,0.3299728355164604,0.36260416028564824,0.21010528343761392,1,bp,NAC,4088,SMAD3
GO:0070585,protein localization to mitochondrion,1/53,139/18493,0.3299728355164604,0.36260416028564824,0.21010528343761392,1,bp,NAC,2810,SFN
GO:0009166,nucleotide catabolic process,1/53,140/18493,0.33190764208274726,0.36456183504516076,0.21123962731800958,1,bp,NAC,3479,IGF1
R-HSA-5684996,MAPK1/MAPK3 signaling,2/45,254/10554,0.29514460375351803,0.36581303000436033,0.29317551447717877,2,re,NAC,1844/3082,DUSP2/HGF
GO:0008643,carbohydrate transport,1/53,141/18493,0.33383696671466667,0.366004751889109,0.21207570281211266,1,bp,NAC,3479,IGF1
GO:0009127,purine nucleoside monophosphate biosynthetic process,1/53,141/18493,0.33383696671466667,0.366004751889109,0.21207570281211266,1,bp,NAC,3479,IGF1
GO:0009168,purine ribonucleoside monophosphate biosynthetic process,1/53,141/18493,0.33383696671466667,0.366004751889109,0.21207570281211266,1,bp,NAC,3479,IGF1
GO:0060041,retina development in camera-type eye,1/53,141/18493,0.33383696671466667,0.366004751889109,0.21207570281211266,1,bp,NAC,8842,PROM1
R-HSA-111885,Opioid Signalling,1/45,83/10554,0.2995545694015759,0.366122251490815,0.29342333552493544,1,re,NAC,55970,GNG12
R-HSA-1236974,ER-Phagosome pathway,1/45,83/10554,0.2995545694015759,0.366122251490815,0.29342333552493544,1,re,NAC,7097,TLR2
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/45,82/10554,0.2965316438835045,0.366122251490815,0.29342333552493544,1,re,NAC,324,APC
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/45,83/10554,0.2995545694015759,0.366122251490815,0.29342333552493544,1,re,NAC,1026,CDKN1A
GO:0007605,sensory perception of sound,1/53,142/18493,0.33576082464645185,0.36760554374275434,0.21300325650005114,1,bp,NAC,1277,COL1A1
GO:0051494,negative regulation of cytoskeleton organization,1/53,142/18493,0.33576082464645185,0.36760554374275434,0.21300325650005114,1,bp,NAC,324,APC
GO:0062013,positive regulation of small molecule metabolic process,1/53,142/18493,0.33576082464645185,0.36760554374275434,0.21300325650005114,1,bp,NAC,3479,IGF1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/45,84/10554,0.30256479233891953,0.3685218231948086,0.2953464372494279,1,re,NAC,9314,KLF4
GO:0038127,ERBB signaling pathway,1/53,143/18493,0.33767923107082864,0.36953576230392565,0.21412169131771008,1,bp,NAC,10252,SPRY1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/45,85/10554,0.3055623648646837,0.3708894911460988,0.2972439701768974,1,re,NAC,1026,CDKN1A
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/53,144/18493,0.33959220113912536,0.37111684481104784,0.21503782473447908,1,bp,NAC,3554,IL1R1
GO:0008203,cholesterol metabolic process,1/53,144/18493,0.33959220113912536,0.37111684481104784,0.21503782473447908,1,bp,NAC,3953,LEPR
GO:2001251,negative regulation of chromosome organization,1/53,144/18493,0.33959220113912536,0.37111684481104784,0.21503782473447908,1,bp,NAC,324,APC
GO:0008277,regulation of G protein-coupled receptor signaling pathway,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,7474,WNT5A
GO:0009142,nucleoside triphosphate biosynthetic process,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,3479,IGF1
GO:0019362,pyridine nucleotide metabolic process,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,3479,IGF1
GO:0035148,tube formation,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,7474,WNT5A
GO:0046496,nicotinamide nucleotide metabolic process,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,3479,IGF1
GO:1903169,regulation of calcium ion transmembrane transport,1/53,145/18493,0.341499749961384,0.3721752545408667,0.2156511036226792,1,bp,NAC,781,CACNA2D1
R-HSA-500792,GPCR ligand binding,3/45,457/10554,0.30898754577672877,0.3724781373746867,0.2985171675132059,3,re,NAC,55970/7472/7474,GNG12/WNT2/WNT5A
R-HSA-5628897,TP53 Regulates Metabolic Genes,1/45,86/10554,0.30854733893872033,0.3724781373746867,0.2985171675132059,1,re,NAC,2810,SFN
GO:0002706,regulation of lymphocyte mediated immunity,1/53,146/18493,0.3434018926064707,0.3737344167588958,0.21655453567234503,1,bp,NAC,3554,IL1R1
GO:0031123,RNA 3'-end processing,1/53,146/18493,0.3434018926064707,0.3737344167588958,0.21655453567234503,1,bp,NAC,79882,ZC3H14
GO:1901292,nucleoside phosphate catabolic process,1/53,146/18493,0.3434018926064707,0.3737344167588958,0.21655453567234503,1,bp,NAC,3479,IGF1
GO:0042391,regulation of membrane potential,2/53,424/18493,0.34383752045370886,0.3740373392675753,0.21673005936047815,2,bp,NAC,3725/781,JUN/CACNA2D1
GO:0031072,heat shock protein binding,1/52,115/17632,0.28877157360319994,0.3748649620066384,0.2454416774659431,1,mf,NAC,3303,HSPA1A
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1/53,147/18493,0.34529864410218425,0.3751120035061645,0.21735275666839424,1,bp,NAC,4804,NGFR
GO:0030902,hindbrain development,1/53,147/18493,0.34529864410218425,0.3751120035061645,0.21735275666839424,1,bp,NAC,3280,HES1
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,1/53,147/18493,0.34529864410218425,0.3751120035061645,0.21735275666839424,1,bp,NAC,3303,HSPA1A
R-HSA-3371556,Cellular response to heat stress,1/45,88/10554,0.3144796985294651,0.37651991116452965,0.30175638813425226,1,re,NAC,3303,HSPA1A
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/45,88/10554,0.3144796985294651,0.37651991116452965,0.30175638813425226,1,re,NAC,3303,HSPA1A
GO:0034767,positive regulation of ion transmembrane transport,1/53,148/18493,0.34719001943536787,0.3769944594599565,0.21844351619365374,1,bp,NAC,781,CACNA2D1
GO:0001764,neuron migration,1/53,149/18493,0.34907603355201655,0.3785238521599158,0.21932969876381295,1,bp,NAC,1281,COL3A1
GO:0060402,calcium ion transport into cytosol,1/53,149/18493,0.34907603355201655,0.3785238521599158,0.21932969876381295,1,bp,NAC,781,CACNA2D1
GO:1902652,secondary alcohol metabolic process,1/53,149/18493,0.34907603355201655,0.3785238521599158,0.21932969876381295,1,bp,NAC,3953,LEPR
R-HSA-5687128,MAPK6/MAPK4 signaling,1/45,89/10554,0.3174271869267682,0.3787605755871946,0.30355213593710567,1,re,NAC,3725,JUN
GO:0072524,pyridine-containing compound metabolic process,1/53,150/18493,0.35095670135738843,0.38038971550951217,0.22041084396527444,1,bp,NAC,3479,IGF1
hsa00565,Ether lipid metabolism,1/50,47/7852,0.2600181105147613,0.3805719617534234,0.22145083096472498,1,kg,NAC,5320,PLA2G2A
R-HSA-418346,Platelet homeostasis,1/45,90/10554,0.3203622826351574,0.3809713631337007,0.305323939353564,1,re,NAC,55970,GNG12
GO:0030670,phagocytic vesicle membrane,1/53,72/19659,0.17693822460129016,0.38145123745213205,0.29993629324073795,1,cc,NAC,7097,TLR2
R-HSA-446728,Cell junction organization,1/45,91/10554,0.323285036580247,0.38186688884646625,0.30604164536738326,1,re,NAC,2318,FLNC
R-HSA-5250924,B-WICH complex positively regulates rRNA expression,1/45,91/10554,0.323285036580247,0.38186688884646625,0.30604164536738326,1,re,NAC,23451,SF3B1
GO:0008360,regulation of cell shape,1/53,151/18493,0.3528320377161118,0.38190013003591894,0.2212860299309539,1,bp,NAC,3679,ITGA7
GO:0035967,cellular response to topologically incorrect protein,1/53,151/18493,0.3528320377161118,0.38190013003591894,0.2212860299309539,1,bp,NAC,3303,HSPA1A
GO:0051017,actin filament bundle assembly,1/53,151/18493,0.3528320377161118,0.38190013003591894,0.2212860299309539,1,bp,NAC,4088,SMAD3
R-HSA-2682334,EPH-Ephrin signaling,1/45,92/10554,0.3261954994832281,0.3827360527269877,0.3067382240754566,1,re,NAC,1969,EPHA2
R-HSA-4086400,PCP/CE pathway,1/45,92/10554,0.3261954994832281,0.3827360527269877,0.3067382240754566,1,re,NAC,7474,WNT5A
GO:0031490,chromatin DNA binding,1/52,119/17632,0.2971800135548439,0.38339890637631097,0.25102925121591757,1,mf,NAC,4088,SMAD3
GO:0016052,carbohydrate catabolic process,1/53,152/18493,0.35470205745229344,0.3835750307510476,0.2222565248342798,1,bp,NAC,3479,IGF1
GO:0070555,response to interleukin-1,1/53,152/18493,0.35470205745229344,0.3835750307510476,0.2222565248342798,1,bp,NAC,3554,IL1R1
R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/45,93/10554,0.3290937218616695,0.383579437401681,0.30741414241522286,1,re,NAC,3725,JUN
R-HSA-390466,Chaperonin-mediated protein folding,1/45,93/10554,0.3290937218616695,0.383579437401681,0.30741414241522286,1,re,NAC,55970,GNG12
hsa04330,Notch signaling pathway,1/50,48/7852,0.2647585454249808,0.3839340156367204,0.2234071748392816,1,kg,NAC,3280,HES1
hsa04913,Ovarian steroidogenesis,1/50,49/7852,0.26946921594378515,0.3839340156367204,0.2234071748392816,1,kg,NAC,3479,IGF1
hsa05030,Cocaine addiction,1/50,49/7852,0.26946921594378515,0.3839340156367204,0.2234071748392816,1,kg,NAC,3725,JUN
GO:0000070,mitotic sister chromatid segregation,1/53,153/18493,0.356566775349629,0.3854162689915535,0.2233234014031887,1,bp,NAC,324,APC
GO:0005179,hormone activity,1/52,121/17632,0.30134759445046766,0.38639047386593706,0.2529879708011676,1,mf,NAC,3479,IGF1
GO:0043271,negative regulation of ion transport,1/53,154/18493,0.35842620615150855,0.38725012186655494,0.224385998638095,1,bp,NAC,6424,SFRP4
R-HSA-5625740,RHO GTPases activate PKNs,1/45,95/10554,0.3348536461018887,0.3877252744337659,0.31073676300313774,1,re,NAC,2810,SFN
R-HSA-69473,G2/M DNA damage checkpoint,1/45,95/10554,0.3348536461018887,0.3877252744337659,0.31073676300313774,1,re,NAC,2810,SFN
GO:0009156,ribonucleoside monophosphate biosynthetic process,1/53,155/18493,0.36028036456112567,0.3889000031440567,0.2253419964213936,1,bp,NAC,3479,IGF1
GO:0061572,actin filament bundle organization,1/53,155/18493,0.36028036456112567,0.3889000031440567,0.2253419964213936,1,bp,NAC,4088,SMAD3
GO:0005262,calcium channel activity,1/52,123/17632,0.30549093491425383,0.38931466705536005,0.25490257727120025,1,mf,NAC,781,CACNA2D1
GO:0002819,regulation of adaptive immune response,1/53,157/18493,0.3639729228160081,0.3923515913220614,0.22734196495975315,1,bp,NAC,3554,IL1R1
GO:0030203,glycosaminoglycan metabolic process,1/53,157/18493,0.3639729228160081,0.3923515913220614,0.22734196495975315,1,bp,NAC,3082,HGF
GO:0046661,male sex differentiation,1/53,157/18493,0.3639729228160081,0.3923515913220614,0.22734196495975315,1,bp,NAC,7474,WNT5A
R-HSA-193704,p75 NTR receptor-mediated signalling,1/45,97/10554,0.3405652093992759,0.3930457498640824,0.31500078039346313,1,re,NAC,4804,NGFR
GO:0002768,immune response-regulating cell surface receptor signaling pathway,2/53,445/18493,0.3657357005799934,0.3939761751545522,0.22828330453601386,2,bp,NAC,2353/3725,FOS/JUN
GO:0015718,monocarboxylic acid transport,1/53,158/18493,0.36581135186764135,0.3939761751545522,0.22828330453601386,1,bp,NAC,5320,PLA2G2A
R-HSA-1236975,Antigen processing-Cross presentation,1/45,99/10554,0.34622880864501504,0.3944095166441595,0.3160937513774963,1,re,NAC,7097,TLR2
R-HSA-1296071,Potassium Channels,1/45,99/10554,0.34622880864501504,0.3944095166441595,0.3160937513774963,1,re,NAC,55970,GNG12
R-HSA-391251,Protein folding,1/45,99/10554,0.34622880864501504,0.3944095166441595,0.3160937513774963,1,re,NAC,55970,GNG12
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/45,99/10554,0.34622880864501504,0.3944095166441595,0.3160937513774963,1,re,NAC,3082,HGF
GO:0016298,lipase activity,1/52,127/17632,0.31370544674927203,0.3949664962084208,0.25860309497403533,1,mf,NAC,5320,PLA2G2A
GO:0051082,unfolded protein binding,1/52,127/17632,0.31370544674927203,0.3949664962084208,0.25860309497403533,1,mf,NAC,3303,HSPA1A
GO:0099173,postsynapse organization,1/53,159/18493,0.3676445669399626,0.39577129025949803,0.22932345577870966,1,bp,NAC,7474,WNT5A
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/45,100/10554,0.3490427449062272,0.396332407119329,0.31763482388750053,1,re,NAC,7474,WNT5A
GO:1901568,fatty acid derivative metabolic process,1/53,160/18493,0.3694725825367875,0.3975591860961451,0.23035942392981895,1,bp,NAC,7097,TLR2
GO:0030139,endocytic vesicle,2/53,293/19659,0.18690242056840034,0.3977666899276212,0.3127651842170262,2,cc,NAC,7097/7474,TLR2/WNT5A
GO:0007409,axonogenesis,2/53,449/18493,0.3698781960016232,0.3978156264549344,0.23050801426652615,2,bp,NAC,4804/7474,NGFR/WNT5A
GO:0050954,sensory perception of mechanical stimulus,1/53,161/18493,0.37129541312237346,0.3986187324627558,0.23097336142434927,1,bp,NAC,1277,COL1A1
GO:0060401,cytosolic calcium ion transport,1/53,161/18493,0.37129541312237346,0.3986187324627558,0.23097336142434927,1,bp,NAC,781,CACNA2D1
GO:1990138,neuron projection extension,1/53,161/18493,0.37129541312237346,0.3986187324627558,0.23097336142434927,1,bp,NAC,7474,WNT5A
GO:2001242,regulation of intrinsic apoptotic signaling pathway,1/53,161/18493,0.37129541312237346,0.3986187324627558,0.23097336142434927,1,bp,NAC,3303,HSPA1A
GO:0043254,regulation of protein complex assembly,2/53,451/18493,0.3719457350160216,0.399136713839395,0.2312734975945147,2,bp,NAC,3725/3303,JUN/HSPA1A
GO:0006733,oxidoreduction coenzyme metabolic process,1/53,162/18493,0.37311307312152864,0.3996679675148626,0.2315813241897018,1,bp,NAC,3479,IGF1
GO:0016125,sterol metabolic process,1/53,162/18493,0.37311307312152864,0.3996679675148626,0.2315813241897018,1,bp,NAC,3953,LEPR
GO:0043902,positive regulation of multi-organism process,1/53,162/18493,0.37311307312152864,0.3996679675148626,0.2315813241897018,1,bp,NAC,3725,JUN
GO:2001257,regulation of cation channel activity,1/53,162/18493,0.37311307312152864,0.3996679675148626,0.2315813241897018,1,bp,NAC,781,CACNA2D1
GO:0005684,U2-type spliceosomal complex,1/53,78/19659,0.190212459320231,0.39968693983744746,0.31427508268765686,1,cc,NAC,23451,SF3B1
GO:0000910,cytokinesis,1/53,163/18493,0.3749255769197156,0.40142864561687697,0.23260152145212343,1,bp,NAC,324,APC
R-HSA-69620,Cell Cycle Checkpoints,2/45,293/10554,0.3565276582128205,0.40323595418137337,0.3231675709348328,2,re,NAC,2810/1026,SFN/CDKN1A
R-HSA-9020702,Interleukin-1 signaling,1/45,103/10554,0.3574136866607628,0.40323595418137337,0.3231675709348328,1,re,NAC,3554,IL1R1
GO:0016234,inclusion body,1/53,80/19659,0.19459035099887623,0.4032582264937891,0.31708319648211697,1,cc,NAC,3303,HSPA1A
GO:0120111,neuron projection cytoplasm,1/53,81/19659,0.19677058039757178,0.4032582264937891,0.31708319648211697,1,cc,NAC,79882,ZC3H14
GO:0001750,photoreceptor outer segment,1/53,84/19659,0.20327658420572836,0.40443002908268394,0.3180045884987496,1,cc,NAC,8842,PROM1
GO:0005902,microvillus,1/53,83/19659,0.2011136819347099,0.40443002908268394,0.3180045884987496,1,cc,NAC,8842,PROM1
GO:0031234,extrinsic component of cytoplasmic side of plasma membrane,1/53,89/19659,0.21400520978120463,0.40443002908268394,0.3180045884987496,1,cc,NAC,55970,GNG12
GO:0034774,secretory granule lumen,2/53,321/19659,0.2143966419233505,0.40443002908268394,0.3180045884987496,2,cc,NAC,3479/3082,IGF1/HGF
GO:0060170,ciliary membrane,1/53,89/19659,0.21400520978120463,0.40443002908268394,0.3180045884987496,1,cc,NAC,8842,PROM1
GO:0071013,catalytic step 2 spliceosome,1/53,87/19659,0.20973087701691717,0.40443002908268394,0.3180045884987496,1,cc,NAC,23451,SF3B1
GO:1902554,serine/threonine protein kinase complex,1/53,87/19659,0.20973087701691717,0.40443002908268394,0.3180045884987496,1,cc,NAC,1026,CDKN1A
GO:0007051,spindle organization,1/53,165/18493,0.3785351732589354,0.4047466915511458,0.23452411103556725,1,bp,NAC,3303,HSPA1A
GO:0051100,negative regulation of binding,1/53,165/18493,0.3785351732589354,0.4047466915511458,0.23452411103556725,1,bp,NAC,3725,JUN
GO:2001252,positive regulation of chromosome organization,1/53,165/18493,0.3785351732589354,0.4047466915511458,0.23452411103556725,1,bp,NAC,3981,LIG4
GO:0045619,regulation of lymphocyte differentiation,1/53,166/18493,0.3803322943751116,0.40648548135910806,0.2355316254699095,1,bp,NAC,7704,ZBTB16
hsa05164,Influenza A,2/50,167/7852,0.2878453842072366,0.4065184812049569,0.23654883836051765,2,kg,NAC,6772/9021,STAT1/SOCS3
GO:0019903,protein phosphatase binding,1/52,133/17632,0.32584884233607125,0.4077988505882568,0.2670050394181485,1,mf,NAC,6772,STAT1
R-HSA-5688426,Deubiquitination,2/45,297/10554,0.36273861659775053,0.4079360800076939,0.32693441818798435,2,re,NAC,4088/324,SMAD3/APC
GO:0006022,aminoglycan metabolic process,1/53,167/18493,0.38212431644081346,0.4080339580135853,0.23642886593766685,1,bp,NAC,3082,HGF
GO:0009124,nucleoside monophosphate biosynthetic process,1/53,167/18493,0.38212431644081346,0.4080339580135853,0.23642886593766685,1,bp,NAC,3479,IGF1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/45,106/10554,0.3656793448517611,0.4086321567867299,0.3274922787644845,1,re,NAC,3082,HGF
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,1/45,106/10554,0.3656793448517611,0.4086321567867299,0.3274922787644845,1,re,NAC,23451,SF3B1
GO:0006941,striated muscle contraction,1/53,168/18493,0.3839112536463487,0.4095742311220355,0.23732135298957308,1,bp,NAC,781,CACNA2D1
GO:0051897,positive regulation of protein kinase B signaling,1/53,168/18493,0.3839112536463487,0.4095742311220355,0.23732135298957308,1,bp,NAC,3082,HGF
hsa03460,Fanconi anemia pathway,1/50,54/7852,0.29258247252578207,0.40961546153609485,0.23835093871665547,1,kg,NAC,3280,HES1
GO:0008380,RNA splicing,2/53,463/18493,0.3842966100244186,0.4098014971471155,0.2374530387169998,2,bp,NAC,3303/23451,HSPA1A/SF3B1
GO:0006986,response to unfolded protein,1/53,169/18493,0.3856931201433058,0.41110633783091943,0.23820910814956117,1,bp,NAC,3303,HSPA1A
GO:0006914,autophagy,2/53,466/18493,0.387369172781475,0.41244561040564043,0.23898512860032023,2,bp,NAC,3953/3082,LEPR/HGF
GO:0022408,negative regulation of cell-cell adhesion,1/53,170/18493,0.3874699300446597,0.41244561040564043,0.23898512860032023,1,bp,NAC,9314,KLF4
GO:0061919,process utilizing autophagic mechanism,2/53,466/18493,0.387369172781475,0.41244561040564043,0.23898512860032023,2,bp,NAC,3953/3082,LEPR/HGF
R-HSA-8957275,Post-translational protein phosphorylation,1/45,108/10554,0.37113193265597866,0.4134127857433686,0.3313236440766232,1,re,NAC,3486,IGFBP3
GO:0140013,meiotic nuclear division,1/53,171/18493,0.38924169742487225,0.414146199765703,0.2399705083853328,1,bp,NAC,7474,WNT5A
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/45,109/10554,0.3738410139340259,0.4151168356617575,0.3326893300160018,1,re,NAC,3725,JUN
GO:0050796,regulation of insulin secretion,1/53,172/18493,0.39100843631999704,0.415839920200784,0.2409519080796894,1,bp,NAC,353500,BMP8A
R-HSA-163685,Integration of energy metabolism,1/45,110/10554,0.37653868309371674,0.4167975360031078,0.3340363027776103,1,re,NAC,55970,GNG12
GO:0015085,calcium ion transmembrane transporter activity,1/52,139/17632,0.33778143113749004,0.4177296988623398,0.2735072316902754,1,mf,NAC,781,CACNA2D1
GO:0052689,carboxylic ester hydrolase activity,1/52,139/17632,0.33778143113749004,0.4177296988623398,0.2735072316902754,1,mf,NAC,5320,PLA2G2A
GO:0005796,Golgi lumen,1/53,103/19659,0.24329693788630335,0.41913119941804505,0.3295641644124134,1,cc,NAC,7474,WNT5A
GO:0005884,actin filament,1/53,99/19659,0.23503895553436527,0.41913119941804505,0.3295641644124134,1,cc,NAC,55970,GNG12
GO:0005913,cell-cell adherens junction,1/53,110/19659,0.2575384478351843,0.41913119941804505,0.3295641644124134,1,cc,NAC,324,APC
GO:0016363,nuclear matrix,1/53,108/19659,0.25349649933751084,0.41913119941804505,0.3295641644124134,1,cc,NAC,862,RUNX1T1
GO:0016605,PML body,1/53,98/19659,0.23296068326879849,0.41913119941804505,0.3295641644124134,1,cc,NAC,7704,ZBTB16
GO:0030532,small nuclear ribonucleoprotein complex,1/53,106/19659,0.24943296393065306,0.41913119941804505,0.3295641644124134,1,cc,NAC,23451,SF3B1
GO:0030665,clathrin-coated vesicle membrane,1/53,107/19659,0.2514674370504648,0.41913119941804505,0.3295641644124134,1,cc,NAC,7474,WNT5A
GO:0031983,vesicle lumen,2/53,339/19659,0.23228208371755715,0.41913119941804505,0.3295641644124134,2,cc,NAC,3479/3082,IGF1/HGF
GO:0060205,cytoplasmic vesicle lumen,2/53,338/19659,0.23128533185818098,0.41913119941804505,0.3295641644124134,2,cc,NAC,3479/3082,IGF1/HGF
GO:0097525,spliceosomal snRNP complex,1/53,99/19659,0.23503895553436527,0.41913119941804505,0.3295641644124134,1,cc,NAC,23451,SF3B1
GO:0097731,9+0 non-motile cilium,1/53,109/19659,0.2555201649062854,0.41913119941804505,0.3295641644124134,1,cc,NAC,8842,PROM1
GO:0097733,photoreceptor cell cilium,1/53,108/19659,0.25349649933751084,0.41913119941804505,0.3295641644124134,1,cc,NAC,8842,PROM1
GO:0098687,chromosomal region,2/53,346/19659,0.2392675417012715,0.41913119941804505,0.3295641644124134,2,cc,NAC,3981/324,LIG4/APC
GO:1902911,protein kinase complex,1/53,107/19659,0.2514674370504648,0.41913119941804505,0.3295641644124134,1,cc,NAC,1026,CDKN1A
GO:0002285,lymphocyte activation involved in immune response,1/53,174/18493,0.3945268846077732,0.41939424747308207,0.2430114071719997,1,bp,NAC,3981,LIG4
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,2/45,309/10554,0.3812439489654098,0.42068297816872807,0.33715023369981795,2,re,NAC,7704/9021,ZBTB16/SOCS3
GO:0008361,regulation of cell size,1/53,175/18493,0.3962786218814124,0.4210681692734578,0.2439813348585527,1,bp,NAC,7474,WNT5A
GO:0035637,multicellular organismal signaling,1/53,176/18493,0.3980253864321428,0.4227353143973361,0.24494733590638443,1,bp,NAC,781,CACNA2D1
GO:0015698,inorganic anion transport,1/53,177/18493,0.3997671921055117,0.42439570661915477,0.2459094240912194,1,bp,NAC,6424,SFRP4
GO:0022843,voltage-gated cation channel activity,1/52,143/17632,0.3456211502934371,0.4249107083019315,0.2782089754684014,1,mf,NAC,781,CACNA2D1
GO:0005543,phospholipid binding,2/52,417/17632,0.3492100371295872,0.42681226760282887,0.2794540155546097,2,mf,NAC,5320/7474,PLA2G2A/WNT5A
GO:0061136,regulation of proteasomal protein catabolic process,1/53,179/18493,0.4032359820134678,0.4278871777010381,0.24793250215159085,1,bp,NAC,3303,HSPA1A
GO:0045177,apical part of cell,2/53,373/19659,0.2663012369474148,0.42918451779874617,0.33746911989248274,2,cc,NAC,8516/8842,ITGA8/PROM1
GO:0002377,immunoglobulin production,1/53,180/18493,0.40496299375056943,0.42933660238022925,0.24877234850857424,1,bp,NAC,3981,LIG4
GO:0006611,protein export from nucleus,1/53,180/18493,0.40496299375056943,0.42933660238022925,0.24877234850857424,1,bp,NAC,2810,SFN
GO:0043312,neutrophil degranulation,2/53,485/18493,0.4066775389709243,0.43077825017450183,0.24960768867178212,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0051224,negative regulation of protein transport,1/53,181/18493,0.40668510161554106,0.43077825017450183,0.24960768867178212,1,bp,NAC,353500,BMP8A
R-HSA-73894,DNA Repair,2/45,316/10554,0.39194215006428856,0.43113636507071745,0.34552794808299125,2,re,NAC,4255/3981,MGMT/LIG4
GO:0000784,"nuclear chromosome, telomeric region",1/53,124/19659,0.28523703041108406,0.4323631291010795,0.3399684718359787,1,cc,NAC,3981,LIG4
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,1/53,123/19659,0.2832926462100771,0.4323631291010795,0.3399684718359787,1,cc,NAC,8842,PROM1
GO:0005923,bicellular tight junction,1/53,122/19659,0.2813430727266619,0.4323631291010795,0.3399684718359787,1,cc,NAC,324,APC
GO:0030018,Z disc,1/53,126/19659,0.28911028512180614,0.4323631291010795,0.3399684718359787,1,cc,NAC,2318,FLNC
GO:0043204,perikaryon,1/53,125/19659,0.2871762388773349,0.4323631291010795,0.3399684718359787,1,cc,NAC,8516,ITGA8
GO:0045335,phagocytic vesicle,1/53,124/19659,0.28523703041108406,0.4323631291010795,0.3399684718359787,1,cc,NAC,7097,TLR2
GO:0120114,Sm-like protein family complex,1/53,117/19659,0.271516889467192,0.4323631291010795,0.3399684718359787,1,cc,NAC,23451,SF3B1
GO:1904813,ficolin-1-rich granule lumen,1/53,124/19659,0.28523703041108406,0.4323631291010795,0.3399684718359787,1,cc,NAC,3303,HSPA1A
GO:0051147,regulation of muscle cell differentiation,1/53,182/18493,0.4084023192659546,0.4324045927045592,0.2505500472977151,1,bp,NAC,3479,IGF1
GO:0002283,neutrophil activation involved in immune response,2/53,488/18493,0.4097012205243916,0.4335867834477095,0.25123504914924166,2,bp,NAC,7097/3303,TLR2/HSPA1A
hsa04360,Axon guidance,2/50,181/7852,0.32095615316358894,0.43423479545662036,0.25267667077894224,2,kg,NAC,1969/7474,EPHA2/WNT5A
hsa04621,NOD-like receptor signaling pathway,2/50,178/7852,0.3138824683432925,0.43423479545662036,0.25267667077894224,2,kg,NAC,3725/6772,JUN/STAT1
hsa04730,Long-term depression,1/50,60/7852,0.3193737266798745,0.43423479545662036,0.25267667077894224,1,kg,NAC,3479,IGF1
hsa05152,Tuberculosis,2/50,179/7852,0.3162419757240946,0.43423479545662036,0.25267667077894224,2,kg,NAC,6772/7097,STAT1/TLR2
GO:0034404,nucleobase-containing small molecule biosynthetic process,1/53,184/18493,0.4118221383670351,0.435250242238582,0.2521989142093329,1,bp,NAC,3479,IGF1
GO:0043112,receptor metabolic process,1/53,184/18493,0.4118221383670351,0.435250242238582,0.2521989142093329,1,bp,NAC,6424,SFRP4
GO:1904950,negative regulation of establishment of protein localization,1/53,184/18493,0.4118221383670351,0.435250242238582,0.2521989142093329,1,bp,NAC,353500,BMP8A
GO:0000819,sister chromatid segregation,1/53,185/18493,0.41352476694677986,0.4368555734337816,0.2531290981474128,1,bp,NAC,324,APC
GO:0016874,ligase activity,1/52,151/17632,0.3610284845965447,0.4386915888411502,0.28723196448929506,1,mf,NAC,3981,LIG4
GO:1902115,regulation of organelle assembly,1/53,187/18493,0.41691552970976486,0.44024206467576416,0.255091347288998,1,bp,NAC,3303,HSPA1A
GO:1903046,meiotic cell cycle process,1/53,188/18493,0.4186036908004117,0.4418284850081576,0.2560105736247525,1,bp,NAC,7474,WNT5A
GO:0042119,neutrophil activation,2/53,498/18493,0.41972821199782107,0.4428188501024039,0.25658442511798807,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0031032,actomyosin structure organization,1/53,189/18493,0.4202870562408696,0.44301534562978184,0.2566982813639877,1,bp,NAC,4088,SMAD3
GO:0035966,response to topologically incorrect protein,1/53,189/18493,0.4202870562408696,0.44301534562978184,0.2566982813639877,1,bp,NAC,3303,HSPA1A
GO:0000776,kinetochore,1/53,133/19659,0.30250519447115176,0.4432468297876772,0.3485263595033099,1,cc,NAC,324,APC
GO:0005814,centriole,1/53,133/19659,0.30250519447115176,0.4432468297876772,0.3485263595033099,1,cc,NAC,3303,HSPA1A
GO:0034399,nuclear periphery,1/53,134/19659,0.3043984252758747,0.4432468297876772,0.3485263595033099,1,cc,NAC,862,RUNX1T1
GO:0002446,neutrophil mediated immunity,2/53,499/18493,0.4207264218625758,0.4432819810319917,0.25685277905842024,2,bp,NAC,7097/3303,TLR2/HSPA1A
GO:0007565,female pregnancy,1/53,191/18493,0.42363945358273947,0.44595600735712904,0.2584022015981949,1,bp,NAC,2353,FOS
GO:0043401,steroid hormone mediated signaling pathway,1/53,191/18493,0.42363945358273947,0.44595600735712904,0.2584022015981949,1,bp,NAC,3164,NR4A1
hsa00590,Arachidonic acid metabolism,1/50,63/7852,0.33239389602788516,0.44596181050407924,0.259500497776156,1,kg,NAC,5320,PLA2G2A
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/45,122/10554,0.4080374829763883,0.44605339753940587,0.35748298606627027,1,re,NAC,3725,JUN
R-HSA-5619507,Activation of HOX genes during differentiation,1/45,122/10554,0.4080374829763883,0.44605339753940587,0.35748298606627027,1,re,NAC,3725,JUN
GO:0031674,I band,1/53,137/19659,0.31004791743303306,0.44754742864246516,0.35190793374550206,1,cc,NAC,2318,FLNC
hsa04062,Chemokine signaling pathway,2/50,190/7852,0.3420758778236558,0.44775785633828113,0.26054559800004595,2,kg,NAC,6772/55970,STAT1/GNG12
hsa04137,Mitophagy - animal,1/50,65/7852,0.34093807249477526,0.44775785633828113,0.26054559800004595,1,kg,NAC,3725,JUN
hsa04927,Cortisol synthesis and secretion,1/50,65/7852,0.34093807249477526,0.44775785633828113,0.26054559800004595,1,kg,NAC,3164,NR4A1
GO:0051168,nuclear export,1/53,194/18493,0.4286324150850055,0.45101233764254123,0.26133201273696893,1,bp,NAC,2810,SFN
GO:0031396,regulation of protein ubiquitination,1/53,195/18493,0.43028728595229315,0.4525533684186436,0.2622249388074917,1,bp,NAC,3303,HSPA1A
GO:0043296,apical junction complex,1/53,142/19659,0.3193638563916661,0.4531145312907399,0.3562853638557498,1,cc,NAC,324,APC
GO:0097730,non-motile cilium,1/53,142/19659,0.3193638563916661,0.4531145312907399,0.3562853638557498,1,cc,NAC,8842,PROM1
GO:0002703,regulation of leukocyte mediated immunity,1/53,196/18493,0.4319374539402989,0.45388743502873663,0.2629979427438432,1,bp,NAC,3554,IL1R1
GO:1903531,negative regulation of secretion by cell,1/53,196/18493,0.4319374539402989,0.45388743502873663,0.2629979427438432,1,bp,NAC,353500,BMP8A
GO:0006575,cellular modified amino acid metabolic process,1/53,197/18493,0.4335829321575565,0.4554152882820977,0.26388323330585906,1,bp,NAC,5320,PLA2G2A
GO:0000086,G2/M transition of mitotic cell cycle,1/53,199/18493,0.4368598715349419,0.4584522394131032,0.265642946922116,1,bp,NAC,1026,CDKN1A
GO:0097164,ammonium ion metabolic process,1/53,199/18493,0.4368598715349419,0.4584522394131032,0.265642946922116,1,bp,NAC,5320,PLA2G2A
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,1/50,68/7852,0.3535537668556218,0.45904964890125083,0.26711617360059714,1,kg,NAC,3725,JUN
GO:0072562,blood microparticle,1/53,147/19659,0.32855635061023214,0.4622063915364283,0.3634343218168491,1,cc,NAC,3303,HSPA1A
R-HSA-1483206,Glycerophospholipid biosynthesis,1/45,129/10554,0.4256874698942874,0.46247527593453447,0.37064406085662455,1,re,NAC,5320,PLA2G2A
R-HSA-1500931,Cell-Cell communication,1/45,129/10554,0.4256874698942874,0.46247527593453447,0.37064406085662455,1,re,NAC,2318,FLNC
GO:0009898,cytoplasmic side of plasma membrane,1/53,149/19659,0.33219914391526884,0.46340384781457666,0.3643758854090521,1,cc,NAC,55970,GNG12
GO:0005911,cell-cell junction,2/53,442/19659,0.3352039242932503,0.46369876193899623,0.3646077773014301,2,cc,NAC,1969/324,EPHA2/APC
GO:0030073,insulin secretion,1/53,203/18493,0.4433580458515963,0.46465642707584665,0.269237865983039,1,bp,NAC,353500,BMP8A
GO:0046434,organophosphate catabolic process,1/53,203/18493,0.4433580458515963,0.46465642707584665,0.269237865983039,1,bp,NAC,3479,IGF1
GO:0090276,regulation of peptide hormone secretion,1/53,203/18493,0.4433580458515963,0.46465642707584665,0.269237865983039,1,bp,NAC,353500,BMP8A
R-HSA-69206,G1/S Transition,1/45,131/10554,0.4306350995520444,0.46641093859175264,0.3737982402589406,1,re,NAC,1026,CDKN1A
GO:2001020,regulation of response to DNA damage stimulus,1/53,206/18493,0.44818334168042373,0.4695066019894483,0.27204822363073256,1,bp,NAC,4255,MGMT
GO:0004674,protein serine/threonine kinase activity,2/52,455/17632,0.3896671893970223,0.47075400337559337,0.3082247314974925,2,mf,NAC,51776/1026,MAP3K20/CDKN1A
GO:0032271,regulation of protein polymerization,1/53,208/18493,0.4513773810507088,0.47264439107819706,0.273866366217237,1,bp,NAC,3303,HSPA1A
hsa04520,Adherens junction,1/50,72/7852,0.3700071707769955,0.47278694043727204,0.2751097593914169,1,kg,NAC,4088,SMAD3
hsa05203,Viral carcinogenesis,2/50,201/7852,0.3676260110751962,0.47278694043727204,0.2751097593914169,2,kg,NAC,3725/1026,JUN/CDKN1A
GO:0007601,visual perception,1/53,209/18493,0.45296759154041677,0.47389218331857064,0.2745893798255983,1,bp,NAC,1277,COL1A1
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,1/53,209/18493,0.45296759154041677,0.47389218331857064,0.2745893798255983,1,bp,NAC,3303,HSPA1A
hsa01524,Platinum drug resistance,1/50,73/7852,0.3740559678799712,0.4741969356588611,0.275930220814898,1,kg,NAC,1026,CDKN1A
GO:0043624,cellular protein complex disassembly,1/53,210/18493,0.4545532794450522,0.4753419958312815,0.275429450906621,1,bp,NAC,324,APC
GO:0000781,"chromosome, telomeric region",1/53,158/19659,0.34835319018238275,0.4779060295064094,0.37577899593401876,1,cc,NAC,3981,LIG4
GO:0016064,immunoglobulin mediated immune response,1/53,212/18493,0.45771113792718365,0.47843388395201875,0.2772209968984076,1,bp,NAC,3981,LIG4
GO:0019724,B cell mediated immunity,1/53,213/18493,0.4592833336325529,0.47965558514633766,0.2779288924600753,1,bp,NAC,3981,LIG4
GO:0050953,sensory perception of light stimulus,1/53,213/18493,0.4592833336325529,0.47965558514633766,0.2779288924600753,1,bp,NAC,1277,COL1A1
GO:0008406,gonad development,1/53,216/18493,0.46397313665243645,0.4843407019137374,0.2806436097583473,1,bp,NAC,7474,WNT5A
GO:0008016,regulation of heart contraction,1/53,217/18493,0.46552751777392365,0.48511149748746296,0.28109023514279535,1,bp,NAC,781,CACNA2D1
GO:0009108,coenzyme biosynthetic process,1/53,217/18493,0.46552751777392365,0.48511149748746296,0.28109023514279535,1,bp,NAC,3479,IGF1
GO:0030595,leukocyte chemotaxis,1/53,217/18493,0.46552751777392365,0.48511149748746296,0.28109023514279535,1,bp,NAC,7474,WNT5A
GO:0043393,regulation of protein binding,1/53,217/18493,0.46552751777392365,0.48511149748746296,0.28109023514279535,1,bp,NAC,7474,WNT5A
GO:0006457,protein folding,1/53,218/18493,0.46707747627457896,0.4863004547202052,0.2817791577304009,1,bp,NAC,3303,HSPA1A
GO:0044839,cell cycle G2/M phase transition,1/53,218/18493,0.46707747627457896,0.4863004547202052,0.2817791577304009,1,bp,NAC,1026,CDKN1A
R-HSA-5576891,Cardiac conduction,1/45,141/10554,0.4547548119526329,0.48654618178518777,0.3899353370766457,1,re,NAC,781,CACNA2D1
R-HSA-6807070,PTEN Regulation,1/45,140/10554,0.4523885246093857,0.48654618178518777,0.3899353370766457,1,re,NAC,3725,JUN
R-HSA-73887,Death Receptor Signalling,1/45,141/10554,0.4547548119526329,0.48654618178518777,0.3899353370766457,1,re,NAC,4804,NGFR
R-HSA-8856828,Clathrin-mediated endocytosis,1/45,140/10554,0.4523885246093857,0.48654618178518777,0.3899353370766457,1,re,NAC,7474,WNT5A
hsa04024,cAMP signaling pathway,2/50,212/7852,0.3928125202811006,0.48785543268705056,0.28387795690845047,2,kg,NAC,2353/3725,FOS/JUN
hsa04260,Cardiac muscle contraction,1/50,78/7852,0.3939205357100408,0.48785543268705056,0.28387795690845047,1,kg,NAC,781,CACNA2D1
hsa04612,Antigen processing and presentation,1/50,77/7852,0.3899976912809796,0.48785543268705056,0.28387795690845047,1,kg,NAC,3303,HSPA1A
GO:0043197,dendritic spine,1/53,164/19659,0.3589089054166583,0.48835146146856784,0.3839922715415499,1,cc,NAC,8516,ITGA8
GO:0044309,neuron spine,1/53,166/19659,0.36239005548573444,0.48907926187505624,0.384564543262568,1,cc,NAC,8516,ITGA8
GO:0019722,calcium-mediated signaling,1/53,220/18493,0.47016417474841665,0.4892999595412406,0.28351717367070256,1,bp,NAC,3479,IGF1
R-HSA-168255,Influenza Life Cycle,1/45,143/10554,0.4594574317804727,0.4900879272325042,0.3927738172796385,1,re,NAC,3303,HSPA1A
GO:0001894,tissue homeostasis,1/53,221/18493,0.47170093930477486,0.4902556091200851,0.28407090980398897,1,bp,NAC,8842,PROM1
GO:0044706,multi-multicellular organism process,1/53,221/18493,0.47170093930477486,0.4902556091200851,0.28407090980398897,1,bp,NAC,2353,FOS
GO:1903320,regulation of protein modification by small protein conjugation or removal,1/53,221/18493,0.47170093930477486,0.4902556091200851,0.28407090980398897,1,bp,NAC,3303,HSPA1A
GO:0045137,development of primary sexual characteristics,1/53,222/18493,0.47323333040683524,0.4914187160294559,0.2847448538278775,1,bp,NAC,7474,WNT5A
GO:0051048,negative regulation of secretion,1/53,222/18493,0.47323333040683524,0.4914187160294559,0.2847448538278775,1,bp,NAC,353500,BMP8A
GO:0031424,keratinization,1/53,224/18493,0.47628504104529623,0.4943718147558771,0.2864559804857878,1,bp,NAC,2810,SFN
GO:0098562,cytoplasmic side of membrane,1/53,172/19659,0.37272260477358454,0.498967358003347,0.3923395839721942,1,cc,NAC,55970,GNG12
GO:0030662,coated vesicle membrane,1/53,174/19659,0.37613014236239706,0.49950082905726334,0.39275905391947147,1,cc,NAC,7474,WNT5A
GO:0051607,defense response to virus,1/53,228/18493,0.48233651577432224,0.5004346572911598,0.2899689993334197,1,bp,NAC,6772,STAT1
GO:0005681,spliceosomal complex,1/53,179/19659,0.3845697296943128,0.500910388473777,0.39386739486841055,1,cc,NAC,23451,SF3B1
GO:0030136,clathrin-coated vesicle,1/53,180/19659,0.3862441549677317,0.500910388473777,0.39386739486841055,1,cc,NAC,7474,WNT5A
GO:0044450,microtubule organizing center part,1/53,179/19659,0.3845697296943128,0.500910388473777,0.39386739486841055,1,cc,NAC,3303,HSPA1A
R-HSA-212165,Epigenetic regulation of gene expression,1/45,148/10554,0.47104116006652097,0.5009259466568441,0.40145978978479124,1,re,NAC,23451,SF3B1
GO:0004721,phosphoprotein phosphatase activity,1/52,182/17632,0.4174420933248387,0.501410330487881,0.32829686710362393,1,mf,NAC,1844,DUSP2
R-HSA-453279,Mitotic G1-G1/S phases,1/45,149/10554,0.4733286045982341,0.5018423759595736,0.4021942486757347,1,re,NAC,1026,CDKN1A
GO:0017137,Rab GTPase binding,1/52,185/17632,0.42263485353126573,0.504746767931626,0.33048138922745596,1,mf,NAC,4804,NGFR
R-HSA-162587,HIV Life Cycle,1/45,151/10554,0.47787451464203246,0.5051406280900763,0.40483758471333875,1,re,NAC,3981,LIG4
GO:0101002,ficolin-1-rich granule,1/53,185/19659,0.39454946574355754,0.5077148163831826,0.3992177376760598,1,cc,NAC,3303,HSPA1A
R-HSA-168254,Influenza Infection,1/45,154/10554,0.4846215294227213,0.5107388573556824,0.40932420386161145,1,re,NAC,3303,HSPA1A
GO:0051015,actin filament binding,1/52,190/17632,0.43118874739317403,0.5120366375293942,0.33525440885832913,1,mf,NAC,2318,FLNC
GO:0005516,calmodulin binding,1/52,192/17632,0.4345753933850838,0.513142696143969,0.3359785973241802,1,mf,NAC,4804,NGFR
R-HSA-5663205,Infectious disease,2/45,382/10554,0.4884268996461386,0.5132127423147487,0.41130686285990614,2,re,NAC,3303/3981,HSPA1A/LIG4
GO:0000775,"chromosome, centromeric region",1/53,194/19659,0.4092220487312731,0.5148857606296083,0.404856273418335,1,cc,NAC,324,APC
GO:0030017,sarcomere,1/53,197/19659,0.41403494163123944,0.5148857606296083,0.404856273418335,1,cc,NAC,2318,FLNC
GO:0032838,plasma membrane bounded cell projection cytoplasm,1/53,196/19659,0.41243493400148445,0.5148857606296083,0.404856273418335,1,cc,NAC,79882,ZC3H14
GO:0070382,exocytic vesicle,1/53,197/19659,0.41403494163123944,0.5148857606296083,0.404856273418335,1,cc,NAC,3479,IGF1
GO:0098858,actin-based cell projection,1/53,198/19659,0.4156306742431778,0.5148857606296083,0.404856273418335,1,cc,NAC,8842,PROM1
GO:0032412,regulation of ion transmembrane transporter activity,1/53,238/18493,0.4971666582382118,0.5155962988619571,0.2987541743217662,1,bp,NAC,781,CACNA2D1
GO:0042393,histone binding,1/52,195/17632,0.4396183135589543,0.5161810535607947,0.3379679524699235,1,mf,NAC,6772,STAT1
GO:0009152,purine ribonucleotide biosynthetic process,1/53,239/18493,0.4986265413997224,0.5166596581475119,0.29937032115227,1,bp,NAC,3479,IGF1
GO:0051924,regulation of calcium ion transport,1/53,239/18493,0.4986265413997224,0.5166596581475119,0.29937032115227,1,bp,NAC,781,CACNA2D1
GO:0032993,protein-DNA complex,1/53,201/19659,0.42039233386046193,0.5169268697839754,0.4064612038884779,1,cc,NAC,2353,FOS
GO:0009755,hormone-mediated signaling pathway,1/53,240/18493,0.5000822658056504,0.5179423467272808,0.30011355489620234,1,bp,NAC,3164,NR4A1
GO:0005244,voltage-gated ion channel activity,1/52,199/17632,0.44627364225673816,0.5181732846203237,0.33927235961038577,1,mf,NAC,781,CACNA2D1
GO:0022832,voltage-gated channel activity,1/52,199/17632,0.44627364225673816,0.5181732846203237,0.33927235961038577,1,mf,NAC,781,CACNA2D1
GO:0046474,glycerophospholipid biosynthetic process,1/53,241/18493,0.5015338430758144,0.5192196250911131,0.30085365377551554,1,bp,NAC,5320,PLA2G2A
GO:1903362,regulation of cellular protein catabolic process,1/53,242/18493,0.5029812847981998,0.5204915122933503,0.30159062883094845,1,bp,NAC,3303,HSPA1A
GO:0030072,peptide hormone secretion,1/53,244/18493,0.5058638077929356,0.5227918882797048,0.30292354555271295,1,bp,NAC,353500,BMP8A
GO:0060047,heart contraction,1/53,244/18493,0.5058638077929356,0.5227918882797048,0.30292354555271295,1,bp,NAC,781,CACNA2D1
GO:0072659,protein localization to plasma membrane,1/53,244/18493,0.5058638077929356,0.5227918882797048,0.30292354555271295,1,bp,NAC,1969,EPHA2
R-HSA-69242,S Phase,1/45,161/10554,0.500034764354232,0.5238459436091955,0.4198286868638289,1,re,NAC,1026,CDKN1A
GO:0022898,regulation of transmembrane transporter activity,1/53,245/18493,0.5072989120828677,0.5240472688675323,0.3036509561097782,1,bp,NAC,781,CACNA2D1
GO:0036464,cytoplasmic ribonucleoprotein granule,1/53,207/19659,0.4298017310148201,0.5246109363857363,0.4125032093331091,1,cc,NAC,3981,LIG4
hsa04211,Longevity regulating pathway,1/50,89/7852,0.4354730516934727,0.5271515888920986,0.30674397784502633,1,kg,NAC,3479,IGF1
hsa04540,Gap junction,1/50,88/7852,0.43181394520976424,0.5271515888920986,0.30674397784502633,1,kg,NAC,80310,PDGFD
hsa04727,GABAergic synapse,1/50,89/7852,0.4354730516934727,0.5271515888920986,0.30674397784502633,1,kg,NAC,55970,GNG12
GO:0000793,condensed chromosome,1/53,221/19659,0.45117802649773375,0.5274334675959422,0.4147225743937657,1,cc,NAC,3981,LIG4
GO:0016323,basolateral plasma membrane,1/53,213/19659,0.43906121141282006,0.5274334675959422,0.4147225743937657,1,cc,NAC,3953,LEPR
GO:0030016,myofibril,1/53,218/19659,0.44666461703413374,0.5274334675959422,0.4147225743937657,1,cc,NAC,2318,FLNC
GO:0034703,cation channel complex,1/53,219/19659,0.4481731184125193,0.5274334675959422,0.4147225743937657,1,cc,NAC,781,CACNA2D1
GO:0035770,ribonucleoprotein granule,1/53,219/19659,0.4481731184125193,0.5274334675959422,0.4147225743937657,1,cc,NAC,3981,LIG4
GO:0044449,contractile fiber part,1/53,214/19659,0.4405900479753583,0.5274334675959422,0.4147225743937657,1,cc,NAC,2318,FLNC
GO:0051321,meiotic cell cycle,1/53,249/18493,0.5129985482626858,0.5297049708070632,0.3069292226047744,1,bp,NAC,7474,WNT5A
hsa05032,Morphine addiction,1/50,91/7852,0.4427221187263155,0.5319273217532597,0.30952292668218445,1,kg,NAC,55970,GNG12
GO:0000287,magnesium ion binding,1/52,208/17632,0.4609659778220435,0.532275631849763,0.34850582795501983,1,mf,NAC,51776,MAP3K20
GO:1901617,organic hydroxy compound biosynthetic process,1/53,251/18493,0.5158240570203183,0.532391322740589,0.3084857870246696,1,bp,NAC,7474,WNT5A
R-HSA-5693532,DNA Double-Strand Break Repair,1/45,166/10554,0.5107673268876758,0.5335017776393528,0.4275672141368019,1,re,NAC,3981,LIG4
GO:0003015,heart process,1/53,252/18493,0.5172307736620201,0.5336116181207304,0.3091928680094003,1,bp,NAC,781,CACNA2D1
GO:0009260,ribonucleotide biosynthetic process,1/53,253/18493,0.5186334801471862,0.5348267197701686,0.30989693956847897,1,bp,NAC,3479,IGF1
R-HSA-69481,G2/M Checkpoints,1/45,168/10554,0.5149969843416724,0.5363282203794931,0.42983242542375644,1,re,NAC,2810,SFN
hsa04912,GnRH signaling pathway,1/50,93/7852,0.4498799390375474,0.5365234828521862,0.31219738459525714,1,kg,NAC,3725,JUN
hsa00564,Glycerophospholipid metabolism,1/50,97/7852,0.4639263275247344,0.5374900330902376,0.31275981003616316,1,kg,NAC,5320,PLA2G2A
hsa04144,Endocytosis,2/50,244/7852,0.46342684168726056,0.5374900330902376,0.31275981003616316,2,kg,NAC,4088/3303,SMAD3/HSPA1A
hsa04640,Hematopoietic cell lineage,1/50,97/7852,0.4639263275247344,0.5374900330902376,0.31275981003616316,1,kg,NAC,3554,IL1R1
hsa04925,Aldosterone synthesis and secretion,1/50,98/7852,0.4673826374697718,0.5374900330902376,0.31275981003616316,1,kg,NAC,3164,NR4A1
hsa04972,Pancreatic secretion,1/50,98/7852,0.4673826374697718,0.5374900330902376,0.31275981003616316,1,kg,NAC,5320,PLA2G2A
GO:0043292,contractile fiber,1/53,229/19659,0.46303794027118605,0.5375125740210971,0.4226478070933167,1,cc,NAC,2318,FLNC
hsa04914,Progesterone-mediated oocyte maturation,1/50,99/7852,0.470817105889492,0.5375996741007675,0.3128236089896588,1,kg,NAC,3479,IGF1
GO:0006164,purine nucleotide biosynthetic process,1/53,258/18493,0.5255872515921884,0.5415279394654351,0.3137798560312755,1,bp,NAC,3479,IGF1
GO:0098813,nuclear chromosome segregation,1/53,258/18493,0.5255872515921884,0.5415279394654351,0.3137798560312755,1,bp,NAC,324,APC
GO:0007411,axon guidance,1/53,259/18493,0.5269661315299792,0.5422438168664173,0.3141946599434024,1,bp,NAC,7474,WNT5A
GO:0046390,ribose phosphate biosynthetic process,1/53,259/18493,0.5269661315299792,0.5422438168664173,0.3141946599434024,1,bp,NAC,3479,IGF1
GO:0071383,cellular response to steroid hormone stimulus,1/53,259/18493,0.5269661315299792,0.5422438168664173,0.3141946599434024,1,bp,NAC,3164,NR4A1
GO:0032409,regulation of transporter activity,1/53,260/18493,0.5283410791568799,0.5427192597127691,0.3144701478305586,1,bp,NAC,781,CACNA2D1
GO:0043270,positive regulation of ion transport,1/53,260/18493,0.5283410791568799,0.5427192597127691,0.3144701478305586,1,bp,NAC,781,CACNA2D1
GO:0097485,neuron projection guidance,1/53,260/18493,0.5283410791568799,0.5427192597127691,0.3144701478305586,1,bp,NAC,7474,WNT5A
GO:0110053,regulation of actin filament organization,1/53,260/18493,0.5283410791568799,0.5427192597127691,0.3144701478305586,1,bp,NAC,4088,SMAD3
GO:0046883,regulation of hormone secretion,1/53,261/18493,0.5297121054720606,0.5438926540641451,0.3151500527510806,1,bp,NAC,353500,BMP8A
GO:0008168,methyltransferase activity,1/52,216/17632,0.4737043820882837,0.5439792080024796,0.3561687083370555,1,mf,NAC,4255,MGMT
GO:1903522,regulation of blood circulation,1/53,262/18493,0.5310792214445252,0.545061022268054,0.3158270453494236,1,bp,NAC,781,CACNA2D1
GO:0005539,glycosaminoglycan binding,1/52,222/17632,0.4830639733346933,0.5516960132620268,0.36122126277543937,1,mf,NAC,7097,TLR2
GO:0007548,sex differentiation,1/53,268/18493,0.5392004105662285,0.5531572805550006,0.32051829500531004,1,bp,NAC,7474,WNT5A
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1/53,270/18493,0.5418766832768183,0.5556631103200836,0.32197025869106705,1,bp,NAC,9314,KLF4
GO:0072522,purine-containing compound biosynthetic process,1/53,271/18493,0.5432090948328917,0.5567893222037139,0.3226228244719852,1,bp,NAC,3479,IGF1
GO:0016741,"transferase activity, transferring one-carbon groups",1/52,228/17632,0.4922602595310004,0.5591434469672777,0.36609744701962277,1,mf,NAC,4255,MGMT
GO:0045017,glycerolipid biosynthetic process,1/53,273/18493,0.5458625217055968,0.5592680209461047,0.324059067512926,1,bp,NAC,5320,PLA2G2A
GO:0022618,ribonucleoprotein complex assembly,1/53,275/18493,0.5485008243964304,0.5614872838634144,0.32534498454128175,1,bp,NAC,23451,SF3B1
GO:0051258,protein polymerization,1/53,275/18493,0.5485008243964304,0.5614872838634144,0.32534498454128175,1,bp,NAC,3303,HSPA1A
R-HSA-72163,mRNA Splicing - Major Pathway,1/45,183/10554,0.5455996963480791,0.566522398567917,0.4540311089001249,1,re,NAC,23451,SF3B1
GO:0051188,cofactor biosynthetic process,1/53,279/18493,0.5537323949981596,0.5665988103724714,0.32830677826460325,1,bp,NAC,3479,IGF1
hsa04931,Insulin resistance,1/50,108/7852,0.5007664967024178,0.5677704645710512,0.3303796753633446,1,kg,NAC,9021,SOCS3
GO:0006310,DNA recombination,1/53,282/18493,0.557616997502258,0.570328266692632,0.3304677531320683,1,bp,NAC,3981,LIG4
GO:0008654,phospholipid biosynthetic process,1/53,284/18493,0.5601882811015022,0.5727118368269013,0.33184887539569463,1,bp,NAC,5320,PLA2G2A
GO:0008017,microtubule binding,1/52,240/17632,0.510174047559016,0.5763587888639694,0.37736913901947133,1,mf,NAC,324,APC
GO:0071826,ribonucleoprotein complex subunit organization,1/53,289/18493,0.5665525108611332,0.5789694331017511,0.3354747412377461,1,bp,NAC,23451,SF3B1
R-HSA-72172,mRNA Splicing,1/45,191/10554,0.5611406128861824,0.5809455756939301,0.46559035372599655,1,re,NAC,23451,SF3B1
GO:0072330,monocarboxylic acid biosynthetic process,1/53,293/18493,0.5715787605641734,0.583854936693129,0.3383055695326927,1,bp,NAC,3479,IGF1
hsa04724,Glutamatergic synapse,1/50,114/7852,0.5198031801030953,0.5840294164001275,0.3398405888173348,1,kg,NAC,55970,GNG12
hsa04726,Serotonergic synapse,1/50,115/7852,0.5229060285128713,0.5840294164001275,0.3398405888173348,1,kg,NAC,55970,GNG12
hsa04919,Thyroid hormone signaling pathway,1/50,116/7852,0.5259892259504254,0.5840294164001275,0.3398405888173348,1,kg,NAC,6772,STAT1
GO:1990778,protein localization to cell periphery,1/53,294/18493,0.5728263608768163,0.5848780962494929,0.33889842326173536,1,bp,NAC,1969,EPHA2
R-HSA-69275,G2/M Transition,1/45,194/10554,0.566833442167587,0.5851183919149285,0.46893459639115087,1,re,NAC,1026,CDKN1A
R-HSA-453274,Mitotic G2-G2/M phases,1/45,196/10554,0.5705884803485155,0.5872723540429166,0.47066085790520823,1,re,NAC,1026,CDKN1A
GO:0004252,serine-type endopeptidase activity,1/52,250/17632,0.5246274670199653,0.5895007559525416,0.38597380142951615,1,mf,NAC,3082,HGF
GO:0005088,Ras guanyl-nucleotide exchange factor activity,1/52,254/17632,0.5302909767276917,0.5926781504603613,0.38805419068167696,1,mf,NAC,3082,HGF
GO:0070588,calcium ion transmembrane transport,1/53,302/18493,0.5826796674575422,0.5946833687613885,0.34457993435822126,1,bp,NAC,781,CACNA2D1
GO:0042113,B cell activation,1/53,303/18493,0.5838955422101533,0.5956686398008342,0.34515083418144044,1,bp,NAC,3981,LIG4
GO:0046879,hormone secretion,1/53,306/18493,0.5875223503987017,0.5991115562813519,0.347145778040941,1,bp,NAC,353500,BMP8A
GO:0007204,positive regulation of cytosolic calcium ion concentration,1/53,309/18493,0.5911181383042636,0.6025199026521812,0.34912069079354846,1,bp,NAC,781,CACNA2D1
R-HSA-397014,Muscle contraction,1/45,206/10554,0.5888913982837964,0.6043433591717094,0.48434216584335565,1,re,NAC,781,CACNA2D1
GO:0007059,chromosome segregation,1/53,312/18493,0.59468316618553,0.605893988512935,0.35107575183189416,1,bp,NAC,324,APC
GO:0000151,ubiquitin ligase complex,1/53,275/19659,0.5265084817410557,0.6069472775626058,0.4772445302331207,1,cc,NAC,3303,HSPA1A
GO:1904062,regulation of cation transmembrane transport,1/53,314/18493,0.5970428900903899,0.6080376842119688,0.35231788262293273,1,bp,NAC,781,CACNA2D1
GO:0009615,response to virus,1/53,315/18493,0.5982176921600971,0.6089733184746193,0.35286002119573145,1,bp,NAC,6772,STAT1
GO:0009914,hormone transport,1/53,316/18493,0.5993891335901507,0.6093832234618974,0.35309753420017886,1,bp,NAC,353500,BMP8A
GO:0015849,organic acid transport,1/53,316/18493,0.5993891335901507,0.6093832234618974,0.35309753420017886,1,bp,NAC,5320,PLA2G2A
GO:0046942,carboxylic acid transport,1/53,316/18493,0.5993891335901507,0.6093832234618974,0.35309753420017886,1,bp,NAC,5320,PLA2G2A
hsa04114,Oocyte meiosis,1/50,125/7852,0.5528735850415885,0.6096756656965462,0.35476387216078864,1,kg,NAC,3479,IGF1
R-HSA-416476,G alpha (q) signalling events,1/45,210/10554,0.5959970067929874,0.6098574022998011,0.4887613152402712,1,re,NAC,55970,GNG12
GO:0032984,protein-containing complex disassembly,1/53,317/18493,0.6005572238096439,0.6100491577186388,0.35348339934208234,1,bp,NAC,324,APC
GO:0090150,establishment of protein localization to membrane,1/53,317/18493,0.6005572238096439,0.6100491577186388,0.35348339934208234,1,bp,NAC,2810,SFN
GO:0030135,coated vesicle,1/53,280/19659,0.532946976415406,0.6101324005859131,0.4797490023630515,1,cc,NAC,7474,WNT5A
GO:0008202,steroid metabolic process,1/53,318/18493,0.6017219722217304,0.6109713279006298,0.3540177363648907,1,bp,NAC,3953,LEPR
R-HSA-1483257,Phospholipid metabolism,1/45,212/10554,0.5995046372601529,0.6116684994654313,0.4902127926337787,1,re,NAC,5320,PLA2G2A
GO:0016042,lipid catabolic process,1/53,321/18493,0.605196260257493,0.6142367507009469,0.35590983430018125,1,bp,NAC,5320,PLA2G2A
GO:0008236,serine-type peptidase activity,1/52,273/17632,0.5563015673408669,0.6151694580647682,0.40278030495300865,1,mf,NAC,3082,HGF
GO:0016791,phosphatase activity,1/52,273/17632,0.5563015673408669,0.6151694580647682,0.40278030495300865,1,mf,NAC,1844,DUSP2
GO:0005096,GTPase activator activity,1/52,279/17632,0.5642179777022103,0.6173903525641987,0.4042344287753505,1,mf,NAC,3725,JUN
GO:0017171,serine hydrolase activity,1/52,277/17632,0.561594690113864,0.6173903525641987,0.4042344287753505,1,mf,NAC,3082,HGF
GO:0009101,glycoprotein biosynthetic process,1/53,326/18493,0.6109207743259333,0.6197822531344153,0.3591230885542693,1,bp,NAC,3479,IGF1
GO:0051260,protein homooligomerization,1/53,328/18493,0.6131877072228387,0.6218167879641409,0.3603019677947238,1,bp,NAC,324,APC
R-HSA-5689880,Ub-specific processing proteases,1/45,220/10554,0.6132397918860488,0.6220761001264818,0.498553812302324,1,re,NAC,4088,SMAD3
R-HSA-6798695,Neutrophil degranulation,2/45,479/10554,0.6123262489731539,0.6220761001264818,0.498553812302324,2,re,NAC,7097/3303,TLR2/HSPA1A
hsa04270,Vascular smooth muscle contraction,1/50,132/7852,0.5727451174060201,0.6235033018908026,0.3628100285601924,1,kg,NAC,5320,PLA2G2A
hsa05206,MicroRNAs in cancer,2/50,299/7852,0.5731583147816073,0.6235033018908026,0.3628100285601924,2,kg,NAC,1026/324,CDKN1A/APC
GO:0032956,regulation of actin cytoskeleton organization,1/53,331/18493,0.6165638287629926,0.6249739065636815,0.36213131056255105,1,bp,NAC,4088,SMAD3
GO:0030667,secretory granule membrane,1/53,295/19659,0.5517514238205915,0.6273338106453301,0.49327452454039905,1,cc,NAC,7097,TLR2
GO:0016324,apical plasma membrane,1/53,308/19659,0.5674462476206434,0.6279738473668455,0.49377778740322664,1,cc,NAC,8842,PROM1
GO:0034702,ion channel complex,1/53,301/19659,0.5590634146892606,0.6279738473668455,0.49377778740322664,1,cc,NAC,781,CACNA2D1
GO:0045121,membrane raft,1/53,304/19659,0.5626753965168692,0.6279738473668455,0.49377778740322664,1,cc,NAC,7097,TLR2
GO:0098857,membrane microdomain,1/53,305/19659,0.5638729270766523,0.6279738473668455,0.49377778740322664,1,cc,NAC,7097,TLR2
GO:0014069,postsynaptic density,1/53,316/19659,0.5768352624779067,0.6299648261271876,0.4953433001887842,1,cc,NAC,8516,ITGA8
GO:0098589,membrane region,1/53,316/19659,0.5768352624779067,0.6299648261271876,0.4953433001887842,1,cc,NAC,7097,TLR2
GO:0032279,asymmetric synapse,1/53,320/19659,0.5814544934614085,0.6308591236247961,0.4960464890898841,1,cc,NAC,8516,ITGA8
GO:1902495,transmembrane transporter complex,1/53,325/19659,0.5871590092364563,0.6329116593068295,0.49766040427423497,1,cc,NAC,781,CACNA2D1
hsa04120,Ubiquitin mediated proteolysis,1/50,137/7852,0.5864065199665992,0.6336338907021642,0.3687049118829201,1,kg,NAC,9021,SOCS3
GO:1990351,transporter complex,1/53,333/19659,0.5961279439964366,0.6384337980865064,0.502002479154894,1,cc,NAC,781,CACNA2D1
GO:0009165,nucleotide biosynthetic process,1/53,344/18493,0.630862655067049,0.6391953105025319,0.37037167962808837,1,bp,NAC,3479,IGF1
R-HSA-162906,HIV Infection,1/45,232/10554,0.6329830132349359,0.6402586800537283,0.5131259756411458,1,re,NAC,3981,LIG4
GO:0098984,neuron to neuron synapse,1/53,342/19659,0.6059895905250157,0.6407278473067044,0.5038062971847264,1,cc,NAC,8516,ITGA8
GO:0099572,postsynaptic specialization,1/53,340/19659,0.6038187383803579,0.6407278473067044,0.5038062971847264,1,cc,NAC,8516,ITGA8
GO:0006898,receptor-mediated endocytosis,1/53,346/18493,0.6330155285287309,0.6411034611760316,0.37147732755496676,1,bp,NAC,6424,SFRP4
GO:1901293,nucleoside phosphate biosynthetic process,1/53,347/18493,0.6340873407835378,0.6419155795586432,0.3719478967917596,1,bp,NAC,3479,IGF1
hsa04072,Phospholipase D signaling pathway,1/50,148/7852,0.614972290294401,0.6429255762168737,0.3741116461804627,1,kg,NAC,80310,PDGFD
hsa04261,Adrenergic signaling in cardiomyocytes,1/50,145/7852,0.6073792703700753,0.6429255762168737,0.3741116461804627,1,kg,NAC,781,CACNA2D1
hsa04514,Cell adhesion molecules (CAMs),1/50,146/7852,0.609926440018641,0.6429255762168737,0.3741116461804627,1,kg,NAC,8516,ITGA8
hsa04723,Retrograde endocannabinoid signaling,1/50,148/7852,0.614972290294401,0.6429255762168737,0.3741116461804627,1,kg,NAC,55970,GNG12
hsa05168,Herpes simplex virus 1 infection,3/50,492/7852,0.6145372901866669,0.6429255762168737,0.3741116461804627,3,kg,NAC,6772/9021/7097,STAT1/SOCS3/TLR2
GO:0006959,humoral immune response,1/53,349/18493,0.6362217596246846,0.6438022742074468,0.3730411123622452,1,bp,NAC,5320,PLA2G2A
GO:0003924,GTPase activity,1/52,301/17632,0.5920771952328457,0.6445006968940873,0.42198484309358525,1,mf,NAC,55970,GNG12
GO:0006732,coenzyme metabolic process,1/53,351/18493,0.6383439616746795,0.645400485060539,0.37396717052996586,1,bp,NAC,3479,IGF1
GO:0006936,muscle contraction,1/53,351/18493,0.6383439616746795,0.645400485060539,0.37396717052996586,1,bp,NAC,781,CACNA2D1
GO:0098978,glutamatergic synapse,1/53,350/19659,0.6145568947588729,0.6456736995567905,0.5076952361765505,1,cc,NAC,7474,WNT5A
hsa04145,Phagosome,1/50,152/7852,0.6248728385080937,0.6490614645148587,0.37768205519334697,1,kg,NAC,7097,TLR2
GO:0030695,GTPase regulator activity,1/52,309/17632,0.6017683879056899,0.6516559226543481,0.4266697050872086,1,mf,NAC,3725,JUN
GO:0006869,lipid transport,1/53,359/18493,0.6467119680756072,0.6535831109578384,0.3787084645406625,1,bp,NAC,5320,PLA2G2A
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/45,243/10554,0.6502130961100999,0.6558023204319632,0.5255831993892529,1,re,NAC,23451,SF3B1
GO:0032535,regulation of cellular component size,1/53,367/18493,0.654889925398258,0.6615667980446293,0.3833344865833384,1,bp,NAC,7474,WNT5A
GO:0005261,cation channel activity,1/52,320/17632,0.6147259614542074,0.6622563192986048,0.43361028208924024,1,mf,NAC,781,CACNA2D1
GO:0005085,guanyl-nucleotide exchange factor activity,1/52,327/17632,0.6227554333660782,0.6640606406811752,0.43479165594838975,1,mf,NAC,3082,HGF
GO:0015631,tubulin binding,1/52,325/17632,0.6204781982104253,0.6640606406811752,0.43479165594838975,1,mf,NAC,324,APC
GO:0033267,axon part,1/53,373/19659,0.6381826523971638,0.6662787440121333,0.5238970466550699,1,cc,NAC,79882,ZC3H14
GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1/53,374/18493,0.6618930700785891,0.6680737354188815,0.387104829207789,1,bp,NAC,23451,SF3B1
GO:0000398,"mRNA splicing, via spliceosome",1/53,374/18493,0.6618930700785891,0.6680737354188815,0.387104829207789,1,bp,NAC,23451,SF3B1
GO:0010959,regulation of metal ion transport,1/53,376/18493,0.6638682289615975,0.6692151964691304,0.3877662308787092,1,bp,NAC,781,CACNA2D1
GO:0032970,regulation of actin filament-based process,1/53,376/18493,0.6638682289615975,0.6692151964691304,0.3877662308787092,1,bp,NAC,4088,SMAD3
GO:0034470,ncRNA processing,1/53,376/18493,0.6638682289615975,0.6692151964691304,0.3877662308787092,1,bp,NAC,4088,SMAD3
hsa04217,Necroptosis,1/50,162/7852,0.6485455810784199,0.669332298420677,0.38947744072860585,1,kg,NAC,6772,STAT1
GO:0000375,"RNA splicing, via transesterification reactions",1/53,377/18493,0.6648515586444939,0.6699224603629688,0.388176043829457,1,bp,NAC,23451,SF3B1
GO:0030133,transport vesicle,1/53,381/19659,0.6460624820043528,0.6702898250795161,0.5270509721614456,1,cc,NAC,3479,IGF1
hsa04141,Protein processing in endoplasmic reticulum,1/50,165/7852,0.6553574019971604,0.6720544058696996,0.3910614064884163,1,kg,NAC,3303,HSPA1A
GO:0022839,ion gated channel activity,1/52,342/17632,0.6394127826555689,0.6783617846447406,0.4441552858414318,1,mf,NAC,781,CACNA2D1
hsa04530,Tight junction,1/50,170/7852,0.6664239953013086,0.6790776154652576,0.39514813845314106,1,kg,NAC,3725,JUN
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,1/53,389/18493,0.676433613752744,0.6813041649741742,0.39477099373697233,1,bp,NAC,3303,HSPA1A
GO:0022836,gated channel activity,1/52,351/17632,0.6490586467940853,0.6838895425837671,0.447774568299621,1,mf,NAC,781,CACNA2D1
GO:0060589,nucleoside-triphosphatase regulator activity,1/52,353/17632,0.6511675549003333,0.6838895425837671,0.447774568299621,1,mf,NAC,3725,JUN
GO:0010876,lipid localization,1/53,393/18493,0.6802063197972459,0.6848139832675066,0.3968047028007465,1,bp,NAC,5320,PLA2G2A
GO:0042623,"ATPase activity, coupled",1/52,357/17632,0.6553481506654762,0.6848388174454226,0.44839610308690486,1,mf,NAC,3303,HSPA1A
GO:0009100,glycoprotein metabolic process,1/53,394/18493,0.6811427322309886,0.6854665329010965,0.39718281243306425,1,bp,NAC,3479,IGF1
GO:0007015,actin filament organization,1/53,397/18493,0.6839358574714581,0.6879862390300877,0.3986428165598624,1,bp,NAC,4088,SMAD3
GO:0042578,phosphoric ester hydrolase activity,1/52,369/17632,0.6675972961265872,0.694168332788342,0.45450457447738335,1,mf,NAC,1844,DUSP2
hsa05034,Alcoholism,1/50,180/7852,0.6875225292149145,0.696170611343404,0.4050943733871394,1,kg,NAC,55970,GNG12
GO:0005874,microtubule,1/53,414/19659,0.6768247704006204,0.697844173208093,0.5487170417108658,1,cc,NAC,324,APC
GO:0046394,carboxylic acid biosynthetic process,1/53,412/18493,0.6975453645574425,0.7013796519736145,0.40640341925256146,1,bp,NAC,3479,IGF1
GO:0006816,calcium ion transport,1/53,413/18493,0.698431935857617,0.7016777116474073,0.40657612524742437,1,bp,NAC,781,CACNA2D1
GO:0016053,organic acid biosynthetic process,1/53,413/18493,0.698431935857617,0.7016777116474073,0.40657612524742437,1,bp,NAC,3479,IGF1
GO:0097060,synaptic membrane,1/53,431/19659,0.6916322032912521,0.7087095416441226,0.5572605146726137,1,cc,NAC,8516,ITGA8
GO:0060249,anatomical structure homeostasis,1/53,425/18493,0.7088739444123646,0.7118674999208628,0.41248043796043093,1,bp,NAC,8842,PROM1
GO:0044441,ciliary part,1/53,441/19659,0.700029325845077,0.712913301167379,0.560565943847527,1,cc,NAC,8842,PROM1
GO:0019932,second-messenger-mediated signaling,1/53,439/18493,0.7206084790613485,0.7233461220801548,0.41913154521841567,1,bp,NAC,3479,IGF1
GO:0015629,actin cytoskeleton,1/53,483/19659,0.7329137291885901,0.7329137291885901,0.5762923425452452,1,cc,NAC,55970,GNG12
GO:0043025,neuronal cell body,1/53,483/19659,0.7329137291885901,0.7329137291885901,0.5762923425452452,1,cc,NAC,8516,ITGA8
GO:0099568,cytoplasmic region,1/53,479/19659,0.7299408349027294,0.7329137291885901,0.5762923425452452,1,cc,NAC,79882,ZC3H14
GO:0010498,proteasomal protein catabolic process,1/53,452/18493,0.7310885997840189,0.733556409403543,0.4250477357838245,1,bp,NAC,3303,HSPA1A
GO:0023061,signal release,1/53,453/18493,0.7318785950288191,0.7340393500542101,0.4253275681558855,1,bp,NAC,353500,BMP8A
GO:0034765,regulation of ion transmembrane transport,1/53,454/18493,0.732666313125464,0.7345196005954273,0.425605841786293,1,bp,NAC,781,CACNA2D1
GO:0070838,divalent metal ion transport,1/53,459/18493,0.7365709710917534,0.7381229537531351,0.42769374815760886,1,bp,NAC,781,CACNA2D1
GO:0015711,organic anion transport,1/53,460/18493,0.7373451608739501,0.7385875284575625,0.4279629386706872,1,bp,NAC,5320,PLA2G2A
GO:0072511,divalent inorganic cation transport,1/53,462/18493,0.7388868493861349,0.7398201801432542,0.42867717932252664,1,bp,NAC,781,CACNA2D1
GO:0003779,actin binding,1/52,421/17632,0.7159237475406559,0.7407329863168173,0.4849926377294699,1,mf,NAC,2318,FLNC
GO:0005216,ion channel activity,1/52,427/17632,0.72103546109142,0.7423468540300827,0.486049312636166,1,mf,NAC,781,CACNA2D1
GO:0016887,ATPase activity,1/52,445/17632,0.735835364742371,0.7465514137434734,0.48880223513800836,1,mf,NAC,3303,HSPA1A
GO:0022838,substrate-specific channel activity,1/52,442/17632,0.7334233407532562,0.7465514137434734,0.48880223513800836,1,mf,NAC,781,CACNA2D1
GO:0046873,metal ion transmembrane transporter activity,1/52,444/17632,0.7350337447007396,0.7465514137434734,0.48880223513800836,1,mf,NAC,781,CACNA2D1
R-HSA-195258,RHO GTPase Effectors,1/45,316/10554,0.7461070810909869,0.7503705501257926,0.6013735270146902,1,re,NAC,2810,SFN
GO:0003729,mRNA binding,1/52,463/17632,0.7498643987974384,0.7536299056433216,0.49343685587324004,1,mf,NAC,23451,SF3B1
GO:0015267,channel activity,1/52,467/17632,0.7528812791659916,0.7536299056433216,0.49343685587324004,1,mf,NAC,781,CACNA2D1
GO:0022803,passive transmembrane transporter activity,1/52,468/17632,0.7536299056433216,0.7536299056433216,0.49343685587324004,1,mf,NAC,781,CACNA2D1
GO:0022613,ribonucleoprotein complex biogenesis,1/53,485/18493,0.7559905153285978,0.7566268709812314,0.4384155522617113,1,bp,NAC,23451,SF3B1
GO:0051656,establishment of organelle localization,1/53,491/18493,0.7602684438435131,0.7605882875304477,0.44071093283934143,1,bp,NAC,10252,SPRY1
GO:0090066,regulation of anatomical structure size,1/53,497/18493,0.7644727632251345,0.7644727632251345,0.44296173124770977,1,bp,NAC,7474,WNT5A
hsa04714,Thermogenesis,1/50,231/7852,0.7763746589960565,0.7812270006147819,0.45458779375427,1,kg,NAC,353500,BMP8A
R-HSA-418594,G alpha (i) signalling events,1/45,396/10554,0.8217589913328548,0.8241001850403559,0.6604630669581799,1,re,NAC,55970,GNG12
R-HSA-194315,Signaling by Rho GTPases,1/45,444/10554,0.8560410387873753,0.8560410387873753,0.6860615980712218,1,re,NAC,2810,SFN
hsa04080,Neuroactive ligand-receptor interaction,1/50,338/7852,0.8899768600690057,0.8899768600690057,0.5178681957903989,1,kg,NAC,3953,LEPR
